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The chest radiograph remains one of the most commonly 
performed examinations in radiology. It is typically the first 
radiologic examination obtained in patients presenting with 
chest pain, shortness of breath, or cough. In the hospital 
setting, chest radiographs are performed in the emergency 
room, critical care unit, and following the placement of 
monitoring and support devices. Chest radiographs are rou-
tinely obtained prior to major surgical procedures, as part 
of annual physical examinations, and to screen for meta-
static disease in patients with malignancy or paraneoplastic 
syndromes.
The accurate interpretation of chest radiographs requires 
an understanding of the normal frontal and lateral chest 
radiographic appearances, as obscuration of normally visual-
ized structures may be the only clue to the presence of an 
abnormality.
Radiography allows visualization and assessment of the 
chest wall, mediastinum, and hila including the heart and 
great vessels, central airways, the lungs including the pulmo-
nary vasculature, the pleural surfaces including the fissures 
and the diaphragm.
The superimposition of complex structures of various 
radiographic density (gas, water, calcium, metal, and fat) 
makes radiographic interpretation challenging. An under-
standing of normal interfaces allows for detection of condi-
tions that manifest with chest symptoms or as asymptomatic 
abnormalities.
1.2  A Systematic Assessment
We present a systematic approach to the analysis of chest 
radiographs (Table 1.1). This should begin with an assess-
ment of technical aspects of the radiographic study includ-
ing patient positioning, mediastinal penetration, sharpness 
of structures (to detect motion), lung volumes, and pres-
ence of artifacts [1] to allow for accurate detection of 
abnormalities. The orderly assessment of each anatomic 
region and structure will yield a comprehensive imaging 
evaluation, will allow identification of subtle abnor-
malities, and will minimize interpretive errors. The fol-
lowing must be evaluated in each chest radiograph: 
support and monitoring devices (if present), chest wall, 
heart and mediastinum, hila, lungs, airways, pleura, and 
diaphragm.
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Learning Objectives
• List the nine components of a chest radiographic 
examination to be systematically analyzed.
• Identify key technical quality aspects to be assessed 
prior to interpretation of a chest radiograph.
• Identify the normal anatomic structures and inter-
faces routinely displayed on chest radiographic 
examinations.
• Detail the different patterns of lung disease seen 
radiographically.
• Describe the different appearances of pleural dis-
ease seen on chest radiography.
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1.3  Technical Quality (Table 1.2)
The initial evaluation of any chest radiograph should include a 
determination of the technical adequacy of the examination to 
confirm that it is of adequate quality for interpretation. This 
step is often overlooked, which can lead to both overdiagno-
sis (as low lung volume may simulate lung disease) and under-
diagnosis (motion or rotation may limit proper evaluation of 
the lungs, mediastinum, and hila). There are five main factors 
to be assessed.
On a properly positioned frontal chest radiograph, the 
spinous processes should align with an imaginary vertical 
line drawn midway between the clavicular heads. The dor-
sal wrists should be placed on the waist with elbows ori-
ented anteriorly to rotate the scapulae laterally so that they 
are not superimposed on the upper lungs. Radiographic 
penetration should allow faint visualization of the verte-
bral bodies and disc spaces through the mediastinum, with 
the lungs gray in density and the pulmonary vessels easily 
seen. Motion is detected by noting the sharpness of the 
superior cortices of the ribs, vessel margins, and diaphrag-
matic contours. Proper inspiration is assessed by noting 
the position of the top of the right hemidiaphragm with 
respect to the ribs; this point should correspond to the sixth 
anterior rib or tenth posterior rib at the mid-clavicular line. 
Artifacts including faulty detectors or visible grid lines 
can be seen in the digital radiography systems used for 
obtaining virtually all conventional chest radiographs in a 
modern radiology department [1].
1.4  Support/Monitoring Devices (Tubes/
Lines/Catheters/Pacemakers) 
(Table 1.3) [2]
Chest radiographs, particularly those obtained in a critical 
care setting, can demonstrate a broad array of different tubes, 
vascular catheters, cardiac pacemakers/defibrillators, and 
other monitoring or therapeutic devices. While in the hospi-
tal setting, chest radiographs are typically obtained to con-
firm proper positioning and to exclude complications 
following placement of a tube or line; the recognition of one 
or more of these devices can provide important clues to 
underlying disease entities.
1.5  Chest Wall
The symmetry of normal chest wall structures such as the 
breast shadows in females and the spine, ribs, and shoulders 
should be analyzed to detect chest wall abnormalities. Poland 
syndrome is a congenital anomaly in which there is unilateral 
underdevelopment of the musculature of the chest wall. 
Nonsurgical absence of a portion of a rib or vertebral body 
may be instrumental in making the diagnosis of malignancy. 
Congenital deformities such as pectus excavatum can mimic 
middle lobe disease, as this chest wall deformity creates a 
vague opacity overlying the region of the middle lobe on 
frontal radiography (Fig. 1.1). Rib destruction adjacent to a 
peripheral lung mass is virtually diagnostic of chest wall 
involvement by lung cancer. Benign pressure erosion of a rib 
is characteristic of neurogenic neoplasms or chest wall vascu-
lar abnormalities such as dilated intercostal arteries in a 
patient with coarctation of the aorta. In patients with anasarca 
Table 1.1 Systematic analysis of chest radiographs
Component 
evaluated Assessment




ET/NG tube, vascular catheters, pacemaker
Chest wall Absence of normal contour, swelling, mass, 
calcification, air, osseous abnormality
Mediastinum Cardiomegaly, mass, widening, position, 
calcification, air
Hila Height (right vs left), size, density, contour
Lungs Atelectasis
Air space opacities Interstitial lung disease
Focal opacities (solitary pulmonary nodules/
masses
Abnormal lucency-localized/unilateral/diffuse
Airways Tracheal diameter, course, nodule/mass
Bronchiectasis
Pleura/diaphragm Costal/diaphragmatic/fissural pleural surfaces 
Diaphragmatic contour/position
Table 1.2 Evaluating the technical adequacy of chest radiographs
Technical parameter Assessment
Positioning Rotation, kyphosis/lordosis
Penetration Visualization of vertebral interspaces
Motion Sharpness of hemidiaphragms, ribs, vessels
Lung volumes Position of diaphragm relative to ribs
Artifacts Detector drops, grid lines
Key Point
• Evaluation of proper chest radiographic technique 
involves analysis of patient positioning, proper 
mediastinal penetration, absence of motion, ade-
quate lung volumes, and the detection of artifacts.
J. S. Klein and M. L. Rosado-de-Christenson
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due to fluid administration, there may be marked swelling of 
the soft tissues lateral to the ribs. Larger chest wall masses 
may produce an “incomplete border sign” radiographically, 
as the mass creates a visible interface with atmospheric air (or 
if intrathoracic with the adjacent lung). Soft tissue calcifica-
tion may indicate prior trauma (myositis ossificans), collagen 
vascular disease (dermatomyositis), or the presence of a vas-
cular lesion (hemangioma) or a bone- forming malignancy 
(osteosarcoma or chondrosarcoma) [3]. Gas within the chest 
wall could indicate an air leak in the setting of trauma, pneu-
momediastinum, or pneumothorax (Table 1.4).
1.6  Mediastinum
The mediastinum is the space between the mediastinal 
pleural reflections bound anteriorly by the sternum and 
posteriorly by the thoracic vertebrae. It courses from the 
thoracic inlet superiorly to the diaphragm inferiorly. It 
contains the heart, pericardium, central great vessels, 
esophagus, trachea, carina and proximal main stem bron-
chi, the thoracic duct, lymph nodes, and mediastinal fat. 
The radiologist must be familiar with the normal mediasti-
nal structures, their contours, and the normal mediastinal 




Fig. 1.1 (a, b) Pectus excavatum chest wall deformity mimicking mid-
dle lobe disease. (a) Frontal chest radiograph of a 25-year-old female 
demonstrates a vague opacity overlying the medial right lower lung 
(arrow). (b) Lateral radiography shows the characteristic posterior 
deformity of the lower sternum (arrow) representing pectus excavatum
Table 1.4 Chest wall abnormalities
Finding Condition
Absence S/P mastectomy, Poland syndrome
Shape Pectus excavatum, carinatum
Bone 
destruction
Peripheral lung cancer, metastasis, infection
Swelling Anasarca, localized edema
Mass Breast cancer
Calcification Dermatomyositis, sarcoma, tumoral calcinosis
Gas Air leak from chest, S/P laparoscopy, S/P drainage 
of pneumothorax
Key Point
• Chest wall masses typically demonstrate an incom-
plete border sign as only a portion of the circumfer-
ence of the mass is typically outlined by atmospheric 
air or intrapulmonary gas.
1 A Systematic Approach to Chest Radiographic Analysis
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1.6.1  Heart
The right cardiac border is formed by the right atrium. From 
inferior to superior, the left cardiac border is formed by the 
left ventricle and a small portion of the left atrial appendage. 
The right ventricle projects anteriorly and inferiorly on the 
lateral chest radiograph, with the posterior cardiac border 
formed by the left ventricle inferiorly and the left atrium 
superiorly.
The heart must be assessed for its shape, size, and loca-
tion. Abnormal cardiac shift may reflect ipsilateral loss of 
volume (e.g., lobar atelectasis) or contralateral increased 
volume (e.g., a large pneumothorax). The normal pericar-
dium is not visible radiographically. Enlargement of the car-
diac silhouette may result from cardiac enlargement and/or 
pericardial effusion. When large, the latter may manifest 
with a “water bottle heart” on frontal chest radiographs or 
with the “epicardial fat pad sign” on lateral radiography. The 
“epicardial fat pad sign” results from visualization of peri-
cardial effusion as a curvilinear band of soft tissue >2 mm 
thick outlined by mediastinal fat anteriorly and subepicardial 
fat posteriorly. Constrictive pericarditis may manifest with 
linear pericardial calcification. Cardiac calcifications may 
correspond to coronary artery, valvular or annular calcifica-
tions, or curvilinear calcification in a left ventricular aneu-
rysm from prior myocardial infarction.
1.6.2  Systemic Arteries
The normal aortic arch is readily visible on radiography and 
characteristically produces an indentation on the left tracheal 
wall. With increasing aortic atherosclerosis and tortuosity, a 
larger portion of the aorta is visible and may exhibit intimal 
atherosclerotic calcification. The left para-aortic interface 
projects through the left heart and courses vertically toward 
the abdomen. The left subclavian artery is seen as a concave 
left supra-aortic mediastinal interface on frontal chest radi-
ography. A right aortic arch is usually associated with a right 
descending thoracic aorta. In the absence of associated con-
genital heart disease, right aortic arch is usually associated 
with non-mirror image branching characterized by an aber-
rant left subclavian artery which may be seen as an indenta-
tion on the posterior trachea on lateral chest radiography.
1.6.3  Systemic Veins
The azygos arch is visible at the right tracheobronchial angle 
and normally measures <1 cm in the upright position. The 
azygos arch may be contained within an accessory azygos 
fissure, an anatomic variant. Enlargement of the azygos arch 
may occur in azygos continuation of the inferior vena cava, 
in which the vertical portion of the azygos vein manifests as 
a right-sided vertical mediastinal interface.
The right lateral margin of the superior vena cava is nor-
mally visible as it interfaces with the medial right upper lobe. 
The inferior vena cava may be visible as it creates a concave 
interface with the right lower lobe in the right cardiophrenic 
angle prior to its entry into the right atrium. The posterior 
margin of the inferior vena cava is most evident on lateral 
radiography as its posterior concave margin is outlined by 
lung.
1.6.4  Pulmonary Arteries
Enlargement of the central pulmonary arteries may represent 
pulmonary hypertension and is typically associated with 
enlargement of the pulmonary trunk. The pulmonary trunk is 
visible as a left mediastinal interface located above the heart 
and below the aorta on frontal chest radiography.
1.6.5  Lines, Stripes, and Interfaces [5]
The anterior and posterior junction lines represent the 
interface between the right and left upper lobes anterior to 
the great vessels (anterior junction line) (Fig. 1.2) and pos-
terior to the esophagus, superior to the aortic arch, and 
anterior to the upper thoracic spine (posterior junction 
line). These lines may be thickened by fat, lymphadenopa-
thy, or mediastinal masses. The paravertebral stripes may 
be thickened by lymphadenopathy fat or may be displaced 
laterally by a paravertebral hematoma or infection. An 
abnormal convex contour of the upper azygoesophageal 
recess may result from subcarinal lymphadenopathy or a 
bronchogenic cyst, while a hiatus hernia often produces 
convexity of the lower 1/3rd of the azygoesophageal 
recess. Convexity of the aortopulmonary reflection nor-
mally a flat or concave interface below the aortic arch and 
above the main pulmonary artery may be caused by lymph-
adenopathy in the aortopulmonary window, mediastinal 
mass, or anomalous vasculature.
1.6.6  Mediastinal Masses (Table 1.5) [6]
Mediastinal masses include primary and secondary neo-
plasms, mediastinal cysts, vascular lesions, glandular 
enlargement (thyroid and thymus), and hernias (hiatus and 
Morgagni). As 10% of mediastinal masses are vascular in 
etiology, a vascular lesion should always be considered in a 
patient with a mediastinal contour abnormality.
J. S. Klein and M. L. Rosado-de-Christenson
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The first step in the assessment of a mediastinal mass is 
determining that there is indeed a mediastinal abnormality. 
Focal unilateral mediastinal masses are typically primary 
neoplasms, enlarged lymph nodes, cysts, and vascular 
aneurysms or anomalous vessels. While diffuse symmetric 
mediastinal widening without mass effect can be seen in 
mediastinal lipomatosis, when lobulated or asymmetric, it 
should suggest lymphadenopathy in advanced lung cancer, 
metastatic disease, or lymphoma (Fig. 1.3) or in patients 
with chest trauma mediastinal hematoma associated with 
vascular injury. Mediastinal masses should then be local-
ized within a mediastinal compartment based on the lateral 
chest radiograph. For the purposes of localizing masses 
and providing a concise differential diagnosis, the medias-
tinum is divided radiographically into the anterior, middle, 
and posterior compartments [6]. The middle mediastinum 
encompasses the heart, pericardium, aorta and great 
vessels, systemic and pulmonary veins, trachea, carina, 
and esophagus. Ancillary findings should be noted such as 
benign pressure erosion in patients with paravertebral 
masses (typical of neurogenic tumors). The cervicotho-
racic sign or obscuration of an abnormal mediastinal con-
tour as it extends above the clavicle into the neck allows 
lesion localization in both the thorax and the neck, for 
which the most frequent etiology is intrathoracic goiter. 
Clinical factors such as age, gender, and presence or 
absence of symptoms allow the radiologist to provide a 
focused differential diagnosis prior to proceeding to cross-
sectional imaging. Mediastinal widening in the  setting of 
trauma may represent hemorrhage from traumatic vascular 
injury.
1.6.7  Mediastinal Calcification
The most common cause of mediastinal/hilar calcifica-
tions is calcified lymph nodes from prior granulomatous 
disease such as tuberculosis, histoplasmosis, and sarcoid-
osis. Patients with treated mediastinal lymphoma may 
a b
Fig. 1.2 Anterior junction line on frontal chest radiograph with CT 
correlation (a,b). (a) Frontal chest radiograph shows an obliquely ori-
ented linear opacity (arrows) overlying the upper mediastinum. (b) 
Coronal multi-detector CT scan at lung windows through the anterior 
chest shows that the anterior junction line represents the right and left 
upper lobes (and corresponding pleural layers) that contact one another 
anterior to the mediastinum
Table 1.5 Differential diagnosis of mediastinal masses
Anterior Middle Posterior









Foregut/pericardial cyst Descending aortic 
aneurysm
Thyroid goiter Hiatus hernia Paravertebral
hematoma/abscess
Key Point
• The most common anterior mediastinal masses in 
adults are lymphoma and thymic neoplasms.
1 A Systematic Approach to Chest Radiographic Analysis
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demonstrate mass-like calcification, while specific 
mediastinal neoplasms such as thymoma and mature tera-
tomas may contain de novo calcification evident 
radiographically.
1.6.8  Pneumomediastinum
While gas may normally be evident radiographically 
within the trachea, central bronchi, and esophagus, medi-
astinal gas located outside of these structures is abnormal 
and usually reflects air leak from the lung or disruption of 
the central airways or esophagus. Pneumomediastinum is 
seen as linear and curvilinear lucencies outlining medias-
tinal structures such as the heart, trachea, and central dia-
phragm. The most common cause of pneumomediastinum 
is alveolar rupture in patients with airway obstruction due 
to asthma or intubated patients receiving mechanical ven-
tilation. Blunt chest trauma can also lead to alveolar 
rupture and pneumomediastinum. The combination of 
pneumomediastinum with left lower lobe lung consolida-
tion and a left pleural effusion or pneumothorax in a 
patient who has had prolonged vomiting or retching 
should prompt consideration of esophageal rupture or 
Boerhaave syndrome, which is a surgical emergency asso-
ciated with high mortality.
1.7  Hila
On normal frontal chest radiographs, the right hilum is lower 
than the left in 97% of cases, and the hila are at the same 
level in 3% of cases [7]. Alterations of this relationship 
should suggest volume loss on the affected side due to atel-
ectasis, scarring, or prior lung resection. The right hilum is 
anterior to the left on lateral chest radiography. The interme-
diate stem line, visible on the lateral chest radiograph, repre-




Fig. 1.3 Anterior mediastinal 
mass due to Hodgkin 
lymphoma (a-c). (a,b) Frontal 
(a) and lateral (b) chest 
radiographs of a 37-year-old 
man with cough and weight 
loss show a large lobulated 
mass mediastinum. (c) 
Coronal contrast-enhanced 
CT through the anterior chest 
shows a large, locally invasive 
soft tissue mass subsequently 
proven to reflect nodular 
sclerosing Hodgkin 
lymphoma




bFig. 1.4 (a–c) Sarcoidosis manifesting as bilateral hilar 
and mediastinal lymph node 
enlargement. (a) Frontal chest 
radiograph of a 71-year-old 
woman with nonproductive 
cough shows bilateral hilar 
(arrows) and right 
paratracheal (arrowheads) 
lymph node enlargement. (b) 
Lateral radiograph confirms 
enlargement and increased 
density of the bilateral hila as 
well as soft tissue in the 
inferior hilar window (the 
so-called doughnut sign) 
consistent with bilateral hilar 
and mediastinal 
lymphadenopathy (arrows). 
(c) Contrast-enhanced coronal 
MIP at mediastinal windows 
at the level of the carina 
confirms enlarged hilar (H), 
bilateral paratracheal (P), and 
subcarinal (S) lymph nodes
Table 1.6 Causes of hilar enlargement
Unilateral Bilateral
Lung cancer Sarcoidosis
Infection (granulomatous) Metastatic lymph node 
enlargement




Valvular pulmonic stenosis (left) Infection (granulomatous)
should be assessed for abnormal thickening which may be 
seen in interstitial edema and central malignancies.
Hilar disease may manifest radiographically as increase 
(Table  1.6) or decrease in size, an increase in density, or 
abnormal convexity of the hilum or hila. Hilar enlargement 
most often results from a central neoplasm, lymph node 
enlargement (Fig. 1.4), or enlarged central pulmonary arter-
ies as in pulmonary hypertension. The hilar convergence 
sign refers to enlarged vessels coursing toward the enlarged 
hilum and signifies a vascular etiology.
1.8  Lungs
1.8.1  Lung Volumes
Lung volume may be increased in obstructive diseases such 
as emphysema and is reduced in restrictive diseases such as 
pulmonary fibrosis and in patients with pleural fibrosis 
(“trapped lung”), neuromuscular disease (myasthenia gravis, 
amyotrophic lateral sclerosis, diaphragmatic dysfunction in 
systemic lupus erythematosus), or extrathoracic disorders 
(obesity, ascites).
Atelectasis may involve the entire lung, a lobe (Fig. 1.5), 
and a pulmonary segment [8] or may be subsegmental. 
Obstructive (resorption) atelectasis is characterized by 
absence of intrinsic air bronchograms. It may result from 
endoluminal obstruction, most often from a mucus plug as 
seen in asthma, bronchitis, or mechanically ventilated 
patients, although a centrally obstructing neoplasm such as 
lung cancer must be excluded.
1 A Systematic Approach to Chest Radiographic Analysis
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Relaxation (passive) atelectasis often results from mass 
effect upon the lung, most commonly pleural effusion. 
Cicatricial atelectasis is due to pulmonary fibrosis. Rounded 
atelectasis occurs adjacent to pleural thickening in which the 
subpleural lung, most commonly in the lower posterior part 
of the chest, “folds” upon itself.
Direct signs of lobar atelectasis include fissural displace-
ment (Fig.  1.5), bronchovascular crowding, and shift of a 
preexisting lung nodule or calcified granuloma. Indirect 
signs include increased pulmonary density, ipsilateral medi-
astinal shift, hilar displacement, ipsilateral hemidiaphragm 
elevation, and compensatory hyperinflation of the adjacent 
lung.
1.8.2  Parenchymal Opacities
Parenchymal opacities include air space and interstitial pro-
cesses. Pneumonia typically manifests with air space opaci-
fication due to alveolar filling by purulent material and may 
be lobar or sublobar (Fig. 1.6) or may manifest with patchy 
pulmonary opacities. Air space opacification often exhibits 
intrinsic air bronchograms and may also result from alveolar 
edema or hemorrhage (Table 1.7).
Interstitial opacities may manifest with reticular, linear, 
and/or small nodular opacities. As the normal interstitium is 
a b
Fig. 1.5 Middle lobe atelectasis (a,b). (a) Frontal radiograph shows a vague opacity (arrow) overlying the lower medial right lung partly obscur-
ing the right heart border. (b) The lateral radiograph shows an atelectatic middle lobe outlined by displaced minor (m) and major (M) fissures
Fig. 1.6 Subsegmental right upper lobe pneumonia as air space opaci-
fication. Frontal chest radiograph of a 17-year-old with cough and fever 
shows a focal area of subsegmental right upper lobe air space opacifica-
tion (arrow) reflecting pneumonia
Key Point
• The most concerning cause of obstructive (resorp-
tive) atelectasis in an adult is an endobronchial neo-
plasm such as lung cancer or a carcinoid tumor.
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not visible radiographically, visualization of peripheral sub-
pleural reticular opacities is always abnormal. A reticulo-
nodular pattern occurs when abnormal reticular opacities are 
superimposed on micronodular opacities. Interstitial opaci-
ties frequently result from interstitial edema characterized by 
perihilar haze, peribronchial thickening, septal thickening 
(Kerley B lines), and subpleural edema often associated with 
cardiomegaly and pleural effusion. Associated radiographic 
findings can help limit the differential diagnosis of intersti-
tial disease (Table 1.8).
Cells and fibrosis may also infiltrate the pulmonary inter-
stitium, producing reticular and reticulonodular interstitial 
opacities in diseases such as sarcoidosis, silicosis, and lym-
phangitic carcinomatosis.
The idiopathic interstitial pneumonias are a distinct group 
of disorders often characterized by basilar predominant pul-
monary fibrosis associated with volume loss [9]. The diagno-
sis usually requires further imaging with high-resolution 
chest CT (HRCT) (Fig. 1.7).
a
b
Fig. 1.7 Usual interstitial pneumonia (UIP)/idiopathic pulmonary fibro-
sis (IPF) as coarse basilar reticular ILD (a,b). (a) Frontal chest radiograph 
of an 84-year-old man with progressive shortness of breath demonstrates 
basal predominant coarse reticular opacities. (b) Coronal CT through the 
posterior chest at lung windows shows lower lobe subpleural reticulation 
with honeycombing (arrows) diagnostic of a UIP pattern
Table 1.7 Differential diagnosis of air space opacification (ASO)
Finding(s) Disease
Focal/segmental Pneumonia, contusion, infarct, lung 
cancer (adenocarcinoma)
Lobar Pneumonia, endogenous lipoid 
pneumonia, adenocarcinoma
Patchy Pneumonia, aspiration, organizing 
pneumonia, contusions adenocarcinoma, 
metastases
Diffuse Edema, hemorrhage, pneumonia
Perihilar Edema, hemorrhage
Peripheral Eosinophilic pneumonia, organizing 




Edema, eosinophilic pneumonia, 
hemorrhage
Table 1.8 Ancillary findings in patients with ILD and differential 
considerations
Finding(s) Disease






Rheumatoid arthritis associated UIP
Pleural effusions Infection, edema
Pleural plaques Asbestosis
Hyperinflation Langerhans cell histiocytosis, stage IV 
sarcoidosis, lymphangioleiomyomatosis, 
emphysema with UIP
Esophageal dilatation Scleroderma associated UIP, recurrent 
aspiration
Conglomerate masses Silicosis/coal worker’s pneumoconiosis, 
sarcoidosis, talcosis
Basilar sparing Langerhans cell histiocytosis, sarcoidosis
Basilar predominance UIP, fibrotic NSIP, aspiration
Key Point
• Chronic, basal predominant ILD is most often due to 
usual interstitial pneumonia (UIP) or fibrotic nonspe-
cific interstitial pneumonia (NSIP). Both conditions 
produce basilar reticular interstitial opacities with 
fibrosis and can be difficult to distinguish clinically 
and on imaging; biopsy is often necessary for defini-
tive diagnosis in patients lacking CT findings of UIP.
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A solitary pulmonary nodule (SPN) is defined as a round 
or ovoid opacity <3  cm in diameter. A benign pattern of 
intrinsic calcification in a smooth or slightly lobulated SPN 
reflects a granuloma or hamartoma and precludes further 
imaging evaluation [10].
However, the presence of calcification can be difficult to 
discern on standard high-kVp chest radiographs. CT pro-
vides superior contrast resolution, and thin-section scans can 
detect calcification that is not evident radiographically. The 
majority of SPNs are indeterminate on radiography and 
require further assessment and characterization with thin- 
section computed tomography (CT) to exclude malignancy 
(Fig. 1.8)(Table 1.9).
A pulmonary mass is a round or ovoid pulmonary opac-
ity ≥3 cm in diameter and is highly suspicious for malig-
nancy, typically lung cancer. The radiologist should look for 
pertinent ancillary findings of malignancy including other 
lung nodules, local invasion of adjacent structures, lymph-
adenopathy, and pleural effusion.
Abnormal lucency can be difficult to detect radiographi-
cally as the lungs are predominantly air filled. The most com-
mon localized lucent lesion is a bulla, seen as a focal lucency 
>1 cm diameter demarcated from adjacent lung by a uniform, 
thin (<1 mm) wall [11]. Unilateral lucency can relate to tech-
nical issues, chest wall defects, or parenchymal abnormalities 
as seen in the Swyer-James or unilateral hyperlucent lung syn-
drome, which is a post-infectious obliterative bronchiolitis 
Key Point
• While chest radiography can detect a solitary pul-
monary nodule (SPN), thin-section CT will almost 





Fig. 1.8 Solitary pulmonary 
nodule with spiculation (a–c). 
(a) Frontal chest radiograph 
of a 43-year-old 
asymptomatic smoker shows 
a right upper lobe nodule 
(arrow) (b,c). Frontal digital 
tomographic image through 
the nodule (b) shows a 
spiculated margin, confirmed 
on coronal CT at lung 
windows through the nodule 
(c). Diagnosis was lung 
adenocarcinoma
Table 1.9 Common causes of a solitary pulmonary nodule
Granuloma
Hamartoma
Malignancy: lung cancer, carcinoid tumor, metastasis
Focal organizing pneumonia
J. S. Klein and M. L. Rosado-de-Christenson
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that results in air trapping and decreased lung vascularity. 
Bilateral hyperlucency is most often seen in severe emphy-
sema or in patients with acute asthma exacerbation.
1.9  Airways
The trachea and bronchi should be assessed for size, patency, 
and course. Tracheal narrowing may be focal or diffuse 
(Table 1.10) [12]. Focal tracheal narrowing or stenosis most 
often occurs secondary to mucosal or cartilaginous damage 
from prolonged intubation. More diffuse tracheal narrowing 
is most common in patients with COPD in which there is 
narrowing of the transverse diameter of the tracheal lumen, 
the so- called saber-sheath trachea. Primary or metastatic air-
way neoplasms may manifest as endoluminal soft tissue nod-
ules that may be associated with volume loss. Endotracheal 
tumors may grow to obstruct up to 75% of the airway lumen 
before symptoms ensue (Fig. 1.9). Airway neoplasms may 
also manifest as focal or diffuse airway stenosis and must be 
differentiated from inflammatory conditions. Tracheal dila-
tation seen in the Mounier-Kuhn syndrome is a rare congeni-
tal condition characterized by tracheal and bronchial 
dilatation due to atrophy of the muscular and elastic tissues 
of the trachea and main bronchi. The trachea may deviate 
toward a region of upper lobe volume loss, as seen in upper 
lobe fibrosis, or may be displaced by a mass in the thoracic 
inlet such as an enlarged thyroid.
Bronchiectasis is abnormal irreversible bronchial dila-
tation and may result from infection, cystic fibrosis, pri-
mary ciliary dyskinesia, or allergic bronchopulmonary 
fungal disease. It is seen radiographically as tram tracks 
which represent the thickened bronchial walls in cylindri-
cal bronchiectasis and clustered, thin-walled cystic lesions 
in cystic bronchiectasis.
1.10  Pleura/Diaphragm
Pleural abnormalities manifest radiographically as gas 
(pneumothorax) or fluid (pleural effusion) in the pleural 
space or as abnormalities of the pleural surfaces including 
thickening (pleural plaques, neoplasms) and calcification 




Fig. 1.9 Tracheal mass 
reflecting local invasion by 
esophageal carcinoma (a–c). 
(a) Frontal chest radiograph 
shows lobular contours of the 
upper mediastinum and 
thickening of the bilateral 
paratracheal stripes (arrows). 
(b) The lateral chest 
radiograph demonstrates 
thickening of the anterior and 
posterior tracheal walls and 
smooth stenosis of the upper 
trachea (arrows). (c) Axial 
contrast CT through the upper 
chest at mediastinal windows 
shows a lobulated soft tissue 
mass involving the anterior 
wall of the esophagus with 
invasion of the mediastinum 
and posterior trachea with 
marked narrowing of the 
tracheal lumen
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Pneumothorax is seen on upright chest radiography as a supe-
rior lucency that parallels the chest wall and outlines the curvilin-
ear visceral pleural line that is inwardly displaced from the chest 
wall. Pneumothorax may be spontaneous or traumatic. 
Spontaneous pneumothorax is categorized as primary (no under-
lying lung disease) and secondary (underlying lung disease).
The radiographic appearance of pleural effusion depends 
on the amount of fluid, whether the fluid is free-flowing or 
loculated, and the position of the patient when the radiograph 
is obtained. A small, free-flowing pleural effusion in an 
upright patient manifests radiographically as a meniscus 
blunting the posterior costophrenic sulcus on lateral 
 radiography, with larger effusions blunting the lateral costo-
phrenic sulcus on frontal radiography and effusions exceed-
ing 500  mL in volume obscuring the hemidiaphragm. 
Loculated pleural effusions are typically infected (so-called 
parapneumonic effusions and empyemas) and produce 
biconvex mass-like opacities along the dependent costal 
pleural surfaces (Fig. 1.10). In such cases, an air fluid level in 
Table 1.10 Tracheal abnormalities seen radiographically
Tracheal 
deviation
Ipsilateral Upper lobe volume loss (fibrosis)
Contralateral Thyroid/thoracic inlet mass
Tracheal 
narrowing
















Tracheal mass Squamous cell carcinoma 
Metastasis






Fig. 1.10 Empyema as a 
loculated pleural effusion 
(a–c). (a,b) Frontal chest 
radiograph of a 37-year-old 
woman with a history of 
intravenous drug use who 
presented with fevers and 
chest pain shows a loculated 
left basilar and lateral (a) and 
posterior (b) pleural 
collection (black arrows), 
confirmed on contrast- 
enhanced sagittal CT (c)
(white arrows)
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Key Point
• Loculated pleural effusions often manifest radio-
graphically as vertically oriented biconvex pleural 
opacities and are usually associated with underlying 
lung infection (termed parapneumonic effusions).
a
c
bFig. 1.11 Diaphragmatic eventration (a-c). (a) Frontal 
and lateral (b) chest 
radiographs show a focal 
bulge in the lateral (arrow in 
(a)) and anterior (arrow in 
(b)) right hemidiaphragm. (c) 
Coronal contrast-enhanced 
CT through the anterior chest 
at mediastinal windows show 
the liver projecting into the 
lower right chest due to 
eventration of the lateral right 
hemidiaphragm (arrow)
the pleural space in the absence of prior intervention is diag-
nostic of a bronchopleural fistula. Massive pleural effusions 
and pleural effusions with associated pleural nodules should 
suggest malignancy in the absence of trauma. Identification 
of circumferential nodular pleural thickening is virtually 
diagnostic of malignancy, with the main diagnostic consider-
ations including metastatic disease, malignant pleural meso-
thelioma, and lymphoma.
The diaphragm is a domed structure, with the right slightly 
higher than the left owing to the position of the heart on the left. 
A uniformly elevated diaphragm is most often due to weakness 
or paralysis of the diaphragm, while focal bulges in the dia-
phragmatic contour are typically due to eventration (thinning) 
of the diaphragm (Fig. 1.11) or diaphragmatic hernia through a 
congenital or acquired diaphragmatic defect [14].
1.11  Concluding Remarks
Although considered relatively “low tech” in the age of 
multi-detector CT, MR, and ultrasound, conventional chest 
radiography remains an important imaging study in the eval-
uation of patients with chest symptoms, in assessing hospi-
talized patients who have tubes or catheters placed for 
monitoring or treatment, and in screening the chest for 
asymptomatic disease. Each study should first be evaluated 
for technical adequacy, followed by a consistent, systematic 
review of the normal anatomy and structures to allow detec-
tion of abnormalities or exclude the presence of disease. 
Each component of the chest radiograph should be reviewed 
with findings reported in the same, consistent fashion, ide-
ally in a systematic way that provides the referring clinician 
with a structured report that parallels the radiographic analy-
sis. While many chest radiographic findings are nonspecific, 
there are important conditions evident radiographically such 
as pneumothorax or pneumonia that can direct specific treat-
ment or, as in the case of a non-calcified SPN, allow the 
 radiologist to make recommendations of appropriate imag-
ing follow-up or management.
1 A Systematic Approach to Chest Radiographic Analysis
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Take-Home Messages
• An analysis of the technical adequacy of a chest 
radiographic study is necessary prior to 
interpretation.
• In critically ill hospitalized patients, chest radio-
graphs performed for the assessment of monitoring 
or support devices provide important information 
regarding proper device positioning and help detect 
complications of placement.
• The radiographic detection of mediastinal abnor-
malities requires a detailed knowledge of normal 
mediastinal imaging anatomy and interfaces.
• Lung radiographic abnormalities can be divided 
into air space and interstitial diseases, solitary pul-
monary nodules or masses, and abnormal decreases 
in density that can be localized, unilateral, or 
diffuse.
• Diaphragmatic contour abnormalities may be local-
ized, such as in patients with eventration or hernia, 
or diffuse as in diaphragmatic weakness of 
paralysis.
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Missed Lung Lesions: Side-by-Side 




Missed lung lesions are one of the most frequent causes of 
malpractice issues [1–3]. Chest radiography plays an impor-
tant role in the detection and management of patients with 
lung cancer, chronic airways disease, pneumonia and inter-
stitial lung disease. Amongst all diagnostic tests, chest radi-
ography is essential for confirming or excluding the diagnosis 
of most chest diseases. However, numerous lesions of a wide 
variety of disease processes affecting the thorax may be 
missed on a chest radiograph. For example, the frequency of 
missed lung carcinoma on chest radiographs can vary from 
12 to 90%, depending on study design [4]. Despite the lack 
of convincing evidence that screening for lung cancer with 
the chest radiograph improves mortality, chest radiography 
is still requested for this purpose. The chest radiograph will 
also help narrow a differential diagnosis, help to direct addi-
tional diagnostic measures and serve during follow-up. The 
diagnostic usefulness of the radiograph will be maximized 
by the integration of the radiological findings with the clini-
cal features of the individual patient. In this chapter, we will 
review the more important radiological principles regarding 
missed lung lesions in a variety of common chest diseases, 
with a special focus on how correlation with multi-detector 
CT (MDCT) of missed lung lesions can help improve inter-
pretation of the plain chest radiograph.
2.2  Reasons for Missed Lung Lesions
Conditions contributing to missed lung lesions, especially 
carcinomas, have been extensively studied [2, 4–6]. Poor 
viewing conditions, hasty visual tracking, interruptions, 
inadequate image quality and observer inexperience are 
amongst the most important [5, 7, 8]. Features of lesions 
themselves, when faced with nodules, such as location, size, 
border characteristics and conspicuity, also play a role [5]. 
Missed lung nodules during initial reading of a chest radio-
graph are not uncommon. Missing a nodule which may rep-
resent malignancy will have adverse consequences on 
patient management, essentially through delayed diagnosis, 
which may carry medicolegal implications. A number of 
authors have explored the reasons why lesions are over-
looked [9–14]. Specific studies have focussed on size [7], 
contrast gradient [15], conspicuity [16] and anatomic noise 
[17]. Importantly, other types of errors, named systemic 
errors, can also occur [18] and include inappropriate orders 
or imaging utilization, procedure phase errors (patient iden-
tification, laterality, technique) and post-procedure phase 
errors (lighting conditions, transcription errors, communi-
cation failures).
One interesting study [19] examined the imaging features 
of non-small-cell lung carcinoma overlooked at digital chest 
radiography and compared general and thoracic radiologists’ 
performance for lung carcinoma detection. Frontal and lat-
eral chest radiographs from 30 consecutive patients with 
lung carcinoma overlooked during initial reading and 30 nor-
mal controls were submitted to two blinded thoracic radiolo-
gists and three blinded general radiologists for retrospective 
review. The location, size, histopathology, borders, presence 
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• To be aware of the actual risks of misdiagnosis 
when reading chest radiographs
• To learn the best tips and tricks for reducing your 
error rate
• To understand the limitations of chest radiographs 
compared with multi-detector CT
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of superimposed structures and lesion opacity were recorded. 
Interobserver agreement was calculated, and detection per-
formance between thoracic and general radiologists was 
compared. The average size of carcinomas missed by the 
thoracic radiologists was 18.1 mm (range 10–32 mm). The 
average size missed by general radiologists was 27.7  mm 
(range 12–60  mm). Seventy-one percent (5/7) of missed 
lesions were obscured by anatomical superimposition. Forty- 
three percent of lesions were located in the upper lobes, and 
63% were adenocarcinomas. Compared with general radiol-
ogists, the lesions missed by thoracic radiologists tended to 
be smaller but also had significantly lower CT density mea-
surements and more commonly had an ill-defined margin. 
The clinical stage of the overlooked lesions did not differ 
between the two groups (p = 0.480). The authors concluded 
that the lesion size, location, conspicuity and histopathology 
of lesions overlooked on digital chest radiography were sim-
ilar to those missed on conventional film screen techniques.
The detection of carcinoma on a chest radiograph remains 
difficult with implications on patient management. 
Nowadays, it is still by far the most frequent cause of mal-
practice suits (42% of cases) [3]. Whereas overlooking 
chronic airways disease, pneumonia and interstitial lung dis-
ease may not have the same potential medicolegal implica-
tions, the consequences for patient care could be critical.
We propose to review how correlation with multi-detector 
computerized tomography (MDCT) of missed lung lesions 
can help improve interpretation of the plain chest radiograph. 
During the course of clinical work, when reporting chest CT, 
whenever available, every effort should be made to review 
previous chest radiographs and their reports, thereby provid-
ing one of the best learning tools for chest radiograph 
interpretation.
Artificial intelligence will probably replace or modify our 
work as chest radiologists, minimizing detection errors and 
helping us to reduce our error rate. Convolutional neural net-
works have already been reported to provide a sensitivity of 
97.3% and specificity of 100% in the detection of tuberculo-
sis on chest X-rays [20].
A CT scan can be performed in patients with a negative 
chest radiograph when there is a high clinical suspicion of 
chest disease. CT scan, especially MDCT reconstructed with 
high-resolution algorithm and iterative reconstruction, is 
more sensitive than plain films for the evaluation of intersti-
tial disease, bilateral disease, cavitation, empyema and hilar 
adenopathy. CT is not generally recommended for routine 
use because the data for its use in chronic airways disease 
and pneumonia are limited, the cost is high, and there is no 
evidence that outcome is improved. Thus, a chest radiograph 
is the preferred method for initial imaging, with CT scan 
reserved for further characterization (e.g., evaluation of pat-
tern and distribution, detecting of cavitation, adenopathy, 
mass lesions or collections).
Many methods have been suggested for correct interpre-
tation of the chest radiograph. There is no preferred scheme 
or recommended system. The clinical question should always 
be addressed. An inquisitive approach is always helpful and 
being aware of the areas where mistakes are made is essen-
tial. Hidden abnormalities can thus be looked for. The diffi-
cult “hidden areas” which must be checked are the lung apex, 
superimposed over the heart, around each hilum and below 
the diaphragm. We will concentrate on difficult areas such as 
lesions at the lung apices or bases or lesions adjacent to or 
obscured by the hila or heart. For a systematic approach, we 
will divide the review into three sections representing spe-
cific problems: missed nodules, missed consolidation and 
missed interstitial lung disease. Finally, we will illustrate 
some of the common signs that may help to detect lesions 
located in difficult anatomical areas of the chest.
2.3  Specific Problems
Specific problems of missed lung lesions can be divided into 
missed nodules, missed consolidation and missed interstitial 
lung disease. In cases of a missed nodule or missed consoli-
dation, the overlooked pathology may have been detected if 
special attention were paid to known “difficult areas”. The 
examples which follow will show how a side-by-side com-
parison of the chest radiograph and CT images improves our 
understanding of the overlooked lesion. There is no harm 
done by learning from one’s mistakes!
2.4  Missed Nodules
2.4.1  Nodular Lesions: Tumours
Nodular lesions are frequently due to lung cancer, which 
may be primary or secondary. Lung cancer is probably one 
of the most common lung diseases that radiologists encoun-
ter in practice. Berbaum formulated the concept that percep-
tion is better if you know where to look and what to look for 
[21]. Our first example is that of a 53-year-old man who 
complained of pain in the right axilla for 4  months and 
underwent chest radiography. The postero-anterior and lat-
eral radiographs were interpreted showing normal findings 
(Fig.  2.1a and b). The subsequent MDCT showed a right 
Key Points
• Missing lesions is frequent.
• Hidden areas are at highest risks for missing lesions.
• Missing lesions is a frequent cause of medicolegal 
issues.





Fig. 2.1 A 53-year-old man who underwent chest radiography for pain 
in the right axilla. Postero-anterior (a) and lateral (b) radiographs inter-
preted as normal. With hindsight bias from MDCT the right apical mass 
is obvious. MDCT coronal and sagittal images with soft tissue (c) and 
bone (d) windows showing a right apical mass with bone destruction
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superior sulcus mass with rib destruction (Fig. 2.1c and d). 
Needle biopsy established a diagnosis of bronchogenic car-
cinoma (adenocarcinoma). Hindsight bias [22] with the 
information available from the MDCT makes the initial 
lesion extremely obvious. Careful scrutiny of both apices is 
essential when reporting a frontal chest radiograph.
Radiologic errors can be divided into two types [23]: cog-
nitive, in which an abnormality is seen but its nature is 
 misinterpreted, and perceptual or the “miss”, in which a 
radiologic abnormality is not seen by the radiologist on ini-
tial interpretation. The perceptual type is estimated to 
account for approximately 80% of radiologic errors [24].
Our second patient illustrates the complexity of the detec-
tion of a lung nodule close to the hilum. A 77-year-old man 
with known prostate cancer underwent chest radiography for 




Fig. 2.2 A 77-year-old man with right upper quadrant pain. Postero- 
anterior (a) and lateral (b) radiographs interpreted as normal. With 
hindsight, the 13 mm nodule in the superior segment of the lingula can 
be seen. Coronal (c) and sagittal (d) reformats (lung window) show the 
position of the lingular nodule, close to the hilum
D. Tack and N. Howarth
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radiographs were reported as normal. The coronal and sagit-
tal reformats demonstrate the position of the nodule (Fig. 2.2c 
and d), which can be seen clearly with hindsight on the 
postero- anterior and lateral chest radiographs.
2.4.2  Nodular Lesions: Infections
Nodular lesions attributed to pulmonary infections are most 
often seen in nosocomial pneumonias and in immunocom-
promised patients. They may be caused by bacteria such as 
Nocardia asteroides and M. tuberculosis, septic emboli and 
fungi. Nocardia asteroides causes single or nodular 
infiltrates with or without cavitation. Invasive pulmonary 
aspergillosis (IPA), mucor and Cryptococcus neoformans 
may present with single or multiple nodular infiltrates, 
which often progress to wedge-shaped areas of consolida-
tion. Cavitation (the “crescent sign”) is common later in the 
course of the infiltrate. In the appropriate clinical setting, 
CT may aid in the diagnosis of IPA by demonstrating the 
so-called halo sign. Figure 2.3 shows a 43-year-old woman 
with fever after a bone marrow transplant. The postero-ante-
rior radiograph was interpreted as normal (Fig. 2.3a). With 
hindsight, a subtle infiltrate can be seen at the left apex. 
Conspicuity is lessened by the overlying clavicle and first 
rib. Axial CT image (Fig. 2.3b) shows nodular consolidation 
a
b
Fig. 2.3 A 43-year-old 
woman with fever after a 
bone marrow transplant. 
Postero-anterior radiograph 
interpreted as normal (a). 
With hindsight, a subtle 
infiltrate can be seen at the 
left apex. Conspicuity is 
lessened by the overlying 
clavicle and first rib. Also 
note the indwelling catheter 
from the left brachial vein to 
the superior vena cava. Axial 
CT image (lung window) 
shows nodular consolidation 
with crescentic cavitation 
(air-crescent sign) and 
surrounding ground-glass 
infiltrate (halo sign) (b)
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with crescentic cavitation (the “crescent sign”) and sur-
rounding ground- glass infiltrate (the “halo sign”). These 
characteristic findings of IPA are best identified on CT.
2.5  Missed Consolidation
2.5.1  Airspace Disease
Airspace disease is usually caused by bacterial infections. 
However, airspace disease can be seen in viral, protozoal, 
fungal infections and malignancy, typically brochioloalveo-
lar carcinoma. Acute airspace pneumonia is characterized by 
a mostly homogeneous consolidation of lung parenchyma, 
well-defined borders, and does not typically respect segmen-
tal boundaries. An air bronchogram is very common. 
Progression to lobar consolidation may occur. As with lung 
nodules, whether consolidation is detected or missed on the 
plain chest radiograph may be determined by any combina-
tion the same factors of size, density, location and overlying 
structures. Location is a significant factor for missed consoli-
dation. Consolidation in the middle lobe and both lower 
lobes can be difficult to diagnose, especially when only the 
postero-anterior view is obtained. Figure  2.4 shows a 
46-year-old woman with cough and right-sided chest pain. 
The postero-anterior radiograph was interpreted as normal 
(Fig. 2.4a). Due to a clinical suspicion of pulmonary embo-
lism, MDCT was requested, showing consolidation in the 
anterior segment of the right lower lobe. The coronal and 
sagittal reformats demonstrate the extent of the consolida-
tion (Fig.  2.4b and c). There were no signs of pulmonary 
embolism on the contrast media study. A diagnosis of right 
lower lobe pneumonia was established, and the patient was 
treated successfully with antibiotics.
Chest radiography is the first recommended imaging test 
for the diagnosis of pneumonia. Chest radiography can diag-
nose pneumonia when an infiltrate is present and differenti-
ate pneumonia from other conditions that may present with 
similar symptoms, such as acute bronchitis. The results of 
the chest radiograph may occasionally suggest a specific 
aetiology (e.g., a lung abscess) and identify a complication 
(empyema) or coexisting abnormalities (bronchiectasis, 
bronchial obstruction, interstitial lung disease). Chest radi-
ography remains a valuable diagnostic tool in primary care 
patients with a clinical suspicion of pneumonia to substan-
tially reduce the number of patients misdiagnosed. MDCT 
imaging is useful in patients with community-acquired pneu-
monia when there is an unresolving or complicated chest 
radiograph and at times in immunocompromised patients 
with suspected pulmonary infections. MDCT can help in dif-
ferentiating infectious from non-infectious abnormalities. 
MDCT may detect empyema, cavitation and lymphadenopa-
thy when the chest radiograph cannot. MDCT should be per-
formed in immunocompromised patients with a clinical 
suspicion of pneumonia when the chest radiograph is nor-
mal. This is especially true when the early diagnosis of pneu-
monia is critical, as is the case with immunocompromised 
and severely ill patients.
2.6  Missed Interstitial Lung Disease
2.6.1  Diffuse (Interstitial or Mixed Alveolar- 
Interstitial) Lung Disease
Diffuse lung disease presenting with widely distributed 
patchy infiltrates or interstitial reticular or nodular abnor-
malities can be produced by a number of disease entities. An 
attempt is usually made to separate the group of idiopathic 
interstitial pneumonias from known causes, such as infec-
tions, associated systemic disease or drug related. The most 
common infectious organisms are viruses and protozoa. In 
general, the aetiology of an underlying pneumonia cannot be 
specifically diagnosed because the patterns overlap. It is 
beyond the aim of this chapter to discuss in detail the contri-
bution of MDCT to the diagnosis of diffuse infiltrative lung 
disease. For over three decades, the development and then 
refinement of high-resolution computed tomography 
(HRCT) have resulted in markedly improved diagnostic 
accuracy in acute and chronic diffuse infiltrative lung dis-
ease. The chest radiograph remains the preliminary radio-
logical investigation of patients with diffuse lung disease but 
is often non-specific. Pattern recognition in diffuse lung 
disease has been the subject of controversy for many years. 
Extensive disease may be required before an appreciable 
Key Points
• Nodule location in hidden areas is the most frequent 
cause for missing nodules
• Low nodule attenuation favours missing the lesion
• Calcified nodules are easiest to detect but not clini-
cally relevant
Key Points
• Chest radiography is the first imaging test for the 
diagnosis of pneumonia.
• Chest radiographs may help identify complications 
of pneumonia.
• Hidden areas are the most frequent reasons for 
missing pneumonia.
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change in radiographic density, or an abnormal radiographic 
pattern can be detected on the plain chest radiograph. At least 
10% of patients who are ultimately found to have biopsy- 
proven diffuse lung disease have an apparently normal chest 
radiograph. HRCT and now MDCT have become an integral 
component of the clinical investigation of patients with sus-
pected or established interstitial lung disease. These tech-




Fig. 2.4 A 46-year-old woman with cough and right-sided chest pain. Postero-anterior radiograph interpreted as normal (a). Coronal (b) and sagit-
tal (c) reformats showing consolidation in the anterior segment of the right lower lobe
Key Points
• Chest radiography is less sensitive and less specific 
than MDCT.
• If the chest radiograph is normal, MDCT may be 
indicated.
• Chest radiographs may be helpful for the follow-up 
of ILD.
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2.7  Key Signs for Reducing the Risk 
of Errors in CXRs
2.7.1  Deep Sulcus Sign
The deep sulcus sign (Fig. 2.5) is seen on chest radiographs 
obtained with the patient in the supine position [25]. It repre-
sents lucency of the lateral costophrenic angle extending 
toward the abdomen. The abnormal deepened lateral costo-
phrenic angle may have a sharp, angular appearance. When 
the patient is in the supine position, air in the pleural space 
(pneumothorax) collects anteriorly and basally within the 
nondependent portions of the pleural space; when the patient 
is upright, the air collects in the apicolateral location. If air 
collects laterally rather than medially, it deepens the lateral 
costophrenic angle and produces the deep sulcus sign. In 
Fig. 2.5, a deep sulcus sign is seen on the left, in addition to 
a continuous diaphragmatic sign, seen when air is seen 
between the diaphragm and the heart.
2.7.2  Spine Sign
On the normal lateral chest radiograph, the attenuation 
decreases (the lucency increases) as one progresses down the 
thoracic vertebral bodies. If the attenuation increases, locally 
or diffusely, there must be a posterior located lesion 
(Fig. 2.6). This lesion might not be seen on the frontal view, 
hidden by the heart or the hila. Interestingly, the positive pre-
dictive value of the spine sign is high (up to 97%) [26].
2.7.3  Silhouette Sign
In a chest X-ray, non-visualization of the border of an ana-
tomical structure that is normally visualized shows that the 
area neighbouring this margin is filled with tissue or material 
of the same density (Fig. 2.6) [27]. The silhouette sign is an 
important sign indicating the presence and the localization of 
a lesion.
2.8  Concluding Remarks
Despite the increasing use of CT imaging in the diagnosis of 
patients with chest disorders, chest radiography is still the 
primary imaging method in patients with suspected chest 
disease. The presence of an infiltrate on a chest radiograph is 
considered the “gold standard” for diagnosing pneumonia. 
Extensive knowledge of the radiographic appearance of pul-
monary disorders is essential when diagnosing pulmonary 
disease. Chest radiography is also the imaging tool of choice 
in the assessment of complications and in the follow-up of 
patients with pulmonary diseases.
MDCT plays an increasing role in the diagnosis of chest 
diseases, especially in patients with unresolving symptoms. 
CT will aid in the differentiation of infection and non- 
infectious disorders. The role of CT in suspected or proven 
chest disease can be summarized as follows:
 1. CT is valuable in the early diagnosis of chest disease, 
especially in patient groups in which an early diagnosis is 
important (immunocompromised patients, critically ill 
patients).
 2. CT may help with the characterization of pulmonary 
disorders.
 3. CT is an excellent tool in assessing complications of chest 
disease.
 4. CT is required in the investigation patients with a persis-
tent or recurrent pulmonary infiltrate.
A side-by-side comparison between the chest radiograph 
and MDCT when confronted with a missed lung lesion is 
very instructive. The radiologist should be able to understand 
the reasons for missing certain lesions. By adopting this 
inquisitive approach, both our cognitive and perceptual 
errors could be reduced.
Awareness of the dangers of systemic errors has become of 
upmost concern, as a result of the high examination volume 
Fig. 2.5 A 78-year-old man with acute left chest pain and previous 
history of pneumoconiosis. Bedside chest radiograph showing a thin 
white line near the left chest wall (white arrows), corresponding to the 
left lung visceral pleura and indicating a pneumothorax. The deep 
lucency of the left lateral costophrenic angle extending towards the 
abdomen is an indirect sign of pneumothorax (black arrow). The con-
tinuous diaphragmatic sign is also seen as air separating the diaphragm 
from the heart (white hollow arrow)




Fig. 2.6 A 69-year-old woman with COPD and haemoptysis. Postero- 
anterior chest radiograph (a) showing an opacity next to the right border 
of the heart (arrow) and obliterating the right side of the spine. This 
silhouette sign of the right posterior mediastinal border indicates that 
the lesion is in a posterior location in the right lower lobe. Lateral view 
(b) showing an increased density (arrow) of the lower spine compared 
with the upper and middle thoracic spine (spine sign). This increased 
density is due to a large mass in the right lower lobe. Coronal CT image 
(c) showing the right lower lobe mass obliterating the border of the 
mediastinum. Sagittal CT image (d) showing the posterior location of 
the mass
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and long shifts experienced by radiologists [28]. Double read-
ings and subsequent readings by subspecialists may become 
common practice, especially if medicine shifts toward physi-
cian payment based on quality or outcomes, rather than volume 
[29]. Artificial intelligence will undoubtedly offer opportuni-
ties to improve our diagnostic accuracy, as systems will be 
developed as adjuncts to human cognition and perception [30].
Artificial intelligence generates fear about the future role 
of radiologists and their employment. Let us remember that 
although we analyse many images, we still decide on what 
imaging examinations should be prescribed and how they are 
performed best, we confer on difficult diagnoses, we discuss 
treatment plans with patients and we translate the conclu-
sions of the research literature into real-life practice. If some 
of the more repetitive tasks can be handled safely by a com-
puterized helper, radiologists will be able to focus on the 
rewarding ones, improving patient care and safety.
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Take-Home Messages
• Be aware that missing lesions is frequent.
• Always look at hidden areas.
• Beware of satisfaction of search.
• Take time to read the lateral view of the chest.
• Learn the key radiologic signs to reduce your error 
rate.
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The mediastinum is an anatomic space defined by the tho-
racic inlet superiorly and the diaphragm inferiorly. It extends 
from the sternum to the vertebral bodies. Yet, despite its 
landmarks, there are no structures that completely separate 
the mediastinum from the neck above or the retroperitoneum 
below. Imaging of the mediastinum and generating a relevant 
different diagnosis rest on the principles of localization and 
characterization.
Once a process or mass can be localized to the mediasti-
num, it should be localized within the mediastinum. Many of 
us use an approach first championed by Ben Felson. Using a 
lateral radiograph or sagittal CT or MR, a line is drawn from 
the anterior tracheal wall to the posterior inferior vena cava. 
This line separates the anterior mediastinum from the middle 
mediastinum. A second line is drawn 1 cm posterior to the 
anterior margin of the vertebral body. This line separates the 
middle from the posterior mediastinum. No anatomic struc-
tures actually divide the mediastinal compartments, but this 
approach can be useful in creating concise, meaningful dif-
ferential diagnoses. Keep in mind certain processes may 
involve more than one compartment and that a large mass 
may be hard to localize.
More recently, the International Thymic Malignancy 
Interest Group (ITMIG) has proposed a modification of 
lesion localization based on MDCT.  In this model, three 
compartments are used: prevascular, visceral, and paraverte-
bral. The main difference from the modified Felson tech-
nique is the inclusion of the heart and aorta in the visceral 
compartment (middle compartment) (Fig. 3.1).
After localization, cross-sectional imaging (either CT or 
MR) should be performed for lesion characterization. 
Knowing whether a lesion has a significant vascular, fluid or 
fat component can be very helpful in suggesting a more spe-
cific diagnosis. PET/CT is used mainly to evaluate lymph 
node metastases in lung cancer. It is used as well in the eval-
uation of solid mediastinal masses.
This approach of localization and characterization will 
provide the interpreting radiologist a solid foundation in 
imaging the mediastinum.
3.2  Anterior Mediastinum/Prevascular 
Compartment
Most anterior or prevascular mediastinal masses are thymic 
in origin. Even lymphomas and germ cell tumors tend to 
arise in cells within the thymus. A useful differential list 
should be based on age, as germ cell tumors are almost 
unheard of in patients older than 45  years. Most anterior 
mediastinal masses tend to be lymphomas, germ cell tumors, 
or thymomas. Many texts will include thyroid goiter in the 
list for anterior mediastinal lesions. We, however, have found 
that most goiters tend to extend into the middle mediastinum 
or visceral compartment (Fig. 3.2).
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Learning Objectives
• To understand an approach to the adult mediasti-
num based on localization of lesions within the 
mediastinum and attenuation/intensity features on 
cross-sectional imaging.
• To highlight conditions that disregard the compart-
mental model.
• To use some cases to show the additional value of 
MR in evaluating the adult mediastinum.
28
Observing fluid attenuation or intensity can be very help-
ful in approaching anterior mediastinal masses. Pure cystic 
lesions are benign (usually thymic or pericardial cysts). 
Separating pericardial from thymic cysts is based on location 
as thymic cysts tend to be spade-shaped and reside in the 
thymic bed, while pericardial cysts tend to be rounder and 
are more commonly found in the right cardiophrenic angle 
(Fig.  3.3). As the amount of soft tissue within the lesion 
increases, one should consider the increased likelihood of a 
malignancy. Both lymphoma and cystic thymoma will tend 
to have soft tissue elements that will enhance on MR or CT 
(Fig. 3.4). Germ cell tumors also follow this rule. The classic 
teaching is that the germ cell tumor should be fat in attenua-
tion. Many teratomas do contain some fat elements, but 
almost all are cystic (Fig. 3.5). As with the other lesions, if 
the soft tissue elements dominate, then a malignant germ cell 
tumor should be favored, such as seminoma. Interestingly, 




Fig. 3.1 ITMIG definition of the mediastinal compartments at the level 
of the transverse aorta (a), left pulmonary artery (b), and heart (c). The 
prevascular compartment is anterior or peripheral to the pericardium (X 
color), whereas the paravertebral compartment is separated from the 
visceral compartment by a line (X color) 1 cm posterior to the anterior 
vertebral body border
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The visualization of fat intensity or attenuation can 
also be very helpful. In the anterior or prevascular medi-
astinum, most fatty masses are benign. As described 
above, an anterior mediastinal mass with fat and fluid sug-
gests a teratoma (benign germ cell tumor) (Fig. 3.5). If the 
mass is purely fat, it may be the very rare thymolipoma 
but more likely will be a fat pad or anterior hernia 
(Morgagni hernia). Coronal or sagittal images are quite 
helpful in depicting vessels originating below the dia-
phragm. Visualization of these are key in separating her-
nias from fat pads or fatty tumors. In our practices, 
infarction of a pericardial fat pad or fat within the 
Morgagni hernia may present with chest pain. In the era of 
the frequent use of CT in the evaluation of chest pain, 
these areas of fat necrosis can simulate a neoplasm. 
Awareness of this potential pitfall will allow the patients 
to be treated appropriately.
Calcification can also be helpful. The incidence of calcifi-




Fig. 3.2 Thyroid goiter. Frontal chest radiograph (a) of an asymptom-
atic 74-year-old man demonstrates a mass in the mediastinum displac-
ing the trachea to the left. Axial (b) and coronal reformations (c) of a 
contrast-enhanced CT confirm the mass is in the visceral or middle 
mediastinum, shows intense enhancement, similar to the enhancement 
of the right thyroid lobe (R in image C), and contains course calcifica-
tions (arrows) and low attenuation regions with it. These findings, of a 
heterogeneous intensely enhancing mass, with low attenuation regions, 
and course calcifications, connecting to the thyroid, are typical for 
intrathoracic extension of a goiter
Fig. 3.3 Pericardial cyst. Axial contrast-enhanced CT (a) of a 56-year- 
old man demonstrates a cystic mass abutting the right heart border with 
imperceptible walls, of water density and no enhancing nodule or septa, 
typical for a pericardial cyst
3 Approach to Imaging of Mediastinal Conditions in the Adult
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peripheral calcification may occur in solid thymomas. 
Teratomas contain calcium in about 35% of cases. Untreated 
lymphomas do not calcify and about 5% of them show calci-
fications after radiation therapy. Peripheral circular calcifica-
tion can be a finding of an aneurysm. In this location, many 
such aneurysms represent bypass graft aneurysms. The pres-
ence of mediastinal wires should be a clue to this potential 
diagnosis.
Vascular or hyperenhancing lesions may present within 
the anterior or prevascular mediastinum. Often, these 
a b
Fig. 3.4 Cystic thymoma. Axial view from a contrast-enhanced coro-
nary artery CT in a 51-year-old woman demonstrated a cystic mass in 
the prevascular mediastinum. At this phase of early imaging after con-
trast injection, intralesional nodular enhancement is not readily seen, 
better demonstrated on a routine contrast-enhanced chest CT (B). 
Delayed imaging after contrast enhancement or MR imaging with its 
improved contrast resolution is used to ensure cystic lesions in the pre-
vascular mediastinum do not contain enhancing soft tissue which usu-
ally indicated malignancy, as was proven in this cystic type B1 
thymoma
Fig. 3.5 Mature teratoma. Axial view of a contrast-enhanced chest CT 
at the level of the thymus (T) in a 5-year-old boy. There is a fluid-filled 
(F) large prevascular mass containing obvious fat
Fig. 3.6 Thymoma with calcifications. Contrast-enhanced chest CT of 
a 65-year-old woman shows a prevascular mass with dense calcifica-
tions proven at resection to represent a type B3 thymoma. Thymoma 
may present with dense or even curvilinear calcifications
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are related to the heart, ascending aorta. Rarely, ectopic 
parathyroid adenomas may present as vigorously enhanc-
ing anterior prevascular masses.
3.3  Middle Mediastinum/Visceral 
Compartment
Most middle mediastinal or visceral compartment masses 
represent lymphadenopathy, foregut duplication cysts, vas-
cular lesion, or esophageal processes. They usually present 
with right paratracheal widening on a frontal chest radio-
graph or occasionally the doughnut sign on a lateral exami-
nation. As with the anterior mediastinal conditions, 
assessment of attenuation or intensity can be helpful. In the 
ITMIG model, the heart is included in this compartment. In 
our experience, left ventricular and left atrial conditions may 
occasionally simulate middle mediastinal, visceral masses.
If the mass is fluid in characteristic, the middle mediasti-
nal mass most likely represents a foregut duplication cyst 
(either bronchogenic or esophageal). These cysts occasion-
ally are higher in attenuation as a result of infection (Fig. 3.7) 
or hemorrhage and may even contain a fluid-calcium level 
from milk of calcium. The risk of malignancy in these condi-
tions tends to almost nonexistent. As with anterior mediasti-
nal lesions, the ratio of soft tissue to fluid needs to be 
considered. A foregut duplication cyst should have no soft 
tissue, enhancing element. If soft tissue is encountered, one 
must consider a potentially more significant process, usually 
low-attenuating lymphadenopathy. Such low-attenuating 
lymph nodes may be encountered in lung cancer, mucinous 
Key Point
• Most anterior mediastinal masses are of thymic ori-
gin. Patient age and attenuation characteristics are 
key in narrowing the differential diagnosis. MR can 





Fig. 3.7 Asymptomatic bronchogenic cyst in a 19-year-old woman 
incidentally discovered on a preoperative chest radiograph (a, b). There 
is a mass posterior to the heart (arrows in A) displacing the right lower 
lobe bronchovascular structures laterally but best appreciated on the 
lateral film (arrow in B). Contrast-enhanced chest CT (b) demonstrates 
a homogeneous mass abutting the takeoff of the right lower lobe bron-
chus and esophagus measuring 41HU, often encountered in duplication 
cysts which contain proteinaceous material. Note the absence of any 
thickened or enhancing septa or nodules
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Fig. 3.8 Tuberculosis. Contrast-enhanced chest CT of a 64-year-old 
febrile new immigrant. Chest radiograph at presentation (a) demon-
strates loss of the right paratracheal line which was clearly present on a 
baseline chest radiograph (arrow in b) performed 1  year earlier. 
Contrast-enhanced chest CT (c) confirms that indeed there are enlarged 
right paratracheal lymph nodes, some of which have peripheral 
enhancement and a low attenuation center (arrow). Such low attenua-
tion lymph nodes in the correct clinical setting are highly suggestive of 
tuberculosis
Fig. 3.9 Renal cell enhancing metastasis to the subcarinal lymph node 
in a 65-year-old man with renal cell carcinoma. Axial contrast-enhanced 
chest CT demonstrates subcarinal lymphadenopathy (arrow) at the level 
of the pulmonary artery (P). The subcarinal lymph node shows avid 
enhancement, measured as 105HU, identical to the contrast within the 
pulmonary artery
neoplasms, and mycobacterial disease (Fig.  3.8). In the 
 superior mediastinum, papillary thyroid carcinoma can 
rarely mimic a foregut duplication cyst.
Unlike the anterior mediastinum or visceral compart-
ment, fat cannot be considered benign. Although esophageal 
or tracheal lipomas and esophageal fibrovascular polyps 
contain fat, so may mediastinal liposarcomas. Although rare, 
these lesions may insinuate through the mediastinum and 
often have a predilection for the middle mediastinum.
Hypervascular lesions in the middle mediastinum or vis-
ceral compartment are most often hypervascular lymph 
nodes, or an intrathoracic extension of a goiter. Rarely a 
paraganglioma may present in this space. Interestingly, many 
of these lesions tend to abut the left atrium. The hypervascu-
lar lymph nodes (defined as higher in attenuation than skel-
etal muscle) may be seen with melanoma, plasmacytoma, 
Castleman’s disease, Kaposi sarcoma, and thyroid and renal 
cell cancer (Fig. 3.9). When the high attenuating structure is 
tubular, a vessel must be considered. Aortic arch anomalies 
and azygous vein enlargement often present as a middle 
mediastinal mass on radiography. Azygous vein variants 
tend to enlarge on portable radiographs (when the patient is 
supine) compared with upright radiographs.
Most mediastinal lymphadenopathy will present in the 
middle mediastinum or visceral compartment. Occasionally, 
these nodes will be calcified. Most often these calcified 
nodes are indicative of an old granulomatous process such as 
healed tuberculosis or histoplasmosis or sarcoidosis, but care 
must be taken to remember that certain tumors also tend to 
present with calcified mediastinal lymph nodes, including 
ovarian serous adenocarcinomas, mucinous colon neo-
plasms, and osteosarcomas.
Another potential for a perceived middle mediastinal 
mass on radiography will be a dilated esophagus. Although a 
distal mass may also result in esophageal dilatation, it is usu-
ally only achalasia that results in esophageal widening that 
can be seen on a chest radiograph.
3.4  Posterior Mediastinum/Paravertebral 
Compartment
A vast majority of posterior mediastinal or paravertebral 
masses will be neurogenic in origin (Fig.  3.10). In adults, 
these tend to be benign nerve sheath tumors, usually schwan-
nomas and neurofibromas. In kids and younger adults, these 
tend to be sympathetic ganglion in origin, such as ganglio-
neuroblastoma, neuroblastoma, or ganglioneuroma. The key 
in separating the two groups is to assess the overall shape, 
comparing Z-axis to the XY-axis. The nerve sheath tumors 
tend to be spherical (equal in all three axes), while the gan-
glion lesions are longer in the Z-axis and are more cylindrical 
(akin to a sausage). Osseous lesions represent the second 
most common group of posterior mediastinal disease. 
Key Point
• Most middle mediastinal masses will consist of 
lymphadenopathy, duplication cysts, vascular 
lesions, or esophageal masses. Attenuation charac-
teristics of the lymphadenopathy compared to skel-
etal muscle can be helpful at honing in on the 
correct diagnosis.
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Although metastases are often considered, one cannot forget 
about diskitis/osteomyelitis. This latter condition can present 
with insidious back pain and can easily be overlooked.
As with the other compartments, attenuation or intensity can 
be helpful. On CT, a potential pitfall is that myelin-rich neuro-
genic lesions may look cystic. For this reason, we often rely on 
MR with posterior mediastinal/paravertebral lesions. True pos-
terior mediastinal cystic lesions are rare. Although neuroenteric 
cysts exist, they are often associated with vertebral anomalies 
and rarely encountered de novo in adults. Instead, a cystic lesion 
in the posterior mediastinum is much more likely to represent a 
lateral meningocoele or post- traumatic nerve root avulsion.
Fatty lesions are unusual in the posterior mediastinum but 
when encountered may invoke extramedullary hematopoiesis. 
Although rare, in patients with anemia, extramedullary hema-
topoiesis may develop in this space. The etiology of this con-
dition remains unknown. Some authors have postulated that it 
develops from extruded marrow, while others have suggested 
that it develops from totipotent cells in the paravertebral space. 
When the patient is anemic, extramedullary hematopoiesis 
will present with bilateral masses that enhance similar to the 
spleen without a connecting bridge. As the patient returns to 
normal hematocrit, the yellow marrow will take over. The net 
effect is bilateral posterior mediastinal fatty masses. In the 
elderly, Bochladek hernias should be included in the differen-
tial diagnosis. Often the diaphragmatic defect can be seen.
Hypervascular lesions in in the posterior mediastinum or 
paravertebral space are less helpful than with the other com-
partments. Most often these are related to an aneurysmal 
aorta or enlarged collateral vessels as with aortic coarctation. 
As described above, extramedullary hematopoiesis may be 
seen with bilateral hypervascular paravertebral masses.
a b
c
Fig. 3.10 Benign peripheral nerve sheath tumor. Frontal chest radio-
graph in an asymptomatic 51-year-old woman demonstrates a posterior 
mediastinal mass (arrow). Contrast-enhanced chest CT (b) at the level 
of the heart demonstrates the mass is centered in the paravertebral 
mediastinum. FDG PET/CT (c) revealed the mass was FDG avid with 
an SUVmax of 6.8. Most masses in this location represent benign 
peripheral nerve sheath tumors. Their FDG avidity is variable and may 
be very high despite being benign
Key Point
• Most posterior mediastinal masses are neurogenic 
in origin. Osseous lesions, however, should not be 
forgotten. Mutiplanar reconstructions and MR are 
particularly helpful in this compartment.
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3.5  Conditions that Disregard 
the Compartment Model
Certain conditions tend to disregard the compartment model 
of the mediastinum. Even with these lesions understanding 
the attenuation or intensity can be helpful. These include 
infection and hematoma, which will result in fat stranding 
and soft tissue attenuation throughout the mediastinum, 
often in more than one compartment.
Lymphangiomas and hemangiomas also tend to disregard 
the compartment model. The former tend to be fluid in their 
attenuation and insinuate throughout, while the latter will be 
higher in attenuation.
Of course, lung cancer may present with metastases to 
any compartment and unfortunately and tends to metastasize 
to more than one region.
3.6  Conclusion
The mediastinum represents a space that may be impacted by 
a large number of lesions. Regardless whether one uses the 
modified Felson technique or the newer ITMIG approach, 
having an approach based on location and characterization 
will allow the radiologist the ability to create a useful, tar-
geted differential diagnosis (Table 3.1).
Table 3.1 Location and characteristic approach to mediastinal masses in the adult












































The main difference between the older Felson technique and the newer ITMIG approach is inclusion of the heart in anterior mediastinum vs. vis-
ceral compartment. The conditions marked with an asterisk (*) may vary on localization based on technique used
Key Point
• Infections, lymphangiomas, and hematomas tend to 
disregard the compartmental model.
Take-Home Messages
• A solid approach to the adult mediastinum uses the 
patient’s age, lesion cross-sectional attenuation/
intensity, and lesion location to generate the differ-
ential diagnosis.
• This compartment model is based on certain ana-
tomic landmarks (Fig. 3.1).
• Although most lesions will be characterized by CT, 
MR may have additional value in characterizing 
cystic lesions, diagnosing thymic hyperplasia and 
separating neurogenic from osseous lesions in the 
posterior mediastinum/paravertebral compartment.
S. Bhalla and E. Marom
35
Suggested Readings
Adam A, Hochholzer L.  Ganglioneuroblastoma of the posterior 
mediastinum: a clinicopathologic review of 80 cases. Cancer. 
1981;47:373–81.
Baron RL, Sagel SS, Baglan RJ. Thymic cysts following radiation ther-
apy for Hodgkin disease. Radiology. 1981;141:593–7.
Carter BW, Benveniste MF, Madam R, et al. ITMIG classification of 
mediastinal compartments and multidisciplinary approach to medi-
astinal masses. RadioGraphics. 2017;37:413–36.
Chen JL, Weisbrod GL, Herman SJ. Computed tomography and patho-
logic correlations of thymic lesions. J Thorac Imaging. 1988;3:61–5.
Cohen AJ, Thompson LN, Edwards FH, et  al. Primary cysts and 
tumours of the mediastinum. Ann Thorac Surg. 1991;51:378–86.
Do YS, Im JG, Lee BH, et al. CT findings in malignant tumors of thy-
mic epithelium. J Comput Assist Tomogr. 1995;19:192–7.
Erasmus JJ, McAdams HP, Donnelly LF, Spritzer CE.  MR imag-
ing of mediastinal masses. Magn Reson Imaging Clin North Am. 
2000;8:59–89.
Faul JL, Berry GJ, Colby TV, et al. Thoracic lymphangiomas, lymphan-
giectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. 
Am J Respir Crit Care Med. 2000;161:1037–46.
Gaerte SC, Meyer CA, Winer-Muram HT, et al. Fat-containing lesions 
of the chest. RadioGraphics. 2002;22:615–78.
Hoffman OA, Gillespie DJ, Aughenbaugh GL, Brown LR.  Primary 
mediastinal neoplasms (other than thymoma). Mayo Clin Proc. 
1993;68:880–91.
Jeung M-Y, Gasser B, Gangi A, et al. Imaging of cystic masses of the 
mediastinum. RadioGraphics. 2002;22:S79–93.
Jolles H, Henry DA, Roberson JP, et al. Mediastinitis following median 
sternotomy: CT findings. Radiology. 1996;201:463–6.
Knapp RH, Hurt RD, Payne WS, et al. Malignant germ cell tumors of 
the mediastinum. J Thorac Cardiovasc Surg. 1985;89:82–9.
Long JA Jr, Doppman JL, Nienhuis AW. Computed tomographic stud-
ies of thoracic extramedullary hematopoiesis. J Comput Assist 
Tomogr. 1980;4:67–70.
Moeller KH, Rosado-de-Christenson ML, Templeton PA. Mediastinal 
mature teratoma: imaging features. Am J Roentgenol. 
1997;169:985–90.
McAdams HP, Rosado-de-Christenson M, Fishback NF, Templeton 
PA. Castleman disease of the thorax: radiologic features with clini-
cal and histopathologic correlation. Radiology. 1998;209:221–8.
Miles J, Pennybacker J, Sheldon P. Intrathoracic meningocele. Its devel-
opment and association with neurofibromatosis. J Neurol Neurosurg 
Psychiatry. 1969;32:99–110.
Miyake H, Shiga M, Takaki H, et  al. Mediastinal lymphangiomas in 
adults: CT findings. J Thorac Imaging. 1996;11:83–5.
Moran CA, Suster S. Primary germ cell tumors of the mediastinum: 
I.  Analysis of 322 cases with special emphasis on teratomatous 
lesions and a proposal for histopathologic classification and clinical 
staging. Cancer. 1997;80:681–90.
Nakata H, Nakayama C, Kimoto T, et  al. Computed tomography 
of mediastinal bronchogenic cysts. J Comput Assist Tomogr. 
1982;6:733–8.
Pombo F, Rodriguez E, Mato J, et al. Patterns of contrast enhancement 
of tuberculous lymph nodes demonstrated by computed tomogra-
phy. Clin Radiol. 1992;46:13–7.
Riccardo Marano MD, Carlo Liguori MD, Giancarlo Savino MD, et al. 
Cardiac silhouette findings and mediastinal lines and stripes radio-
graph and CT scan correlation. Chest. 2011;139:1186–96.
Rosado-de-Christenson ML, Galobardes J, Moran CA.  Thymoma: 
radiologic–pathologic correlation. RadioGraphics. 1992;12:151–68.
Rosado-de-Christenson ML, Pugatch RD, Moran CA, Galobardes 
J. Thymolipoma: analysis of 27 cases. Radiology. 1994;193:121–6.
Rosado-de-Christenson ML, Templeton PA, Moran CA.  From the 
archives of the AFIP. Mediastinal germ cell tumors: radiologic and 
pathologic correlation. RadioGraphics. 1992;12:1013–30.
Rossi SE, McAdams HP, Rosado-de-Christenson ML, et al. Fibrosing 
mediastinitis. RadioGraphics. 2001;21:737–57.
Shaffer K, Rosado-de-Christenson ML, Patz EF Jr, et  al. Thoracic 
lymphangioma in adults: CT and MR imaging features. Am J 
Roentgenol. 1994;162:283–9.
Spizarny DL, Rebner M, Gross BH. CT evaluation of enhancing medi-
astinal masses. J Comput Assist Tomogr. 1987;11:990–3.
Strollo DC, Rosado-de-Christenson ML.  Tumors of the thymus. J 
Thorac Imaging. 1999;14:152–71.
Strollo DC, Rosado de Christenson ML, Jett JR.  Primary medias-
tinal tumors. Part 1: tumours of the anterior mediastinum. Chest. 
1997;112:511–22.
Strollo DC, Rosado-de-Christenson ML, Jett JR. Primary mediastinal 
tumors: part II. Tumours of the middle and posterior mediastinum. 
Chest. 1997;112:1344–57.
Suwatanapongched T, Gierada DS. CT of thoracic lymph nodes. Part II: 
diseases and pitfalls. Br J Radiol. 2006;79:999–1006.
Takahashi K, Al-Janabi NJ.  Computed tomography and magnetic 
resonance imaging of mediastinal tumors. J Magn Reson Imaging. 
2010;32:1325–39.
Thacker PG, Mahani MG, Heider A, Lee EY.  Imaging evaluation of 
mediastinal masses in children and adults practical diagnostic 
approach based on a new classification system. Thorac Imaging. 
2015;30:247–67.
Whitten CR, Khan S, Munneke GJ, Grubnic S. A diagnostic approach 
to mediastinal abnormalities. RadioGraphics. 2007;27:657–71.
Woodring JH, Loh FK, Kryscio RJ. Mediastinal hemorrhage: an evalu-
ation of radiographic manifestations. Radiology. 1984;151:15–21.
Zylak CJ, Eyler WR, Spizarny DL, Stone CH.  Developmental 
lung anomalies in the adult: radiologic-pathologic correlation. 
RadioGraphics. 2002;22:S25–43.
Zylak CJ, Pallie W, Jackson R.  Correlative anatomy and computed 
tomography: a module on the mediastinum. RadioGraphics. 
1982;2(4):555–92.
Open Access  This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.
org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropri-
ate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in 
a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statu-
tory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
3 Approach to Imaging of Mediastinal Conditions in the Adult
37© The Author(s) 2019
J. Hodler et al. (eds.), Diseases of the Chest, Breast, Heart and Vessels 2019–2022, IDKD Springer Series, 
https://doi.org/10.1007/978-3-030-11149-6_4
Plain Film and HRCT Diagnosis 
of Interstitial Lung Disease
Sujal R. Desai, Helmut Prosch, and Jeffrey R. Galvin
There is little doubt that imaging tests have a central role in 
the investigation of patients with suspected and established 
diffuse interstitial lung diseases (DILD). In most cases, phy-
sicians who manage patients with DILD will request a plain 
chest radiograph. However, high-resolution computed 
tomography (HRCT) is usually indicated, particularly at the 
initial review. HRCT, for a variety of reasons discussed 
below, is superior to plain radiography. In many cases where, 
historically, biopsy might have been considered mandatory, 
there has been a paradigm shift because of HRCT. For exam-
ple, in some patients with idiopathic pulmonary fibrosis 
(characterized by the histological pattern of usual interstitial 
pneumonia), the HRCT appearance may be characteristic 
enough to render biopsy unnecessary [4, 22, 58]. In instances 
where a radiological diagnosis is not possible, HRCT may 
provide guidance as to the best site for surgical biopsy. More 
recently, HRCT has moved into the realms of prognostic 
evaluation and disease staging [11, 16, 56, 59].
4.1  The HRCT Technique
In the era of multi-detector row CT machines, a brief 
reminder of the HRCT technique is pertinent. The two tech-
nical features that differentiate HRCT imaging from conven-
tional CT are, first, the narrow x-ray beam collimation that 
significantly improves spatial resolution and, second, the use 
of a dedicated reconstruction algorithm [35]. The “high- 
frequency” algorithm effectively exaggerates the naturally 
high-contrast milieu of the lungs (i.e., aerated lung versus 
more solid elements) [35]. The conspicuity of vessels, small 
bronchi, and interlobular septa is increased compared to con-
ventional (thick-section) CT images [38]. An important 
downside of high-frequency algorithms is the increased vis-
ibility of image noise, although, in practice, this generally 
does not hamper radiological interpretation.
4.2  HRCT in Diffuse Interstitial Lung 
Disease
The term DILD is a convenient “catch-all” for a heteroge-
neous group of disorders (Table 4.1) [4]. The DILDs have 
been subcategorized as follows: (a) DILDs that have a 
known etiology (e.g., secondary to exposure to certain drugs 
or a connective tissue disorder); (b) the idiopathic intersti-
tial pneumonias (which themselves have undergone classifi-
cation [5] and a more recent update [52]); (c) the 
granulomatous DILDs; and (d) a group of diffuse lung dis-
eases that include Langerhans cell histiocytosis and 
lymphangioleiomyomatosis.
In patients with established diffuse lung disease, HRCT 
will not only detect but also characterize parenchymal abnor-
malities with greater accuracy than plain chest radiography. 
One important caveat is that in patients with nodular infil-
trates, traditional “interspaced” HRCT images may mislead; 
on thin-section images, the dimensions of nodules and pul-
monary vessels may be comparable, which makes distinction 
difficult [47]. This is unlikely to be an issue on thin-section 
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volumetric acquisitions. In practice, the range of CT features 
that commonly indicate the presence of ILD is relatively lim-
ited. Thus, radiologists will typically encounter some combi-
nation of reticulation, ground-glass opacification, 
honeycombing, dilatation of airways in regions of reticula-
tion and ground-glass opacification (‘traction bronchiecta-
sis’), nodules, and thickening of the interlobular septa [17].
Findings at HRCT generally reflect the macroscopic 
abnormalities seen by the pathologist. This was elegantly 
demonstrated in the very early days of HRCT by Müller and 
colleagues who showed that morphologic features in patients 
with idiopathic pulmonary fibrosis—at that time still known 
by the moniker “cryptogenic fibrosing alveolitis”—reflected 
the histopathological changes [37]. A reticular pattern was 
seen in seven of nine patients and corresponded to areas of 
irregular fibrosis at microscopy.
Not surprisingly, because there is no anatomical superim-
position, the sensitivity of HRCT is better than that of chest 
radiography. However, a more important issue than sensitiv-
ity is the confidence and accuracy with which a diagnosis can 
be made. In the oft-quoted landmark study by Mathieson and 
colleagues, experienced chest radiologists were asked to 
independently indicate up to three diagnoses, on chest radio-
graphs and CT, in 118 patients with a variety of biopsy- 
confirmed ILDs [34]. Importantly, for the first-choice 
diagnosis, readers were asked to assign a level of confidence. 
The first important finding of this study (which effectively 
put HRCT on the map), was that, compared with chest radi-
ography, a confident diagnosis was made nearly twice as 
often with HRCT. The second, and perhaps more striking, 
message was that when experienced radiologists were confi-
dent of the diagnosis on HRCT, they were almost always cor-
rect [34]; by contrast, a confident diagnosis on chest x-ray 
(which, incidentally, was offered in only one-quarter of 
cases) was associated with a significantly lower rate of cor-
rect diagnoses.
The results of subsequent studies have not always mir-
rored those of the initial study by Mathieson [34, 42]. 
However, because of study design, the majority of the com-
parative studies in HRCT likely undervalued its true utility 
[58]: first, there was no recourse to pretest probabilities for 
observers in early series, and, therefore, these do not accu-
rately reflect clinical practice. Second, radiologists (and spe-
cifically those with an interest in thoracic disease) have 
become increasingly familiar with the spectrum of HRCT 
patterns and disease. This, almost certainly, would be associ-
ated with a proportionate increase in the confidence of expe-
rienced observers in making HRCT diagnoses, were such a 
study to be repeated today. Some justification for this last 
statement comes from a study that addressed the clinically 
vexing issue of “end-stage” lung disease [43], in which two 
experienced thoracic radiologists independently made cor-
rect first-choice diagnoses in just under 90% of cases with 
nearly two-thirds being made with high confidence. On first 
inspection, these data seem less than impressive. However, 
the results of open lung biopsy (the supposed “gold- standard” 
for the diagnosis of DILD) are often inconclusive, in part, no 
doubt, relating to the degree of observer variability between 
pathologists [39].
4.3  An Approach to HRCT Diagnoses
It may come as some comfort to delegates that HRCT inter-
pretation can be difficult, even for trained thoracic radiolo-
gists! This is not surprising given the sheer numbers of 
documented DILDs. This wide spectrum of disorders mani-
fests with a relatively small number of histopathological pat-
terns (e.g., fibrosis, consolidation, intra-alveolar hemorrhage), 
which, in turn, are reflected by a similarly select group of 
HRCT features (i.e., reticulation, ground-glass opacification, 
nodularity, thickening of interlobular septa). However, with a 
Table 4.1 Classification of diffuse interstitial lung diseases (DILD)
DILD with known cause
 • Connective tissue disorders
 • Rheumatoid arthritis
 • Asbestosis
 • Hypersensitivity pneumonitis
 • Others
Idiopathic interstitial pneumonias
• Idiopathic pulmonary fibrosis
 • Idiopathic non-specific interstitial pneumonia
• Respiratory bronchiolitis interstitial lung disease
 • Desquamative interstitial pneumonia





 • Hypersensitivity pneumonia
 • Drug-induced DILD
• Combined variable immune deficiency syndrome
• Others
Other DILD
 • Langerhans cell histiocytosis
• Lymphangioleiomyomatosis
• Lymphoid interstitial pneumonia




• HRCT is the modality of choice for the investiga-
tion of patients with a suspected DILD.
S. R. Desai et al.
39
systematic approach to HRCT interpretation, the observer 
should, in time, be able to offer a sensible (and manageably 
short) list of differential diagnoses. To this end, a proposed 
schema, presented in the form of questions that the observer 
should ask (in roughly the order given), is provided as 
follows.
4.3.1  Is There a “Real” Abnormality?
This is a crucial first question: the radiologist must first 
determine whether what is shown on HRCT represents 
real disease. CT features attributable to technical factors/
normal variation (for instance, caused by a poor inspira-
tory effort, inadequate mAs, regions of physiologically 
dependent atelectasis) must not be overinterpreted and 
reported as “disease.” Making the distinction between 
normality and abnormality can also be difficult when 
there is apparently minimal disease or, conversely, when 
there is diffuse abnormality (e.g., subtle but widespread 
decreased [mosaicism] or increased [ground-glass opac-
ity] attenuation).
4.3.2  If There Is An Abnormality, What Is/Are 
the Predominant HRCT Pattern(s)?
Having decided that there is a definite abnormality on HRCT, 
the observer should attempt to identify the dominant 
pattern(s) using only the standard radiological terms [17]. 
The use of nonstandard terminology (e.g., patchy opacifica-
tion, parenchymal opacities), or descriptive terms in which 
there is an implied pathology (e.g., interstitial pattern or 
alveolitis) is misleading and best avoided.
4.3.3  What Is the Distribution of Disease?
Many DILDs have a predilection for certain zones. Therefore, 
an evaluation of dominant distribution is of diagnostic value. 
For instance, it is known that, in the majority of patients with 
idiopathic pulmonary fibrosis (IPF), disease tends to be most 
obvious in the mid- to lower zones. This contrasts with fibro-
sis in patients with sarcoidosis, which typically has a predi-
lection for the upper lobes. In addition to this, the radiologist 
should take note of the axial distribution (i.e., central versus 
peripheral), which, in contrast to CXR, can readily be made 
on HRCT, is of potential value. Using the example of IPF 
and sarcoidosis again, the former is commonly peripheral 
(subpleural), whereas, in the latter, disease tends to be cen-
tral (and bronchocentric). A final example is seen in patients 
with organizing pneumonia where consolidation may have a 
striking perilobular predilection [53].
In addition to zonal distribution, the distribution on the 
level of the secondary pulmonary nodule can also be of 
diagnostic value. This is particularly true for micronodular 
diseases in which the allocation of nodules to one of the 
three distribution types (centrilobular, perilymphatic, ran-
dom) is of use to narrow the differential diagnosis 
(Table 4.2).
4.3.4  Are There Any Ancillary Findings?
Ancillary HRCT features may suggest or, indeed, exclude 
certain diagnoses. Thus, the presence or absence of the fol-
lowing may be of diagnostic value in specific cases:
 1. Pleural thickening/effusions/plaques (± calcification)—
may suggest asbestos-related lung disease as opposed to 
IPF as a possible cause of lung fibrosis.
 2. Lymph node enlargement (hilar/mediastinal)—reactive 
intrathoracic nodal enlargement is a recognized “normal” 
in fibrotic DILDs. However, symmetrical hilar nodal 
enlargement may suggest a diagnosis of sarcoidosis or 
occupational lung disease. Intrathoracic nodal enlarge-
ment is uncommon in pulmonary vasculitis (e.g., 
Wegener’s granulomatosis).
 3. Bronchiectasis—coexistent suppurative airway disease in 
a patient who has established pulmonary fibrosis may 
point to a diagnosis of an underlying connective tissue 
disease, such as rheumatoid arthritis.
 4. A dilatation of the esophagus in a patient with CT find-
ings suggesting a non-specific interstitial pneumonia 
points toward scleroderma as the underlying disease.
Table 4.2 Differential diagnosis of micronodular diseases based on 
the distribution type
Centrilobular distribution
 • Bronchial diseases
  – Infections
  – Hypersensitivity pneumonia
  – Respiratory bronchiolitis
  – Follicular bronchiolitis
• Vascular diseases
  – Pulmonary edema
  – Vasculitis
  – Pulmonary hypertension
  – Metastatic calcification
Perilymphatic distribution
 • Sarcoidosis
 • Lymphangitic carcinomatosis
 • Pneumoconiosis
Random distribution
 • Miliary TB
 • Viral infections
 • Metastases
4 Plain Film and HRCT Diagnosis of Interstitial Lung Disease
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4.3.5  What Is the Likely Pathology?
A knowledge of the relationships between HRCT appear-
ance and the possible histopathological correlates is crucial. 
Thus, in a patient with predominant consolidation, it is rea-
sonable to conclude that the dominant pathology involves the 
air spaces, whereas, with reticulation, the pathological pro-
cess likely affects the interstitium.
4.3.6  What Is the Clinical Background?
Clinical data must always be integrated when formulating a 
radiological opinion. However, it is often advisable to review the 
clinical information after the evaluation of radiological features. 
This is particularly true at the very start of HRCT interpretation 
when the radiologist is deciding whether or not there is a “real” 
abnormality (see above). Specific clinical features that may be 
of importance in HRCT interpretation include basic demo-
graphic data (age, gender, ethnicity), potential exposures (smok-
ing history, contact with animals, occupation), the time course of 
the illness (i.e., have symptoms developed over hours and days 
or weeks and months?), and any relevant past medical history.
4.4  HRCT Appearances in Select DILDs
A working knowledge of the relationship between histopath-
ological changes and HRCT patterns and the typical appear-
ance of common DILDs is of value in day-to-day practice. 
The following section briefly considers the HRCT appear-
ance in a few DILDs.
4.4.1  Usual Interstitial Pneumonia/Idiopathic 
Pulmonary Fibrosis
Usual interstitial pneumonia (UIP) is the most common form 
of chronic fibrosing lung diseases. At low-power microscopy, 
there is temporally heterogeneous fibrosis admixed with areas 
of unaffected lung [4]. In areas of fibrosis, there will be char-
acteristic honeycombing. The disease has a striking basal and 
subpleural predilection. UIP can be caused by a variety of dis-
eases, including connective tissue diseases, chronic hypersen-
sitivity pneumonia, pneumoconiosis, and, in rare cases, also 
by sarcoidosis. The most common cause of UIP, however, is 
idiopathic pulmonary fibrosis (IPF), in which no underlying 
diseases can be diagnosed [45]. IPF is the most common IIP, 
and, with a median survival from time-to-diagnosis between 2 
and 3 years, the one with the worst prognosis [45]. As current 
treatments are considered to prolong survival, a timely and 
confident diagnosis of IPF is of paramount importance.
To make a diagnosis of a ‘UIP pattern’ on HRCT, the radi-
ologist must, therefore, look for the following: i) a reticular 
pattern; ii) honeycombing (with or without traction bronchi-
ectasis); and iii) a subpleural, basal distribution of disease 
[45]. The radiologist must also ensure that there are no 
changes to suggest other diagnoses (i.e., mid/upper zone pre-
dominance, a peribronchovascular predominance with sub-
pleural sparing, extensive pure ground-glass, widespread 
micronodularity, multiple cysts [away from areas of honey-
combing], and extensive mosaic attenuation with extensive 
sharply defined lobular air-trapping on expiration and con-
solidation) [31] (Fig. 4.1). In the absence of honeycombing 
(but with the other features listed above), an HRCT diagno-
sis of ‘probable UIP’ can be made.
a b
Fig. 4.1 Axial (a) and coronal (b) reformations of a 72-year-old female 
patient with progressive dyspnea on exertion. There are reticular abnor-
malities and honeycombing with basal and subpleural abnormalities. As 
there are no changes to suggest other diagnoses, the diagnosis of UIP 
can be made without histological confirmation
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The presence of a UIP pattern on HRCT is accurate and 
obviates histologic confirmation [22, 31, 44, 46]. In patients 
with a CT pattern of a “probable UIP” and a high clinical 
likelihood of IPF (age >60 years, current or former smoker, 
no other potential causes of fibrosis), a confident diagnosis 
of IPF can be made without a biopsy [31]. However, atypical 
appearances may be present in over half of patients with 
biopsy-proven disease [13, 50].
4.4.2  (Cryptogenic) Organizing Pneumonia
Organization is a common response to lung injury and is part 
of the normal process of lung repair. It is represented on histol-
ogy by plugs of fibroblastic tissue that fill the alveolar spaces. 
This same fibroblastic tissue may be identified in respiratory 
and terminal bronchioles, explaining the use of the older term 
“bronchiolitis obliterans organizing pneumonia” (BOOP), but 
which has been replaced by organizing pneumonia (OP) [5]. 
Organizing pneumonia was first recognized in 1923 as a 
response to unresolved pneumonia [51]. Most cases are likely 
to be post-infectious; however, the pathogen is rarely recov-
ered. The OP pattern is also a common feature in a wide range 
of other diseases including collagen vascular disease, hyper-
sensitivity pneumonitis, chronic eosinophilic pneumonia, 
drug reaction, and radiation- induced lung injury. The appear-
ance of OP on imaging is highly variable depending on the 
prior injury and the stage at which it is imaged [26]. A minor-
ity of cases present as solitary pulmonary nodules or focal 
areas of consolidation. However, the dominant finding in OP 
is bilateral consolidation that is peripheral, often with sparing 
of the subpleural portion of the lung (Fig. 4.2). Opacities are 
often perilobular and may be associated with septal lines. In 
some patients, OP may progress to an NSIP pattern of fibrosis. 
Although many patients with OP will clear with steroids, a 
substantial minority are left with significant disability due to 
pulmonary fibrosis [3, 26, 29].
Most cases of OP respond quite rapidly to steroid treat-
ment. Recurrences are frequently observed, particularly in 
patients subsequent to a too-short steroid treatment.
4.4.3  Non-specific Interstitial Pneumonia
After UIP, non-specific interstitial pneumonia (NSIP) is 
the most common pattern of idiopathic interstitial pneu-
monias (IIP) and is associated with a better rate of survival 
[12, 13, 52]. This pattern of IIP may be idiopathic but, 
more commonly, is seen in a variety of clinical contexts, 
including connective tissue disorders (especially systemic 
sclerosis) and as a consequence of drug-related toxicity. At 
a histologic level, there are varying amounts of interstitial 
inflammation and fibrosis, which, in stark contrast to what 
is seen in UIP, have a temporally and spatially uniform 
appearance.
On HRCT, one of the key findings is ground-glass 
opacification, which is typically bilateral and symmetri-
cally distributed in the lower zones [12, 33] (Fig. 4.3). A 
(relative) sparing of the subpleural space is seen in up to 
43% of the cases [49]. In some patients, over time, the 
extent of ground- glass may decrease and become replaced 
by reticulation (i.e., with UIP-like features) [49]. 
Reticulation (generally without significant honeycombing) 
is usually also present.
Fig. 4.2 Axial CT scan of a 64-year-old male patient with a treatment- 
resistant pneumonia. The CT scan shows bilateral peripheral consolida-
tion, with sparing of the subpleural portion of the lung. The findings are 
suggestive of an organizing pneumonia
Key Point
• Idiopathic pulmonary fibrosis is the most common 
IIP and a specific chronic, progressive, fibrosing 
interstitial pneumonia.
Key Point
• Organizing pneumonia is a non-specific response to 
lung injury and is characterized by a filling of the 
alveolar space with fibroblastic tissue.
Key Point
• NSIP is most commonly seen in patients with con-
nective tissue disorders and, on HRCT, is character-
ized by symmetrical, bilateral ground-glass 
opacification with a basal predominance.
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4.4.4  Smoking-Related Lung Diseases
Respiratory bronchiolitis (RB), of variable severity, is an 
almost invariable pathologic finding in all smokers [41]. 
Importantly, this pathologic lesion is asymptomatic and not 
associated with physiologic impairment in the vast majority 
of cases. However, in a small minority of cases, there will be 
the clinical manifestations of an interstitial lung disease—it 
is this clinico-pathologic/radiologic entity that has been 
called respiratory bronchiolitis interstitial lung disease 
(RBILD). The cardinal HRCT signs of RB/RBILD include 
“soft” centrilobular nodules, ground-glass opacification, 
smooth thickening of the interlobular septa, and lobular foci 
of decreased attenuation [10, 21, 36].
Desquamative interstitial pneumonia (DIP) was first 
described by Liebow in 1965. Dyspneic patients with DIP 
were found to have numerous inflammatory cells in the alve-
olar spaces [30]. The cells were thought to be desquamated 
pneumocytes but are now recognized as the same macro-
phages identified in patients with RB and RB-ILD; the 
majority of patients with DIP are heavy smokers, and it is 
now considered part of the spectrum of inflammatory lung 
disease related to the inhalation of cigarette smoke [21]. 
Patients with DIP suffer an increased incidence of pulmo-
nary fibrosis that fits the histologic pattern of NSIP [9, 60]. 
Imaging in patients with DIP is typified by homogeneous or 
patchy areas of ground-glass opacity in the mid and lower 
lung zones [9, 20].
In adults, Langerhans cell histiocytosis (LCH) is isolated 
to the lungs in approximately 90% of cases. Although the 
pathogenesis is unknown, almost all of the patients are ciga-
rette smokers. PLCH is characterized by bronchiocentric 
collections of Langerhans cells admixed with a variety of 
other inflammatory cells, forming a stellate nodule [55]. 
Over time, infiltration of the airway wall results in damage to 
the airway wall and subsequent dilatation of the airway [23]. 
In the late stage of PLCH, small stellate scars are surrounded 
by emphysematous spaces. The imaging reflects the histo-
logic progression with early bronchiocentric nodules in the 
upper lobes, progressing to a combination of bizarre-shaped 
cysts and nodules [1, 28] (Fig. 4.4). In the final stages, the 
appearance may be indistinguishable from severe bullous 
emphysema.
It is important to recognize that findings of RB, DIP, pul-
monary LCH, and the NSIP pattern of fibrosis commonly 
coexist in biopsies of dyspneic smokers. Some of the histo-
logic changes are reflected on imaging, while others are 
below the resolution of chest computed tomography.
The relationship between cigarette smoke and fibrosis 
remains contentious [8, 10, 15, 24, 25, 61, 62]. Niewoehner’s 
original description of RB did not include fibrosis of the 
alveolar wall [41]. However, there is substantial support for 
a relationship between cigarette smoke exposure and a pat-
tern of alveolar wall fibrosis other than UIP [2, 6, 14, 24, 27, 
40, 57]. In our experience, there is a group of dyspneic ciga-
rette smokers who present with a combination of well- 
formed cystic spaces on computed tomography that follow 
the typical, upper lobe-predominant distribution of smoking- 
related emphysema, with variable surrounding ground-glass 
opacity and reticulation that may extend into the lower lung 
zones [15]. The patients commonly present with strikingly 
normal flows and volumes on pulmonary function testing 
and a low diffusing capacity. The unexpectedly normal flows 
and volumes are the result of the opposing effects of emphy-
sema and fibrosis [57].
4.4.5  Sarcoidosis
Noncaseating, epithelioid cell granulomata are the histopath-
ological hallmark of sarcoidosis. Granulomata distribute 
along the lymphatics. Thus, the lymphatic pathways that sur-
round the axial interstitium, which invests bronchovascular 
structures, and those that exist subpleurally (including the 
subpleural lymphatics along the fissures) are typically 
involved (Fig. 4.4). Not surprisingly, a nodular infiltrate (pre-
sumably reflecting conglomerate granulomata) with a pro-
pensity to involve the bronchovascular elements is a 
characteristic CT finding [7, 32]. Subpleural nodularity is 
also commonly seen. In the later stages of the disease, there 
Fig. 4.3 Axial CT scan of a 61-year-old female patient with known 
scleroderma. The CT scan shows symmetrical, peripheral, extensive 
ground-glass opacities, with a relative sparing of the subpleural space. 
The findings are highly suggestive of a non-specific interstitial pneumo-
nia (NSIP)
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may be obvious signs of established lung fibrosis with upper 
zone volume loss, parenchymal distortion, and traction bron-
chiectasis. Because of the bronchocentric nature of the dis-
ease, signs of small airways disease are seen at CT in some 
patients with sarcoidosis [18].
4.4.6  Hypersensitivity Pneumonitis
Exposure to a range of organic antigens will cause lung dis-
ease in some patients, probably due to an immunologically 
mediated response. In the subacute stage, there is an inter-
stitial infiltrate comprising lymphocytes and plasma cells, 
with a propensity for small airways (bronchioles) involve-
ment. Scattered noncaseating granulomata may be seen. 
Predictably, at CT, there is diffuse ground-glass opacifica-
tion, ill-defined centrilobular nodules and lobular areas of 
decreased attenuation on images performed at end- 
expiration [19, 48] (Fig. 4.5). The CT appearance in sub-
acute hypersensitivity pneumonitis may be identical to that 
in patients with respiratory bronchiolitis-associated inter-
stitial lung disease (RBILD) [10]. However, consideration 
of the smoking history may help in differentiation: a history 
of smoking is the norm in the vast majority of patients with 
RBILD, whereas cigarette smoke appears to lead to a rela-
tive protection against the development of hypersensitivity 
pneumonitis.
a b
Fig. 4.4 Chest radiograph (a) and axial CT scan (b) of a 23-year-old 
male patient with coughing and dyspnea on exertion, which shows thin- 
and thick-walled cysts with an upper lobe predominance. In addition to 
the cysts, the CT scans also show some ill-defined nodules. The find-
ings are highly suggestive of a Langerhans cell histiocytosis 
(LCH)
Fig. 4.5 Axial CT scan of a 19-year-old male patient with flu-like 
symptoms for some weeks. The CT scan shows countless ill-defined 
centrilobular nodules. The suspicion of an acute hypersensitivity pneu-
monia could be confirmed by a high lymphocyte count at bronchoscopy 
and by the history of exposure to mold
Key Point
• Sarcoidosis is a systemic granulomatous disease 
that most frequently manifests in the chest. 
Granulomata in sarcoidosis tend to follow a peri-
lymphatic distribution pattern, with a predominance 
in the upper lung zones.
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Chronic hypersensitivity pneumonia (CHP) is the conse-
quence of a prolonged or repetitive course of acute HP and is 
characterized by fibrotic changes on HRCT and/or histology 
[54]. On HRCT, CHP is characterized by the presence of 
reticular abnormalities and traction bronchiectasis, with a 
predominance in the upper and middle lung fields, and fre-
quently shows a peribronchovascular accentuation with sub-
pleural sparing [54]. Honeycombing is observed in up to 
69% of the cases [54]. Centrilobular nodules, air trapping, 
and/or a mosaic pattern in a patient with a fibrosing lung 
disease is a good clue to the diagnosis of CHP.
4.5  Concluding Remarks
HRCT plays a central role in the differential diagnosis of 
DILD. The final diagnosis requires a combination of radio-
logical, clinical, and serological information, which is best 
accomplished in an interdisciplinary discussion. In many 
cases, the diagnosis achieved in this way is so confident that 
a histopathological confirmation is not necessary.
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CT Diagnosis and Management of Focal 
Lung Disease
Gerald F. Abbott and Ioannis Vlahos
The diagnosis of focal lung disease has progressed in accu-
racy in recent decades, paralleling the technological advances 
of computed tomography (CT). In contrast to chest radiogra-
phy, the utilization of thin-section CT (HRCT) has enabled 
radiologists to more accurately determine the imaging char-
acteristics of individual lung lesions and guide patient man-
agement in a more precise manner.
Focal pulmonary opacities can be broadly categorized as 
nodules, masses, or focal parenchymal airspace disease. 
Nodules are characterized as spherical well-defined opacities 
measuring up to 3  cm. In practice, this definition also 
includes more ill-defined or irregular nodules that might be 
more appropriately considered “nodular opacities.” A mass 
is defined as an opacity (solid or partly solid) measuring 
>3 cm [1]. With its ability to evaluate the density and contour 
morphometry of nodules and masses, CT allows better char-
acterization of these findings, and the resulting CT densitom-
etry data may be supplemented by more specific CT 
techniques to determine enhancement (e.g., dual-energy 
CT), verify the evolution of findings by follow-up CT imag-
ing, assess physiologic activity (PET/CT), and ultimately 
guide fine-needle aspiration or biopsy.
5.1  Benign Solid Nodule Features
CT evaluation may reveal specific benign characteristics of a 
solitary pulmonary nodule including the identification of cal-
cification or fat within the nodule, aided by the utilization of 
thin-section contiguous images (1–3 mm) through nodules 
of interest. Although fat may be evident on visual inspection 
alone, measurements of fat with such technique should be 
less than −30 to −40HU and often are as low as −150HU 
(Fig. 5.1). Measurements should be performed using a suit-
able sized region of interest (ROI) that encompasses an area 
that is still within the nodule on the slices above and below 
the measured slice. This reduces the risk of an erroneously 
low measurement due to partial volume average effects of 
any adjacent low-density lung parenchyma.
There is no absolute Hounsfield unit (HU) measurement 
that confirms calcification although measurements of >200 
are usually related to pixels occupied by calcific material. 
Visual comparison to other thoracic osseous structures is con-
sidered sufficient for determining the calcific nature of 
lesions. The identification of diffuse, central, lamellated, or 
popcorn-type calcification in a pulmonary nodule is diagnos-
tic of a benign lesion—and all but the latter may be indicative 
of healed granulomatous disease. Popcorn-type calcification 
is considered characteristic of a pulmonary hamartoma and 
when found in combination with intralesional fat is consid-
ered diagnostic of that entity. Eccentric calcification is inde-
terminate—sometimes benign and related to granulomatous 
disease—but also occurring in malignant lesions such as 
bronchial carcinoid tumors. Occasionally, eccentric calcifica-
tion within a lung nodule or mass may reflect a small granu-
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Learning Objectives
• To learn the imaging features of benign and malig-
nant pulmonary nodules
• To learn the 2017 revised Fleischner Society guide-
lines for management of CT detected pulmonary 
nodules
• To understand the spectrum of subsolid pulmonary 
nodules, the serial evolution of ground-glass nod-
ules to mixed attenuation nodules, and the signifi-
cance of their solid components
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loma that has been engulfed within an enlarging adjacent 
neoplasm. Dystrophic or stippled calcifications are also inde-
terminate—sometimes benign—but well recognized to occur 
within bronchial carcinoid tumors, non-small cell lung can-
cer, and small cell carcinoma and are thus not a helpful dis-
criminator between benign and malignant nodules. It is 
important for radiologists to be familiar with these patterns of 
calcification that may occur within pulmonary nodules and 
mass lesions (Fig. 5.2). Furthermore, it is recommended that 
pulmonary nodules and masses be inspected on coronal and 
sagittal images in addition to routine axial images. This prac-
tice enables not just the verification of maximal lesion dimen-
sions but also clarifies such features as central versus eccentric 
calcification since the eccentric location of calcification may 
only be evident in those planes [2].
Other morphological features that are associated with 
benign lesions include a polygonal, elongated, elliptical, 
linear, or plaque-like shape, particularly when related to the 
fissures or pleural surfaces. Indeed such lesions are not all 
by definition strictly nodules. Some might be best character-
ized as scars, whereas triangular or elliptoid nodules may 
represent normal intrapulmonary lymph nodes. These find-
ings are reported with variable incidence by pathologists 
and similarly with variable incidence and confidence by 
radiologists.
On CT images, intrapulmonary lymph nodes manifest as 
perifissural nodules (PFNs) and are routinely demonstrated 
on thin-section chest CT. Typical PFNs are small (<10 mm) 
and more often located in the lower lobes, below the level of 
the carina. They characteristically have a lentiform, triangu-
lar, or polygonal shape with 1–3 interlobular septal exten-
sions and are located on or within 10  mm of the visceral 
a b c
Fig. 5.1 Hamartoma. Composite CT image of a pulmonary nodule in 
lung window (a) and soft-tissue window (b) shows a well- circumscribed 
nodule in the right upper lobe that appears heterogeneous on soft-tissue 
window (b). Region-of-interest (ROI) evaluation of Hounsfield units 




Fig. 5.2 Patterns of calcification. Benign patterns of calcification: (a) 
(central), (b) (popcorn), (c) (diffuse), and (d) (lamellated/concentric); 
and indeterminate patterns: (e) (eccentric) and (f) (stippled)
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pleura or a lung fissure (major, minor, or accessory) (Fig. 5.3) 
[3]. In a recent study, there was moderate inter-reader agree-
ment when classifying nodules as perifissural nodules [4]. 
Under the revised 2017 Fleischner Society guidelines for 
management of incidentally detected pulmonary nodules on 
CT, a PFN with a morphology consistent with an intrapulmo-
nary lymph node does not require follow-up CT, even if the 
average dimension exceeds 6 mm [5].
5.2  Malignant Solid Nodule Features
Specific features of malignancy are more common in larger 
pulmonary nodules but relatively uncommon in nodules 
<1 cm. Such imaging features as spiculation, microlobula-
tion, pleural tags, satellite nodules, and the presence of a 
bronchus leading directly into a nodule (“CT bronchus 
sign”) are associated with a higher probability of neoplastic 
disease although this finding may sometimes occur in 
inflammatory and infectious diseases, including mycobacte-
rial infection. Cavitation may be an imaging manifestation 
of neoplastic or infectious disease (including bacterial, 
mycobacterial, and fungal infections) as well as inflamma-
tory disease (e.g., vasculitides, pulmonary Langerhans cell 
histiocytosis). The detection of thicker-walled cavities on 
chest radiographs has historically been described as a fea-
ture favoring neoplasia, but CT evaluation of the wall thick-
ness of nodules or masses does not corroborate this earlier 
radiographic interpretation [6, 7].
5.3  Subsolid Nodules
Subsolid nodules include lesions that are of pure ground- 
glass attenuation on CT as well as those of mixed attenua-
tion—i.e., a combination of ground-glass and solid 
components. It is well recognized that subsolid lesions 
with these characteristics are associated with higher preva-
lence rates of malignancy than solid lesions, particularly 
when the lesion is of mixed attenuation [8]. Malignant 
subsolid nodules lie along a spectrum of disease that 
extends from the small (likely malignant precursor) lesion 
a b c d
Fig. 5.3 Perifissural nodule (PFN) morphology. Intrapulmonary 
lymph nodes (a–d) typically manifest as small perifissural nodules 
(<10 mm), more often in the lower lobes, with a lentiform, triangular, or 
polygonal shape with 1–3 interlobular septal extensions, and are located 
on or within 10  mm of the visceral pleura or a lung fissure (major, 
minor, or accessory). Their characteristic morphology may be more 
apparent on coronal or sagittal reformatted images
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of atypical adenomatous hyperplasia (AAH) through larger 
ground-glass nodules and mixed attenuation nodules to 
solid nodules of invasive adenocarcinoma (Fig. 5.4). This 
spectrum was elucidated by a reclassification of pulmo-
nary adenocarcinoma introduced jointly in 2011 by the 
International Association for the Study of Lung Cancer, 
the American Thoracic Society, and the European 
Respiratory Society [9]. This new classification was based 
on observations regarding the heterogeneity of subsolid 
neoplastic lesions, their characteristics of progression, and 
their clinical impact. These included the demonstration by 
Aoki and colleagues that AAH and the lower-stage lesions 
of what was previously termed bronchioloalveolar carci-
noma (BAC, Noguchi subtype A, B, C) were associated 
with lesions that were almost exclusively ground glass in 
nature. Conversely, the higher-grade lesions (Noguchi D, 
E, F) were associated with lesions that became progres-
sively more reticular, demonstrated traction bronchiolecta-
sis, and eventually developed increasing solid components 
[10, 11].
The current 2011 histopathologic classification replaces 
the lesion previously termed bronchioloalveolar carcinoma 
(BAC). Preinvasive lesions—AAH and adenocarcinoma in 
situ (AIS)—are typically pure ground-glass lesions less than 
5  mm and 3  cm, respectively, in size. Minimally invasive 
adenocarcinoma (MIA) is typically a part-solid lesion where 
the invasive component measures <5  mm. Larger subsolid 
lesions with more extensive solid invasive tumor are now 
termed lepidic predominant adenocarcinoma (LPA). Invasive 
multifocal mucinous adenocarcinoma replaces the entity 
previously termed multicentric BAC.
Multiple observers have documented that nodules of pure 
ground glass or those with minimal solid components typi-
cally progress at a very slow growth rate. In one study a com-
parison of mean volume doubling times in lung cancer 
patients with solid, part-solid, or pure ground-glass lesions 
demonstrated a stepwise increase in CT calculated volume 
doubling times (853 vs 457 vs 158 days) [12]. Therefore, the 
demonstration of 2-year stability of a subsolid lesion may 
not be enough to rule out malignancy. In such cases an initial 
follow-up CT at 3 months may be performed to demonstrate 
that the lesion persists and is not inflammatory. Follow-up 
may then be performed at more prolonged time intervals 
(1–2  years). When comparing these irregular ill-defined 
lesions, it can be difficult to measure incremental size, and 
evaluation should include comparison of comparable con-
tiguous thin-section images and evaluation of whether the 
ground glass or solid component geographically extends 
around more vessels or airways. It is also important to note 
that the natural evolution of these lesions may on occasion 
include a transient reduction in size, likely related to under-
lying alveolar collapse.
The definitive determination that a subsolid lesion is 
malignant can be problematic. A progressive increase in 
overall size or increase in size of the solid component favors 
malignancy. PET/CT imaging in these cases is often noncon-
tributory as it is well recognized that these lesions may have 
low SUV-max activity. Additionally, the evaluation of pre-
dominantly ground-glass lesions by CT-guided fine-needle 
aspiration or biopsy should be treated with caution. The 
results may be subject to significant sampling error and may 
vary significantly from those discovered in the excised speci-
men. The extent of invasive adenocarcinoma in particular 
can be significantly underestimated by percutaneous needle 
sampling even if this is directed to the more solid compo-
nents of a lesion.
a b c
Fig. 5.4 Nodule attenuation patterns. Composite CT image showing a 
spectrum of attenuation in three pulmonary nodules, ranging from pure 
ground-glass attenuation (a) to mixed attenuation (b) to solid (c). The 
solid components in nodules (b) and (c) correspond with areas of tumor 
invasion
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5.4  Indeterminate Pulmonary Nodules
The majority of nodules detected on CT imaging are indeter-
minate and do not manifest with imaging features that can be 
definitively categorized as benign or malignant. In a 2005 
Mayo Clinic screening series of over 1500 patients, over 
3300 indeterminate non-calcified nodules were identified, 
the vast majority of which were small (4 mm or less) and 
benign [13]. Even in established smokers, the risk of malig-
nancy in nodules of this size is less than 1% [14].
In recent years, evidence-based guidelines published by 
the Fleischner Society have greatly transformed the man-
agement of incidental pulmonary nodules detected on 
CT.  The initial Fleischner guidelines, published in 2005, 
focused on solid pulmonary nodules and were followed by 
specific guidelines for subsolid nodules in 2013. Those have 
been supplanted by revised guidelines published in 2017 
that encompass both solid and subsolid pulmonary nodules 
[5]. The recommended changes are based on new data and 
accumulated experience. For solid nodules, the minimum 
threshold size prompting routine follow-up CT has been 
increased to 6 mm, and fewer follow-up examinations are 
recommended for stable nodules. Time intervals for recom-
mended follow-up are now given as a range rather than a 
precise time period (Table 5.1). Patient risk factors have also 
been expanded beyond the previous parameters based on 
subject characteristics (smoking history, lung cancer in a 
first-degree relative, exposure to asbestos, radon, or ura-
nium) to include factors related to gender, race, lesion char-
acteristics (size, attenuation, spiculation, upper lobe 
location), multiplicity, and the presence of emphysema and/
or pulmonary fibrosis (IPF).
For subsolid nodules, a longer time period is now recom-
mended before initial CT follow-up, and the total length of 
follow-up has been extended to 5  years (Table  5.2). The 
revised Fleischner guidelines specify the use of contiguous 
thin-section CT (≤1.5 mm) and also stress the importance of 
utilizing axial, coronal, and sagittal images to facilitate the 
distinction between nodules and linear opacities that can be 
misleading when only axial images are evaluated (Fig. 5.5).
It is important to note that these guidelines apply to the 
management of incidentally detected solid and subsolid pul-
monary nodules but do not apply to patients younger than 
35  years, immunocompromised patients, or patients with 
cancer. The revised Fleischner guidelines are also not 
intended for use in lung cancer screening programs. For 
screening purposes, adherence to the existing American 
College of Radiology Lung CT Screening Reporting and 
Data System (Lung-RADS) guidelines is recommended.
Table 5.1 Revised Fleischner guidelines (2017) for solid nodules
Nodule 
type Low risk High risk
Single
<6 mm
No routine follow-up Optional CT at 12 months
Single
6–8 mm
CT at 6–12 months, then 
consider CT at 
18–24 months




Consider CT, PET/CT or 
tissue sampling at 3 months
Consider CT, PET/CT, or 
tissue sampling at 3 months
Multiple
<6 mm
No routine follow-up Optional CT at 12 months
Multiple
6–8 mm
CT at 3–6 months, then 
consider CT at 
18–24 months




CT at 3–6 months, then 
consider CT at 
18–24 months
CT at 3–6 months, then CT 
at 18–24 months
MacMahon H, Naidich DP, Goo JM et  al. (2017) Guidelines for 
Management of Incidental Pulmonary Nodules Detected on CT Images: 
From the Fleischner Society. Radiology 284:228–243.








CT at 6–12 months to confirm 






CT at 3–6 months to confirm 
persistence. If unchanged and solid 
component remains <6 mm, annual 
CT should be performed for 5 years
Multiple CT at 3–6 months. 
If stable, consider 
CT at 2 and 4 years
CT at 3–6 months. Subsequent 
management based on the most 
suspicious nodule(s)
MacMahon H, Naidich DP, Goo JM et  al. (2017) Guidelines for 
Management of Incidental Pulmonary Nodules Detected on CT Images: 
From the Fleischner Society. Radiology 284:228–243.
Key Points
• CT evaluation may reveal specific benign character-
istics of a solitary pulmonary nodule including the 
identification of calcification or fat within the 
nodule.
• The identification of diffuse, central, lamellated, or 
popcorn-type calcification in a pulmonary nodule is 
diagnostic of a benign lesion.
• Subsolid nodules include lesions that are of pure 
ground-glass attenuation on CT as well as those of 
mixed attenuation—i.e., a combination of ground- 
glass and solid components.
• Subsolid nodules are associated with higher preva-
lence rates of malignancy than solid lesions when 
the lesion is of mixed attenuation.
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In a separate published statement from the Fleischner 
Society, recommendations were made regarding the mea-
surement of pulmonary nodules detected on CT images [15]. 
Those recommendations specify that measurements should 
be performed on axial sections unless the maximal dimen-
sions lie in the coronal or sagittal plane. In those instances, 
the measurements should be made on the respective plane 
and that information should be documented in the radiologic 
report. Detected lung nodules—including the solid portion 
of part-solid nodules—should be measured on lung window 
images, and the dimension of small pulmonary nodules 
(<10 mm) should be expressed as the average of maximal 
long-axis and perpendicular maximal short-axis measure-
ments obtained in the same plane (Fig. 5.6a). Both long- and 
short-axis measurements should be recorded for larger nod-
ules and masses. Part-solid nodules should be measured in a 
similar fashion (average of long and short dimensions) 
including ground-glass and cystic components, and the max-
imum diameter of a solid component should also be recorded 
if >3 mm (Fig. 5.6b). It is also recommended that a pulmo-
nary nodule be determined to have changed in size when its 
average diameter has increased or decreased by at least 
2 mm, as smaller changes can be spurious—especially for 
ill-defined nodules.
5.5  Role of Computer-Assisted Diagnosis 
for Solid Nodules
Computer-aided detection (CAD) is known to improve the 
detection of pulmonary nodules, although sensitivity is 
known to be dependent on lesion characteristics including 
size, density, and location. Technical parameters also affect 
sensitivity including the thickness of evaluated CT images 
and vendor-specific issues related to CT algorithm optimiza-
tion to effect high detection rates with acceptable false- 
positive detection rates. Most CAD systems are also 
accompanied by computer-aided diagnosis (CADx) features 
for the evaluation of pulmonary nodules.
One of the most useful CADx tools is the ability to per-
form segmentation of individual nodules, enabling a 
three- dimensional evaluation of the size and shape of nod-
ular lesions that can be compared with follow-up exami-
nations to determine volumetric growth. This is based 
upon the observation that the doubling time of benign 
lesions is far longer than that of malignant lesions [16]. 
Volumetric evaluation of growth is also more reliable than 
reader applied uni- or bidimensional measurements of 
size [17]. Moreover, volumetric evaluation may be more 
sensitive to the detection of asymmetric growth, a feature 
that is characteristic of malignant lesions (Fig.  5.7). A 
commonly utilized threshold for solid lesion volume 
a b
Fig. 5.5 Linear structure misinterpreted as a semisolid nodule. A het-
erogeneous focal opacity on axial CT ((a), arrow) was reported as a 
“mixed attenuation nodule,” described as “suspicious for lung cancer,” 
and a 3-month follow-up CT was recommended. On sagittal imaging 
(b), the corresponding finding is a linear opacity (arrow), likely an 





Average = 5 mm Average = 8 mm
Solid component = 4 mm
6 mm
10 mm
Fig. 5.6 Nodule measurement technique. The size of a solid nodule 
should be expressed as the average of maximal long-axis and perpen-
dicular maximal short-axis measurements obtained in the same plane 
(a). Subsolid nodules should be measured in a similar fashion (average 
of long and short dimensions) including ground-glass and cystic com-
ponents, and the maximum diameter of a solid component should also 
be recorded if >3 mm (b)
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doubling time is 400 days although several authors have 
advocated a more stringent threshold of 500 days [18–20]. 
The accuracy and reproducibility of lung nodule segmen-
tation has been confirmed in artificial and porcine models. 
However, the reproducibility of in  vivo human nodule 
measurements can be demonstrated to vary by up to 15% 
when evaluating the same nodule in different phases of 
inspiration or by utilizing different thickness CT data or 
software packages [21]. Lesser changes may occur as a 
result of different reconstruction algorithms or dose varia-
tion. The presence or absence of intravenous contrast 
appears to play a largely inconsequential role. Nonetheless, 
by ensuring that a similar technique is employed on initial 
and follow- up examinations, lung nodule volumetry 
shows great promise and may further reduce the need for 
follow-up examinations.
5.6  Focal Parenchymal Airspace Disease
A variety of disease entities may manifest on CT as focal 
airspace opacities. The majority of these will be multifocal 
and infectious or inflammatory in nature, and the diagnosis is 
often impossible to determine on the basis of imaging find-
ings alone unless there are uncommon specific features pres-
ent (e.g., ground-glass halo in invasive aspergillosis). 
However, the differential diagnosis may be narrowed by 
referring to a combination of imaging features, disease chro-
nicity or progression, response to treatment, and the immune 
status of the patient.
The presence of cavitation in airspace disease can be 
helpful although the differential can again be broad incor-
porating staphylococcal or gram-negative bacterial infec-
tions, mycobacterial disease, or fungal infection. Rounded 
pneumonia is commoner in children but also occurs in 
adults, usually due to S. pneumoniae. Appearances are 
mass-like without air bronchograms resulting from propa-
gation of disease through the collateral air-drift mecha-
nisms of the pores of Kohn and the canals of Lambert. 
Focal consolidative opacity that is chronic may be charac-
terized by associated findings of mild volume loss and trac-
tion bronchiectasis, these features being more common in 
patients with chronic eosinophilic lung disease or organiz-
ing pneumonia. The latter may also present with a “reverse 
halo” appearance (i.e., central ground-glass opacity with 
peripheral consolidation) although this appearance is not 
specific to organizing pneumonia and may be a manifesta-
tion of other disease processes, including pulmonary infarc-
tion. At times, progressive focal airspace disease may be 
manifestation of neoplastic disease including lepidic ade-
nocarcinoma, lymphoma, or occasionally mucinous metas-
tases from a gastrointestinal primary tumor. Calcification 
may be present in mycobacterial disease and occasionally 
amyloidosis.
5.7  Dual-Energy CT (DECT)
Recent advances in technology have enabled the clinical 
implementation of dual-energy CT (DECT)—a technique 
that utilizes the near-simultaneous acquisition of CT images 
at two x-ray energy levels—high and low kilovoltages. 
Modern CT scanners, especially those with tube-current 
modulation capabilities, have resolved earlier concerns about 
DECT regarding increased radiation dose. The capabilities 
of DECT include the creation of virtual unenhanced images 
(allowing differentiation of calcifications, talc, and enhanced 
thoracic structures) and the acquisition of pulmonary blood 
volume (PBV) images that allow differentiation of various 
parenchymal abnormalities including infarcts, atelectasis, 
a bFig. 5.7 Adenocarcinoma of the lung. Composite image of 
computer-aided 3-D 
volumetric evaluation of an 
irregular pulmonary nodule at 
baseline (a) and 11 months 
later (b) demonstrating 
asymmetric growth
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and pneumonia (Fig.  5.8). Other applications include 
enhanced capabilities in pulmonary arterial enhancement 
and diagnosis of pulmonary embolism with a reduced vol-
ume of contrast material [22].
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Take-Home Message
• The identification of diffuse, central, lamellated, or 
popcorn-type calcification in a pulmonary nodule is 
diagnostic of a benign lesion.
• Subsolid nodules are associated with higher preva-
lence rates of malignancy than solid lesions, par-
ticularly when the lesion is of mixed attenuation.
• Under the revised 2017 Fleischner Society guide-
lines for solid pulmonary nodules, the minimum 
threshold size prompting routine follow-up CT has 
been increased to 6 mm.
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Current Approach to Acute and Chronic 
Airway Disease
Philippe A. Grenier and Jeffrey P. Kanne
6.1  CT Acquisition and Post-processing 
Techniques [1, 2]
MDCT acquisition is performed through the entirety of the 
lungs at full-suspended inspiration, using thin collimation 
(0.6–1.5  mm) without administration of contrast material. 
Axial images are reconstructed with thin-slice thickness 
(0.8–1.5  mm) and overlap (50% overlap is optimal). 
Complementary MDCT acquisition at full continuous forced 
expiration using reduced technique (120 Kv–20–40 mAs) is 
often recommended and particularly useful for assessing tra-
cheobronchial collapsibility and expiratory air trapping.
Interpretation is best performed on a PACS workstation. 
Evaluation of the overlapped thin-section axial images in 
cine-mode allows the bronchial divisions to be easily followed 
from the carina to the smallest peripheral bronchi visible on 
CT. Real-time manipulation of the data set allows the radiolo-
gist to select the optimal plane to better depict the distribution 
and extent of airway abnormalities. Furthermore, multiplanar 
reformations with use of minimum and maximum intensity 
projections can be helpful to display airway abnormalities. 
Minimum intensity projection (minIP) can highlight airway 
dilation, diverticula, fistulas, and the extent of expiratory air 
trapping and emphysema. Maximum intensity projection 
(MIP) accentuates foci of mucoid impaction and small centri-
lobular nodules and tree-in-bud opacities. Volume rendering 
techniques (CT bronchography) can segment the airway 
lumen-wall interface and can be useful to detect subtle 
changes in airway calibre and to facilitate understanding of 
complex tracheobronchial abnormalities. Virtual bronchos-
copy provides an internal rendering of the tracheobronchial 
inner surface and can better depict subtle mucosal abnormali-
ties such as neoplasia and granulomatous disease.
6.2  Tracheobronchial Tumours  
(Tables 6.1, 6.2, 6.3, and 6.4) [3–6]
6.2.1  Primary Malignant Neoplasms
Primary malignant neoplasms are rare in the trachea com-
pared to the laryngeal or bronchial cancers. The most fre-
quent histological types are squamous cell carcinoma and 
adenoid cystic carcinoma, accounting for nearly 80% of all 
tracheal neoplasms. Adenoid cystic carcinoma (sialadenoid 
neoplasm) is a low-grade malignancy that is not associated 
with cigarette smoking. It occurs in patients in their 40s 
without any sex predilection. In the central airways, adenoid 
cystic carcinoma has a propensity to infiltrate the wall of the 
airways with submucosal extension manifesting as a sessile, 
polypoid, annular, or diffuse infiltration. The inner surface is 
smooth and regular. An extraluminal growth, visible on CT 
scan, is a common feature. Squamous cell carcinoma is the 
most common primary malignancy of the trachea primarily 
occurring in older men with a history of cigarette smoking. 
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Learning Objectives
• To remind the basic principles of volumetric thin- 
collimation CT technique permitting to obtain an opti-
mized evaluation of central and peripheral airway
• To know the CT features of most of the diseases 
involving the trachea and central bronchi
• To know the diagnostic criteria to identify the pres-
ence, distribution, and extent of bronchiectasis
• To know the direct and indirect CT features sugges-
tive of inflammation, infection, and obstruction of 
small airways
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On CT, the tumour appears as a polypoid intraluminal mass 
or as an eccentric irregular wall thickening with an irregular 
surface. The tumour has a tendency to spread to adjacent 
mediastinal lymph nodes and to directly invade the mediasti-
num. Carcinoid tumour is a low-grade malignant neuroendo-
crine neoplasm representing 1–2% of primary lung neoplams. 
It appears on CT scan as a well-circumscribed polypoid mass 
that protrudes into the airway lumen. Segmental or lobar 
atelectasis and obstructive pneumonitis, as well as foci of 
calcification are present in 30% of cases. Marked homoge-
neous early contrast enhancement of an endobronchial nod-
ule reflecting the high vascularity of this neoplasm may be 
present. Mucoepidermoid carcinoma is a rare neoplasm that 
originates from the minor salivary glands lining the tracheo-
bronchial tree, occurring in young patients (<40 years old), 
found mainly in the segmental bronchi and resulting in air-
way obstruction. The typical CT appearance is a smooth, 
ovoid, or lobulated endobronchial mass with occasional 
punctuate calcifications and variable contrast enhancement. 
Lymphoma of the trachea is rare, usually related to mucosa- 
associated lymphoid tissue. The CT appearance is indistin-
guishable from other neoplasms.
6.2.2  Secondary Tracheobronchial 
Malignancy
Direct invasion of the central airways by neoplasm of the 
thyroid, oesophagus, lung, and larynx is much more com-
mon that haematogenous metastases. CT shows the primary 
neoplasm and its extension by contiguity within the main 
airways (endoluminal mass, destruction of cartilage, and 
tracheobronchial-oesophageal fistula).
Many cancers have the potential to metastasize to the trachea 
and bronchi. Endotracheal or endobronchial metastases appear 
as endotracheal nodules or eccentric thickening of the airway 
wall or soft tissue attenuation with contrast enhancement.
6.2.3  Benign Tracheobronchial Neoplasms
Benign tracheal neoplasms are rare. On CT, they present as 
endoluminal masses confined within the tracheobronchial 
lumen without evidence of involvement of surrounding 
structures. Benign neoplasms are typically sharply margin-
ated, round, and smaller than 2  cm in diameter. Histology 
mainly includes hamartomas, lipomas, leiomyomas, fibro-
mas, chondromas, and schwannomas. Endobronchial hamar-
tomas represent 30% of intrathoracic hamartomas. The 
presence of fat with or without calcification is diagnostic.
Respiratory papillomatosis (laryngotracheobronchial 
papillomatosis) is a neoplastic disease caused by human pap-
illomavirus (HPV) infection transmitted from mother to 
child at birth or acquired from orogenital contact. Papillomas 
arise in the larynx and can involve trachea and proximal 
bronchi in up to 50% of cases. Involvement of the lungs is 
rare, occurring in fewer than 1% of patients, and manifests 
on imaging studies as multiple lung nodules and cavitary and 
cystic lesions in the parenchyma. Malignant transformation 
into squamous cell carcinoma is a rare but serious complica-
tion of respiratory papillomatosis.
6.3  Nonneoplastic Tracheobronchial 
Disorders (Tables 6.2, 6.3, and 6.4) [4, 5, 7]
6.3.1  Posttraumatic Stenosis
Posttraumatic strictures of the trachea are usually the result 
of ischemic injury from a cuffed endotracheal or tracheos-
tomy tube or extrinsic neck trauma. The two principal sites 
of stenosis following intubation or tracheostomy tube are at 
Table 6.1 Luminal filling defect
• Benign tracheobronchial neoplasm





Table 6.2 Multinodular appearance of the inner surface of the airway
• Granulomatosis with polyangiitis
• Tracheobronchial metastases (haematogenous spread)
• Respiratory papillomatosis
• Adenoid cystic carcinoma (multicentric)
• Tracheobronchial amyloidosis
• Tracheobronchopathia osteochondroplastica
Table 6.3 Focal tracheobronchial narrowing
• Posttraumatic strictures
• Postinfectious stenoses (e.g. tuberculosis)
• Tracheobronchial neoplasms (primary and secondary malignant)
• Granulomatosis with polyangiitis (can be multifocal)
• Sarcoidosis
• Inflammatory bowel disease
• Extrinsic compression
Table 6.4 Diffuse tracheobronchial wall thickening




• Tracheobronchitis associated with inflammatory bowel disease
• Sarcoidosis (rare manifestation)
aCalcification frequently present and posterior membrane characteristi-
cally spared
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the stroma or at the level of the endotracheal or tracheostomy 
tube balloon.
Postintubation stenosis extends for several centimetres 
and typically involves trachea above the level of the thoracic 
inlet. Posttracheostomy stenosis typically begins 1.0–1.5 cm 
distal to the inferior margin of the tracheostomy stoma and 
extends over 1.5–2.5 cm. These strictures typically have an 
hourglass configuration with thickened tracheal wall. Less 
commonly the tracheal or bronchial stenosis may present as 
a thin membrane or granulation tissue protruding into the air-
way lumen.
6.3.2  Infections
A number of infections, both acute and more often chronic, 
may affect the trachea and proximal bronchi, resulting in 
both focal and diffuse airway disease. Subsequent fibrosis 
may result in localized airway narrowing. The most common 
causes of infectious tracheobronchitis are acute bacterial tra-
cheitis in immunocompromised patients, tuberculosis, rhino-
scleroma (Klebsiella rhinoscleromatis), and necrotizing 
invasive aspergillosis. On CT, the extent of irregular and cir-
cumferential tracheobronchial narrowing is readily apparent, 
and in some patients, an accompanying mediastinitis is evi-
dent, manifesting as infiltration of mediastinal fat. In the 
fibrotic or healed phase, the airway is narrowed but has a 
smooth and normal thickness wall. Occasionally, because of 
the presence of chronic fibrous or granulomatous cheilitis/
mediastinitis, tuberculosis of the trachea and/or proximal 
bronchi may mimic airway malignancy on CT.
6.3.3  Granulomatosis with Polyangiitis 
(Wegener Granulomatosis)
Inflammatory lesions may be present with or without sub-
glottic or bronchial stenosis, ulcerations, and pseudotu-
mours. Radiologic manifestations include thickening of the 
subglottic and proximal trachea with a smooth symmetric or 
asymmetric narrowing over variable length. Tracheal rings 
can become thickened and calcified. Cartilaginous erosions 
and ulcerations also may be seen. Stenosis can develop in 
any main, lobar, or segmental bronchus. Developing nodular 
or polypoid lesions can protrude into the airway lumen.
6.3.4  Relapsing Polychondritis
Relapsing polychondritis is a rare systemic autoimmune dis-
ease that affects cartilage at various sites, including the ears, 
nose, joints, and tracheobronchial tree. Symmetric subglottic 
stenosis is the most frequent manifestation in the chest. As 
the disease progresses, the distal trachea and bronchi may be 
involved. CT scans show smooth thickening of the airway 
wall associated with diffuse narrowing. In the early stages of 
the disease, the posterior wall of the trachea is spared, but in 
advanced disease, circumferential wall thickening can occur. 
Tracheobronchomalacia can develop as a result of weaken-
ing of cartilage, resulting in considerable luminal collapse on 
expiration. Marked destruction of the cartilaginous rings 
with fibrosis may cause stenosis.
6.3.5  Amyloidosis
Deposition of amyloid in the trachea and bronchi may occur 
in association with systemic amyloidosis or as an isolated 
process. CT scans show focal or, more commonly, diffuse 
thickening of the airway wall and narrowing of the lumen. 
Calcification may be present. Narrowing of the proximal 
bronchi can lead to distal atelectasis, bronchiectasis, or both 
with or without obstructive pneumonia.
6.3.6  Tracheobronchopathia 
Osteochondroplastica (TO)
TO is a rare disorder characterized by the presence of multi-
ple cartilaginous nodules and bony submucosal nodules on 
the luminal surface of the trachea and proximal airways. TO 
involves males more frequently than females, and most 
patients are older than 50 years. Histologically, the nodules 
contain heterotopic bone, cartilage, and calcified acellular 
protein matrix. Because it contains no cartilage, the posterior 
wall of the trachea is spared. On CT, tracheal cartilages are 
thickened and show irregular calcifications. The nodules 
may protrude from the anterior and lateral walls into the 
lumen; they usually show foci of calcification.
6.3.7  Sabre-Sheath Trachea
Characterized by narrowing of the transverse diameter and 
increase of the sagittal diameter of the intrathoracic tra-
chea, this deformity is almost always associated with 
COPD. The pathogenesis is unclear but likely results from 
altered mechanics from intrathoracic pressure changes 
associated with COPD. On radiographs and CT, the internal 
transverse diameter of the trachea is decreased to half or 
Key Point
• CT with multiplanar reformations clearly depicts 
the severity and length of the stricture.
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less than the corresponding sagittal diameter. The trachea 
usually shows a smooth inner margin but occasionally has 
a nodular contour. Calcification of the tracheal cartilage is 
common.
6.3.8  Tracheobronchomegaly (Mounier-Kuhn 
Syndrome)
This abnormality is characterized by abnormal dilation of 
the trachea and main bronchi and recurrent lower respira-
tory tract infection. The aetiology is not fully understood, 
but many patients have congenitally atrophic smooth mus-
cle and elastin fibres. Mounier-Kuhn syndrome is often 
associated with tracheal diverticulosis and bronchiectasis. 
The subglottic trachea typically has a normal diameter, but 
the tracheal diameter expands toward the carina, often 
involving the central bronchi, as well. Atrophic mucosa 
prolapses between cartilage rings and gives the trachea a 
characteristically corrugated appearance. Corrugations 
may become exaggerated to form sacculations or divertic-
ula. On CT a tracheal diameter of greater than 3 cm (mea-
sured 2 cm above the aortic arch) and diameter of 2.4 cm 
and 2.3 cm for the right and left bronchi, respectively, are 
diagnosing criteria. Additional findings include tracheal 
scalloping or diverticula (especially along the posterior 
membranous tracheal wall).
6.3.9  Tracheobronchomalacia and Excessive 
Dynamic Airway Collapse [8, 9, 10]
Tracheobronchomalacia (TBM) and excessive dynamic air-
way collapse (EDAC) may be responsible for expiratory cen-
tral airway collapse (ECAC) which is an accepted term to 
describe the narrowing of central airway during expiration. 
TBM is characterized as a weakened or destroyed cartilage 
in the central airways resulting in expiratory airflow limita-
tion. EDAC is characterized by excessive bulging of the pos-
terior membrane inside the central airway lumen during 
expiration without cartilage collapse.
At CT, the diagnosis of EDAC is based on the narrowing 
of the lumen diameter by more than 70% on expiration com-
pared with that on inspiration. The 50% reduction in airway 
cross-sectional area during forced expiration is inadequate 
to define abnormal collapse. No threshold of end-expiration 
collapse reliably predicts EDAC. Therefore dynamic expira-
tory imaging should be considered when there is high clini-
cal suspicion for ECAC.  In addition, dynamic expiratory 
multislice CT may offer feasible alternative to bronchos-
copy in patients with suspected TBM or EDAC by showing 
complete relapse or collapse greater than 80% of airway 
lumen.
6.3.10  Broncholithiasis
Broncholithiasis is a rare condition characterized by erosion 
into or distortion of a bronchus from an adjacent calcified 
lymph node. The underlying abnormality is usually granulo-
matous lymphadenitis caused by Mycobacterium tuberculo-
sis or fungi such as Histoplasma capsulatum. A few cases 
associated with silicosis have been reported. Calcified mate-
rial in the bronchial lumen or bronchial distortion results in 
airway obstruction. This leads to collapse, obstructive pneu-
monitis, mucoid impaction, or bronchiectasis. Occasionally, 
patients will expectorate calcific fragments (lithoptysis). 
Broncholithiasis is recognized on CT by the presence of a 
calcified endobronchial or peribronchial lymph node, associ-
ated with bronchopulmonary complication related to obstruc-
tion in the absence of an associated soft tissue mass.
6.4  Tracheobronchial Fistula, Dehiscence, 
and Diverticula (Table 6.5) [2, 11]
Peripheral bronchopleural fistulas are most commonly 
caused by necrotizing pneumonia or secondary to trauma. 
Nodobronchial and nodobronchoesophageal fistulas are 
characterized by the presence of gas in cavitated hilar or 
mediastinal lymph nodes adjacent to the airways and are 
usually caused by tuberculosis. Occasionally, congenital tra-
cheal diverticula and tracheobronchoesophageal fistulas may 
not present until adulthood, especially the H-type.
Malignant neoplasia, particularly oesophageal, is the 
most common cause of tracheoesophageal fistula in adults. 
Infection and trauma are the most frequent nonmalignant 
causes.
MDCT has a high degree of sensitivity and specificity for 
depicting bronchial dehiscence occurring after lung trans-
plantation. Bronchial dehiscence is seen as a bronchial wall 
defect at the anastomosis associated with extraluminal gas 
collections.
The cardiac bronchus is an uncommon airway anomaly 
characterized by a supernumerary bronchus arising from the 
inferomedial aspect of the mid bronchus intermedius. The 
cardiac bronchus typically is a blind-ending pouch but 
Table 6.5 Tracheobronchial dehiscence, fistulas, and diverticula
• Tracheal or bronchial rupture
• Bronchial dehiscence occurring after lung transplantation
• Tracheal diverticula (tracheocele)
• Paratracheal cyst
• Accessory cardiac bronchus
• Multiple tracheobronchial diverticula
• Nodobronchial and nodobronchoesophageal fistulas
• Tracheoesophageal fistulas
• Bronchopleural fistulas
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occasionally supplies a very small number of pulmonary lob-
ules. Most cardiac bronchi are clinically silent and thus are 
incidentally detected on chest CT. However, they may serve 
as a reservoir for retained secretions leading to chronic 
inflammation and hypervascularity, leading to recurrent epi-
sodes of infection or haemoptysis.
In smokers, bronchial diverticula or outpouchings may be 
seen as small airway collections in the wall of the main and 
lobar bronchi particularly well displayed on coronal refor-
mations with minimal intensity projection. They express the 
fusion of multidepressions and dilations of the bronchial 
gland ducts forming a diverticulum, which herniates between 
and through the smooth muscle cellular bundles.
Paratracheal cysts are characterized by one or several cys-
tic cavities present along the cervicothoracic part of the tra-
chea. These cysts communicate with the tracheal lumen 
through a small wall defect visible on thin CT slices and 
located in the posterolateral angle of the trachea. The great 
majority is located on the right side.
6.5  Bronchiectasis [12, 13]
This chronic condition characterized by local, irreversible 
dilation of bronchi, usually associated with inflammation, 
remains an important cause of haemoptysis and chronic spu-
tum production.
Pathologically, bronchiectasis is classified into three sub-
types, reflecting increasing severity of disease: cylindrical, 
characterized by relatively uniform airway dilatation; vari-
cose, characterized by nonuniform and somewhat serpentine 
dilation; and cystic. As bronchiectasis progresses, the lung 
parenchyma distal to the affected airway increasingly 
collapses.
The CT findings of bronchial dilation include lack of 
tapering of bronchial lumina (the cardinal sign of bronchiec-
tasis), internal diameter of bronchi greater than that of the 
adjacent pulmonary artery (signet ring sign), bronchi visible 
within 1 cm of the costal pleura or abutting the mediastinal 
pleura, and mucus-filled dilated bronchi. With varicose bron-
chiectasis, the bronchial lumen assumes a beaded configura-
tion. Cystic bronchiectasis appears as a string of cysts caused 
by sectioning irregular dilated bronchi along their lengths, or 
a cluster of cysts, caused by multiple dilated bronchi lying 
adjacent to each other. Cluster of cysts are most commonly 
associated with an atelectatic lobe. Fluid levels, caused by 
retained secretions, may be present in the dependent portion 
of the dilated bronchi. Accumulation of secretions within 
bronchiectatic airways is typically recognizable as lobulated 
V- or Y-shaped structures (finger in glove sign). CT may 
show a completely collapsed lobe containing bronchiectatic 
airways. Subtle degrees of volume loss may present in lobes 
in relatively early disease.
Associated CT findings of bronchiolitis are present in 
about 70% of patients with bronchiectasis. These abnormali-
ties are very common in patients with severe bronchiectasis 
and can even precede the development of bronchiectasis. The 
obstructive defect on pulmonary function testing in patients 
with bronchiectasis is the consequence of an obstructive 
involvement of the small airways (constrictive). The extent 
and severity of bronchiectasis and bronchial wall thickening 
correlate with airflow obstruction [14]. In patients with bron-
chiectasis, bronchial wall thickening and the extent of 
decreased lung attenuation are the strongest determinants of 
airflow obstruction. In addition, bronchial wall thickening on 
baseline CT correlates with functional deterioration over-
time [15].
MDCT with thin collimation is the optimal imaging 
test to assess the presence and extent of bronchiectasis. 
Several studies have shown that multiplanar reformations 
increase the detection rate of bronchiectasis, readers’ 
confidence as to the distribution of bronchiectasis, and 
agreement among observers as to the diagnosis of 
bronchiectasis.
The reliability of CT for distinguishing among the 
causes of bronchiectasis is somewhat controversial. An 
underlying cause for bronchiectasis is found in fewer than 
half of patients, and CT features alone do not usually allow 
confident distinction between idiopathic bronchiectasis 
and known causes of bronchiectasis (Table 6.6).
6.6  Small Airway Diseases [2, 16]
Although normal bronchioles are below the resolution of 
thin-section CT, they can become detectable when inflam-
mation of the airway wall and accompanying exudate 
develop. Some bronchiolar changes are too small to be visi-
ble directly but result in indirect signs on CT.
Table 6.6 Specific causes of disseminated bronchiectasis
• Acute, chronic, or recurrent infections
• Genetic abnormalities
  – Cystic fibrosis
  – Dyskinetic (immotile) cilia syndrome
  – Young syndrome
  – Williams-Campbell syndrome
  – Mounier-Kuhn syndrome (tracheobronchomegaly)
  – Immunodeficiency syndromes
  – Yellow nail syndrome
  – Alpha-1-antitrypsin deficiency
• Noninfectious inflammatory diseases
  – Allergic bronchopulmonary aspergillosis
  – Asthma
  –  Systemic diseases (rheumatoid arthritis, Sjögren syndrome, 
systemic lupus erythematosus, inflammatory bowel disease)
  – Post-transplantation bronchiolitis obliterans syndrome
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6.6.1  Small Centrilobular Nodular 
and Branching Linear Opacities 
(Tree-in-Bud)
Tree-in-bud opacities are defined as small centrilobular nod-
ular and branching linear opacities, usually V- or Y-shaped, 
reflecting abnormally dilated bronchioles with thickened 
walls and mucus or exudate filling lumens. Associated peri-
bronchiolar inflammation is often present, contributing to the 
CT appearance. Tree-in-bud opacities are characteristic of 
acute or chronic infectious bronchiolitis. They also occur in 
diffuse panbronchiolitis and aspiration.
6.6.2  Poorly Defined Centrilobular Nodules
Poorly defined centrilobular nodules reflect the presence of 
peribronchiolar inflammation in the absence of airway fill-
ing. When the distribution of nodules is diffuse and homoge-
neous, the pattern is suggestive of bronchiolar or vascular 
diseases. Bronchiolar disease associated with poorly defined 
centrilobular nodules includes respiratory bronchiolitis, 
hypersensitivity pneumonitis, and follicular bronchiolitis.
6.6.3  Decreased Lung Attenuation 
and Mosaic Perfusion
Areas of decreased lung attenuation associated with 
decreased vessel calibre on CT reflect bronchiolar obstruc-
tion and associated reflex vasoconstriction. In acute bron-
chiolar obstruction, decreased perfusion represents a 
physiologic reflex of hypoxic vasoconstriction, whereas irre-
versible vascular remodelling occurs with chronic bronchio-
lar obstruction. The areas of decreased lung attenuation 
related to hypoperfusion can be patchy or widespread. They 
are poorly defined or sharply demarcated giving a geographi-
cal outline, representing a collection of affected pulmonary 
lobules. Redistribution of blood flow to the normally venti-
lated areas causes localized increased attenuation. The patch-
work of abnormal areas of low attenuation and normal lung 
or less diseased areas results in mosaic attenuation on CT, 
also termed mosaic perfusion. Expiratory CT accentuates the 
pattern of mosaic attenuation where areas of air trapping 
remain low in attenuation, whereas normal lung increases in 
attenuation. Usually the regional heterogeneity of lung atten-
uation is apparent at full inspiration.
However, with more extensive air trapping, the lack of 
regional homogeneity of lung attenuation can be challenging 
to detect on inspiratory scans, and, as a result, mosaic attenu-
ation becomes visible only on expiratory scans. In patients 
with particularly severe and widespread involvement of the 
small airways, the patchy distribution of hypoattenuation 
and mosaic pattern is lost. Inspiratory scans show an appar-
ent uniformity of decreased attenuation in the lungs and 
scans obtained at end expiration may appear similar to inspi-
ration scan. In these patients, the most striking features are 
paucity of pulmonary vessels and lack of change of the 
cross-sectional area of lung between inspiration and expira-
tion. Mosaic attenuation may be seen in patients who have 
constrictive bronchiolitis, bronchiolitis associated with 
hypersensitivity pneumonitis, asthma, and COPD.
6.6.4  Expiratory Air Trapping
Lobular areas of air trapping may be readily apparent on 
expiratory CT but are occult on inspiratory CT. Foci of lobu-
lar air trapping are usually well-demarcated reflecting the 
geometry of individual or joined lobules. Lobular areas of air 
trapping may be present on expiratory CT scans of normal 
individuals, especially in the medial and posterior basal and 
apical portions of the superior segments of the lower lobes. 
However, when lobular air trapping is present in the nonde-
pendent portions of the lung or the overall extent is equal or 
greater than one segment, air trapping should be considered 
as abnormal. Expiratory air trapping occurs in smokers and 
in patients with asthma, constrictive bronchiolitis, and bron-
chiolitis associated with hypersensitivity pneumonitis and 
sarcoidosis.
6.7  Constrictive (Obliterative) 
Bronchiolitis [2, 16]
Constrictive bronchiolitis, characterized by submucosal cir-
cumferential fibrosis along the central axis of terminal bron-
chioles, is the result of a variety of causes and, rarely, is 
idiopathic (Table 6.7).
The main thin-section CT findings usually consist of 
areas of decreased lung attenuation associated with vessels 
of decreased calibre on inspiratory scans and air trapping on 
expiratory scans. Bronchial wall thickening and bronchiecta-
sis, both central and peripheral, are also commonly present.
The areas of decreased lung attenuation and perfusion 
may be confined to or predominant in one lung, particularly 
in Swyer-James or MacLeod syndrome, that is a variant form 
of postinfectious constrictive bronchiolitis in which the con-
strictive bronchiolar lesions affect predominantly one lung.
Key Point
• MiniP is helpful in detecting mosaic attenuation.
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6.8  Asthma [17]
The main clinical indication for imaging patients with 
asthma is to identify diseases that may mimic asthma clini-
cally, particularly hypersensitivity pneumonitis, constric-
tive bronchiolitis, and tracheal or carinal obstruction by 
neoplastic or nonneoplastic tracheal disorders. CT of 
patients with asthma can be normal or shows bronchial 
abnormalities. Mucoid impaction and linear bands, reflect-
ing subsegmental or segmental atelectasis, are reversible 
on follow-up. Bronchial wall thickening is commonly 
present and has been shown to correlate with clinical 
severity and duration of asthma and the degree of airflow 
obstruction. It also correlates with pathologic measures of 
remodelling from bronchial biopsies [18]. Bronchiectasis 
may also be present, and its extent is associated with an 
increased severity of asthma.
In patients with persistent moderate asthma, mosaic atten-
uation reflects remodelling in the small airways. The extent 
of expiratory air trapping does not change after inhalation of 
salbutamol. This allows to exclude the hypothesis of bron-
choconstriction to explain gas trapping in these patients and 
to reinforce the role of airway remodelling. In contrast, in 
patients with mild or moderate uncontrolled asthma, therapy 
with inhaled corticosteroids reduces the degree of air trap-
ping on CT, suggesting that CT can be used as a surrogate 
marker for assessing disease control.
6.9  Airway Disease in COPD [19]
Airway disease phenotypes of COPD include abnormalities 
of the small and large airways. Poorly defined centrilobular 
nodules primarily in the upper lobes reflect inflammatory 
changes in and around the bronchioles (respiratory bron-
chiolitis), which are reversible after smoking cessation and 
steroids. Mosaic attenuation and expiratory air trapping 
reflect remodelling of the small airways (obstructive 
bronchiolitis).
Bronchial wall thickening is frequently present. Bronchial 
wall thickness is one of the strongest determinants of 
FEV1 in patients with COPD. The measures of airway thick-
ness are also associated with chronic bronchitis with bron-
chodilator responsiveness and with a paradoxical response to 
bronchodilators. In addition, CT studies have consistently 
showed reduced airway lumen dimensions and fewer periph-
eral airways in COPD.
Moderate tubular bronchiectasis can occur, particularly in 
the lower lobes, as a result of injury to cartilage. Bronchiectasis 
is often associated with more severe COPD exacerbations, 
lower airway bacterial colonization, and increased sputum 
inflammatory markers [20]. However, the presence of bilat-
eral varicose and cystic bronchiectasis in patients with pan-
lobular emphysema should raise the diagnosis of 
alpha-1-antitrypsin deficiency.
6.10  Concluding Remarks
Volumetric thin-collimation CT acquisition at full inspira-
tion and expiration has tremendously improved the accuracy 
of imaging in the detection and characterization of airway 
disease. Both proximal and distal airway disease may be 
identified and correctly assessed in terms of extent and 
severity.
CT and endoscopy play complementary roles in the 
assessment of tracheobronchial lesions, including neo-
plasms, inflammation, and infection.
CT remains the imaging technique of reference in the 
diagnosis and extent assessment of bronchiectasis. It has 
gained much interest from the respiratory physicians in the 
assessment of obstructive lung disease, including COPD, 
chronic asthma, and constrictive bronchiolitis.
Table 6.7 Causes of and association with obliterative (constrictive) 
bronchiolitis
• Postinfection
  –  Childhood viral infection (adenovirus, respiratory syncytial 
virus, influenza, parainfluenza)
  –  Adulthood and childhood (Mycoplasma pneumoniae, 
Pneumocystis jiroveci in AIDS patients, endobronchial spread 
of tuberculosis, bacterial bronchiolar infection)
•  Post-inhalation (toxic fumes and gases)
•  Diffuse aspiration bronchiolitis (chronic occult aspiration in the 
elderly, patients with dysphagia)
•  Connective tissue disorders (rheumatoid arthritis, Sjögren 
syndrome)
•  Allograft recipients (bone marrow transplant, heart-lung, or lung 
transplant)
• Drugs (penicillamine, lomustine)
• Ulcerative colitis
• Other conditions
  – Bronchiectasis
   – Cystic fibrosis
  – Hypersensitivity pneumonitis
   –  Diffuse idiopathic pulmonary neuroendocrine cell 
hyperplasia (DIPNECH)
  –  Excessive Sauropus androgynus (katuk, sweet leaf, or star 
gooseberry) ingestion
• Idiopathic
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Take-Home Messages
• Volumetric thin-collimation CT with multiplanar 
reformations along the long axis and strictly per-
pendicular to the central axis of the airways has 
improved detection, characterization, and extent 
assessment of any tracheal or bronchial lesion.
• MIP images are helpful to detect foci of inflamma-
tory or infectious lesions in terminal bronchioles.
• Expiratory CT scan and minIP are helpful to detect 
gas trapping due to obstruction of the bronchiolar 
lumens.
• Dynamic expiratory CT images may offer feasible 
alternative to bronchoscopy in patients with sus-
pected tracheobronchomalacia or expiratory 
dynamic airway collapse by showing complete 
relapse or collapse greater than 80% of airway 
lumen.
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Respiratory infections are the commonest illnesses occur-
ring in humans, and pneumonia is the leading cause of 
death due to infectious disease. Pneumonia is an acute 
infection of the pulmonary parenchyma that is associated 
with at least some symptoms of acute infection, accompa-
nied by the presence of an acute infiltrate on a chest radio-
graph. The number of immunocompromised patients has 
increased in the last three decades because of three main 
phenomena: the AIDS epidemic, advances in cancer che-
motherapy, and expanding solid organ and hematopoietic 
stem cell transplantation. The spectrum of organisms 
known to cause respiratory infections is broad and con-
stantly increasing as new pathogens are identified and an 
increasing number of patients have decreased immunity 
due to disease or medications.
Epidemiologically, pneumonia can be classified into 
community- acquired pneumonia (CAP), hospital-acquired 
pneumonia (HAP), ventilator-associated pneumonia (VAP), 
and healthcare-associated pneumonia (HCAP) [1, 2].
7.1  Community-Acquired Pneumonia 
(CAP)
Community acquired pneumonia refers to an acute infec-
tion of the lung in patients who did not meet any of the 
criteria for HCAP, presenting select clinical features (e.g., 
cough, fever, sputum production, and pleuritic chest pain) 
and accompanied by an acute infiltrate on a chest radio-
graph. Pulmonary opacities are usually evident on the 
radiograph within 12  h of the onset of symptoms [3]. 
Although the imaging findings do not allow a specific etio-
logic diagnosis, CAP diagnosis and disease management 
most frequently involve chest radiography, and other imag-
ing modalities are not usually required [4].
The spectrum of causative organisms of CAP includes 
gram-positive bacteria such as Streptococcus pneumoniae 
(pneumococcus), Haemophilus influenzae, and Staphylococcus 
aureus, as well as atypical organisms such as Mycoplasma 
pneumoniae, Chlamydia pneumoniae, or Legionella pneu-
mophila and viral agents such as influenza A virus and respira-
tory syncytial viruses [5]. However, many community-acquired 
pneumonias are still commonly caused by S. pneumoniae and 
are lobar in appearance.
7.1.1  Radiographic Patterns of CAP
The radiographic patterns of CAP are often related to the 
causative agent. Infection of the lower respiratory tract, 
acquired by way of the airways and confined to the lung 
parenchyma and airways, typically presents radiologi-
cally as one of three patterns: (a) focal nonsegmental or 
lobar pneumonia, (b) multifocal bronchopneumonia or 
lobular pneumonia, and (c) focal or diffuse “interstitial” 
pneumonia.
7
T. Franquet (*) 
Department of Radiology, Hospital de Sant Pau. Universidad 
Autonoma de Barcelona, Barcelona, Spain
e-mail: Tfranquet@santpau.cat 
J. H. Chung 
Department of Radiology, The University of Chicago Medicine, 
Chicago, IL, USA
Learning Objectives
• To know the variable imaging findings of pulmo-
nary infections.
• To understand the limitations of imaging in the 
diagnosis of pulmonary infections.
• To appreciate the importance of additional clinical 
information in the diagnosis of respiratory 
infections.
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7.2  Hospital-Acquired Pneumonia (HAP)
Hospital-acquired pneumonia (HAP) may be defined as one 
occurring after admission to the hospital, which was neither 
present nor in a period of incubation at the time of admis-
sion. Hospital-acquired pneumonia (nosocomial) is the lead-
ing cause of death from hospital-acquired infections and an 
important public health problem. It occurs most commonly 
among intensive care unit (ICU) patients requiring mechani-
cal ventilation.
7.3  Ventilator-Associated Pneumonia 
(VAP)
Microorganisms responsible for VAP may differ according 
to the population of patients in the ICU, the durations of hos-
pital and ICU stays, and the specific diagnostic method(s) 
used. The spectrum of causative pathogens of VAP in humans 
is Staphylococcus aureus, Pseudomonas aeruginosa, and 
Enterobacteriaceae [6].
Chest radiograph is most helpful when it is normal and 
rules out pneumonia. However, pulmonary opacities were 
detected by computed tomography (CT) scan in 26% of cases 
with a normal portable chest X-ray. When infiltrates are pres-
ent, the particular pattern is of limited value for differentiat-
ing among cardiogenic pulmonary edema, noncardiogenic, 
pulmonary edema, hemorrhage, atelectasis, and pneumonia.
7.4  Healthcare-Associated Pneumonia 
(HCAP)
When pneumonia is associated with healthcare risk factors 
such as prior hospitalization, dialysis, residing in a nursing 
home, and immunocompromised state, it is now classified as a 
healthcare-associated pneumonia (HCAP). The number of 
individuals receiving healthcare outside the hospital setting, 
including home wound care or infusion therapy, dialysis, nurs-
ing homes, and similar settings, is constantly increasing [7].
7.5  Clinical Utility and Limitations 
of Chest Radiography and CT
A clinical diagnosis of pneumonia can usually be readily 
established on the basis of signs, symptoms, and chest radio-
graphs, although distinguishing pneumonia from conditions 
such as left heart failure, pulmonary embolism, and aspira-
tion pneumonia may sometimes be difficult.
Differentiation of etiologies based solely on the radio-
graph is not reliable, yet the pattern of abnormalities should 
be very useful in formulating a differential diagnosis of the 
nature of disease [8].
7.5.1  Chest Radiography
Chest radiographs are of limited value in predicting the caus-
ative pathogen but are of good use to determine the extent of 
pneumonia and to detect complications (i.e., cavitation, 
abscess formation, pneumothorax, pleural effusion), to 
detect additional or alternative diagnoses, and, in some cases, 
to guide invasive diagnostic procedures.
The most common radiographic manifestations of respi-
ratory infection are foci of consolidation, ground-glass opac-
ities, or reticulonodular opacities. Other less common 
radiographic findings include hilar and mediastinal lymph-
adenopathy, pleural effusion, cavitation, and chest wall inva-
sion [8, 9].
7.5.2  Computed Tomography
Computed tomography, particularly high-resolution CT 
(HRCT), has been shown to be more sensitive than the radio-
graph in the detection of subtle abnormalities and may show 
findings suggestive of pneumonia up to 5 days earlier than 
chest radiographs. CT is recommended in patients with clini-
cal suspicion of infection and normal or nonspecific radio-
graphic findings, in the assessment of suspected complications 
of pneumonia or suspicion of an underlying lesion such as 
pulmonary carcinoma.
7.6  Patterns of Pulmonary Infection
Pneumonias are usually divided according to their chest 
imaging appearance into lobar pneumonia, bronchopneumo-
nia, and interstitial pneumonia.
In lobar pneumonia the inflammatory exudate begins in 
the distal airspaces adjacent to the visceral pleura and then 
spreads via collateral air drift routes (pores of Kohn) to pro-
duce uniform homogeneous opacification of partial or com-
plete segments of the lung and occasionally an entire lobe. 
Key Points
• Pneumonia is the leading cause of death due to 
infectious disease.
• A variety of organisms that may present with simi-
lar clinical symptoms result in similar radiographic 
manifestations.
• The radiographic manifestations of a given organ-
ism may be variable depending on the immunologic 
status of the patient.
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As the airways are not primarily involved and remain patent, 
there is little to no volume loss, and air bronchograms are 
common. Some pneumonias present as spherical- or nodular- 
shaped consolidations.
Bronchopneumonia (lobular pneumonia) is character-
ized histologically by peribronchiolar inflammation mani-
festing radiologically as patchy airspace nodules with 
poorly defined margins. Radiologically a bronchopneumo-
nia is  characterized by large heterogeneous, scattered 
opacities which only later, with worsening of disease, 
become more homogeneous. An air bronchogram is usu-
ally absent. The most common causative organisms of 
bronchopneumonia are S. aureus, H. influenzae, P. aerugi-
nosa, and anaerobic bacteria [8].
Characteristic manifestations of bronchopneumonia on 
HRCT include centrilobular ill-defined nodules and branch-
ing linear opacities, airspace nodules, and multifocal lobular 
areas of consolidation [10].
The term atypical pneumonia (interstitial pneumonia) 
was initially applied to the clinical and radiographic 
appearance of lung infection not behaving or looking like 
that caused by S. pneumoniae [11]. Today, when new 
diagnostic techniques such as direct antigen detection, 
polymerase chain reaction, and serology (ELISA) have 
moved beyond the initial diagnostic methods, a debate 
with regard to the appropriate use of the term “atypical 
pneumonia” is open [12].
Radiographically focal or diffuse small heterogeneous 
opacities are seen uniformly distributed in the involved lung. 
Frequently these opacities are described as reticular or retic-
ulonodular. The usual causes of interstitial pneumonia are 
viral and mycoplasma infections [9].
7.7  Aerobic Bacteria
7.7.1  Gram-Positive Cocci
7.7.1.1  Streptococcus Pneumoniae
Streptococcus pneumoniae, a gram-positive coccus, is the 
most common bacterial cause of CAP among patients who 
require hospitalization. Risk factors for the development 
of pneumococcal pneumonia include the extremes of age, 
chronic heart or lung disease, immunosuppression, alco-
holism, institutionalization, and prior splenectomy. The 
characteristic clinical presentation is abrupt in onset, with 
fever, chills, cough, and pleuritic chest pain. The typical 
radiographic appearance of acute pneumococcal pneumo-
nia consists of a homogeneous consolidation that crosses 
segmental boundaries (nonsegmental) but involves 
only one lobe (lobar pneumonia) (Fig. 7.1). Occasionally, 
infection is manifested as a spherical focus of consolidation 
that simulates a mass (round pneumonia). Complications, 
such as cavitation and pneumatocele formation, are rare. 
Pleural effusion is common and is seen in up to half of 
patients.
7.7.1.2  Staphylococcus aureus
Pneumonia caused by S. aureus usually follows aspiration 
of organisms from the upper respiratory tract. Risk factors 
for the development of staphylococcal pneumonia include 
underlying pulmonary disease (e.g., COPD, carcinoma), 
chronic illnesses (e.g., diabetes mellitus, renal failure), or 
viral infection. The clinical presentation of staphylococ-
cal pneumonia is changing and of particular importance is 
the dramatic increase of the incidence of methicillin-
resistant Staphylococcus aureus (MRSA) infections in 
recent years. Increasingly, previously healthy young peo-
ple without traditional risk factors for S. aureus disease 
are presenting with severe necrotizing infection and high 
mortality.
Fever, cough, and purulent sputum are prominent symp-
toms in cases of post-aspirative staphylococcal pneumonia. 
Severe pneumonia caused by community-associated 
methicillin- resistant Staphylococcus aureus (MRSA) carry-
ing genes for Panton-Valentine leukocidin has been described 
in immunocompetent young adults.
The characteristic pattern of presentation is as a bron-
chopneumonia (lobular pneumonia) that is bilateral in 40% 
of patients. The radiographic manifestations usually consist 
of bilateral patchy areas of consolidation. Air broncho-
grams are uncommon. Other features are cavitation, pneu-
matoceles, pleural effusions, and spontaneous 
pneumothorax (Fig.  7.2). Pneumatoceles are seen espe-
cially in children [13].
7.7.2  Gram-Positive Bacilli
7.7.2.1  Actinomycosis
Thoracic actinomycosis is a chronic suppurative pulmonary 
or endobronchial infection caused by Actinomyces species, 
most frequently Actinomyces israelii considered to be a 
gram-positive branching filamentous bacterium. Pulmonary 
infection is characterized pathologically by bronchopneu-
monia with focal or multifocal abscess formation. 
Actinomycosis has the ability to spread across fascial planes 
to contiguous tissues without regard to normal anatomic 
barriers. On CT, parenchymal actinomycosis is character-
ized by airspace consolidation with cavitation or central 
areas of low attenuation and adjacent pleural thickening. 
Endobronchial actinomycosis can be associated with a for-
eign body (direct aspiration of a foreign body contaminated 
with Actinomyces organisms) or a broncholith (secondary 
colonization of a preexisting endobronchial broncholith by 
aspirated Actinomyces organisms).
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7.7.2.2  Nocardia Species
Nocardia is a genus of filamentous gram-positive, weakly 
acid fast, aerobic bacteria that affects both immunosup-
pressed and immunocompetent patients. Nocardia asteroi-
des is responsible of 80% of infections by this organism in 
man. Pulmonary nocardiosis can be an acute, subacute, or 
chronic disease. Nocardiosis usually begins with a focus of 
pulmonary infection and may disseminate through hematog-
enous spread to other organs, most commonly to the 
CNS. Imaging findings are variable and consist of unifocal 
or multifocal consolidation and single or multiple pulmonary 
nodules [14]. Nocardia asteroides infection may complicate 
alveolar proteinosis.
7.7.3  Gram-Negative Bacilli
Gram-negative pneumonias are chiefly caused by 
Klebsiella pneumoniae, Enterobacter sp., Serratia marc-
escens, Escherichia coli, Proteus sp., and Pseudomonas 
aeruginosa. Patients affected are invariably debilitated by 




Fig. 7.1 (a, b, c) Lobar pneumonia. (a) Posteroanterior and lateral (b) 
chest radiographs in this patient with fever and cough demonstrate lat-
eral segment right middle lobe consolidation (arrows). (c) Axial 
contrast- enhanced CT image shows a mixed opacity of consolidation 
(arrow) and ground-glass opacity (small arrows) consistent with lobar 
pneumonia
T. Franquet and J. H. Chung
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tend to be affected, and the radiographic pattern is similar 
to that seen with S. aureus infections in adults.
7.7.3.1  Klebsiella
Klebsiella pneumoniae is among the most common gram- 
negative bacteria accounting for 0.5–5.0% of all cases of 
pneumonia. These features are bulging fissures, sharp margins 
of the advancing border of the pneumonic infiltrate and early 
abscess formation. CT findings consist of ground-glass attenu-
ation, consolidation, and intralobular reticular opacity, often 
associated with pleural effusion. Complications of Klebsiella 




Fig. 7.2 (a, b, c) Staphylococcus aureus pneumonia: (a) Posteroanterior 
chest radiograph demonstrates a dominant right basilar and left upper 
lung mass-like opacities with cavitation in the right basilar opacity 
(arrow). Small left pleural effusion is also seen (small arrow). (b, c) 
Axial contrast-enhanced CT shows a cavitary mass within the right 
lower lobe (arrow) and a mass in the left upper lobe demonstrating sur-
rounding ground-glass opacity (halo sign) (arrows)
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7.7.3.2  Escherichia coli
Escherichia coli accounts for 4% of cases of CAP and 
5–20% of cases of HAP or HCAP. It occurs most commonly 
in debilitated patients. The typical history is one of abrupt 
onset of fever, chills, dyspnea, pleuritic pain, and productive 
cough in a patient with preexisting chronic disease.
The radiographic manifestations usually are those of 
bronchopneumonia; rarely a pattern of lobar pneumonia may 
be seen.
7.7.3.3  Pseudomonas aeruginosa
Pseudomonas aeruginosa is a gram-negative bacillus that is 
the most common cause of nosocomial pulmonary infec-
tion. It causes confluent bronchopneumonia that is often 
extensive and frequently cavitates (Fig. 7.3). The radiologic 
manifestations are nonspecific and consist most commonly 
of patchy areas of consolidation and widespread poorly 
defined nodular opacities [9].
7.7.3.4  Chlamydia
Chlamydia pneumoniae is the most commonly occurring 
gram-negative intracellular bacterial pathogen. It is fre-
quently involved in respiratory tract infections and has also 
been implicated in the pathogenesis of asthma in both adults 
and children. Symptoms include sore throat, headache, and a 
nonproductive cough that can persist for months if treatment 
is not initiated early.
Chest radiographs tend to show less extensive abnormali-
ties than are seen with other causes of pneumonia. On CT, C. 




Fig. 7.3 (a, b, c) Pseudomonas aeruginosa pneumonia: (a) 
Posteroanterior chest radiograph demonstrates multifocal lung consoli-
dation bilaterally consistent with bronchopneumonia. (b) Axial and (c) 
coronal CT images demonstrate bilateral multifocal lung consolida-
tions; cavitary necrosis is observed within the right upper lobe consoli-
dation (arrows); mild superimposed ground-glass opacity is also present 
(small arrows)
T. Franquet and J. H. Chung
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findings that are similar to those of S. pneumoniae pneumo-
nia and M. pneumoniae. Cavitation and hilar or mediastinal 
adenopathy are uncommon.
7.7.3.5  Rickettsial Pneumonia
The most common rickettsia lung infection is sporadic or 
epidemic Q-fever pneumonia caused by Coxiella burnetii, an 
intracellular, gram-negative bacterium.
Infection is acquired by inhalation from farm livestock or 
their products and occasionally from domestic animals. 
Imaging findings consist of multilobar airspace  consolidation, 
solitary or multiple nodules surrounded by a halo of “ground-
glass” opacity and vessel connection, and necrotizing 
pneumonia.
7.7.3.6  Francisella tularensis
Tularemia is an acute, febrile, bacterial zoonosis caused by 
the aerobic gram-negative bacillus Francisella tularensis. It 
is endemic in parts of Europe, Asia, and North America. 
Primary pneumonic tularemia occurs in rural settings. 
Humans become infected after introduction of the bacillus 
by inhalation, intradermal injection, or oral ingestion. Chest 
radiographic findings are scattered multifocal consolida-
tions, hilar adenopathy, and pleural effusion.
7.7.4  Gram-Negative Coccobacilli
7.7.4.1  Haemophilus influenza
Haemophilus influenzae is a pleomorphic, gram-negative 
coccobacillus that accounts for 5–20% of CAP in patients in 
whom an organism can be identified successfully. Factors 
that predispose to Haemophilus pneumonia include COPD, 
malignancy, HIV infection, and alcoholism. The typical 
radiographic appearance of Haemophilus influenza pneumo-
nia consists of multilobar involvement with lobar or segmen-
tal consolidation and pleural effusion.
7.7.4.2  Legionella Species
Legionella is a pathogenic gram-negative bacterium with at 
least 50 species. It is one of the most common causes of 
severe community-acquired pneumonia in immunocompe-
tent hosts. Human infection may occur when Legionella con-
taminates water systems, such as air conditioners and 
condensers. Risk factors for the development of L. pneu-
mophila pneumonia include immunosuppression, posttrans-
plantation, cigarette smoking, renal disease, and exposure to 
contaminated drinking water. Patients with Legionella pneu-
monia usually present with fever, cough, initially dry and 
later productive, malaise, myalgia, confusion, headaches, 
and diarrhea. Thirty percent of patients develop pleuritic 
chest pain.
Imaging findings include peripheral airspace consolida-
tion similar to that seen in acute S. pneumoniae pneumonia. 
In many cases, the area of consolidation rapidly progresses 
to occupy all or a large portion of a lobe (lobar pneumonia) 
or to involve contiguous lobes or to become bilateral. 
Cavitation is uncommon in immunocompetent patients, and 
pleural effusion may occur in 35–63% of cases.
7.7.5  Gram-Negative Cocci
7.7.5.1  Moraxella catarrhalis
Moraxella catarrhalis (formerly known as Branhamella 
catarrhalis) has emerged as a significant bacterial pathogen 
of humans over the past two decades. It is an intracellular 
gram-negative coccus now recognized as one of the common 
respiratory pathogens [15]. M. catarrhalis causes otitis 
media and sinusitis in children and mild pneumonia and 
acute exacerbation in older patients with COPD.  It is cur-
rently considered the third most common cause of commu-
nity-acquired bacterial pneumonia (after S. pneumoniae and 
H. influenzae). The majority of patients with pneumonia 
(80–90%) have underlying chronic pulmonary disease. Chest 
radiographs show bronchopneumonia or lobar pneumonia 
that usually involves a single lobe.
7.8  Miscellaneous Infections
7.8.1  Mycoplasma pneumoniae
M. pneumoniae is one of the most common causes of 
community- acquired pneumonia. It accounts for up to 37% 
of CAP in persons treated as outpatients. Patients with COPD 
appear to be more severely affected with M. pneumoniae 
than normal hosts.
The radiographic findings in M. pneumoniae are variable 
and in some cases closely resemble those seen in viral infec-
tions of the lower respiratory tract. Chest radiograph shows 
fine linear opacities followed by segmental airspace consoli-
dation [16].
Key Points
• A “tree-in-bud” pattern is a characteristic CT mani-
festation of infectious bronchiolitis.
• Focal areas of consolidation secondary to infection 
in immunocompromised patients are most com-
monly due to bacterial pneumonia.
• Interstitial and/or mixed interstitial and airspace 
opacities in CAP are typically due to viruses or M. 
pneumoniae.
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7.9  Mycobacteria
7.9.1  Mycobacterium Tuberculosis
Mycobacterium tuberculosis accounts for more than 95% of 
pulmonary mycobacterial infections. Other mycobacterial 
species, M. kansasii and M. avium–intracellulare complex 
(MAC), account for the remainder.
Factors that contribute to the large number of cases seen 
worldwide are human immunodeficiency virus (HIV) infection, 
inner city poverty, homelessness, and immigration from areas 
with high rates of infection. Other predisposing conditions are 
diabetes mellitus, alcoholism, silicosis, and malignancy.
7.9.1.1  Primary tuberculosis
This form is seen in infants and children. With improved 
control of tuberculosis in western societies, however, more 
people reach adulthood without exposure, and primary pat-
terns of disease are being seen with increasing frequency in 
adulthood and represents about 23–34% of all adult cases of 
tuberculosis.
Although primary tuberculosis typically presents with 
radiographic manifestations, chest radiograph may be nor-
mal in 15% of cases. Lymphadenopathy is the most common 
manifestation of primary tuberculosis in children and occurs 
with or without pneumonia. In adults hilar or mediastinal 
lymphadenopathy is less common declining to about 50% of 
cases in the older population. Pleural effusion occurs in chil-
dren, who usually have parenchymal or nodal disease, or in 
teenagers and young adults, when it is frequently isolated.
7.9.1.2  Postprimary tuberculosis
Most cases are due to reactivation of quiescent lesions, but 
occasionally a new infection from an exogenous source 
occurs. Pathologically, the ability of the host to respond 
immunologically results in a greater inflammatory reaction 
and caseous necrosis.
The radiological manifestations may overlap with those 
of primary tuberculosis, but the absence of lymphadenopa-
thy, more frequent cavitation, and a predilection for the upper 
lobes are more typical of postprimary tuberculosis. A 
Rasmussen aneurysm is a rare life-threatening complication 
of cavitary tuberculosis caused by granulomatous weakening 
of a pulmonary arterial wall.
Endobronchial spread can occur with or without cavitary 
disease and is similar to that seen with primary tuberculosis 
leading to the appearance of the typical images of “tree-in- 
bud” [17, 18].
After antituberculous treatment healing results in scar 
formation. The fibrosis produces well-defined, upper lobe 
nodular and linear opacities, often with evidence of severe 
volume loss and pleural thickening. Residual thin-walled 
cavities may be present in both active and inactive disease.
Although classically a manifestation of primary disease, 
miliary tuberculosis is now more commonly seen as a 
postprimary process in older patients. Multiple small 
(1–2 mm) discrete nodules are scattered evenly throughout 
both lungs.
A tuberculoma may occur in the setting of primary or 
postprimary tuberculosis and represents localized parenchy-
mal disease that alternately activates and heals. It usually 
calcifies and frequently remains stable for years [19].
7.9.1.3  Pulmonary Nontuberculous Mycobacteria 
(NTMB)
As mentioned above, 1–3% of pulmonary mycobacterial 
infections are caused by agents other than M. tuberculosis: 
usually M. avium–intracellulare complex (MAC) and less 
commonly M. kansasii. Patients are often predisposed by 
reason of underlying debilitating disease, immune compro-
mise, chronic airflow obstruction, previous pulmonary tuber-
culosis, or silicosis and following lung transplantation [20]. 
Clinically, MAC may be an indolent process with symptoms 
of cough, with or without sputum production.
More commonly, MAC presents with a radiological pat-
tern that does not resemble that of postprimary tuberculosis. 
It consists of multiple nodules, with or without small ring 
opacities, showing no specific lobar predilection and bron-
chiectasis particularly in the lingula and right middle lobe. 
The most typical form of pulmonary nontuberculous myco-
bacteria (NTMB) infection is frequently associated to elderly 
men with underlying lung disease and to elderly white 
women without underlying lung disease (Lady Windermere 
syndrome). Radiological findings consist of mild to moder-
ate cylindrical bronchiectasis and multiple 1–3 mm diameter 
centrilobular nodules.
7.10  Fungal Infections
Fungi involved in pulmonary infections are either pathogenic 
fungi, which can infect any host, or saprophytic fungi, which 
infect only immunocompromised hosts. Pathogenic fungi 
include coccidioidomycosis, blastomycosis, and histoplas-
mosis. Saprophytes include Pneumocystis, Candidiasis, 
Mucormycosis, and Aspergillosis. Pulmonary fungal infec-
tions may be difficult to diagnose, and a definitive diagnosis 
of pulmonary fungal infections is made by isolating the fun-
gus from tissue specimen.
7.10.1  Aspergillus Infection
Aspergillosis is a fungal disease caused by Aspergillus spe-
cies, usually A. fumigatus that can take different forms 
depending on an individual’s immune response to the 
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organism. Classically, pulmonary aspergillosis has been 
categorized into saprophytic, allergic, and invasive forms 
[21, 22].
Aspergillus mycetomas are saprophytic growths which 
colonize a preexisting cavity in the lung (e.g., from sarcoid-
osis or tuberculosis). Most cavities and thus mycetomas are 
in the upper lobes or superior segments of the lower lobes.
Allergic bronchopulmonary aspergillosis (ABPA) describes 
a hypersensitivity reaction which occurs in the major airways. 
It is associated with elevated serum IgE, positive serum pre-
cipitins, and skin reactivity to Aspergillus. The radiographic 
appearances consist of nonsegmental areas of opacity most 
common in the upper lobes, lobar collapse, branching thick 
tubular opacities due to bronchi distended with mucus and 
fungus, and occasionally pulmonary cavitation. The mucus 
plugs in ABPA are usually hypodense, but in up to 20% of 
patients, the mucus can be hyperdense on CT (Fig. 7.4).
Angioinvasive aspergillosis is seen in immunocompro-
mised hosts with severe neutropenia. This form is character-
ized by invasion and occlusion of small-to-medium 
pulmonary arteries, developing necrotic hemorrhagic nod-
ules or infarcts. The most common pattern seen in CT con-
sists of multiples nodules surrounded by a halo of 
ground-glass attenuation (halo sign) or pleural-based wedge- 
shaped areas of consolidation [21].
7.10.2  Candidiasis
Candida species has been increasingly recognized as an 
important source of fungal pneumonia in immunocompro-
mised patients, particularly in those with underlying 
malignancy (acute leukemia and lymphoma), intravenous 
drug abuse, and acquired immune deficiency syndrome 
a b
c
Fig. 7.4 (a, b, c) Allergic bronchopulmonary aspergillosis: (a) 
Posteroanterior chest radiograph demonstrates basilar branching opaci-
ties suggestive of mucus-filled bronchiectasis (arrows). (b) Axial CT 
image confirms the presence of left basilar bronchiectasis, mucus-filled 
airways (arrows). (c) Hyperdensity of mucus-filled airways on axial 
MIP image (arrows) from chest CT is diagnostic of allergic bronchopul-
monary aspergillosis
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(AIDS), and following bone marrow transplantation. The 
most common thin-section CT findings of pulmonary can-
didiasis consist of multiple bilateral nodular opacities 
often associated with areas of consolidation and ground-
glass opacity [23].
7.10.3  Pneumocystis jiroveci
Pneumocystis jiroveci a unique opportunistic fungal patho-
gen that causes pneumonia in immunocompromised indi-
viduals such as patients with AIDS, patients with organ 
transplants, and patients with hematologic or solid organ 
malignancies who are undergoing chemotherapy. In 90% of 
patients with Pneumocystis jiroveci, pneumonia chest radio-
graphs show diffuse bilateral infiltrates in a perihilar distri-
bution (Fig.  7.5). The most common high-resolution CT 
finding in Pneumocystis jiroveci pneumonia is diffuse 
ground-glass opacity [24].
7.10.4  Mucormycosis
Mucormycosis is an opportunistic fungal infection of the 
order Mucorales, characterized by broad, nonseptated 
hyphae that randomly branch at right angles.
The most common radiographic findings consist of lobar 
or multilobar areas of consolidation and solitary or multiple 
pulmonary nodules and masses with associated cavitation or 
an air-crescent sign [25].
7.11  Viral Pneumonias
Viruses can result in several pathologic forms of lower respira-
tory tract infection including tracheobronchitis, bronchiolitis, 
and pneumonia. Viral infections predispose to secondary bacte-
rial pneumonia. Organizing pneumonia, a nonspecific repara-
tive reaction, may result from a variety of causes or underlying 
pathologic processes including viral infections [26].
a c
b
Fig. 7.5 (a, b, c) Pneumocystis pneumonia: (a) Posteroanterior chest 
radiograph demonstrates diffuse lung opacities, left greater than right, 
in this patient with history of HIV. (b) Axial and (c) coronal images 
from chest CT demonstrate diffuse upper lung predominant ground- 
glass opacity and mild left upper lobe consolidation (arrows). Upper 
lobe preponderance of disease has been described in the setting of 
Pneumocystis pneumonia
T. Franquet and J. H. Chung
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7.11.1  Influenza a
Influenza type A is the most important of the respiratory 
viruses with respect to the morbidity and mortality in the gen-
eral population. In recent years, both influenza and parainflu-
enza viruses have been recognized as a significant cause of 
respiratory illness in immunocompromised patients, including 
solid organ transplant recipients. The predominant high-reso-
lution CT findings are ground-glass opacities, consolidation, 
centrilobular nodules, and branching linear opacities.
7.11.2  Adenovirus
Adenovirus accounts for 5–10% of acute respiratory infec-
tions in infants and children but for less than 1% of respiratory 
illnesses in adults. Swyer-James-MacLeod syndrome is con-
sidered to be a post-infectious bronchiolitis obliterans (BO) 
secondary to adenovirus infection in childhood.
7.11.3  Respiratory Syncytial Virus (RSV)
Respiratory syncytial virus (RSV) is the most frequent viral 
cause of lower respiratory tract infection in infants. The 
major risk factors for severe RSV disease in children are pre-
maturity (< 36  weeks gestation), congenital heart disease, 
chronic lung disease, immunocompromised status, and mul-
tiple congenital abnormalities. CT findings consist of small 
centrilobular nodules, airspace consolidation, ground-glass 




Fig. 7.6 (a, b, c) Respiratory syncytial virus pneumonia: (a) 
Posteroanterior chest radiograph demonstrates subtle basilar nodularity 
and mild right basilar pleuroparenchymal scarring (arrow). (b) Axial 
CT image and (c) MIP images from chest CT demonstrate tree-in-bud 
opacities in the lower lobes (arrows)
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7.11.4  Epstein-Barr Virus (EBV)
Primary infection with EBV occurs early in life and presents 
as infectious mononucleosis with the typical triad of fever, 
pharyngitis, and lymphadenopathy, often accompanied by 
splenomegaly. Mild, asymptomatic pneumonitis occurs in 
about 5–10% of cases of infectious mononucleosis. The CT 
manifestations of EBV pneumonia are similar to those of other 
viral pneumonias. The findings usually consist of lobar con-
solidation, diffuse and focal parenchymal haziness, irregular 
reticular opacities, and multiple miliary nodules or small nod-
ules with associated areas of ground-glass attenuation (“halo”).
7.11.5  Varicella Virus
Varicella is a common contagious infection in childhood 
with increasing incidence in adults. Clinically presents in 
two forms: varicella (chickenpox) representing a primary 
disseminated disease in uninfected individuals and zoster 
(shingles) representing reactivation of latent virus (unilateral 
dermatomal skin eruption).
Pneumonia, although rare, is the most serious complication 
affecting adults with chickenpox. The thin-section CT appear-
ances in varicella pneumonia reflect the multicentric hemor-
rhage and necrosis centered on airways. Common findings 
include numerous nodular opacities measuring 5–10  mm in 
diameter, some with a surrounding halo of ground-glass opacity, 
patchy ground-glass opacities, and coalescence of nodules.
7.11.6  Cytomegalovirus (CMV)
Cytomegalovirus pneumonia is a major cause of morbidity 
and mortality following hematopoietic stem cell (HSCT) and 
solid organ transplantation and in patients with AIDS in 
whom CD4 cells are decreased to fewer than 100 cells/mm3. 
This complication characteristically occurs during the 
 post- engraftment period (30–100 days after transplantation) 
with a median time onset of 50–60 days posttransplantation.
CT features of CMV pneumonia consist of lobar consolida-
tion, diffuse and focal ground-glass opacities, irregular reticu-
lar opacities, and multiple miliary nodules or small nodules 
with associated areas of ground-glass attenuation (“halo”).
7.12  New Emerging Viruses
7.12.1  Severe Acute Respiratory Distress 
Syndrome (SARS)
Severe acute respiratory distress syndrome (SARS) caused by 
SARS-associated coronavirus (SARS-CoV) is a systemic 
infection that clinically manifests as progressive pneumonia. 
Severe acute respiratory distress syndrome was first detected in 
the Guangdong Province of China in late 2002, with major out-
breaks in Hong Kong, Guangdong, Singapore, and Toronto and 
Vancouver, Canada. Over 8000 people were affected, with a 
mortality rate of 10%. The typical clinical presentation consists 
of an incubation period of 2–10 days, early systemic symptoms 
followed within 2–7 days by dry cough or shortness of breath, 
the development of radiographically confirmed pneumonia by 
day 7–10, and lymphocytopenia in many cases. Histologically, 
acute diffuse alveolar damage with airspace edema is the most 
prominent feature. The imaging features consist of unilateral or 
bilateral ground- glass opacities, focal unilateral or bilateral 
areas of consolidation, or a mixture of both [27, 28].
7.12.2  Middle East Respiratory Syndrome 
(MERS)
MERS is a viral disease caused by a coronavirus (MERS- 
CoV), with most of the infections believed to have originated 
in Saudi Arabia and the Middle East. Most patients develop 
a severe acute respiratory illness. CT may depict ground- 
glass opacities, consolidation, interlobular thickening, and 
pleural effusion. During the subsequent weeks, other find-
ings may be present, such as centrilobular nodules, a “crazy- 
paving” pattern, obliterative bronchiolitis, peribronchial air 
trapping, and organizing pneumonia [29].
7.12.3  Swine Influenza (H1N1)
In the spring of 2009, an outbreak of severe pneumonia was 
reported in conjunction with the concurrent isolation of a novel 
swine-origin influenza A (H1N1) virus, widely known as swine 
flu, in Mexico. On June 11, 2009, the World Health Organization 
declared the first pandemic of the twenty-first century caused 
by swine-origin influenza virus A (H1N1). The predominant 
CT findings are unilateral or bilateral ground-glass opacities 
with or without associated focal or multifocal areas of consoli-
dation. On CT, the ground-glass opacities and areas of consoli-
dation have a predominant peribronchovascular and subpleural 
distribution, resembling organizing pneumonia [30].
Key Points
• Primary TB occurs most commonly in children.
• The most typical form of pulmonary NTMB infec-
tion is frequently associated to elderly non-smoking 
white women without underlying lung disease 
(Lady Windermere syndrome).
• With respect to the morbidity and mortality, influ-
enza type A is the most important of the respiratory 
viruses in the general population.
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Lung cancer is a major cause of cancer-related mortality 
worldwide and is the leading cause of cancer-related mortal-
ity in the United States in both men and women, accounting 
for more deaths than colorectal, breast, prostate, and pancre-
atic cancers combined [1, 2]. Lung cancer is staged using a 
typical tumor (T), node (N), and metastasis (M) scheme. 
The seventh edition of the tumor-node-metastasis (TNM) 
staging system for lung cancer (TNM-7) included key 
changes to the T and M descriptors and the recommendation 
that both small cell lung carcinoma and bronchopulmonary 
carcinoid tumors be staged with this system [3]. Updated 
revisions to the TNM staging system, in the form of the 
eighth edition (TNM-8), have been accepted by the Union 
for International Cancer Control (UICC) and the American 
Joint Committee on Cancer (AJCC) based on proposals 
from the International Association for the Study of Lung 
Cancer [4]. TNM-8 features additional changes to the T and 
M descriptors, modifications, and additions to the overall 
stage groups, new recommendations for the staging of 
patients with multiple sites of pulmonary involvement, and 
recommendations for lesion measurement. In this manu-
script, we discuss the role of imaging in the diagnosis of 
lung cancer and the key features of TNM-8 with which radi-
ologists must be familiar.
8.2  Diagnosis of Lung Cancer
8.2.1  Clinical Symptoms
Most patients diagnosed with lung cancer manifest in the 
fifth and sixth decades of life [5]. Approximately three- 
fourths of patients demonstrate clinical symptoms at the time 
of presentation, the most common of which include cough 
(50–75%), hemoptysis (25–50%), dyspnea (25%), and chest 
pain (20%). Nonspecific symptoms related to systemic mani-
festations of the malignancy such as anorexia, weight loss, or 
fatigue may be present. Clinical symptoms also depend on 
the local effects of the primary tumor, the presence of 
regional or distant metastases, and the coexistence of para-
neoplastic syndromes. While patients with solitary, peripher-
ally located tumors tend to be asymptomatic, those with 
central endobronchial tumors may demonstrate fever, dys-
pnea, hemoptysis, and cough. Symptoms related to invasion 
of the mediastinum and associated vital structures include 
chest pain, vocal cord paralysis and hoarseness, facial and 
upper truncal edema, headaches, neck vein distention and 
enlarged collateral chest wall vessels (as seen in superior 
vena cava obstruction), and dysphagia (as seen in esophageal 
involvement). Lung cancers may produce symptoms via the 
release of bioactive substances or hormones or result in 
immune-mediated neural tissue destruction caused by anti-
body or cell-mediated immune responses. Such paraneoplas-
tic syndromes occur in 10–20% of lung cancer patients, the 
most common of which are related to the release of antidi-
uretic and adrenocorticotropin hormones, which can result in 
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Learning Objectives
• Understand the role of imaging in diagnosing and 
staging lung cancer.
• Describe the tumor (T), lymph node (N), and metas-
tasis (M) descriptors and stage groups outlined in 
the eighth edition of the TNM staging system 
(TNM-8).
• Employ TNM-8 to properly characterize and stage 
lung cancers with multiple sites of pulmonary 
involvement, including those with multiple tumor 
nodules, ground-glass lesions, and consolidation.
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hyponatremia and serum hypo-osmolarity and in Cushing’s 
syndrome (central obesity, hypertension, glucose intoler-
ance, plethora, hirsutism), respectively [5].
8.2.2  Imaging Evaluation of Pulmonary 
Nodules
Once a solitary pulmonary nodule is identified, it may be 
further evaluated with cross-sectional imaging techniques 
such as computed tomography (CT) and/or positron emis-
sion tomography (PET)/CT.  Key features that should be 
assessed include morphology, density, growth, and meta-
bolic activity.
8.2.2.1  Morphology and Density
Pulmonary nodules may be described as solid or subsolid, the 
latter of which includes part-solid (combination of solid and 
ground-glass components) and nonsolid (pure ground- glass) 
nodules. Updated guidelines for the evaluation of solid and 
subsolid pulmonary nodules have been published by the 
Fleischner Society but are beyond the scope of this manu-
script. Continuous improvement in CT technology has enabled 
the widespread utilization of thin collimation imaging and 
improved the detection and characterization of subsolid pul-
monary nodules [6]. In general, subsolid nodules that persist 
on CT have a higher incidence of malignancy than solid nod-
ules, as 63% of part-solid nodules are malignant as compared 
to 18% for ground-glass opacities and 7% for solid nodules 
[6]. For subsolid nodules, the likelihood of malignancy varies 
according to the size of the soft tissue component on CT. The 
frequency of lobulation, spiculation, and pseudocavitation 
(small focal lucencies) has also been reported to be signifi-
cantly higher in malignant part-solid nodules. The “classic” 
morphology of a lung cancer has often been described as irreg-
ular or “spiculated”; however, it is important to recognize that 
benign lesions may occasionally demonstrate this appearance. 
Similarly, although many benign pulmonary nodules have a 
smooth margin, malignant lesions, including lung cancer, can 
have a similar manifestation.
The presence of intralesional fat (defined as Hounsfield 
Units of −40 to −120 on CT) almost always represents a 
benign hamartoma or, less commonly, lipoid pneumonia. 
Pulmonary metastases may contain fat in the setting of a pri-
mary soft tissue tumor that contains fat such as a liposar-
coma, although this is rare. Different patterns of calcification 
may be identified within pulmonary nodules, some of which 
are typically benign and others of which tend to be malig-
nant. For instance, central, popcorn, and laminated patterns 
of calcification tend to be benign and may be seen in the set-
ting of granulomatous disease or hamartomas. Eccentric and 
stippled patterns of calcification are more concerning for 
malignant lesions.
8.2.2.2  Growth
The stability of nodules can be assessed by comparison to 
any chest radiographs or CT examinations performed in the 
past. In general, solid pulmonary nodules that have been 
stable for >2 years are considered benign and may represent 
granulomas, hamartomas, or intrapulmonary lymph nodes. 
The determination of stability for subsolid nodules, includ-
ing part-solid and nonsolid (pure ground-glass) nodules is 
more complex, as such lesions can remain stable for a long 
period of time (>2 years) due to slow growth rates.
Lung cancers typically double in volume (defined as an 
increase of 26% in diameter) between 30 and 400 days (with 
an average of 240 days). Extremely rapid doubling times are 
more likely to reflect a benign etiology. For example, volume 
doubling times <20–30 days are suggestive of an infectious 
or inflammatory etiology but can occur with lymphoma or 
rapidly growing metastases. Small lung cancers may demon-
strate long volume doubling times. For instance, in a screen-
ing study analyzing the growth rates of small lung cancers on 
CT, the doubling time ranged from 52 to 1733 days (mean of 
452 days), and 20% of these malignancies had a volumetric 
doubling time  >2  years [7]. These lesions were typically 
well-differentiated adenocarcinomas. For subsolid nodules, 
an increase in overall size, density, and/or an associated solid 
component should raise the suspicion for malignancy [8].
8.2.2.3  Metabolic Activity
PET/CT using the radiopharmaceutical [18F]-fluoro-2-deoxy- 
D-glucose (FDG), a D-glucose analog labeled with fluorine-
 18, compliments conventional radiologic assessment of lung 
nodules. The reported sensitivity and specificity for detecting 
malignant pulmonary lesions are 97% and 78%, respectively. 
Thus, when solid nodules measuring 1 cm or greater in diam-
eter demonstrate little to no FDG uptake, the likelihood of 
malignancy is generally considered to be low. One of the limi-
tations of PET/CT is that the spatial resolution of PET scan-
ners is in the range of 6 mm; therefore, smaller lesions may not 
appear FDG-avid even when cancer cells are present. Other 
limitations include false-positive studies with benign lesions, 
such as infection, inflammation, and granulomatous disease, 
and false-negative examinations due to indolent neoplasms 
such as bronchopulmonary carcinoid and lesions in the adeno-
carcinoma spectrum (adenocarcinoma in situ and minimally 
invasive adenocarcinoma), small foci of metastasis, and non-
enlarged lymph nodes (those measuring <10 mm).
Key Point
• In the evaluation of pulmonary nodules for poten-
tial malignancy, the most important features to con-
sider include morphology, density, growth over 
time, and metabolic activity on FDG PET/CT.
B. W. Carter and J. J. Erasmus
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8.3  Patient Evaluation and the Role 
of Imaging
Once a diagnosis of lung cancer has been made, a variety of 
imaging techniques are available to further evaluate patients. 
For non-small cell lung cancer, the National Comprehensive 
Cancer Network (NCCN) recommends that the initial patient 
evaluation include (1) pathology review, (2) history and 
physical examination, (3) CT of the chest and upper  abdomen 
with intravenous contrast (including coverage of the adrenal 
glands), (4) laboratory studies (typically complete blood 
count, platelets, and chemistry profile), and (5) smoking ces-
sation counseling [9]. Additional imaging examinations 
including FDG PET/CT and magnetic resonance (MR) 
imaging may be used depending on the clinical stage and 
have specific advantages and disadvantages.
8.3.1  Computed Tomography
CT with intravenous contrast is the imaging modality of 
choice for evaluating most patients with lung cancer, as the 
modality accurately demonstrates the location and size of the 
primary lesion, the extent of local disease, and the relation-
ship of the tumor to intrathoracic structures. Additionally, it 
can be used to determine the presence of intrathoracic and 
extrathoracic lymph node metastases, which are typically 
considered abnormal when they measure >1 cm in short-axis 
diameter. However, the strictly anatomic information pro-
vided by limits its effectiveness in this regard. For instance, 
in one study, 44% of metastatic nodes measured <1 cm, and 
77% of patients without lymph node metastases had nodes 
measuring >1 cm [10].
8.3.2  FDG PET/CT
FDG PET/CT is more accurate than CT or stand-alone PET 
in determining the tumor classification, with integrated PET/
CT correctly predicting the tumor stage in 86% of cases 
compared to 68% with CT and 46% with PET [11]. 
Additionally, FDG PET/CT can distinguish between tumor 
and associated post-obstructive atelectasis/pneumonitis, 
with the former typically demonstrating greater FDG uptake 
[12]. As FDG PET/CT combines the anatomic information 
of CT and the functional information of PET, it is more accu-
rate than CT in detecting lymph node metastases. Early stud-
ies demonstrated a pooled average sensitivity, specificity, 
positive predictive value, negative predictive value, and 
accuracy of PET/CT of, respectively, 73%, 91%, 71%, 90%, 
and 86%, compared to 74%, 73%, 52%, 88%, and 73% of 
CT alone and 83%, 81%, 71%, 89%, and 82% of PET alone 
[13]. FDG PET/CT is superior to both CT and PET in 
identifying distant metastatic disease, particularly soft tissue 
and pleural metastases, and is better than nuclear medicine 
bone scintigraphy as the imaging modality of choice for 
detecting osseous metastases [13].
8.3.3  MR Imaging
MR imaging is typically not routinely performed in the eval-
uation of patients with lung cancer; however, it has been 
shown to be superior to CT and FDG PET/CT for identifying 
invasion of the mediastinum and chest wall and evaluating 
the heart, pericardium, and vascular structures [14, 15]. 
Characteristic MR imaging features of chest wall invasion 
include (1) infiltration or disruption of the normal extrapleu-
ral fat plane on T1-weighted imaging, (2) hyperintensity of 
the parietal pleura on T2-weighted imaging, (3) rib destruc-
tion on short tau inversion recovery (STIR) sequences, and 
(4) fixation of the tumor to the chest wall during breathing on 
cine MR imaging. MR imaging is better than CT in differen-
tiating between the primary neoplasm and post-obstructive 
atelectasis/pneumonitis, the former of which typically usu-
ally shows higher signal on T2-weighted imaging than the 
central tumor [14]. MR imaging is the best imaging modality 
for identifying brain and liver metastases and can be used to 
diagnose adrenal metastases; specifically, chemical shift 
techniques can be used to differentiate adrenal metastases 
from adenomas, with reported sensitivity and specificity of 
100% and 81%, respectively.
8.4  Lung Cancer Staging
8.4.1  Rationale and Methodology for TNM-8
A significant limitation of the International Association for 
the Study of Lung Cancer (IASLC) Staging Project that 
informed TNM-7 was the retrospective nature of the data-
base. An international group led by the IASLC collected new 
lung cancer cases with retrospective and prospective clinical 
information for the creation of a large database that would 
ultimately inform TNM-8 [4, 16]. The database included 
data on 94,708 cases diagnosed between 1999 and 2010 
Key Point
• Once a diagnosis of lung cancer has been made, 
most patients are further assessed with contrast- 
enhanced CT. Additional imaging modalities such 
as FDG PET/CT and MR imaging may be obtained 
depending on the suspected clinical stage and/or 
further evaluation of specific findings.
8 Current Concepts in the Diagnosis and Staging of Lung Cancer
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gathered from 35 sources in 16 countries, 4667 of which 
were submitted through an online electronic data capture 
system stored at Cancer Research and Biostatistics in Seattle, 
Washington. Of these cases, 17,552 were excluded due to 
unknown or different histologic type and incomplete stage 
information. Thus, 77,156 patients (70,967 with non-small 
cell lung cancer and 6189 with small cell lung cancer) with 
clinical and pathologic staging information were available 
for analysis.
8.4.2  Modifications to TNM-8
8.4.2.1  T Classification
The tumor (T) classification assigns specific descriptors to 
characterize the primary lung cancer [17] (Table 8.1). When 
evaluating tumors, the key imaging features to consider 
include lesion size (typically measured in long-axis diame-
ter), the presence or absence of local invasion, and the pres-
ence or absence of tumor nodules. Analysis of the new lung 
cancer staging database evaluated the impact of these fea-
tures on patient survival, and several significant changes are 
introduced in TNM-8.
8.4.2.2  Tumor Size
The overall size of the primary lung cancer is one of the most 
important considerations in T descriptor determination, and 
significant differences in survival between lung cancers of 
various sizes have influenced additional changes introduced in 
TNM-8. Analysis of the new lung cancer staging database 
revealed separation of T1 lesions from T2 lesions based on a 
size threshold of 3 cm and progressively worse survival for 
each cut point of 1 cm. Thus, T1 lung cancers are divided into 
three groups at 1 cm thresholds: T1a tumors measuring 1 cm 
or less, T1b nodules measuring greater than 1 cm and less than 
or equal to 2 cm, and T1c lesions measuring greater than 2 cm 
and less than or equal to 3 cm. Similarly, T2 lung cancers are 
divided into two groups: T2a lesions measuring greater than 
3 cm and less than or equal to 4 cm and T2b tumors measuring 
greater than 4 cm and less than or equal to 5 cm. Finally, T3 
lesions measure greater than 5 cm and less than or equal to 
7 cm, and T4 tumors measure greater than 7 cm in TNM-8.
8.4.2.3  Involvement of Main Bronchi
A lung cancer invading a main bronchus 2 cm or more from 
the carina was classified as T2, whereas involvement of the 
more proximal aspect of a main bronchus was classified as a 
Table 8.1 TNM Descriptors for TNM-8
T descriptor Definition
TX Tumor cannot be assessed or tumor proven by the presence of malignant cells in sputum or bronchial washings but not 
visualized by imaging or bronchoscopy
T0 No evidence of the primary tumor
Tis Carcinoma in situ
T1 Tumor ≤3 cm in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more 
proximal than the lobar bronchus
T1a Tumor ≤1 cm in greatest dimension
T1b Tumor >1 cm but ≤2 cm in greatest dimension
T1c Tumor >2 cm but ≤3 cm in greatest dimension
T2 Tumor >3 cm but ≤5 cm or tumor with any of the following features: Involvement of a main bronchus regardless of distance 
from carina, invasion of the visceral pleura, associated with partial or complete lung atelectasis/pneumonitis
T2a Tumor >3 cm but ≤4 cm in greatest dimension
T2b Tumor >4 cm but ≤5 cm in greatest dimension
T3 Tumor >5 cm or one that directly invades any of the following structures: Parietal pleura, chest wall (including superior sulcus 
tumors), phrenic nerve, parietal pericardium, or separate tumor nodule(s) in the same lobe
T4 Tumor measuring >7 cm that invades any of the following structures: Mediastinum, diaphragm, heart, great vessels, trachea, 
recurrent laryngeal nerve, esophagus, vertebral body, carina, or separate tumor nodule(s) in a different lobe of the same lung
N descriptor Definition
NX Lymph nodes cannot be assessed
N0 No regional lymph nodes
N1 Ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct 
extension
N2 Ipsilateral mediastinal and/or subcarinal lymph node(s)




M1a Separate tumor nodule(s) in contralateral lung; malignant pleural effusion or pleural thickening/nodules/masses; malignant 
pericardial effusion or pericardial thickening/nodules/masses
M1b Single distant (extrathoracic) metastasis in single organ
M1c Multiple distant (extrathoracic) metastases in single or multiple organs
Adapted from [25]
B. W. Carter and J. J. Erasmus
83
T3 lesion in TNM-7. Analysis of the new lung cancer staging 
database revealed that lung cancers invading a main bron-
chus less than 2 cm from the carina, but without direct inva-
sion of the carina, were associated with better survival 
compared to lung cancers with other characteristic T3 fea-
tures. Thus, in TNM-8, lung cancers involving a main bron-
chus, regardless of the distance from the carina, are grouped 
together as T2 tumors.
8.4.2.4  Atelectasis or Pneumonitis of the Lung
A lung cancer resulting in partial atelectasis or pneumonitis, 
defined as involving less than an entire lung, was classified 
as T2  in TNM-7, whereas atelectasis or pneumonitis of an 
entire lung was classified as a T3 lesion. Analysis of the new 
lung cancer staging database revealed that patients with 
complete atelectasis or pneumonitis of a lung had better sur-
vival than those with other characteristics T3 features. Thus, 
partial and complete forms of lung atelectasis and pneumo-
nitis are grouped together as T2 lesions in TNM-8 (Fig. 8.1).
8.4.2.5  Diaphragmatic Invasion
In TNM-7, invasion of the diaphragm was included in T3. 
Analysis of the new database demonstrated that the 5-year 
survival of patients with this feature was worse than that of 
patients with other T3 lung cancers but similar to that of 
patients with T4 tumors. Therefore, diaphragmatic invasion 
has been reclassified as T4 in TNM-8 (Fig. 8.2).
8.4.2.6  Involvement of the Mediastinal Pleura
In TNM-7, involvement of the mediastinal pleura was clas-
sified as T3. Analysis of the new database showed that lung 
cancers with this feature were associated with a better 
prognosis than other T3 lesions; however, only a small 
number of cases were available. It was also noted that 
mediastinal pleura invasion was rarely used in clinical 
staging reports as it can be difficult to accurately deter-
mine. Therefore, invasion of the mediastinal pleura has 
been eliminated from the T classification in TNM-8.
a b
Fig. 8.1 Atelectasis/pneumonitis. (a) Contrast-enhanced axial CT of a 
63-year-old man with non-small cell lung cancer demonstrates occlu-
sion of the right upper lobe bronchus (arrow) and complete atelectasis 
of the right upper lobe (*) due to a right perihilar mass. (b) Contrast- 
enhanced axial CT of a 55-year-old man with non-small cell lung can-
cer demonstrates complete occlusion of the right main bronchus (arrow) 
and complete atelectasis of the right lung (*) due to a large right perihi-
lar mass. In TNM-8, partial and complete lung atelectasis/pneumonitis 
are grouped together as a T2 descriptor
Key Point
• The most important features to consider in the clas-
sification of tumors include lesion size, location, 
and local extension. Modifications to the T classifi-
cation have been made on the basis of 1 cm incre-
ments in tumor size; grouping of lung cancers that 
result in partial or complete lung atelectasis or 
pneumonitis; grouping of tumors with involvement 
of a main bronchus irrespective of distance from the 
carina; reassignment of diaphragmatic invasion in 
terms of T classification; and elimination of medi-
astinal pleural invasion.
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8.4.2.7  Lymph Node (N) Classification
The lymph node (N) classification assigns specific descrip-
tors that are related to the presence or absence of intratho-
racic lymph node disease (Table 8.1). In contrast to primary 
lung cancers, for which the long-axis diameter is measured 
and reported, lymph nodes are typically measured in short- 
axis diameter. IASLC recommends use of a standardized 
lymph node map that assigns nodes into specific supracla-
vicular, upper, aorticopulmonary, subcarinal, lower, hilar/
interlobar, and peripheral zones [18]. The analysis of the new 
database revealed that the current N classification provides 
consistent separation of prognostically distinct groups. Thus, 
the lymph node descriptors are unchanged for TNM-8 [19]. 
N0 is defined as the absence of lymph node disease. N1 is 
characterized by ipsilateral peripheral or hilar lymph nodes, 
N2 includes ipsilateral mediastinal including subcarinal 
lymph nodes, and N3 involves ipsilateral or contralateral 
supraclavicular lymph node or contralateral mediastinal, 
hilar/interlobar, or intrapulmonary lymph nodes.
The potential prognostic impact of the number of lymph 
node stations involved and skip metastases was also evaluated. 
To assess the former, pathologic staging (pN) was divided into 
several groups, in which the letter “a” denoted single lymph 
node station involvement and the letter “b” represented multi-
ple lymph node station involvement within an N category. 
Therefore, single (pN1a) and multiple (pN1b) pN1 stations and 
single (pN2a) and multiple (pN2b) pN2 stations were delin-
eated. No significant difference was seen between the pN1b 
and pN2a groups, although survival differences between the 
pN1a and pN1b groups and between the pN2a and pN2b 
groups were significant. To assess the skip metastases, pN2a 
was divided into several components, in which a designation 
ending in “1” indicated the presence of skip metastases and a 
designation ending in “2” indicated the absence of skip metas-
tases. Thus, single pN2 with skip (no pN1 involvement, pN2a1) 
and single pN2 without skip (pN1 and pN2 involvement, 
pN2a2) categories were recognized. Although the survival of 
patients with pN2a1 was better than those with pN1b, this dif-
ference was not significant. Although significant differences in 
survival were present between the pN2a1 and pN2a2 groups 
and between the pN2a2 and pN2b groups, no significant differ-
ence was present between the pN1b and pN2a1 groups.
For the purposes of clinical staging, IASLC recommends 
that radiologists document the number of lymph node sta-
tions involved and classify the N category using descriptors 
such as N1a (single lymph node station), N1b (multiple 
lymph node stations), N2a (single lymph node station), and 
N2b (multiple lymph node stations). The presence or absence 
of skip metastasis (pN2a1 or pN2a2) should be noted when 
such information is available.
a b
Fig. 8.2 Diaphragmatic invasion. (a) Axial contrast-enhanced axial 
CT of a 61-year-old man with non-small cell lung cancer shows a mass 
(*) in the right lower lobe inseparable from the right hemidiaphragm 
(arrow). (b) Axial cine T2-weighted MR confirmed invasion of the right 
hemidiaphragm. Because the 5-year survival of patients with diaphrag-
matic invasion is similar to that of patients with other T4 tumors, dia-
phragmatic invasion has been reclassified from T3 to T4 in TNM-8
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8.4.2.8  Metastasis (M) Classification
The metastasis (M) classification assigns specific descriptors 
reflecting the absence (M0) or presence (M1) of intrathoracic 
or extrathoracic metastatic disease (Table 8.1). The M clas-
sification for TNM-7 included M1a and M1b components for 
intrathoracic and extrathoracic metastatic disease, respec-
tively. Analysis of the new lung cancer staging database 
revealed that patients with a single metastasis in one extra-
thoracic organ (median survival of 11.4 months) had similar 
survival to that of patients with M1a (median survival of 
11.5 months) but better survival compared to patients with 
multiple metastases in one or more extrathoracic organs 
(median survival of 6.3  months) [20]. Therefore, M1 is 
divided into M1a, M1b, and M1c components based on sur-
vival differences. M1a, or intrathoracic metastatic disease, 
describes pleural or pericardial spread of disease and tumor 
nodules in the contralateral lung (Fig. 8.3). M1b and M1c 
describe extrathoracic metastatic disease, the former of 
which includes a single metastasis involving a single distant 
(extrathoracic) organ and the latter of which includes multi-
ple metastases in one or more distant (extrathoracic) organs 
(Fig. 8.4). Overall, the most common sites of metastatic dis-
ease include the brain, liver, adrenal glands, and bone.
It is recommended that radiologists document the follow-
ing features on imaging studies performed for the purposes 
of clinical staging: (1) the number and location of metastatic 
lesions, (2) the diameter of individual metastases, and (3) the 
number and location of organs affected.
a b
Fig. 8.3 Intrathoracic metastases. (a) Contrast-enhanced axial CT of a 
66-year-old man with non-small cell lung cancer demonstrates exten-
sive pleural thickening and nodularity (*) in the right hemithorax com-
patible with metastatic disease. (b) Contrast-enhanced axial CT of a 
57-year-old woman with non-small cell lung cancer shows several nod-
ules (arrows) involving the pericardium and a small amount of pericar-
dial fluid, compatible with metastatic disease. M1a is used to describe 
pleural or pericardial spread of disease and tumor nodules in the contra-
lateral lung
Key Point
• The current nomenclature for lymph node classifica-
tion is maintained in TNM-8 due to consistent sepa-
ration of prognostically distinct groups, which is 
primarily based on lymph node location. In general, 
ipsilateral hilar (N1) lymph nodes are considered 
resectable, ipsilateral mediastinal or subcarinal 
lymph nodes (N2) may be resectable (usually after 
induction chemotherapy), and contralateral mediasti-
nal lymph nodes and scalene or supraclavicular ade-
nopathy (N3) are generally considered unresectable.
Key Point
• The M1 descriptor is subdivided into M1a (intra-
thoracic metastatic disease, including pleural or 
pericardial spread, cardiac metastasis, and contra-
lateral tumor nodule), M1b (extrathoracic meta-
static disease, with one lesion in one distant organ), 
and M1c (extrathoracic metastatic disease, with 
more than one lesion in one or more distant organs) 
based on the location and number of metastases.
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8.4.3  Stage Groups
Due to changes to the T and M descriptors in TNM-8, the 
stage groups in TNM-7 have been modified, and new 
groups have been added [21] (Table 8.2). For example, in 
response to the separation of T1 lesions into T1a, T1b, and 
T1c components based on 1  cm increments, three new 
associated stages have been created and designated as IA1, 
IA2, and IA3, respectively. In another instance, to describe 




Fig. 8.4 Distant (extrathoracic) metastases. (a) Axial contrast- 
enhanced T1-weighted MR image of a 53-year-old man with non-small 
cell lung cancer demonstrates an enhancing metastasis (arrow) with 
surrounding edema in the left middle frontal gyrus. (b) Contrast- 
enhanced axial CT of a 64-year-old man with non-small cell lung can-
cer demonstrates numerous heterogeneously hypodense masses in the 
liver (arrows), consistent with metastases. C. Fused axial FDG PET/CT 
of a 71-year-old man with non-small cell lung cancer demonstrates 
hepatic (white arrow) and left adrenal (black arrow) metastases. TNM-8 
recognizes differences in survival based on both the location and num-
ber of metastases; thus, distant metastatic disease is designated as M1b 
(solitary metastasis in a single distant organ) and M1c (multiple metas-
tases in one or more distant organs)
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lesions) with N3 but no evidence of metastatic disease, a 
new stage designated as stage IIIC has been created for 
TNM-8. Intrathoracic metastatic disease, including pleu-
ral, pericardial, and cardiac spread, as well as tumor nod-
ules in the contralateral lung, remains classified as stage 
IVA. A single metastasis to a single distant organ (M1b) is 
considered stage IVA, whereas multiple distant metasta-
ses in one or more distant organs (M1c) are classified as 
stage IVB.
8.4.4  Lung Cancers with Multiple Sites 
of Pulmonary Involvement
Multiple distinct patterns of lung cancer manifesting with 
several sites of pulmonary involvement have been described, 
including multiple primary lung cancers, lung cancers with 
one or more tumor nodules, multiple ground-glass lesions, 
and consolidation [22]. Recommendations for the staging of 
tumors resulting in these patterns is included for the first 
time in TNM-8 and are based on review of the literature and 
expert opinion provided by IASLC.
8.4.4.1  Multiple Primary Lung Cancers
When a lung cancer is identified on an imaging examination 
and there are multiple additional lung lesions, the radiologist 
must consider data from several sources when attempting to 
determine whether such lesions represent multiple primary 
lung cancers. IASLC recommends that the decision to clas-
sify two (or more) lung lesions as synchronous primary lung 
cancers or two foci of a single lung cancer should be based 
on multidisciplinary evaluation that incorporates clinical, 
relevant findings on prior and current imaging and histopath-
ologic findings obtained at image-guided or surgical biopsy 
or surgical resection [22, 23]. If two (or more) lung lesions 
are determined to represent separate primary lung cancers, 
then each separate malignancy should be staged using 
TNM-8.
8.4.4.2  Lung Cancer with One or More Tumor 
Nodules
When a lung cancer is identified on an imaging examination 
with one or more nodules, these other lesions may or may 
not be of the same histologic subtype as the primary lesion. 
Tumor nodules related to the primary malignancy should be 
suspected when one or more solid lung nodule is identified 
along with a dominant lung lesion resulting in the “classic” 
lung cancer appearance, such as a spiculated nodule or mass. 
Analysis of the new lung cancer staging database revealed a 
progressive decrease in survival with increasing distance 
between a primary lung cancer and associated tumor nodule. 
Thus, patient survival is better when lung cancers have tumor 
nodules in the same lobe as the primary tumor (T3) com-
pared with those lesions with nodules in a different ipsilat-
eral lobe (T4) or the contralateral lung (M1a) [22, 24] 
(Fig. 8.5).
8.4.4.3  Multiple Ground-glass Lesions
In general, lung cancers appearing as multiple lesions with 
ground-glass or lepidic features are almost always adeno-
carcinoma, tend to affect women and nonsmokers, and are 
associated with excellent patient outcomes and infrequent 
recurrences [22, 25]. Compared to other types of lung can-
cer, subsolid adenocarcinomas tend to have a lower likeli-
hood of resulting in lymph node spread or metastasis, have 
a greater propensity for developing additional subsolid 
lung cancers, and are more likely to behave in an indolent 
manner [25].
IASLC recommends that the term multifocal adenocarci-
noma be used to describe lung lesions if a malignant subsolid 
nodule is present (suspected at clinical staging or histopatho-
logically proven) and if other ground-glass lesions are pres-
ent [25]. This definition also includes cases in which a 
subsolid lesion with a 50% or greater solid (invasive) compo-
nent appears to have arisen from a ground-glass nodule and 
other ground-glass opacities are present. The term multifocal 
lung adenocarcinoma should not be applied to patients with 
multiple ground-glass nodules likely representing benign 
lesions or preneoplastic/preinvasive lesions such as atypical 
adenomatous hyperplasia.
Table 8.2 Stage Groups for TNM-8
Stage Tumor Node Metastasis
Occult carcinoma TX N0 M0
Stage 0 Tis N0 M0






Stage IA2 T1b N0 M0
Stage IA3 T1c N0 M0
Stage IB T2a N0 M0

















































Stage IVB Any T Any N M1c
mi minimally invasive
Adapted from [25]
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For the purposes of staging, IASLC recommends that the 
T classification be determined by the lesion with the highest- 
level T descriptor and the number of lesions (#)—or simply 
“(m)” for multiple—indicated in parentheses (Fig.  8.6). 
Lesion size is determined by the largest diameter of the solid 
component measured on CT or the largest diameter of the 
invasive component at pathologic examination. 
Adenocarcinoma in situ and minimally invasive adenocarci-
noma should be classified as Tis and T1a(mi), respectively 
[26]. It is recommended that the T(#/m) multifocal classifi-
cation should be used regardless of whether these lesions are 
suspected on the basis of imaging or if there is histopatho-
logic proof and regardless of whether the lesions are in the 
same lobe or in different lobes of the same or different lung. 
Once the T classification has been determined, the N and M 
descriptors apply to all of the tumor foci collectively.
8.4.4.4  Consolidation
The dominant manifestation of some lung cancers may 
appear as diffuse consolidation or a “pneumonic type” of 
adenocarcinoma, most of which are invasive mucinous 




Fig. 8.5 Lung cancers with separate tumor nodules. (a) Contrast- 
enhanced axial CT of a 39-year-old woman with non-small cell lung 
cancer demonstrates the tumor in the right upper lobe (*) and a separate 
tumor nodule (arrow) in the adjacent lung. These findings are desig-
nated as T3. (b) Contrast-enhanced coronal CT of a 72-year-old woman 
with non-small cell lung cancer demonstrates the tumor in the right 
upper lobe (*) and a separate tumor nodule in the middle lobe (arrow). 
These findings are classified as T4. (c) Contrast-enhanced axial CT of a 
63-year-old man with non-small cell lung cancer demonstrates the 
tumor in the left lung (*) and a separate tumor nodule in the right upper 
lobe (arrow). Biopsy of the right upper lobe nodule confirmed malig-
nancy, and these findings are designated as M1a
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consolidative pattern on CT without evidence of an obstructed 
bronchus and may only involve a specific region (such as a 
segment or lobe), multiple regions (appearing confluent or 
separate), or the lung in a diffuse manner. Lymph node 
involvement and metastatic disease are uncommon at pre-
sentation, even in the setting of extensive lung disease [30–
32]. Progression is typically slow; however, the overall 
survival is worse compared with that of patients with multi-
focal ground-glass lesions.
For the purposes of staging, IASLC recommends that, 
when the lung cancer involves a single area, the T classifica-
tion is determined by the size of the lesion. When multiple 
sites of involvement are present, the disease is characterized 
as T3 if confined to one lobe, T4 if different lobes of the 
same lung are affected, and M1a if both lungs are involved 
(Fig. 8.7). When disease is present within both lungs, the T 
classification is based on the appropriate T category for the 
lung with the greatest extent of tumor involvement. For a 
lesion that is confined to a single lobe but is difficult to mea-
sure reliably, the T3 descriptor should be used. Lesions in 
which there is extension of tumor into an adjacent lobe or a 
discrete separate area of involvement of an adjacent lobe is 
identified should be classified as T4. Once the T classifica-
tion has been determined, the N and M descriptors apply to 
all of the tumor foci collectively. This algorithm should also 
be used to stage lung cancers presenting with a miliary pat-
tern of disease, characterized by numerous small pulmonary 
nodules in the lungs. Miliary disease is often difficult to mea-




Fig. 8.6 Multiple ground- 
glass lesions (multifocal 
adenocarcinoma). (a) 
Unenhanced axial CT of a 
58-year-old woman with 
multifocal lung 
adenocarcinoma demonstrates 
several ground-glass nodules 
in the right lung, the largest of 
which measures 1.6 cm. (b) 
Unenhanced axial CT of a 




nodules bilaterally, the largest 
of which measures 4.5 cm. In 
the setting of multiple 
ground-glass lesions, the 
IASLC recommends the 
utilization of the dominant 
lesion for T descriptor 
purposes. In the first case, the 
nodule is classified as a T1b 
lesion, and the overall 
descriptor can be listed as 
either T1b (# of lesions) or 
T1b (m). In the second case, 
the nodule is classified as a 
T2b lesion, and the overall 
descriptor can be listed as 
either T2b (# of lesions) or 
T2b (m)
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8.4.5  Tumor Measurement
For the purposes of initial clinical staging on cross-sectional 
imaging, lung cancers should be measured and reported in 
centimeters with millimeter increments. Solid and nonsolid 
lesions should be measured on the image showing the great-
est tumor dimension, regardless of plane (axial, sagittal, or 
coronal), whereas part-solid lesions should be measured on 
the image showing the largest average tumor diameter and 
the greatest diameter of the solid component of the lesion. 




Fig. 8.7 Lung cancer manifesting as consolidation. (a) Unenhanced 
axial CT of a 69-year-old woman with non-small cell lung cancer dem-
onstrates consolidation isolated to the right lower lobe (*) with sur-
rounding ground-glass opacity. As this lesion is limited to the right 
lower lobe, it is designated as T3. (b) Contrast-enhanced axial CT of a 
49-year-old woman with multifocal adenocarcinoma demonstrates 
multifocal consolidation (*) in the left upper lobe and extensive ground- 
glass opacities in the left lung. As these lesions are present in both lobes 
of the left lung, the designation is T4. (c) Contrast-enhanced axial CT 
of a 53-year-old woman with multifocal adenocarcinoma shows con-
solidation and extensive ground-glass opacities in the lungs bilaterally. 
As consolidation is present in both lungs, the designation is M1a
Key Point
• A subcommittee of the IASLC staging and prog-
nostic factors committee identified four distinct pat-
terns of disease in cases of lung cancer characterized 
by multiple sites of pulmonary involvement, includ-
ing multiple primary lung cancers, lung cancers 
with separate tumor nodules, multiple ground-glass 
lesions, and consolidation. Specific criteria have 
been outlined in order to categorize and stage 
lesions with these patterns of disease.
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longest diameter should be used for solid and nonsolid 
lesions, and the longest diameter of the solid component 
should be used for part-solid lesions [17, 26] (Fig. 8.8).
Regarding optimal CT scan technique, thin-section 
images (specifically, 1  mm sections if possible for small 
lesions measuring 10 mm or less) help reduce the variability 
in measurement and allow visualization of specific tumor 
features such as density, shape, and margin due to enhanced 
spatial resolution [33–36]. It is recommended that lung or 
intermediate window settings should be used to detect and 
measure the solid components of subsolid lesions and that 
the long-axis measurement of the largest solid component 
should be identified.
8.4.6  Small Cell Lung Cancer
IASLC first recommended that SCLC should be evaluated 
with the TNM staging system at the release of TNM-7. A 
separate staging system developed by the Veterans 
Administration Lung Study Group that divides SCLC into 
two subgroups, limited-stage SCLC and extensive-stage 
SCLC, based on the extent of disease and the ability to treat 
in a single radiation portal, is still often used in current 
clinical practice. Limited-stage SCLC is confined to one 
hemithorax and can be treated in a single radiation portal, 
and extensive-stage SCLC, which includes all other cases. 
The TNM staging system has been shown to better differ-
entiate stage-specific survival compared with the Veterans 
Administration Lung Study Group system [37, 38]. 
Analysis of the new database confirmed the prognostic 
value of TNM staging in patients with SCLC, and the 
IASLC recommends its use for staging of patients with 
SCLC. Radiologists should record the following informa-
tion regarding SCLC: (a) the number of extrathoracic meta-
static sites, (b) the number of organs involved, (c) the 
diameter of individual metastatic sites, (d) the types of 
examinations and studies used for staging, and (e) whether 
patients with brain metastases are symptomatic or asymp-
tomatic [39].
8.5  Concluding Remarks
The revised TNM staging system, TNM-8, includes impor-
tant modifications to the T and M classifications, changes 
and additions to stage groups, and the introduction of new 
recommendations regarding the staging of lung cancers with 
multiple pulmonary sites of involvement and guidelines for 
tumor measurement. Understanding TNM-8 will allow radi-
ologists to accurately stage patients with lung cancer and 
optimize patient management.
a b
Fig. 8.8 Measurement of part-solid tumors. (a) and (b) Contrast- 
enhanced axial CT of a 57-year-old woman demonstrates a part-solid 
nodule in the left upper lobe with measurement of the entire lesion (A) 
and just the solid component (B). For the purpose of evaluating part- 
solid lesions, IASLC recommends that the image showing the largest 
average tumor diameter and the greatest diameter of the solid compo-
nent of the lesion be used. For determining the T descriptor, the longest 
diameter of the solid component should be used for part-solid lesions
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When imaging the chest wall, pleura, and diaphragm, chest 
radiography is helpful in problem-solving, whereas in the 
mediastinum, CT is much more useful. With extrapulmonary 
lesions arising in the superior sulcus (apical) region, or chest 
wall masses, magnetic resonance imaging (MRI) is excellent 
because of its tissue characterization abilities.
In general, normal variants, unlike disease, are reasonably 
symmetric and often bilateral, and thus a side-by-side com-
parison can be made. The soft tissues, fat, and musculature 
should be fairly symmetric. When assessing for skeletal 
abnormalities, which are frequently challenging to see, it is 
critical to examine the individual bones carefully, one by 
one. To help differentiate an extrapulmonary (chest wall, 
pleural, or diaphragmatic) lesion from a pulmonary paren-
chymal lesion, assessing the angle the mass makes with the 
lung edge (obtuse angle for extra-parenchymal masses and 
acute angles for pulmonary masses) may be helpful. With 
extrapulmonary masses, it can be difficult to determine if it 
is arising from the chest wall or pleura, as their shapes may 
be similar, but the presence of bone destruction suggests an 
extrapleural origin.
9.2  Chest Wall Disease
The chest wall should normally be symmetric with the most 
common causes of apparent asymmetry being patient rota-
tion or thoracic kyphoscoliosis. The more lucent side is that 
to which the patient is rotated toward (e.g., in a right anterior 
oblique (RAO)/left posterior oblique (LPO) position, the left 
side becomes more lucent). Chest radiography is useful to 
detect subcutaneous emphysema and calcification and to 
evaluate skeletal disease.
9.3  Hyperlucent or Hyperopaque 
Hemithorax
Asymmetry in the opacity (hyperlucency or hyper-opacity) 
of the hemithoraces has many causes, and a reliable approach 
(once rotation has been excluded) is to start from the outside 
(skin) and work inward (through subcutaneous tissues, mus-
cles, bones, pleura, and pulmonary parenchyma), to reach 
the vasculature (pulmonary arteries). Tables 9.1 and 9.2 
depict the most common causes of a hyperlucent or hyper-
opaque hemithorax.
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Learning Objectives
• To learn which imaging modalities to use in evalu-
ating the chest wall, pleura, and diaphragm.
• To generate a differential diagnosis for diseases of 
the chest wall, pleura, and diaphragm.
• To distinguish extrapulmonary pathology from pul-
monary pathology on imaging studies.
• To apply physics principles when assessing fluid 
and air in the pleural space.
• To become familiar with the imaging appearances 
in diaphragmatic trauma.
Key Point
• Normal variants tend to be symmetric.
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9.4  Soft Tissue Masses
These need to be differentiated from asymmetries due to 
patient positioning, contralateral surgery (such as mastec-
tomy), and contralateral atrophy (e.g., poliomyelitis or 
stroke). Lipomas are the most common benign primary 
tumor, and the patient can often provide a history of a sta-
ble or slowly enlarging soft mass. Other benign entities 
include hemangiomas, neurogenic lesions (neurofibromas, 
schwannomas), and fibromatosis. Neurofibromas arise 
from intercostal nerves or paraspinal ganglia which can be 
multiple in von Recklinghausen disease, neurofibromato-
sis type 1. The most common nonneoplastic tumor of the 
thoracic skeleton is fibrous dysplasia, accounting for 30% 
of chest wall benign bone tumors [1]. These slow-growing 
tumors arise in the posterolateral ribs and are usually 
asymptomatic until pathologic fractures or pressure symp-
toms occur. On imaging, fibrous dysplasia presents as an 
expansile lytic lesion with a “ground glass” or hazy or 
matrix (Fig. 9.1).
Chest wall malignancies are rare and can result from 
direct spread of or metastatic disease from adjacent 
tumors including primary bronchogenic neoplasms, meso-
thelioma, thymoma, and breast cancer. Plasmacytoma and 
multiple myeloma are the most common malignant neo-
plasms of the thoracic skeleton and can present as extra-
pulmonary masses with bone destruction, similar 
appearances to other metastases [2]. Well-defined bone 
lesions with a punched-out appearance are found, which 
can erode, expand, and destroy cortex, sometimes with 
surrounding bone reaction, the so- called soap bubble 
appearance. Other primary chest wall malignant bone 
tumors are rare and include chondrosarcoma, osteosar-
coma, Ewing’s sarcoma family of tumors, (evaluate for 
Table 9.1 Causes of a hyperlucent hemithorax
Rotation to that side—patient positioning or thoracic kyphoscoliosis
Mastectomy or chest wall resection on the ipsilateral side
Poland syndrome—congenital
Stroke/polio—acquired disease





Table 9.2 Causes of a hyperopaque hemithorax
Rotation away from that side—patient positioning or thoracic 
kyphoscoliosis
Chest wall mass on the ipsilateral side
Pleural effusion—large
Fibrothorax
Consolidation involving most of the ipsilateral lung
Mass—large, in ipsilateral lung
Pneumonectomy or lobectomy on the contralateral side
a
b
Fig. 9.1 (a, b). A 25-year-old male with a palpable hard mass in the 
right lateral chest wall. Frontal chest radiography (a) shows an expans-
ile oval lesion of the right eighth rib laterally, with a hazy matrix. Axial 
CT demonstrates an expansile lesion of the lateral right rib with well- 
defined borders
Key Point
• With unequal lucency of the hemithoraces, it is 
helpful to start by working one’s way in from the 
outside (skin and subcutaneous tissues) to the inside 
(pulmonary vasculature) to evaluate the cause. 
Don’t forget patient rotation and kyphoscoliosis!
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chondroid or osseous matrix here), multiple myeloma/
plasmacytoma, fibrosarcoma, and malignant fibrohisticy-
toma in adults. Malignant soft tissue masses are a heterog-
enous group and include undifferentiated pleomorphic 
sarcoma, liposarcoma, angiosarcoma, and malignant 
peripheral nerve sheath tumor (which result from malig-
nant transformation of a peripheral chest wall neurofi-
broma in neurofibromatosis 1 patients) [3–6].
SAPHO (synovitis, acne, pustulosis, hyperostosis, and 
osteitis) syndrome is a distinct clinical entity representing 
involvement of the musculoskeletal and dermatologic sys-
tems. SAPHO syndrome can mimic some of the more com-
mon disease entities such as infection, tumor, and other 
inflammatory arthropathies. Treatment is empirical, includ-
ing nonsteroidal anti-inflammatory drugs (NSAIDs) as first- 
line agents, as well as corticosteroids, disease-modifying 
antirheumatic drugs, antibiotics, and biological agents. 
Imaging can be helpful by offering a detailed evaluation of 
the abnormalities [7]. Ossification of the costoclavicular 
ligament and hyperostosis at the sternal end of the first ribs 
are important early findings.
9.5  Inflammatory Disease of the Chest 
Wall
Chest wall involvement with bacterial infection typically 
involves ribs and sternum but is rare. Hematogenous or 
direct spread from a nearby infectious process can cause 
osteomyelitis with Staphylococcus aureus or Pseudomonas 
aeruginosa most commonly implicated. Soft tissue swell-
ing and underlying rib destruction with periosteal reaction 
may be seen by radiography in chronic cases of osteomy-
elitis; however, cross-sectional imaging with CT and MRI 
is much more sensitive and specific. MRI is more sensi-
tive than CT in detecting early osteomyelitis manifest as 
marrow hypointensity on T1 and bone marrow edema 
on T2 images. On the other hand, CT better depicts 
cortical destruction and periosteal reaction compared 
with MRI.
Chest wall involvement with tuberculosis (TB) is uncom-
mon, with hematogenous spread or, very rarely, direct exten-
sion from the adjacent pleural space (empyema necessitans) 
or the underlying lung parenchyma. Chest wall involvement 
with TB manifests as soft tissue masses with calcification 
and rim enhancement, and osseous and cartilaginous destruc-
tion can be seen [8]. In immunocompromised patients, fun-
gal infections of the chest wall and bones can occur with 
Aspergillus species accounting for 80–90% of cases [9]. 
Thoracic actinomycosis can also invade the chest wall, creat-
ing fistulous tracts and empyema necessitatis. In post-op 
patients, nocardia infection can also cause destructive chest 
wall masses.
9.6  Calcification
Soft tissue calcification may be metastatic or dystrophic. 
Metastatic calcification is found with elevated serum cal-
cium with calcium hydroxyapatite crystals being deposited 
in multiple locations, including the lung, stomach, kidney, 
and vascular system [10]. Dystrophic calcification occurs in 
altered, necrotic, or dead tissues, in patients with normal 
serum calcium and phosphorus levels, for example, in con-
nective tissue disorders, like dermatomyositis, where it can 
be deposited in the subcutaneous tissues, muscles, and fas-
cial planes as calcification universalis.
9.6.1  Pectus Excavatum
In this congenital variant of chest wall development (inci-
dence 1/400–1/1000), the sternum is depressed relative to the 
anterior ribs and often tilts rightward, with the mediastinal 
structures displaced leftward [9, 11]. Many cases are asymp-
tomatic and cosmetic only, but if severe [9].
9.6.2  Injuries to the Thoracic Skeleton/Rib 
Fractures/Trauma
Fractures of the upper ribs and scapulae suggest severe 
trauma and should prompt a search for associated injury to 
the aorta, great vessels, and brachial plexus [12]. Fractures of 
the sternum and medial clavicle have higher risks of associ-
ated vascular or cardiac injury. Sternal fractures are extremely 
difficult to see on frontal chest radiographs but may be seen 
on the lateral view. CT is indicated if they are suspected. 
Nearly all sternal fractures will be visible on CT, and adja-
cent hematoma can be demonstrated. With sternal fractures, 
one should evaluate for associated cardiac or vascular injury. 
For suspected fractures of the lower ribs, abdominal radio-
graphs are more helpful, as they are better penetrated. 
Fractures of the lower ribs may be associated with hepatic, 
splenic, or renal injury, and abdominal CT is indicated in 
these cases.
A flail chest (or flail segment) occurs when there are five 
or more consecutive rib fractures (or three or more ribs are 
fractured in two or more places). During the respiratory 
cycle, the flail segment moves paradoxically which can result 
in ventilatory compromise. Fractures of the thoracic spine 
account for 15–30% of all spinal fractures, with the most 
vulnerable segment being the thoracolumbar junction (T9 to 
T12) region. More than two thirds of thoracic spine fractures 
are demonstrated by radiography, with almost all visible at 
CT. CT has the added advantage of demonstrating displace-
ment or retropulsion of bone fragments into the spinal canal 
and impingement upon the spinal cord.
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9.7  Thalassaemia
With chronic hemolytic anemias (most commonly thalassae-
mia), hematopoietic tissues outside the bone marrow pro-
duce blood (extramedullary hematopoiesis). Normal marrow 
tissue expands outside the medulla through permeative ero-
sions or by reactivation of previously dormant hematopoietic 
tissues [13]. Erythropoiesis is ineffective, leading to expan-
sion of bone marrow space in the vertebral column, ribs, long 
bones, skull, and characteristically the facial bones (frontal 
bossing). Paravertebral and rib lesions are most often inci-
dental but can occasionally cause cord compression due to 
mass effect on the spinal canal. On chest radiographs, thalas-
semia can manifest as bilateral lobulated paravertebral 
masses with rib expansion.
9.8  Pleural Disease
When assessing for pleural effusion or pneumothorax on 
radiography, one must keep in mind the patient’s positioning 
(whether supine, semi upright, or upright), as air will rise 
upward and fluid will gravitate downward within the pleural 
space and influence the appearances. In critically ill supine 
patients, air will rise to lie in the anterior inferior costo-
phrenic sulcus, leading to the deep sulcus sign with radiolu-
cency inferior and laterally. The ipsilateral hemidiaphragm 
may also be more sharply delineated due to the air above it. 
Conversely, pleural fluid will layer posteriorly and can “cap” 
over the lung apex. On upright radiographs, intraperitoneal 
“free” gas will rise to the highest point, under the diaphrag-
matic domes, if sufficient time is allowed. Alternatively, ill 
patients can be rolled onto their side for decubitus views to 
diagnose pneumothorax or effusions. For suspected pneumo-
thorax, the abnormal side should be put up to allow any air to 
rise, whereas to evaluate effusions, the side should down to 
get fluid to layer along the inner ribs.
9.9  Pleural Effusion
On upright radiographs, free-flowing pleural fluid displaces 
the lung away from the costophrenic sulci and blunts the 
angle, producing a fluid meniscus sign. With small pleural 
effusions, on upright lateral chest radiographs, one needs to 
check the posterior costophrenic sulcus (the lowest point) to 
look for dependent fluid. On the frontal view, view the lateral 
costophrenic angle or sulcus but bear in mind that subpul-
monic pleural fluid can be present without blunting the lat-
eral costophrenic angle. With a subpulmonic effusion, the 
ipsilateral “hemidiaphragm” will be of uniform attenuation, 
with a more lateral position of the apparent dome of the 
hemidiaphragm (with a gradual sloping medial aspect and a 
more sharply sloping lateral aspect). On supine radiographs, 
a fluid meniscus or interface (with lung or normal pleura) 
may not be seen if free-flowing pleural fluid layers posteri-
orly. With large pleural effusions, in supine patients, an api-
cal pleural cap may be visualized as fluid layers around the 
apex of the lung.
If there are fibrinous adhesions or scars, pleural effusions 
may become loculated into localized components. Pleural 
fluid tracking into fissures can have a tapering cigar-shaped 
appearance. If pleural fluid in a fissure has a more rounded 
shape, it can look mass-like giving a “pseudotumor” appear-
ance. Clues to its nature include the “mass” being homoge-
nous in density, with a smooth outline, and having a different 
shape on two orthogonal projections. One can also review 
prior radiographs and see a decrease in size or resolution on 
follow-up.
When pleural effusions are large, they can deviate the 
mediastinal structures toward the opposite side. A rare but 
serious complication of large pleural effusions is diaphrag-
matic inversion. With diaphragmatic inversion, during respi-
ration, the two hemidiaphragms move in opposite directions. 
This causes air to move over and back between the two lungs 
(pendulum respiration), resulting in increased dead space 
and significant respiratory compromise. Symptoms can be 
relieved with thoracocentesis which restores the affected 
hemidiaphragm to its normal position. It is easier to diagnose 
left hemidiaphragm inversion, as this causes mass effect 
upon the left upper quadrant, displacing the stomach air bub-
ble inferiorly.
In hospitalized patients, pleural effusions are most com-
monly related to congestive cardiac failure or postsurgical. 
With congestive heart failure, the effusions are usually rela-
tively symmetric bilaterally but occasionally more asymmet-
ric (right larger than left) or unilateral. When effusions are 
unilateral or asymmetric with the left larger than the right in 
nonsurgical patients, other causes should be considered 
including pneumonia, infarction, neoplasm, trauma, and 
connective tissue disorders (especially systemic lupus 
Key Point
• Fractures of the sternum are extremely difficult to 
see on radiographs, and CT with contrast is indi-
cated to evaluate for aortic and vascular injury, if 
sternal fracture is suspected.
Key Point
• Chest radiography still plays a key role in the evalu-
ation of the chest wall, particularly for calcification 
and air but also to assess the skeletal structures.
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erythematosus and rheumatoid arthritis). In acute pulmonary 
embolus (PE), small unilateral or bilateral hemorrhagic pleu-
ral effusions may be found.
Upper abdominal pathologies can cause sympathetic 
pleural effusions, usually unilateral. These include subdia-
phragmatic abscess, pancreatitis, splenic trauma, and ascites. 
Clinical history will help, and thoracentesis can help distin-
guish some entities, for example, elevated amylase with pan-
creatitis. With ascites, due to hepatic failure, bilateral pleural 
effusions may develop from leak of fluid through diaphrag-
matic defects or with third spacing from hypoalbuminemia. 
With suspected right subdiaphragmatic fluid collections, 
ultrasound can be very helpful, but for suspected left upper 
quadrant abscess, CT is better.
Trauma, as the etiology of unilateral pleural effusion, may 
be apparent when there are multiple rib fractures but less 
obvious when due to vascular damage in the absence of frac-
tures. Another less apparent cause might include incorrectly 
placed enteric tubes or vascular catheters. Accidental feeding 
tube placement into the lung may be uneventful as long as 
the malposition is detected before feeding is commenced. 
Malpositioned tubes in the pleural space are usually symp-
tomatic due to complications including tension pneumotho-
rax and empyema.
9.10  Empyema
Patients with pneumonia commonly have small sympathetic 
pleural effusions. Infection of the pleural space (empyema) 
can occur as a complication of pneumonia, with infections 
such as Mycobacterium tuberculosis and fungi, known for 
involving the pleural space. Differentiating empyema from 
lung abscess on chest radiographs can be performed by eval-
uating the shape of the collection on orthogonal views. A 
lung abscess tends to make acute angles with the adjacent 
chest wall, while empyemas will make a more obtuse angle. 
Furthermore, lung abscesses are round and of similar appear-
ances and size on different projections in contrast to empy-
emas, which tend to be oval or linear on one projection and 
more spherical on the orthogonal projection. On contrast- 
enhanced CT, empyema will have a space-occupying effect, 
deviating nearby bronchi and vessels, while bronchi and 
vessels will appear to enter and be obliterated by the lung 
abscess. The empyema will tend to have smoother margins 
than lung abscess which will be more ill-defined due to sur-
rounding consolidation. In empyema, the “split pleura sign” 
with separation of the thickened visceral and parietal pleura 
may also be seen.
The presence of infection in the pleural space cannot be 
confirmed with imaging alone, and clinical (and laboratory) 
information are needed to support the diagnosis of infection. 
Imaging’s role is to localize the source of infection to the 
pleural space, with the cause of pleural effusion often sug-
gested based on clinical information. Early on, an empyema 
may be difficult to differentiate from a loculated pleural effu-
sion. In some cases, thoracentesis and analysis of pleural 
fluid will be needed for diagnosis. Thoracic wall ultrasound 
can be helpful to guide thoracentesis.
9.11  Pneumothorax
Air can enter the pleural space in up to 40% of patients with 
acute chest trauma as a result of lung, tracheobronchial, or 
esophageal injury, and pneumothorax may be seen. To detect 
pneumothorax, upright frontal radiography is indicated as air 
tends to rise within the pleural space. However, if upright 
radiography is not feasible, lateral decubitus radiography 
(with the side of suspected pneumothorax up) is an alterna-
tive option. Computed tomography can identify many small 
and moderate-sized pneumothoraces which may not be visi-
ble on supine radiography.
Pneumothorax is best diagnosed by visualization of the 
visceral pleura outlined by air in the pleural space. Lucency 
and absence of vessels are less reliable signs which can be 
seen with presence of focal emphysema or bullae. As is the 
case with pleural effusions, detection of pneumothorax 
becomes difficult in the supine position, with the nondepen-
dent portion of the pleural space being at the anterior inferior 
costophrenic recess. Look for the deep sulcus sign, with 
lucency over the lower lateral chest and a sharply defined 
ipsilateral hemidiaphragm. A “too easily seen” sharply 
defined hemidiaphragm or increased lucency over the lung 
bases should raise concern for basilar pneumothorax, even 
without seeing the pleural line. A further sign is the “deep 
sulcus sign” corresponding to a sharply demarcated lateral 
sulcus. Pneumothorax can track into the fissures with air in 
the minor fissure a reported sign of supine pneumothorax.
Tension pneumothorax is a medical emergency, due to 
compression of mediastinal structures resulting in decreased 
venous return to the heart and hemodynamic collapse. As 
intrapleural pressure increases, the ipsilateral hemidia-
phragm is depressed, with deviation of the mediastinal struc-
tures contralaterally.
Key Point
• Patient positioning for radiography affects the 
appearances of pleural fluid with fluid layering 
dependently and posteriorly in the supine position, 
and if there is sufficient fluid, an apical pleural cap 
may be seen.
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Pneumothorax is most often due to trauma or iatrogenic 
(with surgery or other interventions), but they can also occur 
secondary to ruptured blebs, and with interstitial lung dis-
eases, where honeycomb change or cysts increase the risk of 
pneumothorax (e.g., in lymphangiomyomatosis or eosino-
philic granuloma).
Other causes of pneumothorax, with an apparently nor-
mal CXR, include cavitary lesions in a subpleural location, 
for example, metastases or tuberculosis. Cavitary metastases 
include mostly squamous primary neoplasms and sarcomas. 
Increased intrathoracic pressure can potentially cause pneu-
mothorax with an otherwise normal or nearly normal CXR, 
as can occur in asthma and pregnancy. Bronchial injury or 
bronchopleural fistula should be suspected when there is per-
sistent or increasing pneumothorax with a functioning chest 
tube in place or the tube is on suction.
Pneumothorax ex vacuo is a complication of lobar col-
lapse, with a sudden increase in negative intrapleural pres-
sure surrounding the collapsed lobe [14]. This results in gas 
from the ambient tissues and blood being drawn into the 
pleural space with the seal between the visceral and parietal 
pleura of the adjacent lobe or lobes remaining intact. Once 
the bronchial obstruction is relieved and the collapsed lobe 
re-expands, the pneumothorax will resolve. It is critical to 
recognize this entity, as treatment is to relieve the bronchial 
obstruction rather than to insert a pleural drainage catheter.
9.12  Hemothorax
Hemothorax resulting from injury to large central pulmonary 
vessels, systemic thoracic veins or arteries, or lacerated vis-
cera can be catastrophic with hemodynamic collapse, requir-
ing urgent surgical intervention, whereas bleeding from 
low-pressure pulmonary vessels is usually self-limited. Like 
pleural effusion, hemothorax may be difficult to detect in the 
supine position, due to layering posteriorly. On supine radio-
graphs, signs of hemothorax include an apical pleural cap, 
hazy increased opacity projected over the hemithorax, and 
confluent lateral pleural opacification. Whenever rib frac-
tures are found, a hemothorax should always be considered, 
and CT is the most accurate way to detect tiny amounts of 
pleural fluid. A hemothorax can be suggested by CT, when 
the pleural fluid attenuation is >35 to 40 HU, and dependent 
layering of the higher attenuation hematocrit elements may 
be visible with enough blood in the pleural space. Consider a 
chylous pleural effusion when there is delayed or late appear-
ance of pleural fluid that continues to slowly accumulate 
over days, particularly with penetrating injuries or following 
thoracic surgery, secondary to thoracic duct disruption.
9.13  Pleural Plaques or Thickening
With repeated asbestos exposure, bilateral pleural plaques 
occur commonly and sometimes visibly calcify. They are 
typically located at the hemidiaphragmatic domes and beside 
the posterolateral lower ribs [15]. When calcified plaques are 
viewed en face, they appear as irregularly shaped, poorly 
marginated opacities, sometimes with scalloped outlines giv-
ing a holly leaf-like appearance. A clue to the extrapulmo-
nary origin of pleural plaques is that their long axis doesn’t 
run parallel to that of the underlying pulmonary vasculature 
and bronchi.
Unilateral pleural plaques can be seen with asbestos 
exposure but also occur with previous hemothorax in trauma 
or following empyema. A small hemithorax with extensive 
pleural calcification (fibrothorax) may be seen after tubercu-
losis and untreated hemothorax. Non-calcified pleural 
plaques (and pleural implants) are often better demonstrated 
with CT rather than by radiography, in contrast to pleural 
effusion or pneumothorax.
9.14  Pleural Implants and Masses
While pleural masses may be seen with metastatic disease, 
pleural effusions more commonly occur. Many pleural 
implants are obscured on chest radiography (and even on 
CT) by surrounding pleural fluid. Some pleural masses, such 
as malignant thymoma, cause unilateral multifocal pleural 
implants without accompanying pleural fluid. On contrast- 
enhanced CT, the higher attenuation soft tissue implants may 
be visualized, suggesting the malignant nature of the effu-
sion. Intravenous contrast enhancement (and narrow soft tis-
sue window widths) help distinguish the solid elements from 
pleural fluid. Dependent layering of hematocrit components 
with chronic pleural hematoma may look similar to malig-
nant effusion and implants on CT.
Benign mesothelioma (benign fibrous tumor of the pleura) 
is often a single pleural mass, which ranges in size from 
small to very large [16]. These masses may be pedunculated 
and change in position and appearances by twisting around 
their pedicle. Large benign fibrous tumors are generally dis-
tinguishable from malignant mesothelioma due to their focal 
nature, with malignant mesothelioma being typically more 
widespread. Benign mesotheliomas are generally recogniz-
Key Point
• In the supine position, a pleural edge may not be 
seen with pneumothorax, and the radiologist may 
have to rely on secondary signs including the deep 
sulcus sign or a hemidiaphragm that is too clearly 
defined.
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able as extra-parenchymal pleural lesions due to their shape, 
with a broad based ill-defined pleural base, making obtuse 
angles to the lung. Difficulty arises when they occur in the 
fissures, appearing rounded and more sharply defined, rais-
ing suspicion for malignancy. Multiplanar imaging with CT 
localizes the “mass” to the fissure, making benign fibrous 
tumor a more likely diagnosis. Clinical associations can 
sometimes help in distinguishing benign fibrous tumor, such 
as associated hypertrophic pulmonary osteoarthropathy, and 
sometimes hypoglycemia. Benign mesotheliomas undergo 
malignant degeneration in up to a third of cases, and there-
fore management includes imaging workup prior to 
excision.
Pleural metastases are much more common than primary 
pleural neoplasms. Many cancers metastasize to the pleura 
with those in close proximity most likely, including the lung 
and breast. When a pleural mass is found and there is pri-
mary neoplasm elsewhere, metastatic disease should still be 
considered even if the primary malignancy isn’t one fre-
quently associated with pleural spread.
Malignant mesothelioma is the most common primary 
tumor associated with pleural effusion. Lobulated pleural 
masses occur along with effusions, often unilateral. Previous 
asbestos exposure (or bilateral calcified pleural plaques) is a 
helpful clue, but note that asbestos exposure is only docu-
mented in about half of malignant mesothelioma patients. 
Malignant mesothelioma can be differentiated from benign 
plaques by the involvement of the mediastinal pleura and the 
presence of pleural effusion. In some patients, a lack of 
mediastinal shift away from the affected side of and a 
decrease in volume in the presence of extensive pleural 
abnormality are clues to malignant mesothelioma [17, 18]. A 
differential to consider with circumferential nodular pleural 
masses often including the medial pleura are encountered is 
metastatic adenocarcinoma (Fig. 9.2).
Peritoneal metastases often occur with ovarian cancer, 
and malignant pleural effusions can occur when malignant 
seedlings pass through congenital hemidiaphragm defects. 
Massive malignant pleural effusions in ovarian cancer are 
known as Meigs syndrome.
9.15  Diaphragmatic Disease
On posteroanterior radiographs, the upper border of the right 
hemidiaphragm usually lies between the level of the fifth rib 
anteriorly and the anterior sixth–seventh rib interspace, typi-
cally a rib interspace higher than the left hemidiaphragm. On 
radiography, the diaphragm is inseparable from the abdomi-
nal structures below. On CT, the diaphragm is a thin 
ba
Fig. 9.2 (a, b): A 65-year-old man with progressive shortness of breath 
on exertion and a dry cough. Frontal chest radiography (a) demon-
strates a smaller right hemithorax with circumferential pleural thicken-
ing, including the mediastinal or medial aspect (white arrowheads). 
Coronal contrast-enhanced CT (b) shows nodular pleural thickening 
over the hemidiaphragmatic and mediastinal aspects, with a decrease in 
volume of the right hemithorax
Key Point
• Consider malignant mesothelioma or metastatic 
adenocarcinoma when lobulated pleural masses 
involving the mediastinal surface of the pleura are 
found.Key Point
• Pleural implants are more commonly caused by 
metastatic disease, with the main primaries being 
the lung, breast, mesothelioma and thymoma 
locally, and ovarian cancer.
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soft- tissue attenuation linear structure which is thinner (and 
sometimes not clearly visible) toward the central tendon in 
contrast to the edges [19]. Muscle slips run obliquely along 
the inferior surface and may be asymmetric, with a mass-like 
appearance sometimes seen on cross section, especially in 
males, as they are more prominent. Prominent muscle slips 
with the muscle bulging upward on either side of the slips 
can give a scalloped appearance to the diaphragm, a normal 
variant. Multiplanar CT is useful to see the diaphragm due to 
the differences in attenuation of the diaphragm, adjacent 
intraperitoneal fat, nearby extrapulmonary fat, and aerated 
lung. Diaphragmatic defects (eventration) and hernias 
(Bochdalek posteriorly, Morgagni anteromedially) may be 
congenital or acquired (hiatus hernia, trauma, paresis, or 
paralysis). Predisposing conditions for all abdominal hernias 
include pregnancy, trauma, obesity, chronic constipation, 
and chronic cough.
9.16  Bochdalek Hernia
In adult patients, 90% of congenital diaphragmatic hernias 
found are Bochdalek hernias, more commonly left sided, pos-
sibly because of the protective effect of the liver on the right 
side [20]. Bochdalek hernias occur posterolaterally, through 
which intraperitoneal fat and, occasionally, solid organs such 
as kidneys or bowel loops pass through gaps between the cos-
tal and vertebral portions of the diaphragm [21]. Neonates and 
infants can present with respiratory compromise, with older 
children or adults sometimes presenting with acute or chronic 
gastrointestinal symptoms. Rarely, Bochdalek hernias can 
present as an acute abdomen due to complications of bowel 
incarceration, strangulation, perforation, or shock. With wide-
spread CT imaging, most are discovered incidentally nowa-
days, as small defects, sometimes bilateral, particularly in 
patients with chronic obstructive airways disease. In these 
incidentally discovered Bochdalek hernias, no further action is 
needed. On CT imaging, discontinuity of the diaphragm pos-
teriorly or posteromedially is usually easily seen with protru-
sion of peritoneal or retroperitoneal fat through the defect 
[21]. Less commonly, kidney, colon, small bowel, liver, or 
spleen may also herniate through a Bochdalek hernia. On 
chest radiography, the differential diagnosis for a contour 
deformity in the posterior hemidiaphragm includes lipomas, 
lung or diaphragmatic masses, neurogenic tumors, pulmonary 
sequestrations, or intrathoracic kidneys.
9.17  Morgagni Hernia
In adults, less than 10% of congenital diaphragmatic hernias 
found are Morgagni hernias, found anteromedially, due to 
failure of fusion of the sternal and costal portions of the 
hemidiaphragm [20, 22]. Morgagni hernias are more com-
mon on the right, perhaps because of greater support pro-
vided by the pericardial attachments on the left. In adults, 
omentum is most commonly found, with bowel, stomach, or 
liver rarely passing through. On imaging, Morgagni hernias 
appear as low attenuation masses in the anterior cardio-
phrenic angle and can be difficult to differentiate from prom-
inent epicardial fat pads or pericardial cysts on radiographs. 
Other differential diagnoses for masses in the anterior car-
diophrenic region include lipoma, liposarcoma, thymoma, 
thymolipoma, or teratoma. Coronal plane reformatted CT or 
MR images can demonstrate displaced curvilinear omental 
vessels within the “mass” or coursing across the diaphrag-
matic defect, typical features of Morgagni hernia.
9.18  Diaphragmatic Eventration
Hemidiaphragmatic eventration occurs with congenital mus-
cular aplasia or thinning of a portion of tendon, which bulges 
upward with abdominal contents, most commonly anteriorly, 
because of the pressure gradient between the peritoneum and 
the thorax [21]. Unlike true hernias, the chest and abdominal 
contents are still separated by a layer of pleura, diaphrag-
matic tendon or muscle, and peritoneum and are incidental 
findings [19]. Rare symptoms of eventration include dys-
pnea, tachypnea, recurrent pneumonia, and failure to thrive, 
and these cases can be treated with surgical plication (tuck-
ing or folding and suturing). Hemidiaphragm eventration is 
nearly always found on the right side anteromedially, and 
with increasing intra-abdominal pressure (such as from 
increased abdominal obesity), it can become more pro-
nounced. On imaging in eventration, there is elevation of the 
anterior portion of the hemidiaphragm, with a normal poste-
rior origin (takeoff point) and position. This differs from dia-
phragmatic paresis or paralysis, where the entire 
hemidiaphragm will be elevated, including the posterior por-
tion and origin (takeoff point). Relative thickening of the 
muscle at the edge of the eventration may be seen or some-
times undercut edges with ballooning upward of the even-
trated portion on CT [21].
9.19  Esophageal hiatus hernia
The esophageal hiatus lies at the level of the tenth thoracic 
vertebral body and conveys the esophagus, sympathetic 
nerve branches, and the vagus nerve [20]. This hiatus func-
tions as an anatomic sphincter by constricting on inspira-
tion and preventing gastroesophageal reflux. The 
esophageal hiatus can enlarge with increasing age, abdom-
inal obesity, and with general weakening of the musculo-
fascial structures, leading to hiatal hernia. Herniation of 
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part of the stomach most commonly occurs, with occasion-
ally other abdominal organs, bowel loops or fat, or, rarely, 
the entire stomach. Intrathoracic hiatal hernias are most 
commonly sliding (in 90% of cases), with displacement of 
the gastroesophageal junction and a portion of (or entire) 
stomach upward into the thoracic cavity and loss of the 
usual antireflux mechanism. Less commonly, intrathoracic 
hiatal hernias are the rolling (paraesophageal) type, with a 
portion of (or all) the stomach or other abdominal con-
tents, such as spleen or intestines rolling up above the gas-
troesophageal junction to enter the thoracic cavity. A 
combination of the two types (sliding and rolling) can also 
occur. On chest radiography, herniation of stomach will be 
visible as opacification behind the heart on the lateral view 
and obliteration of the azygoesophageal line on a frontal 
view [23]. On CT imaging, one can evaluate the location 
of the stomach and intra-abdominal organs, bowel loops, 
and peritoneal fat.
9.20  Blunt Traumatic Diaphragmatic 
Rupture
In about 5% of patients with blunt trauma, diaphragmatic 
rupture occurs, with most associated with significant intra- 
abdominal injuries [24]. Injury mechanisms include fron-
tal impact, causing increased intra-abdominal pressure and 
“blowing out” of the diaphragm, and lateral impact distort-
ing the chest wall, causing shearing forces across the dia-
phragm. Diaphragmatic ruptures are thought to occur with 
equal frequency bilaterally, with ruptures on the right 
being clinically more occult due to protection from the 
liver. Consequently, left ruptures are reported in most (75–
90%) cases, with most tears posterolaterally at the weakest 
portion, the musculotendinous junction. After blunt 
trauma, most diaphragmatic tears are longer than 2 cm and 
many left tears even more than 10 cm in length.
About half of diaphragmatic ruptures are complicated 
by visceral organ herniation with the stomach and colon 
most commonly herniating on the left, and occasionally 
small bowel, spleen and kidney. The liver most commonly 
herniates on the right and sometimes colon. Herniated 
organs can strangulate, leading to ischemia, infarction, or 
obstruction. Sometimes, herniation after diaphragmatic 
rupture is delayed, with the relatively increased intra-
abdominal pressure gradually causing the defect to increase 
in size, increasing the likelihood of herniation of intra-
abdominal contents into the thorax. The increase in size of 
the diaphragmatic defect may be slowed down or prevented 
if patients receive positive pressure ventilation after their 
injury as this eliminates or reverses the pressure gradient. 
The time delay between injury and herniation is known as 
the latent phase and last for months to years, but most cases 
of strangulation manifest clinically within 3  years of the 
trauma.
Secondary signs of herniation can be seen at radiography 
including apparent elevation of the hemidiaphragm; an 
altered, irregular, discontinuous, or obscured contour; medi-
astinal shift to the contralateral side; viscera containing air 
above the hemidiaphragm; and if present, the gastric tube tip 
may be elevated with a U-shaped configuration. Similar 
appearances can be seen with other entities, including atelec-
tasis, lung contusion, posttraumatic lung cysts, pneumotho-
rax, subpulmonic pleural effusion, hiatal hernia, and phrenic 
nerve paralysis. Diaphragmatic eventration can have similar 
appearances, and comparison with old studies may be help-
ful here.
Multiplanar CT is more sensitive and specific, with signs 
of diaphragmatic injury including focal hemidiaphragmatic 
discontinuity; difficulty seeing the hemidiaphragm; a large 
defect between the torn ends of the hemidiaphragm; thicken-
ing and curling at the torn ends (due to muscular contrac-
tion); herniation of intraperitoneal fat, omentum, bowel 
loops, or abdominal viscera; focal narrowing of an organ or 
loop of bowel at the muscular defect (the the dependent vis-
cera sign sign and “the dependent viscera sign”) (the unsup-
ported herniated organs or bowel fall dependently, abutting 
the posterior ribs) (Fig.  9.3). Other accompanying signs 
include pneumothorax, hemothorax, pneumoperitoneum, 
and hemoperitoneum. Coronal T2-weighted MRI is an alter-
native modality that can be used to evaluate for diaphrag-
matic injuries in the non-acute setting.
9.21  Penetrating Diaphragmatic Injury
Penetrating injuries of the diaphragm are more common than 
blunt injuries. The site of injury depends on the location and 
trajectory of the penetrating object. Penetrating injuries tend 
to be smaller, related to the size of the penetrating object, 
with most less than 2  cm and many below 1  cm. Visceral 
herniation is uncommon with smaller penetrating injuries. 
Penetrating injuries are usually diagnosed clinically rely-
ing on the entry site and direction of the wound. Exploratory 
Key Point
• Hemidiaphragmatic ruptures can go unnoticed ini-
tially, particularly in intensive care patients with 
positive end inspiratory pressure ventilation, due to 
equal intrathoracic and intra-abdominal pressures, 
but they usually progress later, due to the relatively 
increased intra-abdominal pressure, and therefore 
should be repaired.
9 Diseases of the Chest Wall, Pleura, and Diaphragm
104
surgery is usually indicated in patients with penetrating inju-
ries, at which time the diaphragmatic injury is diagnosed and 
repaired. CT imaging findings include pneumothorax, hemo-
thorax, or radiopaque material associated with the projectile 
near the diaphragm or indicating the path through the 
diaphragm.
9.22  Diaphragmatic Paresis or Paralysis
Many processes result in diaphragmatic paresis or paralysis, 
including central nervous disease or local damage to the phrenic 
nerve from surgery or masses, but most cases are idiopathic, 
possibly caused by viral infection [25]. Thoracic imaging is usu-
ally unhelpful in determining etiologies for diaphragmatic 
paralysis, except in the case of direct invasion by intrathoracic 
tumors. Diaphragmatic paralysis is more commonly unilateral 
and often asymptomatic, being an incidental finding on imag-
ing. Bilateral diaphragmatic paralysis is usually symptomatic, 
often presenting as respiratory compromise.
With bilateral diaphragmatic paralysis, frontal radio-
graphs will demonstrate smooth elevation of the hemidia-
phragms and decreased lung volumes and deep and narrow 
costophrenic and costovertebral recesses. The lateral view 
reveals a smooth contour and elevation of the entire dia-
phragm. Adjacent bibasilar linear atelectasis may be present. 
Apparent bilateral diaphragmatic elevation can also be seen 
with poor inspiratory effort, obesity, subpulmonic pleural 
effusions, subdiaphragmatic processes (like ascites, dilated 
bowel, and hepatomegaly), and pleural adhesions. With a 
unilateral elevated hemidiaphragm, the left may lie at a 
higher position compared to the right, or the right will lie 
more than one rib interspace higher than the left. A weak or 
paralyzed hemidiaphragm will show elevation in its entire 
course, including the posterior takeoff point, which helps dif-
ferentiate it from hemidiaphragm eventration.
Fluoroscopic sniff testing can be helpful with unilateral 
diaphragmatic weakness or paralysis, by demonstrating 
slower downward (caudal) or paradoxical upward (with 
paralysis) movement during quiet inspiration, deep inspira-
tion, and sniffing [25]. Sniff tests are not as useful for bilat-
eral paralysis, may be falsely positive in normal individuals, 
and require user expertise. Ultrasonography can be used to 
diagnose paralysis, using the same principles as the fluoro-
scopic sniff test to assess diaphragmatic movement, but it 
requires operator experience. Chest and abdominal CT can 
be utilized to evaluate for processes that cause diaphragmatic 
elevation and simulate paralysis, including chronic obstruc-
tive airways disease, pleural effusions, subdiaphragmatic 
abscess, ascites, organomegaly, or ileus. Coronal (or sagittal) 
plane dynamic T2-weighted MRI imaging can be used to 
assess for paralysis (in centers with experience) with the dia-
phragm seen as a low T2 signal structure. Quantitative evalu-
ation, including excursion, synchronicity, and velocity of 
diaphragmatic motion can also be performed with MRI.
9.23  Tumors of the Diaphragm
Primary tumors are rare, with more than half being benign, 
and the most common are lipomas [26]. Benign tumors are 
resected if there is diagnostic uncertainty or if they cause 
a
b
Fig. 9.3 (a, b): A 62-year-old woman who sustained blunt chest 
trauma in a road traffic accident. Axial contrast enhanced CT (a) shows 
diaphragmatic rupture, with thickened ends (black  arrows) due to mus-
cular contractions at the edge of the rupture. Note also the dependent 
location of the spleen (dependent viscera sign). There are also fractures 
of the right ribs and subcutaneous emphysema and a right basilar pleu-
ral drainage tube. Sagittal contrast-enhanced CT (b) demonstrates her-
niation of loops of colon through a large defect in the left hemidiaphragm, 
with thickening of the muscle at the margins (black  arrows) of the 
defect, especially anteriorly
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symptoms [26, 27]. Primary malignant lesions include rhab-
domyosarcoma, followed by fibrosarcoma [2]. Secondary 
malignant lesions spread to the diaphragm by direct involve-
ment from lung cancer, and other intrathoracic (mesotheli-
oma, esophageal cancer) or intra-abdominal tumors (hepatic 
and adrenal cancer) more commonly occur. With malignant 
thymoma, drop metastases via the pleural space to the dia-
phragm can also occur as can intraperitoneal or serosal 
spread in ovarian cancer. Implants to the diaphragm can be 
found in benign processes such as endometriosis.
9.24  Conclusion
In evaluating the chest wall structures, the pleura, and the 
diaphragm, a combination of different imaging modalities 
can be employed, along with relevant clinical history (espe-
cially trauma and known primary malignancy). Previous 
imaging studies are particularly helpful in cases of suspected 
diaphragmatic trauma or paralysis. Comparing to the other 
(unaffected) side is helpful for chest wall pathology. Being 
familiar with image study techniques, coupled with knowl-
edge of physics principles (air, water, blood, and soft tissue), 
can give valuable diagnostic clues.
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Take-Home Messages
• Chest radiography has a major role in the evaluation 
of the chest wall, particularly for calcification and 
air but also to assess the skeletal structures.
• Certain fractures such as the sternum are extremely 
difficult to see on radiographs, and CT with contrast 
is indicated to evaluate for aortic and vascular 
injury, if sternal fracture is suspected.
• Remember the physical principles of fluid and air 
when assessing radiographs for pleural fluid or air. 
Pleural fluid will layer dependently in the supine 
position, posterior to the lungs. In the supine posi-
tion, the pleural edge may not be seen with pneu-
mothorax, and secondary signs, including the deep 
sulcus sign or a hemidiaphragm that is too clearly 
defined, should be looked for. Pleural implants are 
more commonly due to metastatic disease.
• Hemidiaphragmatic ruptures may not manifest ini-
tially, especially with positive end inspiratory pres-
sure ventilation, which equalizes intrathoracic and 
intra-abdominal pressures, but defects will steadily 
progress after this, and therefore repair is 
indicated.
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Symptomatology referable to the chest is one of the most 
common reasons for which pediatric patients present for 
clinical evaluation. While subsequent diagnosis widely var-
ies depending upon the specific symptoms, clinical context, 
and age of the patient, imaging plays a critical role in eluci-
dation of differential considerations. Furthermore, imaging 
provides valuable information in the evaluation of disease 
extent and associated abnormalities thereby directly impact-
ing patient management decisions. Furthermore, diagnostic 
imaging provides a detailed assessment of treatment 
response.
Given the broad range of pathologies which affect the 
pediatric chest, anatomic localization is a useful classifica-
tion approach and can be thought of in a three-compartment 
model, including primary processes of the lung parenchyma, 
abnormalities of the large airway, and pathology originating 
in the mediastinum. Here, we present this practical approach 
as it applies to some of the most commonly encountered 
pediatric chest pathologies. This chapter also reviews the 
advantages and disadvantages of current imaging modalities 
and characteristic imaging findings of pediatric thoracic dis-
orders encountered in daily clinical practice.
10.2  Advantages and Disadvantages 
of Imaging Modalities
Three most commonly used imaging modalities for evaluat-
ing pediatric thoracic disorders are chest radiography, com-
puted tomography (CT), and magnetic resonance imaging 
(MRI). Their advantages and disadvantages are briefly sum-
marized in the following section.
10.2.1  Chest Radiography
Chest radiography is the first-line and most commonly per-
formed imaging examination in pediatric patients with 
potential thoracic disorders. Frequently, it is also the sole 
imaging study required for diagnosis. In thoracic pathologies 
unable to be fully characterized by chest radiography alone, 
such as those involving mediastinum or airway, it is often 
sufficient for appropriately tailoring subsequent imaging 
examinations. Given that ionizing radiation is required for 
the generation of chest radiography, its use must be weighed 
against the potential risk factor of radiation-induced malig-
nancy. This is heightened in pediatric patients due to their 
increased susceptibility to the effects of ionizing radiation as 
well as their longer potential for repeated exposure as com-
pared with adults. In the implementation of the ALARA 
principle, whereby radiation levels are maintained as low as 
reasonably achievable (ALARA), diagnostic chest radiogra-
phy can be generated with very low radiation dose [1, 2]. 
This, thus, translates into a very low risk of the development 
of radiation-induced malignancy. Additionally, chest radiog-
raphy offers the advantages of easy acquisition, low cost, and 
ready availability.
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10.2.2  Computed Tomography
CT is the most common cross-sectional examination utilized 
in the evaluation of abnormalities of the lung parenchyma. 
This is due to its superior anatomic resolution and the high 
contrast between lung pathology and the adjacent air-filled 
lung parenchyma, a difference which can be further aug-
mented with the use of intravenous contrast. Compared with 
chest radiography, CT provides superior characterization of 
abnormalities and aids in preprocedural evaluation by afford-
ing superior relational anatomy. Specialized CT techniques 
such as high-resolution acquisition, inspiratory and expira-
tory sequences, and volumetric 3D/4D image reconstruction 
can be used to answer specific clinical questions [3]. The 
rapid acquisition time afforded by the multidetector CT 
(MDCT) scanners currently in use is of further benefit, espe-
cially in the pediatric population, because it can diminish the 
need for sedation. While the benefits of CT are numerous, 
the most glaring disadvantage is the added ionizing radiation 
incurred over radiography, and, thus, the risk to benefit ratio 
must be weighed carefully. Tailored image acquisition 
parameters which account for patient body size as well as 
image optimization techniques such as iterative reconstruc-
tion in accordance with the principal of ALARA must be 
used for dose reduction [4].
10.2.3  Magnetic Resonance Imaging
MRI affords superior soft tissue contrast as compared to 
CT. Therefore, it is an ideal modality for characterization of 
extra-parenchymal soft tissue lesions such as those of the 
mediastinum or within the soft tissues of the chest wall. The 
lack of ionizing radiation, as compared with CT, is of added 
benefit especially in susceptible pediatric patients. Use of 
MRI in the evaluation of the lung parenchyma is hindered by 
the intrinsic paucity of photons within the air-filled alveoli 
which results in a small magnitude of MRI signal generation 
[5]. This generated signal is further degraded by increased 
susceptibility artifact which results from the many air-tissue 
interfaces within the lung. The decreased special resolution of 
MRI as compared with CT further limits its use in the evalu-
ation of subtle pathologic changes of the lung parenchyma 
[6]. As such, MRI is of limited utility in the evaluation of lung 
parenchymal pathologies which result in an increase of air, 
the so-called negative pathologies, such as cystic lung disease 
or emphysema. However, recent development of improved 
MRI sequences has increased utilization of MRI for evalua-
tion of the so-called plus pathologies which result in the 
deposition of material within the lung parenchyma [7, 8]. 
Because of this additive process, a larger number of photons 
are present within the lung parenchyma thereby increasing 
the magnitude of the MR signal generated. Disadvantages of 
MRI include availability and cost. In addition, because of 
long acquisition times, sedation is usually required as patient 
motion, in addition to the respiratory and cardiac motion 
intrinsic to imaging of the chest, can significantly degrade 
image quality and interfere with image interpretation.
10.3  Spectrum of Pediatric Thoracic 
Disorders
10.3.1  Pediatric Lung Disorders
10.3.1.1  Neonatal Lung Disorders
Surfactant Deficiency Syndrome due to Prematurity
Surfactant deficiency syndrome is the most common cause of 
death in premature infants, affecting 6.1/1000 live births [9], 
with incidence inversely related to gestational age. A lipopro-
tein produced by type II pneumocytes, surfactant production 
begins at 23  weeks gestation and maturation occurs at 
35 weeks gestation [10]. Allowing for full opening of lung 
alveoli by reducing alveolar surface tension, surfactant 
increases lung compliance. In the absence of surfactant, lung 
compliance decreases leading to atelectasis and alveolar dam-
age. Alveolar destruction results in the generation of cellular 
debris and fibrin which combine to form hyaline membranes 
which in turn impair oxygen exchange. Besides prematurity, 
other risk factors for developing surfactant deficiency syn-
drome include male gender, cesarean delivery, multiple gesta-
tions, and maternal diabetes due to decreased surfactant 
maturation at high serum insulin levels. Within minutes of 
birth, affected infants typically develop symptoms including 
grunting, nasal flaring, retractions, tachypnea, and cyanosis.
Chest radiography is the main imaging modality for eval-
uating surfactant deficiency syndrome [10] (Fig.  10.1). It 
classically demonstrates low lung volumes with diffuse fine 
granular/reticulogranular opacities or, in more severe cases, 
complete lung opacity. Air bronchograms may be variably 
present. In the absence of treatment, imaging findings prog-
ress reproducibly, being most severe at birth and normalizing 
over the course of days to weeks or progressing to chronic 
lung disease of prematurity (Fig. 10.2a). CT is infrequently 
utilized in surfactant deficiency syndrome but may help in 
the evaluation of long-term sequela (Fig. 10.2b).
Three currently available treatments include [1] delaying 
labor to allow for surfactant maturation to continue in utero, 
[2] administering antenatal maternal glucocorticoids which 
cross the placenta and stimulate surfactant production, and 
[3] providing surfactant replacement therapy at birth either 
in aerosolized or nebulized form. Although treatment 
advances have significantly decreased mortality from surfac-
tant deficiency as a result of prematurity, the archetypal 
radiographic features have changed. Mechanical ventilator 
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support may artificially increase lung volumes or result in 
pneumothorax secondary to barotrauma. Inhomogeneous 
delivery of exogenous surfactant can result in variable aera-
tion with areas of atelectasis distributed within persistent 
heterogeneous granular opacities which can mimic the 
appearance of meconium aspiration syndrome or neonatal 
pneumonia. Exogenous surfactant can also cause alveoli to 
hyper-expand creating bubbly lucencies that resemble the 
typical features of pulmonary interstitial emphysema. 
Additionally, antenatal maternal glucocorticoid administra-
tion can maintain patency of the ductus arteriosus resulting 
in pulmonary edema which manifests as diffuse pulmonary 
opacification with an enlarging heart radiographically.
Congenital Surfactant Deficiency
More rarely, surfactant deficiency can result from congenital 
genetic mutations in surfactant production and metabolism 
rather than solely on the basis of prematurity. Unlike surfac-
tant disease of prematurity, congenital surfactant deficiency 
manifests most commonly in full-term infants who develop 
respiratory distress soon after birth without identifiable 
cause. Importantly, symptoms do not improve. Although a 
diverse variety of rare genetic mutations can result in surfac-
tant deficiency, all ultimately lead to decreased oxygen 
exchange across the alveolar membrane.
Unlike the hyaline membranes generated in surfactant 
deficiency of prematurity, histologically, congenital surfac-
tant deficiency results in diffuse alveolar hyperplasia 
and foamy macrophages. This histological appearance can 
sometimes mimic pulmonary alveolar proteinosis (PAP), 
although it is important to note that PAP is an acquired con-
dition of children and adults rather than the result of inherent 
genetic mutation. Affected individuals may benefit from tar-
geted genetic therapies for specific mutations but frequently 
require chronic ventilator dependence, infection prophy-
laxis, and long-term corticosteroids. Lung transplant may be 
necessary in severe cases.
Chest radiography typically demonstrates similar findings 
to surfactant deficiency syndrome due to prematurity includ-
ing diffuse, hazy granular opacities with or without superim-
posed atelectasis (Fig. 10.3a). Unlike in surfactant deficiency 
syndrome due to prematurity, CT is more frequently utilized 
for initial evaluation and biopsy planning as pathological and 
Fig. 10.1 A former 30-week gestation boy on the first day of life with 
surfactant deficiency of prematurity who presented with respiratory dis-
tress. Frontal chest radiograph shows diffuse symmetric hazy granular 
opacities in both lungs. Also noted is an endotracheal tube
a
b
Fig. 10.2 A former 32-week gestation, now 71-day-old boy with 
chronic lung disease of prematurity. (a) Frontal chest radiograph shows 
bilateral hyperinflated lungs with coarse, reticular opacities (arrow) and 
architectural distortion. (b) Axial non-enhanced lung window setting 
CT image demonstrates coarse interstitial thickening (arrow), chronic 
appearing atelectasis, and areas of hyperinflation (asterisks)
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genetic evaluation is required in pediatric patients with con-
genital surfactant deficiency. On CT, diffuse ground-glass 
opacities are observed which eventually coalesce into thin- 
walled cysts, the size and number of which increase over 
time. Intralobular septal thickening can also result, produc-
ing an imaging pattern similar to the crazing paving observed 
in PAP.  Superimposed consolidative airspace disease may 
too be present (Fig. 10.3b).
Transient Tachypnea of Newborn
Transient tachypnea of newborn (TTN) is the most common 
cause of respiratory distress in full-term infants. Resulting 
from the delayed clearance of fetal lung fluid after birth, 
transient tachypnea of the newborn characteristically 
resolves within 48–72  h without long-term sequela [10]. 
Typically, affected infants are normal at birth and become 
increasingly tachypneic over the subsequent hours develop-
ing mild to moderate respiratory distress. Fluid within the 
fetal lungs is normally removed after birth via the tracheo-
bronchial tree, interstitial lymphatics, and pulmonary capil-
laries aided by adrenergic sodium channel activation in labor 
and passage through the birth canal. Incidence of TTN, 
therefore, increases in cesarean delivery particularly those 
performed before the onset of labor. Other risk factors 
include fetal hypotonia, postnatal sedation, delivery prior to 
38 weeks gestation, male gender, low birth weight, macroso-
mia, and maternal gestational diabetes or asthma [11]. 
Supportive treatment may be required in the initial hours to 
days of life with affected infants recovering fully.
Radiographic findings of TTN reflect increased fluid 
within the interstitium including perihilar prominence and 
trace fluid within the fissures [12] (Fig. 10.4). Lung volumes 
are typically normal to minimally increased and cardiac 
enlargement may be transiently present. The most specific 
imaging feature is improvement within 1–2  days. 
Infrequently, irregular bilateral opacities may be demon-
strated mimicking meconium aspiration syndrome or neona-
tal pneumonia. Diffuse granular opacities may too be seen in 
a b
Fig. 10.3 A 13-month-old girl with congenital surfactant deficiency 
(ABCA3 mutation). The patient was born at term but with chronic 
respiratory failure since shortly after birth. Genetic testing and patho-
logical analysis after lung biopsy confirmed the diagnosis of congenital 
surfactant deficiency (ABCA3 mutation). (a) Frontal chest radiograph 
shows diffuse interstitial thickening (arrow) and ground-glass opacity 
(asterisk). Also noted is a tracheostomy tube. (b) Coronal non-enhanced 
lung window CT image demonstrates multiple small bilateral lung cysts 
(asterisks) in addition to diffuse, bilateral ground-glass opacity and sep-
tal thickening (arrows)
Fig. 10.4 An infant body on the first day of life born at term with tran-
sient tachypnea of newborn. The patient presented with respiratory dis-
tress. Frontal chest radiograph shows increased central interstitial 
markings (white arrow) and trace amount of fluid (black arrow) along 
the right minor fissure, suggestive of fetal lung fluid
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a pattern similar to surfactant deficiency syndrome. In these 
cases, correlation with birth history and follow-up radio-
graphs can aid in diagnosis.
Meconium Aspiration
Fetal inhalation of colonic material and subsequent aspira-
tion is the most common cause of significant morbidity and 
mortality in full and postterm infants. Meconium is generally 
passed during the 24  h of antenatal life. Before 35  weeks 
gestation, however, approximately 10–15% of deliveries 
have meconium staining of amniotic fluid [10]. Aspiration, 
evidenced by the presence of meconium below the vocal 
cords, also increases with cesarean and postmaturity deliver-
ies [13]. Additional risk factors include small for gestational 
age, intrauterine stress, and maternal factors such as hyper-
tension, diabetes, or cardiovascular disease. The incidence of 
meconium aspiration has been improving in recent decades 
with closer fetal monitoring and improvement in obstetric 
practice of postterm mothers.
Aspiration of meconium produces both a mechanical 
obstruction secondary to plugging of small to medium air-
ways and chemical pneumonitis which results in surfactant 
inactivation predisposing patients to superimposed infection. 
Additionally, pulmonary vasoconstriction in the setting of 
hypoxia may result in pulmonary hypertension. With sup-
portive treatment, exogenous surfactant, deep suctioning, 
antibiotic prophylaxis, and mechanical ventilation, most 
patients recover within 2–3 days [10], although extracorpo-
real membrane oxygenation (ECMO) may be required in 
severe cases. Rarely, long-term complications such as pul-
monary interstitial emphysema may result.
Radiographic findings of meconium aspiration vary on 
the severity of aspiration. Classically, lungs are hyperinflated 
with asymmetric, coarse, linear pulmonary opacities, fre-
quently described as “ropelike,” which radiate from the 
hilum. Pneumothorax should raise suspicion for meconium 
aspiration occurring in 10–40% of cases [10] (Fig. 10.5). Air 
trapping and segmental atelectasis are frequently seen con-
current findings. Although generally not required for diagno-
sis, CT may be helpful in atypical cases to evaluate for other 
etiologies of neonatal respiratory distress or to evaluate for 
sequela.
Neonatal Pneumonia
Neonatal pneumonia is defined as an infection of the lower 
respiratory tract occurring within the first 28 days of life [10] 
and is the most common cause of neonatal sepsis. One of the 
most frequently detected underlying infectious etiologies is 
B. streptococcus, the transmission of which occurs during 
passage through an affected birth canal. However, in utero or 
postnatal transmission can also occur. Risk factors of neona-
tal pneumonia include prolonged rupture of membranes, 
maternal infection, mechanical ventilation, prematurity, 
meconium aspiration syndrome, and therapeutic cooling. 
Although neonatal pneumonia is often associated with a sig-
nificant morbidity and mortality, symptoms are frequently 
nonspecific including respiratory distress, labile tempera-
ture, and hypothermia. Screening mothers during the third 
trimester of pregnancy has decreased incidence. Empiric 
antibiotic therapy is the mainstay of treatment, in combina-
tion with supportive care, because blood and respiratory cul-
tures are generally negative.
Radiographically, the imaging features of neonatal pneu-
monia are nonspecific, and thus a high clinical suspicion and 
corroborative history are required for accurate diagnosis. 
Diffuse and bilateral pulmonary opacities are the most fre-
quent radiographic pattern, although focal airspace disease 
can also occur (Fig.  10.6). Neonatal pneumonia can also 
result in diffuse hazy opacities similar to surfactant defi-
ciency syndrome or coarse irregular opacities similar to 
meconium aspiration syndrome. Pleural effusions are more 
frequently seen in neonatal pneumonia than in other causes 
of neonatal respiratory distress, a feature which can help dif-
ferentiate these entities (Fig. 10.5a).
10.3.1.2  Pulmonary Infection in Children
Round Pneumonia
Pneumonia is the most common cause of illness in childhood 
and remains a significant cause of morbidity and mortality in 
both the developed and developing world [14]. While pediat-
ric pneumonia can present as focal airspace opacity as is 
Fig. 10.5 An infant girl born at term on the first day of life who pre-
sented with respiratory distress due to meconium aspiration. She has 
history of meconium stained amniotic fluid at birth. Frontal chest radio-
graph shows hyperinflated lungs with asymmetric, coarse, linear, “rope-
like” opacities (black arrow) which radiate from the hilum. An 
associated small left-sided pneumothorax (white arrow) is also noted
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classically observed in adults, round pneumonia is a distinct 
manifestation of lower respiratory tract infection in children 
less than 8 years of age [15]. Distinct differences in juvenile 
lung parenchyma including small alveoli, immature collateral 
pathways of air circulation via pores of Kohn and channels of 
Lambert, and closely opposed septa limit the spread of infec-
tion and round pneumonia results. Most commonly associ-
ated with Streptococcus pneumoniae, round pneumonia can 
also occur with Klebsiella pneumoniae and Haemophilus 
influenzae. Children with round pneumonia can present with 
more nonspecific clinical symptoms than demonstrated in 
adults including cough, rhinitis, vomiting, and high fever.
Radiographically, round pneumonia typically presents as 
a solitary, well-defined, round lesion measuring on average 
3–4 cm usually located within the posterior lower lobes in 
contact with the adjacent pleura, hilum, or pulmonary fissure 
[15] (Fig.  10.7). Given the focality, size, and spherical 
appearance, round pneumonia may simulate a mass; although 
given appropriate clinical history, round pneumonia should 
be the primary differential consideration. Additionally, air 
bronchograms and satellite lesions may be present. While 
round pneumonia may evolve to demonstrate the more clas-
sic appearance of lobar pneumonia, with proper antibiotic 
treatment, 95% resolve without complications [16].
Cross-sectional imaging is unnecessary in classic cases of 
round pneumonia with appropriate clinical history. CT may 
be warranted if there is increased clinical risk for an underly-
ing pulmonary mass, in the absence of appropriate clinical 
history, or in older children as larger alveoli and better devel-
oped collateral pathways prohibit the development of round 
pneumonia. A round airspace opacity in these populations 
should prompt alternative diagnostic considerations 
including atypical microorganism infection, immunodefi-
ciency, and primary or secondary malignancy. Rarely, 
complications may result in round pneumonia necessitating 
cross-sectional imaging evaluation by CT including cavita-
tion, calcification, or pleural effusion. Ultrasound can be a 
helpful imaging modality in the evaluation of pleural and 
parenchymal lung abnormalities in pediatric patients because 
it obviates the need for sedation and radiation. In addition, 
ultrasound may help to distinguish lung consolidation, as in 
the case with round pneumonia, from a solid pulmonary mass.
10.3.2  Pediatric Large Airway Disorders
10.3.2.1  Large Airway Neoplasms
Subglottic Hemangioma
Subglottic hemangioma is a benign neoplasm of the subglot-
tic airway and the most common obstructing subglottic soft 
tissue mass in the pediatric population. Characteristically 
arising along the posterior or lateral walls of the trachea, sub-
glottic hemangioma accounts for 1.5% of congenital laryn-
geal malformations [17]. Although generally small, acute 
airway compromise can result with up to 50% mortality if 
untreated [17]. Symptoms typically develop at approximately 
6–12  weeks of age due to postnatal lesional growth and 
include cough, inspiratory stridor, feeding difficulties, and 
hemoptysis [17]. Female, Caucasian infants are most com-
monly affected with up to 50% of patients also demonstrating 
cutaneous hemangiomas. Additional risk factors include low 
birth weight, prematurity, and multiple gestations [18].
Fig. 10.7 A 5-year-old girl with cough and fever due to round pneu-
monia. Frontal chest radiograph shows a solitary, well-defined, and 
round opacity (asterisk) in the right upper to mid-lung zone adjacent to 
the minor fissure
Fig. 10.6 An infant girl born at term on the third day of life with fever 
and respiratory distress due to neonatal pneumonia. Frontal chest radio-
graph shows bilateral diffuse and patchy opacities (white arrows) and 
trace of bilateral pleural effusions (black arrows)
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The classic radiographic appearance of subglottic heman-
gioma is nonspecific, eccentric narrowing of the subglottic 
trachea on frontal views [19]. Such asymmetric appearance 
can help differentiate from other causes of subglottic tracheal 
narrowing such as croup (Fig. 10.8a). Following radiography, 
cross-sectional evaluation with CT or MRI is routinely per-
formed for pretreatment planning with either modality typi-
cally demonstrates an avidly enhancing lesion at the 
posterolateral aspect of the subglottic trachea with soft tissue 
characteristics (Fig. 10.8b) [3, 20, 21].
Novel treatment techniques such as laser ablation, pro-
pranolol injection, or sclerotherapy have become the stan-
dard of care in the treatment of subglottic hemangioma, 
thereby reducing the morbidity associated with surgical 
excision.
Carcinoid Tumor
Carcinoid tumor is the primary neuroendocrine tumor of the 
lung. Although rare and less common than carcinoid tumor 
of the gastrointestinal tract, it is the most common primary 
lung tumor in the pediatric population with a mean age of 
presentation of 14 years [22]. A centrally located carcinoid 
tumor within a large airway is more likely to result in symp-
toms in comparison to a carcinoid tumor located more 
peripherally within the lung parenchyma. Affected children 
typically present with cough, shortness of breath, hemopty-
sis, or, most commonly, recurrent pneumonias. Histologically, 
carcinoid tumor can be classified as typical or atypical with 
typical lesions demonstrating fewer mitoses per high power 
field, lower likelihood of necrosis, and less malignant 
potential.
Radiographically, carcinoid tumor can present as a well- 
circumscribed, round, or ovoid lesion. However, if central 
in location, it may be obscured by hilar structures and only 
secondary signs observed such as atelectasis or pneumonia 
(Fig.  10.9a). The parallel sign has been described in the 
literature to describe the orientation of a non-spherical car-
cinoid tumor along axis of the nearest major bronchus or 
pulmonary artery. Cross-sectional imaging with CT or MRI 
is important for presurgical planning and typically demon-
strates a well-defined or lobulated lesion with soft tissue 
attenuation characteristics and robust post-contrast 
enhancement (Fig. 10.9b) [23, 24]. Associated calcification 
may be demonstrated more commonly with central lesions 
versus those in the periphery. 111In-labeled pentetreotide 
(Octreoscan) is suggested by the Pediatric Carcinoid Tumor 
Clinical Guidelines to assess for sites of metastatic disease.
Treatment is primarily surgical with low recurrence rates 
observed with segmentectomy or wedge resection. 
Chemotherapy or somatostatin-based therapies are reserved 
for unresectable cases.
10.3.2.2  Nonneoplastic Disorders of the Large 
Airway
Tracheomalacia
Tracheomalacia is defined as dynamic and disproportionate 
collapse of the tracheal lumen with expiration [25]. It results 
from weakening of the supporting cartilage, softening of the 
airway walls, or hypotonia of the supporting muscles [26]. 
Affecting both premature and term infants, tracheomalacia 
a
b
Fig. 10.8 A 3-month-old boy with subglottic hemangioma who pre-
sented with stridor. (a) Frontal soft tissue neck radiograph shows eccen-
tric narrowing (arrow) of the left subglottic trachea. (b) Axial enhanced 
soft tissue window setting CT at the level of the subglottic trachea dem-
onstrates a well-circumscribed, avidly enhancing soft tissue lesion 
(arrow) at the lateral aspect of the left subglottic trachea
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may be due to primary, congenital causes such as prematurity, 
tracheoesophageal fistula, or congenital cartilage disorder or 
may be acquired secondarily as a result of intubation, infection, 
surgery, extrinsic compression from vascular anomaly, cardio-
vascular defects, or neurologic causes. Typical symptoms 
include cough, recurrent lower airway infection due to 
decreased clearance, dyspnea, recurrent wheeze, or stridor with 
symptoms frequently worsening with activity or agitation.
Fluoroscopic measurement of the tracheal diameter has 
a limited role in the evaluation of tracheomalacia with a 
specificity of 96–100% but a sensitivity of only 23.8–62% 
because the trachea of a normal infant may collapse up to 
50% with forceful crying [27]. A barium esophagram may 
help to evaluate causes of acquired tracheomalacia such as 
due to tracheoesophageal fistula or extrinsic compression 
due to vascular ring but with limited anatomic detail. In 
intubated infants using breath-hold technique as well as 
older children who can follow breathing instructions, CT 
with paired inspiratory and expiratory series can be used to 
evaluate precise localization, extent, and severity of tra-
cheomalacia [28]. In recent years, with the availability of 
higher row multidetector CT (MDCT), real-time and 
dynamic 3D and 4D imaging of the large airway can be 
obtained even in infants and young children who cannot fol-
low breathing instructions obviating the need for intubation 
(Fig. 10.10a–d). Additionally, CT allows for the identifica-
tion of underlying causes as well as associated anomalies 
such as air trapping.
Cases of primary tracheomalacia due to prematurity 
and intrinsic weakness of the supporting cartilage may 
require only supportive care during the first 1–2 years of 
life after which normal stiffening of the cartilage occurs 
and the condition self-resolves [27]. In severe cases, 
aggressive treatment may be required including continu-
ous positive airway pressure, tracheostomy, airway stent-
ing, or surgical repair with pexy procedures. Recently, 
customized, bioresorbable 3D-printed splints have been 
used in cases of severe tracheomalacia with preliminary 
success in both pediatric and adult patients although larger 
and longer studies are necessary to evaluate long-term out-
comes and complications [29].
Foreign Body Aspiration
Because infants and young children aged 6 months to 3 years 
lack molar teeth, have uncoordinated swallowing mecha-
nisms, and, most importantly, engage with their surround-
ings by placing objects in their mouths, they are prone to 
foreign body aspiration [30]. Aspirate objects, most com-
monly peanuts, lodge with the highest frequency within the 
right main stem bronchus due to its larger size and more ver-
tical alignment as compared with the left.
Chest radiography is the first-line imaging study in cases 
of suspected foreign body aspiration because it is readily 
available, low in cost, and associated with minimal radiation 
exposure [31]. As only 10% of aspirated foreign bodies are 
radiopaque [32], however, indirect signs of aspiration includ-
ing air trapping, focal airspace disease, pleural effusion, 
mediastinal shift, pneumothorax, or subcutaneous emphy-
sema are important imaging surrogates. Unilateral hyperin-
flation [33] is the most commonly identified indirect sign of 
aspiration [34] (Fig.  10.11a). This finding may be further 
evaluated with bilateral decubitus radiographs to assess for 
air trapping with the side of foreign body aspiration failing to 
deflate in the dependent position (Fig. 10.11b and c). Lateral 
a
b
Fig. 10.9 A 16-year-old girl with endobronchial carcinoid who pre-
sented with cough and shortness of breath. The patient underwent surgi-
cal excision of the endobronchial mass in the left lower lobe bronchus 
and histological analysis confirmed the diagnosis of low-grade carci-
noid tumor. (a) Frontal chest radiograph shows an opacity with volume 
loss in the left lower lobe (arrow) due to left lower lobe collapse. (b) 
Axial enhanced soft tissue window setting CT image, at the level of the 
left atrium, demonstrates a well-circumscribed, heterogeneously 
enhancing soft tissue mass (asterisk) near the left hilum




Fig. 10.10 A 3-month-old girl with tracheobronchomalacia who pre-
sented with recurrent wheezing and stridor. Subsequently obtained 
bronchoscopy confirmed the diagnosis of tracheobronchomalacia. (a) 
Axial non-enhanced lung window setting CT image, at the level of the 
mid-thoracic trachea, obtained at end-inspiration shows patent trachea 
(arrow). (b) Axial non-enhanced lung window setting CT image, at the 
level of the mid-thoracic trachea, obtained at end-expiration demon-
strates focal collapse of the trachea (arrow) with greater than 50% 
decrease in cross-sectional area consistent with tracheomalacia. (c) 3D 
volume-rendered CT image of the large airways obtained at end- 
inspiration shows patent trachea (arrow). Patent bilateral main stem 
bronchi are also seen. (d) 3D volume-rendered CT image of the large 
airways obtained at end-expiration demonstrates focal marked collapse 
of the trachea (arrow) consistent with tracheomalacia. Also noted is 
similar focal marked collapse (arrowheads) of the distal right main stem 
bronchus and proximal left main stem bronchus, consistent with bilat-
eral bronchomalacia





Fig. 10.11 A 30-month-old boy with an endobronchial non- radiopaque 
foreign body aspiration who presented with acute onset of wheezing 
and respiratory distress. (a) Frontal chest radiograph shows asymmetric 
hyperinflation of the right lung (asterisk) as compared with the nor-
mally aerated left lung. (b) Left lateral decubitus radiograph demon-
strates expected deflation of the left lung (asterisk) in the dependent 
portion. (c) Right lateral decubitus radiograph shows persistent relative 
hyperinflation representing air trapping of the right lung (asterisk) 
despite dependent positioning. Radiographic findings suspicious for 
aspirated non-radiopaque foreign body in the right main stem bronchus. 
Subsequently obtained bronchoscopy demonstrated a nearly obstruc-
tive foreign body (likely almond) located within the right main stem 
bronchus
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decubitus radiography, however, have only 68–74% sensitiv-
ity and 45–67% specificity [35]. Furthermore, it has been 
shown to increase false-positive rates without increasing the 
rate of true-positive identification. As such, a negative chest 
radiography in the setting of high clinical suspicion should 
prompt further evaluation with CT.
CT has an accuracy close to 100% for the detection of 
aspirated foreign body [35] able to identify both an endolumi-
nal mass as well as secondary signs of aspiration. Because of 
the increased radiation exposure of CT as compared with 
radiography, study benefits must be weighed. 3D virtual 
bronchoscopy reconstructions can be utilized to assess for-
eign body aspiration and may be used for preprocedural plan-
ning. Additionally, following bronchoscopic removal, CT can 
be used to assess for residual aspirated foreign body [36].
10.3.3  Pediatric Mediastinal Disorders
10.3.3.1  Vascular Lesions
Vascular rings are congenital abnormalities of the aortic arch 
which result from abnormal development of the aortic arches 
formed during the fourth and fifth weeks of embryonic 
development. Depending upon the location of failed arch 
regression, various anomalous anatomic variants may result 
which encircle the trachea and esophagus to various degrees. 
While some remain asymptomatic and may be incidental 
findings later in life, others, namely, double aortic arch and 
right aortic arch with aberrant left subclavian artery, result in 
symptoms earlier in life and thus frequently present to clini-
cal attention in early infancy. Abnormalities of aortic arch 
development may be associated with additional congenital 
cardiac anomalies, as is frequently the case with right aortic 
arch with mirror image branching, while others are isolated 
findings without additional congenital associations.
Double Aortic Arch
A double aortic arch is caused by persistence of the both the 
right and left embryonic arches which arise from the ascend-
ing aorta. Because a complete vascular ring encircling the 
trachea and esophagus is formed, affected pediatric patients 
generally develop symptoms early in life including wheez-
ing, stridor, cyanosis, and dysphagia frequently exacerbated 
by activity or crying. In a double aortic arch, one arch is usu-
ally dominant with the descending aorta typically located on 
the side contralateral to the dominant arch, most commonly 
manifesting as a dominant right arch with left-sided descend-
ing aorta. A double aortic arch is rarely associated with addi-
tional congenital heart abnormalities.
Radiographically, a double aortic arch demonstrates 
bilateral aortic knobs on the frontal projection with dis-
placement of the tracheal air column away from midline and 
indentation upon the right lateral tracheal border 
(Fig.  10.12a). On the lateral projection, the retrotracheal 
aorta may result in anterior displacement of the trachea. On 
barium esophagram, there may be bilateral indentations on 
the esophagus on frontal views and posterior indentation on 
the lateral view.
Whereas the presence of a double aortic arch may be 
inferred radiographically or fluoroscopically, cross-sectional 
imaging with CT or MRI has improved sensitivity and results 
in superior anatomic detail allowing for elucidation of rela-
tional anatomy to other mediastinal structures [37]. 
Characteristic of a double aortic arch is a symmetric vascular 
branching pattern demonstrated on single axial image at the 
level of the thoracic inlet consisting of the origins of the 
common carotid and subclavian arteries bilaterally, so-called 
the “four- vessel” sign (Fig. 10.12b). Cross-sectional imaging 
is also useful for planning of surgical approach with refor-
matted images offering important insight into arch size, posi-
tion, and dominance (Fig. 10.12c).
The current management of double aortic arch involves 
surgical ligation of the nondominant arch usually via an ipsi-
lateral thoracotomy.
Right Aortic Arch
In normal development, a left aortic arch forms from the 
involution of the right fourth arch and dorsal aorta. When 
there is involution of the left fourth arch and dorsal aorta, 
which occurs in 0.1% of the population [38], a right aortic 
arch results. Right aortic arch is the second most common 
aortic arch variant after double aortic arch. There are two 
main types of right aortic arch: right aortic arch with an aber-
rant subclavian artery and right aortic arch with mirror imag-
ing branching. A right arch may be associated with an 
aberrant left subclavian artery arising from or independent to 
a Kommerell diverticulum occurring between the left com-
mon carotid and left subclavian arteries. A right aortic arch 
may also be associated with mirror imaging branching where 
the embryonic arch is interrupted just distal to the left ductus 
arteriosus. In addition, although the right aortic arch typi-
cally descends within the right aspect of the thoracic cavity, 
rarely the arch can cross to the midline posterior to the 
esophagus with the descending aorta located on the left as 
occurs in the case of right circumflex aorta. Such vascular 
anatomy creates a vascular ring which is completed by a left 
ductus or ligamentum arteriosum. Although a right aortic 
arch with an aberrant left subclavian artery is infrequently 
associated with additional congenital heart anomalies, a right 
arch with mirror image branching is highly associated with 
accompanying congenital heart anomalies (90–98%) most 
commonly Tetralogy of Fallot [39].
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Chest radiography characteristically demonstrates a 
right- sided aortic arch with variable positioning of the 
descending aorta (Fig. 10.13a). In cases of right aortic arch 
with mirror image branching, findings associated to the 
accompanying congenital heart disease may be present 
such as situs inversus or cardiac enlargement. As in cases of 
double aortic arch, cross-sectional evaluation with CT or 
MRI again provides superior anatomic resolution and 
allows for clarification of mediastinal relationships 
(Fig. 10.13b and c).
Management of right aortic arch depends on associated 
anomalies and symptomatology. An asymptomatic right arch 
with aberrant left subclavian artery requires no treatment. 
However, surgical ligation is required in symptomatic pedi-
atric patients with right aortic arch constituting a vascular 
ring. Repair of underlying cardiac anomalies may be also 
needed in pediatric patients with right aortic arch with mirror 
imaging branching.
Pulmonary Artery Sling
A pulmonary artery sling results from failure of development 
of the left sixth aortic arch. As a result, there is anomalous 
origin of the left pulmonary artery from the right pulmonary 
artery with the left pulmonary artery then passing between 
the trachea and esophagus as it courses toward the left hilum. 
Consequently, compression of the trachea and right main 
stem bronchus may result with secondary development of 
tracheobronchomalacia or stenosis. A pulmonary artery sling 
is classified according to the associated airway abnormali-
ties. Type I results in compression of the trachea and right 
main stem bronchus with normal airway branching. Type II 
often results in long segment tracheobronchial stenosis often 
with associated abnormal airway branching with develop-
ment of a T-shaped carina.
Radiographically, a pulmonary sling may manifest as uni-
lateral hyperinflation, low position of the left hilum, and 




Fig. 10.12 A 74-day-old girl with double aortic arch who presented 
with wheezing and feeding difficulty. (a) Frontal chest radiograph 
shows minimal leftward deviation (black arrow) of thoracic trachea 
with indentation along the right lateral tracheal wall. There is also 
prominence (white arrow) of the superior mediastinum. (b) Axial 
enhanced soft tissue window setting CT image, at the level of thoracic 
inlet, demonstrates a symmetric vascular branching pattern comprised 
of the origins of the bilateral common carotid arteries (black arrows) 
and bilateral subclavian arteries (white arrows), the so-called the four- 
vessel sign. (c) Posterior view of 3D volume-rendered CT image shows 
double aortic arch anatomy including the left (black arrow) and right 
(white arrow) aortic arches which comprise a complete vascular ring. 
Right-sided descending aorta (asterisk) is also seen
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tion. Barium esophagram classically demonstrates anterior 
indentation on the esophagus. Cross-sectional imaging again 
better defines the vascular and airway anatomy while aiding 
in the exclusion of right pulmonary agenesis as a differential 
consideration. Additionally, CT can aid in the evaluation of 
secondary tracheobronchomalacia and stenosis. Cross- 
sectional imaging is also helpful for presurgical evaluation 
because treatment usually involves median sternotomy, car-
diopulmonary bypass, reimplantation of the anomalous left 
pulmonary artery, and repair of large airway anomaly or 
abnormality if present (Fig. 10.14) [40].
10.3.3.2  Nonvascular Lesions
Foregut Duplication Cyst
Foregut duplication cyst is the most common primary medi-
astinal mass and comprises 11% of all mediastinal masses 
[41]. It is believed to arise from disturbances in embryologic 
differentiation of the primitive gut which typically develops 
into the pharynx, respiratory tract, esophagus, stomach, and 
the proximal duodenum [42]. In general, symptoms relate to 
the level of cyst, mass effect by the cyst on adjacent struc-




Fig. 10.13 A 15-year-old girl with a right aortic arch who presented 
with wheezing. (a) Frontal chest radiograph shows right-sided aortic 
knob (black arrow) which indents upon and leftward deviation (white 
arrow) of the thoracic trachea. (b) Coronal enhanced soft tissue window 
setting CT demonstrates a right-sided aortic arch (asterisk) and descend-
ing aorta (DA). Compression (arrow) of the trachea due to right aortic 
arch is also seen. (c) Posterior view of 3D volume-rendered CT image 
demonstrates right aortic arch anatomy with right-sided descending 
aortic arch (asterisk) and descending aorta (DA)
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Foregut duplication cyst can be broadly classified into 
three types which include bronchogenic cyst, esophageal 
duplication cyst, and neurenteric cyst. Bronchogenic cyst 
arises from abnormal lung budding during ventral foregut 
division and can occur anywhere along the tracheoesopha-
geal tree, most commonly in the subcarinal or paratracheal 
regions. Although usually asymptomatic, if large, broncho-
genic cyst can result in dyspnea from secondary compres-
sion of an adjacent airway. Esophageal duplication cyst is 
the result of abnormal division of the posterior embryonic 
foregut. It is most commonly associated with dysphagia as 
the duplication cyst may occur anywhere along the esopha-
gus, though most arise in the upper one third. A failure of 
complete separation of the gastrointestinal tract from the 
primitive neural crest can result in a neurenteric cyst which 
is one variant of split notochord syndrome. Usually occur-
ring in the posterior mediastinum, neurenteric cyst may 
communicate with the spinal cord resulting in pain as well 
as an associated cleft within the adjacent vertebral body.
Radiographically, foregut duplication cysts of all sub-
types manifest as smooth, oval, or round middle or posterior 
mediastinal masses (Fig.  10.15a) requiring further cross- 
sectional imaging with CT or MRI evaluation prior to surgi-
cal removal [41, 43]. Although neurenteric cyst may have an 
associated vertebral body anomaly, other imaging features 
are less specific with a well-marginated cystic lesion most 
commonly identified. Uniform fluid attenuation or homoge-
neous T2 hyperintensity is demonstrated in up to one half of 
lesions (Fig. 10.15b). Heterogeneity, however, can result in 
the setting of prior hemorrhage, infection, or increased inter-
nal protein although most lesions still retain intrinsic T2 
hyperintensity. After administration of contrast, irregular 
border and peripheral contrast enhancement may also be 
identified in the setting of prior or superimposed infection 
(Fig. 10.15c).
The current management of symptomatic pediatric 
patients with foregut duplication cysts is surgical resection.
Neuroblastoma
Thoracic neurogenic tumors may arise from any component 
of the nervous system within the chest. They are the most 
common posterior mediastinal masses in children, accounting 
for 90% of posterior mediastinal masses [41]. Mediastinal 
location of neuroblastoma is associated with more benign and 
mature subtype of neuroblastoma as compared with intra-
abdominal location. Thoracic neurogenic tumors can be sepa-
rated into two main categories based upon the origin of their 
precursor cell from either an autonomic nerve ganglia or the 
nerve sheath. Lesions of autonomic nerve ganglia origin are 
more commonly encountered in pediatric patients with differ-
ential consideration ranging from the benign ganglioneuroma 
to the malignant neuroblastoma with ganglioneuroblastoma 
having histological features of each and being of transitional 
malignant potential. Although imaging alone is not possible to 
differentiate these tumor types, imaging plays an important 
role in identifying and characterizing the mass and its extent.
Neuroblastoma is the most common posterior extracra-
nial solid malignancy of childhood and most frequently 
occurs in patients less than 3 years of age. Depending on 
primary tumor location, presenting clinical symptoms may 
include Horner syndrome or heterochromia if the primary 
tumor is cervical or apical in location, paraplegia or loss of 
bladder/bowel function if there is spinal cord compression, 
or opsoclonus- myoclonus syndrome if circulating autoanti-
bodies are present. In addition, associated nonspecific 
symptoms may be present including fever, irritability, 
weight loss, anemia, and pain. Levels of catecholamines or 
neurotransmitters, which are detected by blood or urine 
tests, are typically elevated in pediatric patients with 
neuroblastoma.
Classically included in the radiographic differential of a 
posterior mediastinal lesion, neuroblastomas frequently 
demonstrate associated calcification (50%) and may cause 
secondary osseous findings including rib erosion or 
enlargement of the neuroforamen [44] (Fig. 10.16a and b). 
Neuroblastoma usually lacks a well-defined capsule and 
may invade adjacent mediastinal structures or metastasize. 
Cross- sectional imaging with CT or MRI provides crucial 
staging information including location, lesion size, and the 
presence of metastatic disease (Fig. 10.16c). MRI is espe-
cially helpful in the classification of extradural disease due 
to the intrinsic high lipid and water content of these tumors 
which results in both T1 and T2 hyperintensity. MRI, in 
comparison to CT, can also better demonstrate the exten-
sion of thoracic neuroblastoma into the adjacent neural 
foramen.
Fig. 10.14 A 2-month-old girl with pulmonary artery sling who pre-
sented with respiratory distress. Axial enhanced soft tissue window set-
ting CT image demonstrates anomalous origin of the left pulmonary 
artery (asterisk) from the main pulmonary artery (PA). The left anoma-
lous pulmonary artery (asterisk) passes between the trachea (black 
arrow) and esophagus (white arrow) as it courses toward the left hilum
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Overall survival rate of thoracic neuroblastoma is supe-
rior to primary abdominal neuroblastoma with treatment 
usually involving a combination of surgical resection, che-
motherapeutic agents, and radiation.
Lymphatic Malformation
Lymphatic malformation results from embryologic malfor-
mation of the lymphatic system. Such malformation results 
in lymph-containing smooth and skeletal muscle-lined chan-
nels with intervening fibro-connective tissue creating micro-
cystic, macrocystic, or combined lesions of variable size. 
Intrathoracic lymphatic malformation in isolation is rare, 
accounting for less than 1% of all lymphatic malformations, 
and more generally results from extension of cervical, axil-
lary, or mediastinal malformation. Typically present at birth, 
the majority of affected patients present to clinical attention 
before 2 years of age with an asymptomatic palpable mass 
although pain may occur with intralesional hemorrhage or 
infection. Large lesions, however, may produce symptoms 
such as dyspnea if there is secondary airway or vascular 
compression.
Intrathoracic lymphatic malformation, if small and 
asymptomatic, may be incidental findings on chest radiogra-
phy performed for different indication. If located in the 
mediastinum, lymphatic malformation may present as a 
well-circumscribed mass or vague mediastinal fullness 
(Fig. 10.17a). If there is extension of the lymphatic malfor-
mation into the cervical region, deviation of the trachea may 
be identified on either the frontal or lateral radiography. MRI 
is currently considered the gold standard imaging modality 
in the evaluation of lymphatic malformations because it 
affords superior soft tissue contrast as compared with CT 
and enables evaluation of local extent and relationship to 
normal structures. As lymphatic malformations contain fluid, 
there is intrinsic T2 hyperintensity (Fig. 10.17b). Following 
contrast administration, there is variable enhancement of the 
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Fig. 10.15 A 14-year-old girl with esophageal duplication cyst who 
presented with dyspnea. The mediastinal mass was surgically excised 
and pathology was consistent with an esophageal duplication cyst. (a) 
Frontal chest radiograph demonstrates a well-circumscribed opacity 
(black arrow) overlying the right aspect of the heart. (b) Axial 
T2-weighted, fat-suppressed MR image shows a cystic lesion (asterisk) 
within the middle mediastinum. (c) Coronal enhanced T1-weighted, 
fat-suppressed MR image demonstrates a peripheral enhancement of 
the lesion (asterisk) within the right aspect of the middle mediastinum





Fig. 10.16 A 2-year-old boy with thoracic neuroblastoma who pre-
sented with chest pain and paresthesia. (a) Frontal chest radiograph 
shows a well-circumscribed mass (asterisk) in the right hemithorax. 
Posterior mediastinal location of the mass is suspected by the presence 
of splaying of the right-sided posterior ribs. (b) Lateral chest radio-
graph confirms posterior mediastinal location of the mass (asterisk). (c) 
Axial enhanced bone window setting CT image demonstrates a large, 
well-circumscribed mass (asterisk) within the posterior mediastinum 
with associated punctate calcifications (arrow). The mass displaces the 
heart (white arrowhead) anteriorly. Lack of normal rim of cerebrospinal 
fluid surrounding the spinal cord (black arrowhead) and amorphous soft 
tissue attenuation within the spinal canal raise concern for intracana-
licular invasion
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intervening septa and surrounding walls, which may increase 
in the setting of prior hemorrhage or infection (Fig. 10.17c).
Surgical resection and localized sclerotherapy are the pri-
mary forms of treatment for thoracic lymphatic malforma-
tions although complete surgical resection may be limited in 
extensive, infiltrative lymphatic malformations. With either 
therapy, relapse is common. Recently, given the success of 
topical therapies in the treatment of facial angiofibromas and 
the capillary vascular malformations associated with Sturge- 
Weber syndrome, novel topical treatment modalities such as 
rapamycin have been described for lymphatic malformation 
with promising early results.
10.4  Conclusion
Thoracic disorders mainly arise from lung parenchyma, 
large airway, or the mediastinum in the pediatric popula-
tion. Imaging assessment plays an important role for initial 
detection, preoperative assessment for surgical lesions, and 
follow- up evaluation. Clear understanding of advantages 
and disadvantages of currently available imaging modali-
ties as well as characteristic imaging findings of thoracic 




Fig. 10.17 A 14-year-old girl with thoracic lymphatic malformation 
who presented with cough. (a) Frontal chest radiograph shows promi-
nence and undulating contour (arrow) of the right superior mediasti-
num. (b) Axial T2-weighted, fat-suppressed MR image demonstrates a 
cystic lesion (asterisk) located in the superior mediastinum posterior to 
the superior vena cava (arrow). (c) Axial enhanced T1-weighted, fat- 
suppressed MR image shows a peripheral enhancement (white arrow) 
of the lesion (asterisk) located within the superior mediastinum
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Key Points
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portive care in the first years of life.
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90% of posterior mediastinal masses.
Take-Home Messages
• Differential considerations of commonly encoun-
tered pediatric chest radiology pathologies include 
both congenital conditions, such as surfactant defi-
ciency syndrome due to prematurity and tracheo-
malacia, as well as acquired conditions, such as 
round pneumonia and neuroblastoma.
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can help to narrow differential considerations in the 
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• Chest radiography is the first-line and most com-
monly performed imaging examination in pediatric 
patients with potential thoracic disorders. The use of 
CT must be carefully weighed in pediatric chest 
radiology due to heighted susceptibility of pediatric 
patients to the harmful effects of ionizing radiation.
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The diagnosis of systemic diseases involves an analysis of 
their characteristic clinical manifestations in different organ 
systems. Clinical features are often correlated with serologic 
abnormalities, radiologic findings, and, in some cases, histo-
pathology. Systemic diseases may affect a variety of differ-
ent compartments of the thorax including the lungs, pleura, 
pericardium, lymph nodes, vessels, and heart. This discus-
sion will focus on their lung manifestations; however refer-
ence will also be made to their extrapulmonary manifestations, 
as these often provide important clues to diagnosis. The 
prevalence of lung involvement varies: while it is a predomi-
nant feature of certain systemic diseases, such as sarcoidosis 
or granulomatosis with polyangiitis (GPA, formerly 
Wegener’s granulomatosis), it is only rarely present in others 
such as Henoch-Schönlein purpura.
The roles of imaging in systemic diseases vary somewhat 
depending upon the specific disorder. Radiology, and in par-
ticular computed tomography (CT), may be important in 
establishing a diagnosis. Sarcoidosis, as an example, is a dis-
ease for which typical CT findings are often critical in estab-
lishing an accurate diagnosis. Connective tissue disease, on 
the other hand, is often diagnosed primarily using clinical 
and serologic findings; thus imaging has a somewhat limited 
role in diagnosis. However, it is also seen in clinical practice 
that findings on CT such as signs of lung fibrosis (especially 
the NSIP pattern) represent the trigger for diagnostic work-
 up for the presence of an underlying systemic disease. When 
imaging doesn’t play a major role in diagnosis, it is still 
important in establishing the presence and pattern of lung 
disease as well as disease extent, all of which have an impact 
on treatment decisions. Imaging also has important roles in 
serial follow-up of lung abnormalities over time and evaluat-
ing patients with worsening or acute symptoms.
In the following we will focus on the more common sys-
temic disorders that develop pulmonary abnormalities such 
as sarcoidosis, connective tissue diseases, and vasculitis. 
While a comprehensive review of the lung manifestations of 
all systemic diseases is not possible, a few selected rare dis-
orders will also be discussed including inflammatory bowel 
disease, amyloidosis, Erdheim-Chester disease, and IgG4- 
related sclerosing disease.
11.2  Sarcoidosis
Sarcoidosis is a systemic disorder of unknown origin. A 
genetic predisposition to sarcoidosis is indicated by observa-
tions of familial clustering. Sarcoidosis is characterized by 
noncaseating epithelioid cell granulomas in multiple organs, 
but morbidity and mortality are closely related to pulmonary 
manifestations occurring in >90% of patients [1]. The CT 
appearance of pulmonary sarcoidosis varies greatly [2] and 
is known to masquerade many other diffuse infiltrative lung 
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• Discuss the typical lung manifestations of systemic 
diseases including sarcoidosis, connective tissue 
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computed tomography, in the diagnosis and man-
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• Identify typical CT findings and patterns of sys-
temic diseases and their differential diagnoses.
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diseases; conversely several diseases can resemble classical 
sarcoidosis.
The histology of pulmonary sarcoidosis consists of non-
caseating granulomas with a rim of lymphocytes and fibro-
blasts in a perilymphatic distribution, which may resolve or 
cause fibrosis. The disease may occur at any age but mostly 
affects individuals between 20 and 40 years of age and only 
rarely occurs in over 65 years of age. The prognosis is mostly 
good with disease resolution often occurring in <2 years and 
mortality between 1% and 5%.
The three criteria for diagnosis are (1) typical clinical and 
radiological manifestations, (2) the presence of noncaseating 
granulomas, and (3) exclusion of alternative diseases. The 
respective weight of each criterion varies with individual 
presentation: while in some patients with suspected sarcoid-
osis typical findings on a chest radiograph can be sufficient 
in the correct context (i.e., uveitis, erythema nodosum), in 
other patients a classic nodular pattern on CT is necessary to 
establish diagnosis, and last there is a subgroup of patients in 
which controversial or nonspecific clinical and radiological 
findings make histological proof necessary (e.g., biopsy of 
skin lesions, endobronchial ultrasound-guided transbron-
chial needle aspiration for mediastinal or hilar 
lymphadenopathy).
Pulmonary findings on CT include small, well-defined 
nodules in a characteristic perilymphatic distribution in 
relation to the subpleural surface, adjacent to the major fis-
sures, along thickened interlobular septa, and adjacent to 
vessels in the lobular core [3]. The nodules may be evenly 
distributed throughout both lungs with predominance of the 
upper and middle lung zones; however they may be also 
clustered in the perihilar and peribronchovascular regions 
with relative sparing of the lung periphery, or they may be 
grouped in small areas. Confluence of granulomas results in 
larger nodules (1–4 cm, nodular sarcoid, galaxy sign) or ill- 
defined opacities (ground glass or consolidations, up to 
10 cm, alveolar sarcoidosis).
Lymphadenopathy is typically seen in a subcarinal, right 
paratracheal, aortopulmonary, and symmetric hilar distribu-
tion. In advanced stage CT calcifications are seen in lymph 
nodes with an eggshell or amorphous cloudlike (“icing 
sugar”) pattern.
Up to 25% of patients develop irreversible pulmonary 
fibrosis with architectural distortion, displacement of the 
interlobular septa, traction bronchiectasis, honeycombing, 
and bullae (stage IV). Conglomerate masses, mostly in a 
perihilar location, represent areas of fibrosis with character-
istic traction bronchiectasis. Volume loss of the upper lobes 
is associated with hilar retraction and septal displacement.
Airway abnormalities include airway compression caused 
by surrounding lymphadenopathy and traction bronchiecta-
sis caused by surrounding fibrosis. Granulomas within the 
bronchial walls cause irregular bronchial wall thickening 
with narrowing of the large and small airways. Involvement 
of the small airways causes lobular air trapping more easily 
identifiable on expiratory CT scans.
Sarcoidosis may present with very characteristic HRCT 
features allowing for a secure diagnosis and obviating fur-
ther invasive procedures. However, sarcoidosis is also known 
to present with less typical features (Table 11.1).
Especially in advanced disease with fibrosis, the differen-
tial diagnosis between sarcoidosis and other fibrosing dis-
eases can be challenging. Table  11.2 summarizes imaging 
findings helpful for differentiating diseases.
Complications include the development of an aspergil-
loma and pulmonary hypertension.
Mycetomas are a typical complication of stage IV sar-
coidosis: they present with a soft tissue mass located in a 
preexisting cavity in patients with fibrotic sarcoidosis. Life- 
threatening hemoptysis may require immediate interven-
tional therapy (embolization of bronchial arteries).
Pulmonary hypertension occurs in patients with end-stage 
fibrosis but may be also caused by mediastinal fibrosis, 
extrinsic compression of the pulmonary arteries by lymph-
adenopathy, or intrinsic sarcoid vasculopathy including fea-
tures of pulmonary veno-occlusive disease.
Staging based on chest radiography (Siltzbach classifica-
tion, Table  11.3) was developed decades ago, before the 
broad use of CT; it is purely descriptive and does not indicate 
disease activity.
FDG-PET can be used to accurately assess inflammatory 
activity, for example, in patients with persistent disabling 
symptoms without serological inflammatory activity [4]. 
PET has also been described to be helpful to predict pulmo-
nary deterioration at 1 year and to monitor therapy response. 
Table 11.1 HRCT manifestations of Sarcoidosis
Typical features
Lymphadenopathy: hilar, mediastinal, bilateral symmetric, well 
defined




subpleural, interlobular septa, 
peribronchovascular
Fibrosis: reticular opacities, architectural distortion, 
bronchiectasis, volume loss
Distribution: predominance of upper lobes and perihilar 
areas
Atypical features 




conglomerate masses, confluent alveolar 
opacities (alveolar sarcoidosis)
Linear opacities: interlobular septal thickening
Fibrocystic changes: cysts, bullae, honeycomb-like opacities, 
upper lobe predominance
Airway involvement: atelectasis, mosaic pattern
Pleural disease: effusion, pneumothorax, pleural plaques
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Inhibition of the physiological myocardial FDG uptake, e.g., 
by appropriate diets, enables the detection of cardiac sar-
coidosis active lesions.
Recently an integrated clinicoradiological staging system 
[5] has been proposed to identify patients with poor progno-
sis and at risk for mortality (50% in 5.5 years): while initial 
separation between the two prognostic groups was done by 
applying a weighted combination of lung function parame-
ters, further separation was yielded if extent of fibrosis on 
CT exceeded 20% and/or a pathological diameter ratio of the 
main pulmonary and ascending aorta (>1) was seen.
11.3  Connective Tissue Disease
Connective tissue diseases (CTDs) are characterized pri-
mary upon clinical grounds, namely, typical clinical com-
plaints and physical examination findings. The presence 
of specific autoantibodies also assists in making a specific 
diagnosis. While imaging has an important role in deter-
mining the presence and pattern of lung disease present, 
its role in diagnosis is limited. It is important to note, 
Table 11.2 Diseases with imaging features that overlap with sarcoidosis
Differential diagnosis Overlapping finding Suggestive for sarcoidosis
Lymphangitic 
carcinomatosis
•  Irregular “beaded” thickening of the interlobular 
septa
•  Upper lobe predominance
• Absence of pleural effusion
• Less central bronchial cuffing
Silicosis/pneumoconiosis • Pleural pseudoplaques
• Egg shell calcifications of lymph nodes
• Perihilar fibrotic masses
• No calcifications in pseudoplaques,
• Pseudoplaques consist of confluent nodules
•  The perihilar fibrotic masses extend directly from the 
hilar structures and move posteriorly (volume loss 
upper lobe)





•  Lobular distribution of areas with air trapping (in 
the presence of obliterative bronchiolitis) and 
fibrosis
•  UIP pattern predominantly in upper lobes or perihilar 
region
• Thickened interlobular septa
• Lymph node calcifications
•  Fibrosis and traction bronchiectasis tend to run from 
the hilar structures dorsolaterally
Lymphoproliferative 
disorders
• Lymphadenopathy • Usually but not always symmetric
•  Presence of typical parenchymal findings (caveat: 
biopsy may be necessary)
Chronic beryllium disease • Nodular pattern • Large hilar lymphadenopathy
• No exposure to beryllium
• Other organ involvement
Tuberculosis •  Nodular pattern
(normally random versus perilymphatic nodules; 
however, sarcoidosis may occasionally show a 
random pattern)
•  Egg shell or disperse calcifications as opposed to 
rough TB calcifications
•  Symmetric calcifications (in Tb frequently 
asymmetric)
•  Clinical symptoms of acute infection in patients with 
military TB
Common variable immune 
deficiency (CVID)
• Nodules in perilymphatic distribution
• Ill-defined nodules in mid-lower predominance
•  Different clinical histories (in CVID recurrent 
bacterial infection)
• Different histological features
EAA, exogenic allergic alveolitis; HP, hypersensitivity pneumonitis
see also Spagnolo P, Sverzellati N, Wells AU, and Hansell D. Eur Radiol 2014;24: 807
Table 11.3 Siltzbach classification of sarcoidosis
CXR findings Stage at diagnosis
Spontaneous 
remission in
Stage 0 Normal chest 
radiograph
5–10%




Stage 2 Lymphadenopathy and 
nodular opacities
25–30% 40–70%





Stage 4 Fibrosis 5%, in up to 25% 
progression to 




• The typical CT findings of sarcoidosis include (1) 
perilymphatic nodules located predominantly in the 
peribronchovascular and subpleural interstitium, 
(2) symmetric bilateral hilar and mediastinal 
lymphadenopathy, and (3) upper lobe and peribron-
chovascular fibrosis.
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however, that lung abnormalities may precede the other 
clinical manifestations, sometimes by more than 5 years. 
In these cases, imaging may suggest the possibility of 
CTD, even when a patient doesn’t meet the criteria for a 
specific one (see interstitial pneumonia with autoimmune 
features below).
CTD can affect different compartments of the thorax 
including the lung, pleura, pericardium, lymphatics, vascula-
ture, and heart. Commonly, more than one compartment is 
involved. Involvement of the respiratory system is common 
in CTDs and results in significant morbidity and mortality. 
Many of the lung manifestations of CTD [6] are similar to 
the idiopathic interstitial pneumonias and can be classified 
using the same system [7].
Lung biopsy is rarely obtained in patients with a defined 
CTD. For this reason, high-resolution CT often determines 
the predominant pattern of injury present. This pattern is 
important in determining treatment and prognosis. While 
many possible patterns of injury are associated with each 
specific CTD [8], certain patterns are more common than 
others (Table 11.4). For instance, organizing pneumonia is 
most commonly seen in association with polymyositis or 
dermatomyositis. It is also important to note that more 
than one pattern of injury may be present in the same 
patient.
11.3.1  Rheumatoid Arthritis
Most patients with rheumatoid arthritis (RA) have abnor-
malities on high-resolution chest CT; however they are com-
monly asymptomatic. The most common CT findings in the 
lungs include bronchial wall thickening (12–92%), bronchial 
dilation (30–40%), reticulation (10–20%), ground-glass 
opacity (15–25%), honeycombing (10%), and consolidation 
(5%) [9].
Airways disease appears to be the earliest manifestation 
of RA in the lung [10]. Bronchiectasis and air trapping are 
common findings [11]. There is a recognized association 
between RA and obliterative bronchiolitis (constrictive bron-
chiolitis) in which bronchioles are destroyed and replaced by 
scar tissue. The characteristic CT finding is mosaic perfusion 
with expiratory air trapping often associated with bronchial 
dilation. Follicular bronchiolitis is a second type of small air-
way disorder recognized in rheumatoid lung disease. The 
major CT finding is centrilobular nodules and areas of 
ground-glass opacity.
RA lung fibrosis is substantially more common in men 
than in women. The two most common patterns of lung 
fibrosis are UIP and NSIP [12]. Of all CTDs, RA is the most 
common to present with a UIP pattern. CT findings in inter-
stitial pneumonia associated with RA are often indistinguish-
able from the idiopathic varieties; however other findings 
such as nodules, pulmonary arterial enlargement, or pleural 
abnormality may provide a clue to the underlying diagnosis. 
UIP and NSIP both typically demonstrate a subpleural and 
basilar distribution of findings. A confident diagnosis of UIP 
may be made when honeycombing and reticulation is present 
in this distribution. A confident diagnosis of NSIP may be 
made when there is an absence of honeycombing and sub-
pleural sparing is present.
The new generation of biologic agents used to treat RA 
has resulted in a new array of potential pulmonary side 
effects. The most important of these is impaired immunity 
related to use of anti-TNFα antibodies (etanercept, inflix-
imab, and adalimumab), which results in a substantially 
increased incidence of tuberculosis (sometimes dissemi-
nated or extra-articular) and nontuberculous mycobacterial 
infection.
Table 11.4 Different connective tissue diseases and their primary pul-
monary manifestations
Connective 





•  Usual interstitial 
pneumonia
•  Nonspecific interstitial 
pneumonia
• Airways disease
Scleroderma •  Nonspecific interstitial 
pneumonia
•  Pulmonary 
hypertension




•  Pulmonary 
hemorrhage
•  Diffuse alveolar 
damage
•  Pulmonary 
hypertension
•  Pulmonary 
thromboembolism
Myositis •  Nonspecific interstitial 
pneumonia
•  Organizing 
pneumonia




•  Nonspecific interstitial 
pneumonia






•  Nonspecific interstitial 
pneumonia
•  Usual interstitial 
pneumonia
Key Point
• The diagnosis of CTD is made predominantly using 
clinical and serologic findings. Imaging is impor-
tant in the detection and characterization of lung 
disease, particularly given that pathology is not usu-
ally obtained.
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Low-dose methotrexate [13] may be associated with sub-
acute hypersensitivity pneumonitis in 2–5% of cases. 
Preexisting radiographic evidence of interstitial lung disease 
probably predisposes to the development of methotrexate 
pneumonitis in patients with RA. Infections, such as pneumo-
cystis pneumonia, are also a potential complication of therapy.
11.3.2  Scleroderma (Progressive Systemic 
Sclerosis)
Parenchymal lung involvement is very common in patients 
with scleroderma. Scleroderma is, in fact, the only CTD in 
which lung disease is a component of the defining criteria. 
At autopsy, the lungs are abnormal in at least 80% of cases. 
Lung fibrosis is the most common pattern of abnormality, 
with NSIP being much more common (>90%) than UIP 
[14]. Pulmonary hypertension is also common, either as an 
isolated finding or in association with lung fibrosis. 
Pulmonary hypertension is particularly common in patients 
with limited scleroderma (CREST syndrome) [15]. 
Esophageal dilation is found in up to 80% of cases on CT.
CT findings in scleroderma reflect the dominant NSIP his-
tology. Cellular NSIP presents with ground-glass opacity, 
often in a posterior and subpleural distribution. Fibrotic NSIP 
shows irregular reticulation and traction bronchiectasis as the 
predominant findings. Honeycombing is often absent, but 
when present, it is limited in extent [16]. Cellular and fibrotic 
NSIP often coexist, so findings may overlap. Subpleural spar-
ing is particularly suggestive of a NSIP pattern.
The lung fibrosis associated with scleroderma is associ-
ated with a much better prognosis than that found in idio-
pathic lung fibrosis [17], most likely due in part to the 
predominant NSIP histology [18]. Fibrotic changes may stay 
stable for many years.
Pulmonary arterial hypertension usually causes enlarge-
ment of the main and proximal pulmonary arteries on chest 
radiograph or CT; however normal-sized pulmonary arteries 
do not exclude the diagnosis, and the presence of pericardial 
thickening or fluid in patients with scleroderma is also a strong 
predictor of echocardiographic pulmonary hypertension.
There is an increased prevalence of lung cancer in sclero-
derma, with relative risk of malignancy ranging from 1.8 to 
6.5. Lung cancer in this condition often occurs in individuals 
with lung fibrosis.
11.3.3  Systemic Lupus Erythematosus (SLE)
Pleuritis is the most common pleuropulmonary manifesta-
tion of SLE, found in 40–60% of patients, and may or may 
not be associated with pleural effusion.
Fibrotic interstitial lung disease [19] is less common in 
SLE than in the other CTDs. While pulmonary infection is 
said to be the most common pulmonary complication of 
SLE, acute pulmonary hemorrhage is also an important pul-
monary complication of this condition, characterized radio-
logically by diffuse or patchy consolidation and ground-glass 
opacity [20].
Acute lupus pneumonitis is a poorly defined entity, char-
acterized by a variable degree of respiratory impairment 
accompanied by focal or diffuse pulmonary consolidation, 
occurring in patients with lupus. It is now believed that most 
cases previously identified as lupus pneumonitis probably 
represented diffuse alveolar damage with or without pulmo-
nary hemorrhage.
Other complications of lupus may include diaphragmatic 
dysfunction, pulmonary hypertension, and pulmonary 
thromboembolism [21], which may be related to antiphos-
pholipid antibodies. Diaphragmatic dysfunction, thought to 
be due to a diaphragmatic myopathy, is manifested by 
reduced lung volumes (“shrinking lungs” with platelike 
atelectasis).
11.3.4  Polymyositis/Dermatomyositis  
(PM/DM)
The presence of interstitial lung disease (ILD) in PM/DM 
correlates strongly with the presence of anti-Jo-1. About 
50–70% of patients who are anti-Jo-1 positive have ILD, 
whereas the frequency of ILD falls to about 10% if antibod-
ies are absent. ILD may antedate myositis in patients with 
anti-Jo-1 antibodies.
The most common pathologic findings are NSIP [22] and 
OP, often occurring in combination. As with other CTDs, the 
occurrence of interstitial pneumonia may precede the devel-
opment of clinical myositis.
Lung disease associated with PM/DM or with the anti-
synthetase syndrome, a closely related entity, is often asso-
ciated with a characteristic CT appearance [23]. Confluent 
ground- glass opacity and consolidation in the lower lobes is 
superimposed on a background of traction bronchiectasis. 
This pattern reflects the characteristic histologic combina-
tion of organizing pneumonia and NSIP. On serial evalua-
tion after treatment, consolidation often shows significant 
Key Point
• Fibrotic lung disease is much less common with 
SLE compared to other CTDs. Hemorrhage, diffuse 
alveolar damage, and pulmonary hypertension are 
more common findings.
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improvement or resolution; however fibrosis, manifested by 
reticulation and traction bronchiectasis, usually persists.
Diffuse alveolar damage is another pattern that may be 
seen in patients with PM/DM.  Patients present with acute 
symptoms, as opposed to the subacute or chronic symptoms 
of NSIP and/or organizing pneumonia. Typical CT features 
of diffuse alveolar damage include symmetric bilateral 
ground-glass opacity and/or consolidation.
There is an increased risk for malignancy (especially for 
breast, lung, ovary, and stomach malignancies) that is 
 concurrently diagnosed within 1 year follow-up in up to 20% 
of patients.
11.3.5  Sjögren Syndrome
CT provides substantial information regarding the pattern of 
pulmonary involvement in Sjögren syndrome. The patterns 
may be divided into airway abnormalities, interstitial fibro-
sis, pulmonary hypertension, and lymphoid interstitial pneu-
monia [24].
Airway-related abnormalities are common and consist of 
bronchial wall thickening, bronchiectasis, bronchiolectasis, 
and tree-in-bud opacities. Small airway disease may mani-
fest by mosaic attenuation on inspiratory CT and air trapping 
on expiratory air trapping [25].
Nonspecific (NSIP) and lymphoid (LIP) interstitial pneu-
monia are the most common patterns of parenchymal lung 
disease. NSIP resembles that seen in scleroderma as above. 
LIP is characterized by ground-glass opacity due to the 
homogenous lymphocytic infiltration. Perilymphatic or cen-
trilobular nodules may also be seen. Cysts measuring 
5–30 mm may be seen in isolation or associated with other 
findings. These changes are ascribed to bronchiolar obstruc-
tion on the basis of lymphocytic wall infiltration. Cysts are 
helpful in distinguishing LIP from lymphoma.
Lymphoma should be suspected if consolidation, large 
nodules (>1  cm), mediastinal lymphadenopathy, or effu-
sions are present. However, similar large “pseudo-alveolar” 
nodules can be found in combined amyloidosis and LIP. In 
contrast to other cystic lung diseases such as lymphangi-
oleiomyomatosis, the cysts of LIP are fewer in number and 
show a peribronchovascular and lower lung predominance.
11.3.6  Mixed Connective Tissue Disease
Mixed connective tissue disease (MCTD) is an overlap syn-
drome that is a distinct clinicopathological entity. The princi-
pal characteristics are the presence of (1) features of SLE, 
scleroderma, and PM/DM, occurring together or evolving 
sequentially during observation and (2) antibodies to an 
extractable nuclear antigen (RNP).
Pulmonary involvement is common in MCTD with infil-
trative lung disease present in as many as two thirds of 
patients. Many affected patients are asymptomatic. The pul-
monary abnormalities resemble those seen in SLE, SS, and 
PM/DM. Thus, pleural thickening and pleural and pericar-
dial effusions are common. Ground-glass attenuation is the 
commonest parenchymal abnormality [26]. The CT pattern 
corresponds most closely to NSIP.  Less common findings 
include honeycombing, consolidation, and poorly defined 
centrilobular nodules.
Other important complications of MCTD include pulmo-
nary arterial hypertension and esophageal dysmotility with 
sequelae of recurrent aspiration in the lungs.
11.3.7  Interstitial Pneumonia 
with Autoimmune Features
There is growing attention in the literature toward patients 
with interstitial lung disease that have some, but not all, fea-
tures of a CTD.  Multiple studies retrospectively identified 
subgroups of patients with one or multiple serological fea-
tures of an autoimmune process in patients with histologi-
cally proven UIP or NSIP that were originally diagnosed as 
idiopathic because they did not fulfill the criteria of one of 
the stablished CTDs. Several terms have been suggested as a 
description for these subgroups including interstitial pneu-
monia with autoimmune features, undifferentiated CTD 
(UCTD), or lung-dominant CTD.
The term interstitial pneumonia with autoimmune fea-
tures (IPAF) has been proposed for a subgroup of patients 
with findings suggestive but not diagnostic of a CTD [27]. To 
meet criteria for IPAF, patients must demonstrate specific 
features in two of the three following domains: (1) clinical, 
(2) serologic, and (3) anatomic. The anatomic domain may 
be satisfied by either typical patterns on CT or pathology. 
The CT patterns that are suggestive of CTD include nonspe-
cific interstitial pneumonia (NSIP), organizing pneumonia 
(OP), an overlap of NSIP and OP, or lymphoid interstitial 
pneumonia. The presence of multi-compartmental findings 
is also suggestive including the combination of an interstitial 
pneumonia with any of the following: unexplained pleural 
effusion or thickening, pericardial effusion or thickening, 
airways disease, or pulmonary vasculopathy.
Key Point
• IPAF is a term used to describe patients who have 
some, but not all features, of a specific CTD. CT 
patterns that are suggestive of this diagnosis include 
NSIP, OP, an overlap of NSIP and OP, LIP, and 
multi-compartmental disease (e.g., interstitial pneu-
monia with pleural thickening).
C. Schaefer-Prokop and B. M. Elicker
133
11.3.8  Pulmonary Vasculitis/Diffuse Alveolar 
Hemorrhage
The term “vasculitis” refers to disorders characterized by 
inflammation of blood vessel walls. Pathology includes the 
presence of leucocytes and fibrinoid necrosis in the vessel 
wall with consequent compromise of vessel integrity and 
hemorrhage, narrowing of vessel lumen with consequent 
downstream ischemia, and necrosis.
Classification of systemic vasculitis (Table 11.5) remains 
controversial. The current classification dated from the 
Chapel Hill Consensus Conference (CHCC) in 2012 contin-
ued to consider the predominant vascular size involved and 
distinguishes large-, medium-, or small-vessel vasculitis 
(LVV, MVV, or SVV, respectively). For the first time, ANCA 
(antineutrophil cytoplasmic antibody) was included in the 
classification.
Pulmonary involvement is typically seen with small- 
vessel vasculitis (SVV). SVV affects arterioles, venules, and 
capillaries. It is divided into antineutrophil cytoplasmic anti-
body (ANCA)-associated vasculitis (AAV) that includes 
microscopic polyangiitis, granulomatosis with polyangiitis 
(formerly Wegener), and eosinophilic granulomatosis with 
polyangiitis (formerly Churg-Strauss) [28]. The second 
group refers to immune complex SVV comprising among 
others antiglomerular basement membrane disease 
(Goodpasture) as the only one with regularly seen lung 
involvement. Behcet disease also belongs to immune 
complex- mediated vasculitis but involves variable vessel 
sizes (variable vessel vasculitis).
Clinical symptoms and radiologic signs [29] suggestive 
of pulmonary vasculitis include diffuse alveolar hemorrhage 
(DAH), acute glomerulonephritis, upper airway disease, 
lung nodules or cavitary nodules, mononeuritis multiplex, 
and palpable purpura [30]. Combined involvement of the 
lungs and kidneys by some of these diseases is also described 
as pulmonary-renal syndrome.
In addition to the abovementioned “primary pulmonary 
vasculitis,” there is pulmonary vasculitis associated with 
connective tissue disorders such as rheumatoid arthritis, 
SLE, and systemic sclerosis as well as sarcoidosis and relaps-
ing polychondritis. This type of vasculitis is considered “sec-
ondary vasculitis,” though the differentiation between 
primary and secondary becomes increasing “blurry” as more 
and more etiologies for secondary vasculitis are discovered 
(e.g., drug-associated immune complex vasculitis). 
Nevertheless they all have in common the involvement of the 
small vessels (>100 μm and <1 mm).
Diffuse alveolar hemorrhage (DAH) consisting of hemop-
tysis, diffuse alveolar infiltrates, and drop in hematocrit is a 
clinical syndrome and not a disease in itself. It occurs in all 
primary and secondary small-vessel vasculitides with capil-
laritis (GPA, EGPA, MPA, Henoch-Schonlein purpura, 
Behcet, SLE, and Goodpasture). It has to be differentiated 
from other conditions such as bland pulmonary hemorrhage 
(e.g., coagulation disorders, mitral stenosis, drug-induced, 
etc.) and hemorrhage associated with diffuse alveolar dam-
age (drug-induced, ARDS, bone marrow transplantation, or 
cocaine inhalation).
11.3.9  ANCA-Associated Granulomatous 
Vasculitis with Polyangiitis (GPA, 
Former Wegener’s Disease)
GPA is the most common of the AAV. It affects the sinuses, 
kidneys, and lungs resulting in the classic triad of symptoms 
comprising upper airway diseases (sinusitis, otitis, ulcer-
ations, subglottis, and bronchial stenosis), lower respiratory 
tract involvement (clinically presenting as hemoptysis, chest 
pain, dyspnea, and cough), and glomerulonephritis (present-
ing as hematuria and azotemia). However, at initial presenta-
tion patients may not have the full spectrum (limited 
expressions of GPA); on the other hand, any part of the body 
may be affected in the course of disease. Females and males 
are affected equally and at any age (mostly age 40–55). 
Airway involvement is more frequent in men. The most com-
mon cause of death is renal failure. With treatment, the 
24 months survival is 80%. The factors initiating disease are 
unknown; current data support the involvement of (recurrent) 
infection for GPA. Up to 80% of patients are (in the course of 
disease) ANCA positive (mostly PR3-ANCA). Histologic 
findings include necrotizing granulomatous vasculitis of 
small to medium vessels without associated infection.
Though a number of attempts have been made to define 
diagnostic criteria (e.g., ACR criteria, CCHC nomenclature), it 
can be difficult to reliably distinguish GPA from MPA. Patients 
are usually included in the GPA category, if they are ANCA 
positive and if they have respiratory tract involvement support-
ing GPA, even though there is lack of identifiable evidence of 
systemic vasculitis (no renal involvement).
The most frequently seen pulmonary abnormalities are 
multiple nodules or masses of varying size with or without a 
CT halo sign (perinodular hemorrhage). They tend to involve 
Key Point
• Small-vessel vasculitis is the most common to 
affect the lungs and primarily includes three dis-
eases: microscopic polyangiitis, granulomatosis 
with polyangiitis (formerly Wegener), and eosino-
philic granulomatosis with polyangiitis (formerly 
Churg-Strauss) [28]. Typical CT findings include 
multiple cavitating nodules and diffuse alveolar 
hemorrhage characterized by bilateral groundglass 
and consolidations.
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the subpleural regions; there is no predilection for upper or 
lower lung zones. Lesions can be as large as 10 cm; however 
most are smaller. Lesions are often cavitary and have thick 
walls. Peripheral wedge-shaped areas of consolidation 
resemble infarcts and may also cavitate. Diffuse consolida-
tion or ground-glass opacity is present in patients with pul-
monary hemorrhage. Focal fibrotic changes reflect prior 
episodes of active disease, although diffuse lung fibrosis may 
occasionally be seen (mostly UIP pattern). Superinfection of 
cavitating nodules is not uncommon. A reverse halo sign 
may also be seen, reflecting organizing pneumonia. A key 
feature of GPA is the rapid temporal evolution of the nodules 
and airspace opacities.
In addition there may be a concentric thickening of tra-
cheal or bronchial walls (in about 70%) with a reduction in 
the luminal diameter and associated with atelectasis (seen in 
about 15%). Bronchial abnormalities mainly involve the seg-
mental and subsegmental bronchi. Involvement of the sub-
glottic trachea is most typical.
The differential diagnosis depends upon the predominant 
manifestation. When nodules are the predominant feature, 
the differential diagnosis includes neoplasms (adenocarci-
noma, metastases, and lymphoma) and certain infections 
(fungal and mycobacterial infections). In the setting of air-
space consolidation, infection is also considered. When air-
way thickening is present, other considerations include 
amyloidosis, granulomatous disease, and relapsing poly-
chondritis for airway disease.
11.3.9.1  Eosinophilic Granulomatosis 
with Polyangiitis (EGPA, Former 
Churg-Strauss)
Eosinophilic granulomatous disease with polyangiitis (for-
merly called Churg-Strauss syndrome) is caused by a SVV 
that almost exclusively occurs in patients with asthma and is 
characterized by a marked serum eosinophilia. Clinically, 
radiologically, and pathologically, it combines features of 
GPA and eosinophilic pneumonia (allergic granulomatosis 
and angiitis) [31]. Many other organs may be involved 
including the heart (up to 47%), the skin (up to 40%), and the 
musculoskeletal system (up to 50%). Involvement of the 
peripheral nerves (in up to 75%) is more frequent, while 
renal involvement and pulmonary hemorrhage are less com-
mon than in GPA.
Up to 30% are ANCA positive mostly MPO-ANCA; 
ANCA positivity is higher in active disease. Biopsy 
Table 11.5 Classification of vasculitis according to the 2012 Chapel Hill Consensus conference (CHCC)
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confirmation is recommended in case of ANCA negativity 
(in up to 40%) and the presence of easily accessible lesions 
(e.g., skin). Histology demonstrates small-vessel (arteries 
and veins) vasculitis with eosinophilic infiltrates and vascu-
lar and extravascular granulomas. The 5-year survival is 
reported in up to 80% of patients; 50% of deaths are related 
to cardiac involvement. Clinically EGPA presents in three 
distinct phases (asthmatic, eosinophilic, and vasculitis 
phase), although these are not necessarily seen in that order. 
The asthmatic phase precedes the vasculitic phase by 
8–10 years.
Upper airway disease and pulmonary abnormalities are 
seen in up to 70% of patients with EGPA. The most com-
mon pulmonary findings include transient, multifocal, and 
non- segmental consolidations or ground-glass opacifica-
tions without zonal predilection [32]. The presence of 
(non- cavitating) small nodules or diffuse reticular opaci-
ties has also been reported. If located subpleurally, the 
consolidations mimic eosinophilic pneumonia. Pleural 
effusions are seen in about one third of patients due to car-
diomyopathy or eosinophilic pleuritis. Interlobular thick-
ening is seen in about 50% and is secondary to cardiogenic 
pulmonary edema, eosinophilic septal infiltration, or mild 
fibrosis.
Airway abnormalities are also an important thoracic man-
ifestation and include wall thickening, dilatation, small cen-
trilobular nodules, and mosaic perfusion. Bronchial wall 
thickening refers to eosinophilic and lymphocytic infiltration 
of the airway wall (the clinical symptom of asthma some 
time during disease course is obligatory for the diagnosis). 
Increased interlobular septa may reflect edema caused by 
cardiac and/or renal involvement or eosinophilic infiltration 
of the septa. Eosinophilic pleural effusion is seen in up to 
50% of patients.
Airway changes consisting tree-in-bud, bronchial wall 
thickening and bronchial dilatation are likely to be related to 
asthma and are seen in almost patients; the wall thickening 
can also be caused by eosinophilic involvement.
The differential diagnosis includes chronic eosinophilic 
pneumonia, organizing pneumonia, and simple eosinophilic 
pneumonia (Löffler syndrome) in airspace disease. In 
airway- dominant disease, the list is longer and includes 
EAA, MPA, SLE, infectious bronchiolitis, and asthma.
11.3.9.2  Microscopic Polyangiitis (MPA)
Microscopic polyangiitis (MPA) is a systemic necrotizing 
small-vessel vasculitis without granulomatous inflammation. 
Clinically it is characterized by a long prodromal phase with 
weight loss and fever followed by a rapidly progressive glo-
merulonephritis. Microscopic polyangiitis is the most com-
mon cause of pulmonary-renal syndrome: rapidly progressive 
glomerulonephritis is seen in up to 90% and pulmonary 
involvement in up to 30–50%. More than 75% of patients are 
ANCA positive in the course of disease, mostly MPO ANCA 
(in 35–65%).
Microscopic polyangiitis is characterized by the combi-
nation of glomerulonephritis and diffuse alveolar hemor-
rhage (DAH). Imaging findings include patchy, bilateral, or 
diffuse airspace opacities. The opacity can show both fea-
tures of consolidations and ground glass dependent on the 
amount of alveolar filling by blood. Typically DAH is more 
extensive in the perihilar areas, sparing lung apices, and the 
costophrenic angles. A halo surrounding a consolidation or 
nodule underlines the character of hemorrhage. During the 
phase of resorption, interlobular lines (crazy paving) may 
become more apparent.
Repeated hemorrhage leads to fibrosis with honeycomb-
ing, reticulation, and traction bronchiectasis. Interstitial lung 
disease may be seen in some patients, more frequently in 
MPA than in GPA.
11.3.10  Antiglomerular Basement 
Membrane Disease (Anti-GBM 
Disease)
Anti-GBM disease belongs to the group of immune com-
plex SVV and is characterized by circulating antibodies 
against an antigen intrinsic to the glomerular basement 
membrane. It results in necrotizing glomerulonephritis 
with acute renal failure. The diagnosis is usually made via 
renal biopsy. Diffuse alveolar hemorrhage (DAH) occurs in 
about 40–60%; isolated pulmonary involvement is 
extremely rare. The term Goodpasture syndrome is used for 
patients with glomerulonephritis and pulmonary hemor-
rhage irrespective of underlying cause, while the term 
Goodpasture disease is restricted to the combination of 
DAG, glomerulonephritis, and anti- GBM antibodies.
The serology comprises c-ANCA or p-ANCA positivity 
in 30% and anti-basement membrane antibodies in >90%. 
Young men are more often affected than women (M:F = 9:1), 
though it may also be seen in elderly women. With treatment 
the prognosis is good. Underlying pulmonary injury, e.g., by 
smoking or cocaine inhalation, is thought to predispose to 
pulmonary involvement. Recurrent episodes cause pulmo-
nary fibrosis.
Imaging features consist of diffuse or patchy ground 
glass or consolidation, due to the alveolar hemorrhage, 
that typically resolve within days. Typically there is spar-
ing of the subpleural space with predominance of the peri-
hilar areas in the mid- and lower lung zones. Pleural 
effusion is uncommon. After recurrent episodes traction 
bronchiectasis, reticular opacities and honeycombing may 
evolve.
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11.4  Miscellaneous Systemic Disorders
11.4.1  Inflammatory Bowel Disease
Ulcerative colitis and Crohn’s disease are associated with a 
wide variety of pulmonary complications [33]. Pulmonary 
complications may precede the diagnosis of inflammatory 
bowel disease or may occur years after the initial diagnosis 
and even after complete colectomy for ulcerative colitis. 
Indeed there is some suggestion that pulmonary complica-
tions may be more common after surgical treatment, perhaps 
because anti-inflammatory treatment is withdrawn. Both 
Crohn’s disease and ulcerative colitis can be associated with 
tracheobronchitis and airway stenosis [34]. Bronchiectasis 
and bronchial wall thickening are also common. Parenchymal 
abnormalities associated with inflammatory bowel disease 
include organizing pneumonia, pulmonary hemorrhage, and 
granulomatous infiltration in Crohn’s disease.
11.4.2  Amyloidosis and Light Chain 
Deposition Disease
Amyloidosis and light chain deposition disease are rare disor-
ders characterized by the extracellular deposition of proteins 
in one or more organs. They both share clinical, radiographic, 
and pathologic features. The main difference between these 
two entities is the Congo red staining and fibrillar structure on 
electron microscopy of amyloidosis. Both entities may be 
associated with a plasma cell dyscrasia.
Three radiographic manifestations of amyloidosis are 
described: nodular parenchymal, diffuse alveolar septal, and 
tracheobronchial [35]. The nodular parenchymal form pres-
ents radiographically as one or more solid lung nodules, 
often found incidentally. These may be confused with malig-
nancy, particularly when spiculated borders are present. A 
slow growth rate is typical, and calcification may be present. 
The diffuse alveolar septal form is characterized by the pres-
ence of widespread deposits throughout the lungs. The most 
common findings are small nodules (typically in a perilym-
phatic distribution), consolidation, ground-glass opacity, and 
reticulation. The presence of calcification associated with 
these abnormalities may be particularly suggestive. The tra-
cheobronchial form shows extensive thickening of the tra-
chea and/or bronchi with or without calcification.
The imaging findings of light chain deposition disease are 
less well described. There are two types: nodular and diffuse 
[36]. The nodular type presents with scattered solid nodules, 
often associated with cysts. The nodules are typically located 
within or adjacent to the wall of the cysts. The diffuse type 
may show diffuse small nodules, resembling the diffuse alve-
olar septal type of amyloidosis.
11.4.3  Erdheim-Chester Disease
Erdheim-Chester disease is an infiltrative disorder in which 
non-Langerhans’ cell histiocytes are found in one or more 
organ systems. The primary organs affected include bones, 
brain, kidneys, and the cardiovascular system. Middle-aged 
males are most commonly affected. While pathology is help-
ful in excluding lymphoproliferative malignancies, the 
pathologic findings may be nonspecific; thus typical radio-
graphic features are a key to appropriate diagnosis. 
Characteristic imaging findings [37] in the chest include 
periadventitial aortic soft tissue thickening. This thickening 
may involve the aorta and its main branches diffusely, giving 
rise to the term “coating” of the aorta. The most common 
lung finding seen is smooth interlobular septal thickening, 
resembling pulmonary edema. The most characteristic find-
ing outside of the chest is circumferential perinephric soft 
tissue, resembling lymphoma.
11.4.4  IgG4-Related Sclerosing Disease
IgG4-related sclerosing disease is a disorder originally 
thought to be isolated to the pancreas and previously called 
lymphoplasmacytic sclerosing pancreatitis. It is now recog-
nized as a systemic order associated with IgG4 plasma cells 
and fibrosclerosis in multiple organ systems. The primary 
organs involved include the pancreas, hepatobiliary system, 
salivary glands, and lymph nodes. The findings in the chest 
are variable and may include nodules, lymphadenopathy, air-
way thickening, and pleural abnormalities [38]. Also, it is 
possible that IgG4-related sclerosing disease may account 
for a proportion of cases of idiopathic interstitial 
pneumonias.
11.5  Conclusions
Systemic disorders demonstrate a wide variety of manifesta-
tions in the chest. Imaging, and in particular computed 
tomography, plays a critical role in the diagnosis of these 
disorders, however the imaging findings must be correlated 
with the typical clinical manifestations affecting multiple 
organ systems. An in-depth knowledge of both typical and 
atypical imaging features is critical in the multidisciplinary 
diagnosis and follow-up of patients with these diseases.
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Both blunt and penetrating traumas commonly affect the tho-
rax, blunt trauma occurring predominantly as the result of 
motor vehicle collisions. The thorax is the fourth most 
injured area in unrestrained motor vehicle passengers but is 
the most commonly injured area in individuals who are 
restrained by a seat belt [1]. Other common causes of blunt 
thoracic trauma include falls from heights of greater than 10 
feet and motor vehicle collisions involving pedestrians/
bicyclists.
While not as common as blunt thoracic injury, penetrating 
thoracic trauma is not rare. Records from the Centers for 
Disease control (CDC) show that in 2016, the deaths from 
gunshot wounds in the United States were comparable to the 
number of deaths from motor vehicle accidents (MVAs). 
Tissue damage from these injuries may be complex and is 
dependent not only on the trajectory of the projectile but 
upon the pressure gradient that radiates laterally from the 
tract causing temporary cavitation within adjacent tissue [2]. 
In both blunt and penetrating trauma, radiologists’ familiar-
ity with typical injury patterns assists with rapid diagnosis 
and treatment.
While the initial screening test in thoracic trauma is the 
frontal chest radiograph obtained in the trauma bay, in many 
emergency rooms, this is accompanied by E-FAST (extended 
focused assessment with sonography in trauma) performed 
by non-radiologists. In addition to detecting intraabdominal 
trauma, this study can detect important thoracic injuries, spe-
cifically pneumothoraces, hemothoraces, and hemopericar-
dium. Patients with large hemothoraces or hemopericardium 
can be directed to emergent surgery, while the remaining 
patients with significant trauma mechanism should usually 
be further evaluated by CT [3]. Among patients with pene-
trating trauma, CT with multiplanar reconstructions is par-
ticularly useful to determine the trajectory of a bullet through 
the chest and identify injured organs. Used in hemodynami-
cally stable patients, CT can accurately identify those 
patients that can be managed nonoperatively, reported nega-
tive predictive values as high as 99% [4].
12.1  Acute Traumatic Aortic Injury
Acute traumatic aortic injury (ATAI) is a common cause of 
prehospital mortality in MVAs, accounting for approxi-
mately 15–20% of deaths in high-speed collisions. Of indi-
viduals with ATAI, 70–90% die at the trauma scene [5]. Most 
of the surviving 10–20% individuals with ATAI from blunt 
trauma undergo CT imaging. Patients with penetrating aortic 
trauma who reach the hospital usually proceed to surgery 
without intervening imaging.
Decision rules using clinical parameters for predicting 
ATAI have had very limited success. An initial case control 
study restricted true positive cases to those confirmed by sur-
gery or conventional angiography. In that population, the 
Learning Objectives
• Understand how the CT spectrum of ATAI influ-
ences treatment decisions.
• Know the imaging appearance of the most common 
survivable cardiac injuries.
• Describe the differences in imaging findings 
between blunt and penetrating diaphragm injuries.
• Know the coexisting injury patterns associated with 
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likelihood of ATAI was approximately 5% if three clinical 
predictors were present and 30% if four or more predictors 
were present. A more recent case control validation study 
performed by the same group in the era of CT angiography 
identified only four composite clinical criteria that were pre-
dictive of ATAI (abdominopelvic injury, thoracic injury, 
hypotension, and history of MVA while unrestrained). The 
likelihood of ATAI in patients with three or four of these cri-
teria was only 2%, much lower than the derivation study, and 
is probably more relevant to current clinical practice [6].
Among patients surviving to reach the hospital, 90% of 
blunt aortic injuries are seen at the level of the aortic isthmus, 
which extends from the origin of the subclavian artery 
approximately 2 cm to the insertion of the ligamentum arte-
riosum. The propensity for injury to occur at this location is 
incompletely understood, and multiple mechanisms have 
been proposed. The ascending aorta is injured in less than 
5% of blunt ATAI victims who survive transport, but injuries 
at that site are more common at autopsy series [5]. Ascending 
aorta injuries are frequently (80%) associated with signifi-
cant cardiac damage, including damage to the aortic valve or 
pericardial tamponade. Traumatic aortic injuries located at 
the diaphragmatic hiatus account for less than 2% of cases.
The continuous motion of the heart during cross-sectional 
scanning leads to motion artifacts of the ascending aorta that 
can have the appearance of aortic dissection or pseudoaneu-
rysm in non-cardiac-gated acquisitions, even with current 
rapid acquisition multidetector CT scanners. These artifacts 
can often be differentiated from intimal flaps, appearing less 
distinct and sometimes extending outside the vessel wall.
Because less than 5% of surviving patients will have an 
ascending aortic injury, the benefit of gated cardiac CT at 
initial presentation is limited. Most patients with ATAI are 
too unstable to undergo prolonged imaging, and thus evalua-
tion of the aorta with standard, nongated contrast-enhanced 
CT is generally preferred. In patients whose initial CT con-
tains artifacts closely mimicking aortic root injury, cardiac- 
gated CT can be performed.
Transesophageal echocardiography is a potential alterna-
tive to CTA for exclusion of ATAI if there are no contraindi-
cations, such as vertebral body fracture or severe maxillofacial 
injury. The disadvantages of transesophageal echocardiogra-
phy include the logistical time required to perform the study 
and its user dependence as well as inability to evaluate the 
remainder of the thorax.
ATAI ranges from intimal hemorrhage to complete tran-
section. The adventitia may be injured in up to 40% of cases 
and is almost universally fatal because of rapid exsanguina-
tion, although in rare cases, temporary tamponade may be 
achieved by surrounding mediastinal soft tissues. Historically, 
of those patients who survive to the hospital after aortic rup-
ture, 22% die during initial resuscitation, 28% die during or 
shortly after surgical repair, and 14% develop subsequent 
paraplegia [7]. Shift of current practice to endovascular 
stenting has been associated with post-procedure mortality 
rates <10% and a decrease in the incidence of paraplegia to 
<2% [8].
12.1.1  Radiography
Although the principal purpose of the trauma bay chest 
radiograph is the rapid detection of pneumothorax and hemo-
thorax, it can also be assessed for evidence of a mediastinal 
bleeding. This bleeding can be seen secondary to ATAI, ster-
nal/thoracic spine fracture, or small artery or vein damage 
within the mediastinum. The resulting mediastinal blood can 
be free or partially free flowing (associated with small medi-
astinal vessel rupture) or form a contained hematoma which 
is more concerning for an ATAI.
The negative predictive value of a properly obtained chest 
radiograph may be as high as 93–98%, but consideration of 
mechanism severity is important before ATAI can be 
excluded. The positive predictive value of an abnormal 
radiograph remains low, only 15%. Specificity of mediasti-
nal widening is degraded by mediastinal fat, vascular con-
gestion, anomalous vessels, and rotation. When the right 
paratracheal region is equal to or more opaque than the aortic 
arch or a left apical cap is present, mediastinal widening is 
more likely to represent a free-flowing mediastinal blood [9].
Radiographic findings more suggestive of a contained 
aortic rupture include rightward deviation of an enteric tube, 
rightward deviation of the trachea, downward displacement 
of the left main bronchus, loss of aortic arch definition, 
increased aortic arch opacity, and increased width and opac-
ity of the descending aorta [9].
12.1.2  Computed Tomography
Multidetector helical CT is a very sensitive diagnostic tool 
for exclusion of ATAI, often quoted as the gold standard for 
ATAI detection [10]. A morphologically normal aorta with 
no mediastinal hematoma has a 100% negative predictive 
value for exclusion of ATAI. The positive predictive value of 
an equivocal study (i.e., para-aortic hematoma only) is 
uncertain; these studies require additional imaging or clini-
cal follow-up. Mediastinal hematomas not in contact with 
the aorta, but located in the anterior or posterior mediasti-
num, are more likely to be related to chest wall or spinal 
fractures [11]. If the patient is a victim of penetrating trauma 
with a wound trajectory passing near the aorta, a repeat CTA 
should be obtained in 24–48 h.
The direct signs of ATAI on CT include aortic wall or con-
tour abnormality (pseudoaneurysm) contrast extravasation 
(Fig. 12.1), polypoid intraluminal clot or low-density filling 
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defect, change in caliber of the aorta (i.e., pseudocoarcta-
tion), and dissection [10]. The least severe injury, intimal 
tear, appears on contrast-enhanced CT as either a rounded or 
triangular intraluminal filling defect attached to the wall of 
the aorta.
Recently the surgical treatment of ATAI has become more 
nuanced, and reporting of ATAI should include details useful 
for surgical decision-making. Initially nonoperative therapy 
was focused on “minimal” aortic injuries that were some-
times described as small (<1 cm) intimal flaps (Fig. 12.2). 
More recently initial nonoperative therapy has been extended 
to intimal injuries extending over more than 1  cm and to 
intramural hematomas [12]. These intramural hematomas 
may involve the entire circumference of the aortic wall or 
occur within a portion of the aortic wall, such that the high- 
attenuation thrombus appears crescentic in shape. Neither 
intimal injuries nor intramural hematomas, classified as 
grade I and II in the surgical literature, are accompanied by 
an abnormal outer contour of the aorta. If initial management 
is nonoperative, follow-up CT imaging is necessary. Exact 
timing of follow-up is not well established, but a reasonable 
approach would be a repeat CT in 36–72 h and then again in 
several weeks if stable [13]. A minority of these injuries 
demonstrate progression on follow-up CT imaging, at which 
time endovascular stenting can be performed if necessary.
Unlike lower-grade injuries described above, pseudoan-
eurysm do cause an abnormal outer contour abnormality. 
Small pseudoaneurysms (less than 1 cm in length and less 
than 50% of the aortic diameter) may also be initially treated 
nonoperatively in hemodynamically stable patients 
a c
db
Fig. 12.1 Traumatic aortic injury. (a) AP chest radiograph shows wid-
ened mediastinum and indistinctness of aortic arch contour. (b, c) Axial 
(b) and sagittal (c) contrast-enhanced CT demonstrates disruption of 
the proximal descending thoracic aortic wall contour with contrast 
extravasation indicating aortic rupture. (d) AP chest radiograph follow-




Fig. 12.2 Minimal traumatic aortic injury. (a, b) Axial (a) and coronal (b) contrast-enhanced CT demonstrates an intimal flap involving the proxi-
mal descending thoracic aorta
a c
b
Fig. 12.3 Minimal traumatic aortic injury. (a) Axial contrast-enhanced 
CT demonstrates a small pseudoaneurysm arising from the undersur-
face of the aortic arch. (b, c) 2 weeks following presentation, axial (b) 
and sagittal (c) contrast-enhanced CT show no change in small 
pseudoaneurysm
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(Fig.  12.3). Those pseudoaneurysms that involve greater 
than 50% of the aortic circumference or are accompanied by 
an adjacent mediastinal hematoma >15  mm thick are at 
higher risk for progression and may be difficult to differenti-
ate from aortic ruptures. These injuries warrant more urgent 
intervention. True thoracic aortic rupture/transection remains 
a surgical emergency.
12.2  Great Vessel and Supra-aortic Branch 
Vessel Injury
Injuries to the superior and inferior vena cava, the pulmonary 
artery, and the pulmonary veins are commonly associated 
with other severe, non-survivable injuries and therefore are 
rarely imaged. When encountered, SVC ruptures are associ-
ated with right atrial rupture and azygous vein ruptures and 
are accompanied by mediastinal hematoma [14]. Blunt 
trauma injuries to the supra-aortic branch vessels, the bra-
chiocephalic artery (right subclavian/right common carotid), 
left common carotid artery, and the left subclavian artery are 
also uncommon. In one retrospective series of blunt trauma, 
ATAI made up 84% of the vascular injuries, isolated branch 
vessel injury 14%, and combined injuries only 4% [15].
Penetrating trauma with potential injury to the great vessels 
and supra-aortic vessels often involves a transmediastinal tra-
jectory of the projectile. These are frequently severe injuries, 
and hemodynamically unstable patients usually proceed to 
surgery with minimal imaging. Patients who are hemodynam-
ically stable may undergo echocardiography or E-Fast exam 
followed by CTA. Since transmediastinal penetrating trauma 
can involve the esophagus and tracheobronchial tree, exams 
optimally include upper alimentary tract contrast (see below).
12.2.1  Radiography
The screening trauma radiograph is unlikely to aid in the 
diagnosis of great vessel and supra-aortic branch vessel 
injury, other than to identify ballistic trajectory in the setting 
of penetrating trauma. As in ATAI, a mediastinal hematoma 
is usually present.
12.2.2  Computed Tomography
Similar to the setting of ATAI, CT may demonstrate intimal 
flaps and pseudoaneurysms. Alternatively, subtle findings, 
such as asymmetric vascular caliber or decreased contrast 
enhancement, may provide evidence of vascular injury. 
Although multidetector CT scans are likely to detect a trau-
matic injury to the supra-aortic branch vessel, catheter angi-
ography maintains a role in confirming injury [15].
CT findings caused by penetrating vascular trauma 
include those signs of injury described above, as well forma-
tion of arteriovenous fistula. Additional indirect findings 
include proximity to ballistic fragments and end organ 
infarcts due to peripheral embolization of intraluminal 
thrombus. As for blunt injuries, many vessel abnormalities 
seen on CTA warrant catheter-directed angiography for con-
firmation and possible treatment.
12.3  Cardiac Injury
Significant cardiac injuries are uncommon in blunt trauma 
victims surviving to reach the emergency department. 
Autopsy data indicate that numerous prehospital deaths 
result from traumatic cardiac or valvular rupture. Penetrating 
injury to the heart is traditionally suspected when wounds 
penetrate the “cardiac box,” an area on the anterior thorax 
bounded by the clavicles, the midclavicular lines, and the 
costal margin where intersected by the midclavicular lines. 
Recent literature has defined the cardiac box in three dimen-
sions, extending anterior-posterior, particularly in the left 
hemithorax.
Blunt cardiac injury can cause cardiac contusion and 
more critical injuries specifically pericardial, myocardial, or 
valvular rupture. Myocardial injuries most commonly 
involve the right ventricular free wall, while valvular injuries 
more commonly occur in the left-sided chambers, likely 
related to higher transvalvular pressures. The most innocu-
ous and most common of these injuries, cardiac contusion, is 
usually diagnosed based on troponin levels and ECG find-
ings. Although CT can reveal multiple ancillary signs of car-
diac contusion, myocardial enhancement is an insensitive 
indicator and should not be used to rule out cardiac injury 
[16]. Echocardiogram and occasionally MRI may aid diag-
nosis of cardiac contusion by evaluating for wall motion 
abnormalities.
Hemopericardium may be the result of cardiac chamber 
rupture (usually fatal prior to arrival in the hospital), myocar-
Key Points
Report Elements to Include on CTAs Positive for TAI
• Presence of intimal flap and its length
• Presence of endoluminal thrombus
• Presence of outer contour abnormality
 – Extent of involvement of the aortic circumfer-
ence (e.g., <50%)
 – Length of abnormality along the axis of the aorta 
(e.g., <1 cm)
• Distance of proximal extent of injury from the sub-
clavian artery (relevant for TEVAR)
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dial contusion, aortic root injury, coronary lacerations, or 
damage to the small surrounding pericardial vessels such as 
those damaged from displaced rib fractures. Pericardial rup-
ture is a rare injury. It commonly occurs on the left side, 
often along the course of the phrenic nerve, and can be 
accompanied by tears of the adjacent pleura or diaphragm. 
Such injuries become hemodynamically significant when the 
heart herniates through the tear, impeding cardiac filling and 
potentially causing coronary vessel occlusion. The proposed 
mechanism of injury for pericardial rupture likens the injury 
to a pendulum since the inferior portion of the heart is free 
floating without significant attachments. In the setting of a 
lateral deceleration injury, the heart presumably collides 
with the adjacent pericardium, creating the rupture [17]. 
Cardiac herniation through a pericardial defect may not be 
present initially and may occur after the administration or 
discontinuation of positive-pressure ventilation.
The most commonly ruptured cardiac chamber in the 
autopsy of blunt trauma victims is the right ventricle, while 
the atria are the most commonly ruptured chambers in indi-
viduals who survive to hospitalization. Penetrating trauma 
most commonly affects the right ventricle, followed in fre-
quency by the left ventricle. Right ventricle and right atrial 
wounds are more likely to be survivable than left-sided 
chambers. Unfortunately, the increased relative incidence of 
gunshot wounds compared to stabbing injuries over the last 
two decades has been associated with multichamber cardiac 
injuries, which have a much lower survival rate.
12.3.1  Radiography
Hemopericardium may or may not be evident on chest radio-
graph at presentation. Chest radiography may show an 
unusual position or configuration of the heart if cardiac her-
niation is present. As noted above, in the setting of penetrat-
ing trauma, chest radiographs can yield important clues to 
the projectile’s trajectory.
12.3.2  Computed Tomography
Most patients who have a mechanism of injury sufficient to 
produce hemopericardium are imaged with CT if stable. 
Simple fluid should demonstrate attenuation values of 0–10 
HU, whereas hemopericardium will have attenuation values 
in the 35 HU range. The rapid accumulation of hemopericar-
dium may result in cardiac tamponade, the diagnosis sug-
gested when CT demonstrates a triad of high-attenuation 
pericardial effusion, distention of the inferior vena cava and 
renal veins, and periportal low-attenuation fluid. 
Hemopericardium is visible on nearly all CT scans in cases 
of pericardial rupture. Not all pericardial tears are associated 
with cardiac herniation; the chest radiograph and CT scan 
may be unrevealing. Pericardial rupture is diagnosed on CT 
by the presence of a focal pericardial defect with a collar sign 
of herniated cardiac tissue. The presence of adjacent pneu-
mothorax, pneumomediastinum, or both may complicate the 
diagnosis if the pericardium is mistaken for the pleura.
CT does not play a diagnostic role in patients with pen-
etrating injury that are either hemodynamically unstable or 
demonstrate hemopericardium on ultrasound. As with 
transmediastinal penetrating injuries, CT may be useful in 
establishing bullet trajectory in hemodynamically stable 
patients and suggest occult cardiac injury based on the pro-
jectile track or the presence of ballistic fragments. CT may 
demonstrate occult cardiac trauma in 3–4% of hemody-
namically stable patients with penetrating thoracic trauma, 
usually by demonstrating hemopericardium or pneumo-
pericardium [18].
12.4  Pneumomediastinum
Pneumomediastinum is present in 10% of patients with blunt 
thoracic injury and is most commonly secondary to the 
Macklin effect [19]. This is the process by which air dissects 
along bronchovascular bundles after alveolar rupture and 
spreads to the mediastinum. Mediastinal air may also occur 
from the extension of subcutaneous or deep cervical emphy-
sema. Direct extension of retroperitoneal air to the mediasti-
num occurs via periesophageal and periaortic fascial planes 
and at the level of the sternocostal attachment of the dia-
phragm [9].
12.4.1  Radiography
Pneumomediastinum can be identified on the chest radio-
graph by visualization of lucency along the pericardium and 
lateral mediastinum outlined laterally by the pleura [9]. 
Pneumomediastinum may be difficult to differentiate from 
medial pneumothorax; this can best be done by searching for 
other manifestations of the two entities. Air within the medi-
astinum characteristically outlines other structures so that 
they are more conspicuous than usual. These include the 
“ring around the artery sign” (air surrounds right pulmonary 
artery), “tubular artery sign” (air outlines supra-aortic ves-
sels), and “double bronchial wall sign” (air outlines the outer 
contour of a major bronchus) [20]. Air posterior to the peri-
cardium yields the continuous diaphragm.
Differentiation of pneumomediastinum from pneumoperi-
cardium on radiography relies on recognition that air is not 
confined to the limits of the pericardium, an assessment most 
L. Ketai and S. L. Primack
145
commonly confirmed by identifying subcutaneous emphysema 
in the neck. An additional pitfall is the error in perception 
caused by Mach effect, which causes an apparent lucency sur-
rounding the convexity of the heart border that mimics pneu-
momediastinum. The absence of an adjacent opaque pleural 
line usually differentiates this from true pneumomediastinum.
Pneumomediastinum typically resolves with time. Serious 
complications, such as tension pneumomediastinum, are rare. 
Failure of resolution or lack of improvement with time raises 
the suspicion of tracheobronchial or penetrating esophageal 
injury. Esophageal rupture from blunt trauma is rare.
12.4.2  Computed Tomography
CT can prove the presence of Macklin effect by demonstrat-
ing the triad of a bronchus, a pulmonary vessel, and an addi-
tional adjacent air collection (Fig.  12.4). The presence of 
Macklin effect does not exclude the possibility of a tracheo-
bronchial or esophageal injury, though both are unlikely if 
the resulting pneumomediastinum is confined to the anterior 
compartment. The absence of the Macklin effect calls for 
increased scrutiny of the CT images to identify signs of 
esophageal or airway injury (see below).
12.5  Esophageal Injury
Esophageal injuries caused by non-iatrogenic trauma are 
rare but potentially catastrophic. Mortality for undiagnosed 
rupture after 24  h is 10–40%. Chest radiograph findings 
include pneumomediastinum and pleura effusions, left sided 
if the lower third of the esophagus is injured, right side if 
upper two thirds is injured. Fluoroscopic esophagography is 
moderately sensitive, e.g., 75%, and very specific but can be 
technically difficult to perform in critically ill patients. CT 
esophagography (CTE) performed after ingestion or instilla-
tion of contrast and effervescent granules was shown to be 
100% sensitive in detecting injury in a small group of 
patients. A more recent study following a similar protocol 
with the exception of effervescent granules has reported a 
sensitivity near 80%. In the setting of penetrating trauma, 
concomitant performance of CTA and CTE may diminish 
specificity [21].
12.6  Airway Injury
Tracheobronchial injuries include mucosal tears and com-
plete transection of the airway. These are uncommon inju-
ries, occurring in 1–3% of patients with blunt thoracic 
trauma.
12.6.1  Radiography
The radiographic manifestations of tracheobronchial injury 
are usually nonspecific and include pneumomediastinum, 
pneumothorax, deep cervical emphysema, and subcutaneous 
emphysema. Injuries to the trachea or proximal left main 
bronchus typically result in pneumomediastinum but not 
pneumothorax. The fallen lung sign is specific to bronchial 
fracture. This sign describes the lung “falling” dependently, 
rather than collapsing centrally toward the hilum in the pres-
ence of a pneumothorax.
Tracheal or bronchial tear should be suspected with per-
sistent or increasing soft tissue emphysema, or if pneumo-
thorax persists despite continuous chest tube drainage. 
Extraluminal position of the endotracheal tube and cuff over-
inflation also indicate tracheal injury [22].
12.6.2  Computed Tomography
Approximately 75% of tracheobronchial injuries occur 
within 2 cm of the carina. Right main bronchus injuries gen-
erally occur closer to the carina (usually within 2.5 cm) than 
injuries to the left main bronchus, and the right main bron-
chus is injured more frequently than either the trachea or the 
left main bronchus. While CT can readily demonstrate sec-
ondary signs of trachea bronchial injury (pneumomediasti-
num and pneumothorax), older literature demonstrated 
relatively low sensitivity in detection of direct evidence of 
Fig. 12.4 Pneumomediastinum due to Macklin effect following gun-
shot wound to the right lung. Axial CT demonstrates extensive pneumo-
mediastinum secondary to alveolar rupture. Note peribronchovascular 
interstitial air in the right lower lobe. Macklin effect is most commonly 
related to blunt trauma or barotrauma
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tracheobronchial injuries [23]. Direct visualization of a tear 
on CT can be difficult and best accomplished using thin (<3- 
mm) collimation (Fig. 12.5). More recent small series using 
thinner collimation have reported sensitivities >90% [24]. 
Nevertheless complications of tracheobronchial injury can 
be severe, including bronchopleural and tracheoesophageal 
fistulas, and chronic tracheal or bronchial stenosis leading to 
postobstructive pneumonia and bronchiectasis. Accordingly, 
a high index of suspicion and liberal use of bronchoscopy are 
important for the prompt diagnosis of tracheobronchial 
injury.
12.7  Pulmonary Contusion
Pulmonary contusion is seen in 30–70% of patients with blunt 
thoracic injury [1, 25]. It is the most common cause of pulmo-
nary parenchymal opacification on chest radiography in blunt 
thoracic trauma. Short-term morbidity is substantial, and clini-
cal signs and symptoms include hypoxia, mild fever, hemopty-
sis, and dyspnea. Acute respiratory failure may develop, 
requiring intubation and mechanical ventilation. Contusion 




Fig. 12.5 Left bronchial tear. (a) AP chest radiograph shows extensive 
predominantly left-sided subcutaneous air, pneumomediastinum and 
left rib fractures. (b) CT at the level of the main bronchi shows exten-
sive pneumomediastinum, left pneumothorax and subcutaneous air. (c) 
CT inferior to the level of (b) demonstrates complete disruption of left- 
sided airways. At surgery, there was near complete disruption of the 
distal left main bronchus with tear extending into the left upper and lobe 
bronchi
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Pulmonary contusion represents pulmonary hemorrhage 
and edema from disruption of the alveolar capillary mem-
brane [9]. It is often caused by a direct blow to the chest wall 
with injury of the adjacent lung and may be accompanied by 
contrecoup injuries. Contusion is frequently seen where the 
lungs have been compressed against the denser heart, liver, 
chest wall, and spine. In deceleration injuries, such as motor 
vehicle accidents, the alveolar capillary membrane is 
 disrupted as the lower-density alveoli shear from the higher- 
density bronchovascular bundles [9, 26].
12.7.1  Radiography
Pulmonary contusions can manifest as focal, patchy, or dif-
fuse ground-glass opacities or parenchymal consolidation. 
These opacities cross fissural boundaries and are often pres-
ent at the site of impaction and adjacent to rib fractures. The 
lung bases are most frequently affected secondary to 
increased basilar mobility [9]. Air bronchograms are usually 
absent owing to blood filling the airways.
Pulmonary parenchymal contusion follows a predictable 
temporal pattern on imaging. Contused lung may not be 
apparent on initial chest radiography but is usually present 
within 6 h after the inciting injury. Conspicuity of pulmonary 
opacities peaks at 24–72  h and gradually diminishes over 
1 week although severe contusions may be radiographically 
evident for 2 weeks. Persistence beyond this duration should 
prompt consideration of other pulmonary diseases, such as 
pneumonia, atelectasis, aspiration pneumonitis, and hydro-
static or noncardiogenic pulmonary edema.
12.7.2  Computed Tomography
CT is superior to chest radiography in the detection of pul-
monary contusion, but the clinical utility of this higher sensi-
tivity is likely low. Contusions visible on CT but not on chest 
radiograph are associated with low mortality and low likeli-
hood of requiring mechanical ventilation, both <5%. 
CT-based quantification of more extensive contusions may 
be helpful in predicting respiratory complications [27]. For 
example, the likelihood of development of ARDS is much 
higher in those patients with contusion involving >20% of 
the lung. CT may also be helpful in distinguishing acute 
aspiration from contusion, tree in bud opacities being present 
in the former and absent in pulmonary contusions. CT dem-
onstration of subpleural sparing by parenchymal opacities 
(Fig. 12.6) has been shown to accurately differentiate pulmo-
nary contusions from pneumonia and atelectasis in children.
12.8  Pulmonary Laceration and Traumatic 
Lung Cyst
Lacerations of the lung parenchyma cause traumatic lung 
cysts that may be filled with air (pneumatocele), blood 
(hematoma), or both. Several mechanisms of injury in 
blunt trauma have been proposed based on CT and surgical 
findings. Type 1, the most common type, occurs when a 
sudden compressive force causes alveolar rupture. Type 2 
results from shear injury of the lower lung near the spine 
as a compressive force causes the lung to shift across the 
vertebral column. Type 3 manifests as lung cysts near the 
chest wall adjacent to a rib fracture fragment that has 
directly punctured the pulmonary parenchyma. Type 4 
occurs when previously formed pleuropulmonary adhe-
sions tear the lung after sudden movement or fracture of 
the attached chest wall.
12.8.1  Radiography
In approximately half of the cases, pulmonary lacerations are 
obscured by the consolidation related to pulmonary contu-
sion on the initial chest radiograph. As the lung contusion 
resolves, pulmonary lacerations become visible as thin- 
walled cystic spaces or as soft tissue nodules (pulmonary 
hematomas). Radiographic resolution of traumatic lung cysts 
occurs over weeks to months. Uncommonly, the cysts persist 
for years. If clot remains in the cavity, these cysts can be 
mistaken for pulmonary nodules, and air-filled cavities may 
mimic other forms of cystic lung disease. Knowledge of pre-
vious trauma is important in correctly differentiating between 
these entities.
Fig. 12.6 Pulmonary contusion. Axial CT demonstrates peripheral 
homogeneous ground-glass opacity anteriorly in the right middle lobe. 
Note the thin region of subpleural sparing
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12.8.2  Computed Tomography
On CT imaging, traumatic lung cysts manifest as ovoid 
structures secondary to the elastic recoil of the lung [9]. 
Blood may completely fill the cavity causing an ovoid pul-
monary hematoma or can partially fill the cavity, causing an 
air-fluid level is present. Large cystic spaces may be present, 
or blunt trauma can create multiple, small, air-filled lung 
cysts sometimes referred as “pulverized” or “Swiss cheese” 
appearance of the lungs [26]. The most common complica-
tion associated with a pulmonary laceration from blunt is a 
pneumothorax, and, while rare, other complications of 
 traumatic lung cysts include infection with formation of a 
pulmonary abscess and the development of a bronchopleural 
fistula.
Lung lacerations commonly occur secondary to penetrat-
ing trauma and can manifest as linear lung defects along the 
projectile track or as round or oval air cysts. Like blunt 
trauma, penetrating trauma to the lungs usually can be man-
aged with chest tube placement. Occasionally treatment of 
bronchopleural fistula or hemorrhage requires surgery, most 
commonly pneumonorraphy, tractotomy, or wedge resec-
tion, rarely lobectomy or pneumonectomy [28].
12.9  Hemothorax
Hemothorax occurs in approximately 50% of blunt thoracic 
trauma. Intrathoracic blood may arise from any surrounding 
structures, including the lung, mediastinum, thoracic wall, 
and diaphragm [26]. Hemothoraces may be large and increase 
rapidly if the bleeding source is arterial. Delayed hemothorax 
occurs rarely but is more common in patients with multiple 
rib fractures and/or flail chest. It presents as new onset sharp 
pleuritic chest pain and dyspnea. Occasionally, intraperito-
neal blood migrates to the pleural space via diaphragmatic 
defects or rupture of the diaphragm.
12.9.1  Radiography
Small hemothoraces may be missed easily on chest radiogra-
phy. On the supine radiograph, the apex is the most depen-
dent portion of the pleural space, and fluid should be 
suspected if an apical cap is seen. Larger amounts of fluid 
will extend inferiorly along the lateral chest wall. On supine 
radiographs fluid also may manifest as a hazy opacity of the 
lower or entire hemithorax.
12.9.2  Computed Tomography
Hemorrhage within the pleural space typically can be dif-
ferentiated from simple fluid or chyle by its relatively high, 
and often heterogeneous, attenuation, usually 35–70 HU. On 
contrast-enhanced CT, fluid with attenuation within 10–15 
HU of vascular structures suggests active extravasation. 
Occasional findings include fluid-hematocrit levels and 
coalescence of blood clots that may mimic pleural-based 
tumors. CT can also be useful in quantifying retained hemo-
thoraces, which are associated with high rates of pneumonia 
and empyema. Volume of residual hemothorax can be esti-
mated by the following formula: volume  =  maximal 
length × (maximal distance from lung to pleural surface) [2]. 
Residual hemothorax >300 cc usually requires video-assisted 
thoracoscopy (VATS) or thoracotomy [29].
12.10  Pneumothorax
Pneumothorax is a common sequela of blunt chest trauma. 
Mechanisms include rupture of the alveoli and dissection 
through the interstitium to the pleural space, lung puncture 
from rib fracture fragments, tracheobronchial injury, and 
extension of pneumomediastinum through a tear in the pari-
etal pleura [9, 25]. Small pneumothoraces can expand rap-
idly in patients receiving positive-pressure ventilation.
12.10.1  Radiography
The definitive radiographic finding of pneumothorax, a thin 
pleural line seen when air is present on either side of the 
visceral pleura, is often absent on supine radiographs. On 
supine radiographs air often accumulates in the anterome-
dial recess, the least dependent aspect of the pleural space 
Key Points
Acute Lung Parenchymal Trauma
• Pulmonary contusion
 – Peak extent in 24–72 h
 – Peripheral, nonanatomic opacities, sometimes 
with immediate subpleural sparing
• Lung lacerations
 – Pneumatoceles appear as thin-walled cystic 
spaces.
Unilocular or multilocular
With or without air-fluid levels
 – Hematomas manifest as soft tissue masses that 
may persist for months.
• Acute aspiration
 – Tree in bud opacities, dependent lung or diffuse
 – May progress to ARDS
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and in the subpulmonic recess. Signs of anteromedial pneu-
mothorax include sharp delineation of the mediastinal struc-
tures, outlining of the medial diaphragm beneath the heart, 
and a deep anterior cardiophrenic sulcus. A subpulmonic 
pneumothorax manifests as a hyperlucent upper abdominal 
quadrant, deep lateral costophrenic sulcus, and visualization 
of the anterior costophrenic sulcus and inferior surface of 
the lung. Subcutaneous air coupled with rib fractures indi-
cates the presence of pneumothorax even if pleural air is 
radiographically occult.
Tension pneumothorax is a life-threatening condition that 
occurs when intrathoracic pressure exceeds atmospheric 
pressure, causing hemodynamic compromise. Mild 
 mediastinal shift is commonly present in the absence of ten-
sion, since the negative pleural pressure in the unaffected 
hemithorax will always be lower than in the pleural space 
affected by the pneumothorax. The most specific radiographic 
finding of tension pneumothorax is depression or inversion of 
the diaphragm, which indicates that pleural pressure has 
exceeded subdiaphragmatic pressure [9].
12.10.2  Computed Tomography
CT is much more sensitive than radiography in the detection 
of pneumothoraces, 30% of which are missed on supine and 
semirecumbent chest radiographs [9]. Prospective study has 
suggested that many pneumothoraces seen on CT only may 
be managed without tube thoracostomy, even if on positive 
pressure ventilation [30]. Risk of tension pneumothorax has 
diminished with the current use of lower tidal volumes for 
mechanical ventilation, but this complication can still occur.
12.11  Traumatic Diaphragmatic Injury
Traumatic diaphragmatic tears can result from penetrating or 
blunt injury. Penetrating diaphragmatic injury is twice as 
common as blunt injury. Diaphragmatic rupture occurs in 
0.8–8% of all patients with major blunt trauma [9]. Detection 
of diaphragmatic injury requires a high index of suspicion 
since masking of the injury by pleural fluid or pulmonary 
contusion may delay diagnosis. In addition, diaphragmatic 
injury is associated with other major traumatic injuries, 
including pneumothorax, hepatic and splenic lacerations, 
and pelvic fractures, which may distract from identification 
of diaphragmatic injury [31].
12.12  Mechanism of Injury
Blunt frontal impact can cause sufficient increase in intraab-
dominal pressure to rupture the diaphragm. Shearing injury 
may occur when a lateral blow distorts the chest wall [31]. 
Diaphragmatic tears associated with blunt trauma are usually 
10 cm or greater. Injury is most frequently left-sided (75%) 
owing to the protective cushioning effect of the liver. Relative 
difficulty in detection of right-sided injury may contribute to 
its underdiagnosis and underrepresentation in the literature.
Penetrating injury results from shootings, stabbings, and, 
less commonly, iatrogenic causes such as a malpositioned 
chest tube. Stabbings and shootings usually result in left- 
sided diaphragmatic damage, presumably because most 
assailants are right-handed and facing their victims. Entrance 
wound occurring anywhere between the level of the nipples 
and inferior costal margin have the potential to cross the dia-
phragm. The resulting focal diaphragmatic injury often pro-
duces a small tear in the diaphragm (usually <1 cm in length). 
CT detection of penetrating diaphragm injury has increased 
in importance as more patients with penetrating trauma (most 
commonly stabbing victims) undergo nonoperative manage-
ment, such that laparotomy cannot be relied upon to discover 
small diaphragm defects. Occult diaphragm injury has been 
found in up to 20% of patients with penetrating trauma who 
would otherwise be managed nonoperatively [32].
12.12.1  Radiography
The chest radiograph, although a useful screening tool, is 
relatively insensitive in the detection of diaphragmatic rup-
ture. Overall sensitivity ranges from 17% to 64%, although 
serial radiographs can increase sensitivity by 12% [10]. 
Radiographic signs of diaphragmatic injury include obscura-
tion of the hemidiaphragm, elevation of the hemidiaphragm, 
and contralateral shift of the mediastinum [31]. The most 
specific radiographic finding of diaphragmatic injury is the 
presence of gas-containing stomach or bowel within the tho-
rax. Termination of a nasogastric tube within the left hemi-
thorax is another specific finding.
12.12.2  Computed Tomography
CT using thin collimation and thin reconstruction images (1- 
to 2-mm-thick slices) is the imaging modality of choice in 
the evaluation of suspected diaphragmatic injury in patients 
with blunt or penetrating trauma. Sagittal and coronal refor-
mations have been shown to increase sensitivity and confi-
dence of interpretation. Sensitivities of 70–90% are reported.
A constellation of CT findings has been evaluated for the 
detection of diaphragmatic rupture. The most frequently 
cited are direct discontinuity or focal defect of the dia-
phragm, intrathoracic herniation of abdominal viscera, the 
collar sign, and the dependent viscera sign (Fig.  12.7). 
Visualization of a focal discontinuity of the diaphragm is 
73–82% sensitive and 90% specific for diaphragmatic injury. 
Bochdalek hernias, focal defects in the posterolateral dia-
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phragm, may mimic traumatic rupture and account for false- 
positive findings. Intrathoracic herniation has a sensitivity of 
55–75% and a specificity of 100% [33]. Waist-like constric-
tion of herniated abdominal contents at the level of diaphrag-
matic rupture creates the collar sign, best depicted on coronal 
and sagittal reformations. With thin section helical CT, the 
collar sign has a sensitivity of 63% and a specificity of 100%. 
The dependent viscera sign describes the position of the 
stomach, spleen, or bowel that has herniated into the thorax 
and lies adjacent the dependent aspect of the chest wall. This 
sign yields sensitivity of 55–90% for blunt trauma diaphrag-
matic injuries. Other signs suggestive of diaphragmatic 
injury include thickening and segmental non-visualization of 
the diaphragm [33].
Penetrating diaphragm injuries tend to be considerably 
smaller than blunt diaphragmatic injuries, and accordingly 
radiologic signs based on the herniation of abdominal vis-





Fig. 12.7 Traumatic diaphragmatic injury with herniation. (a) AP 
chest radiograph shows an elevated left hemidiaphragm with stomach 
projecting in the lower left hemithorax. (b) Axial contrast-enhanced CT 
demonstrates stomach displaced posteriorly (dependent viscera sign) 
and suggestion of a waist-like constriction (arrow). (c, d) Coronal CT 
images demonstrate herniation of a portion of the stomach into the tho-
rax and depict the collar sign (arrows in (c)) and abrupt discontinuity of 
left hemidiaphragm (arrow in (d))
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demonstration of a simple breach of the diaphragm. Direct 
visualization of the diaphragm defect on CT is specific but 
uncommonly seen. CT demonstration of contiguous injuries 
on both signs of the diaphragm is the most sensitive CT find-
ing and in many cases and its absence can be used to exclude 
injury. Unfortunately, its specificity can be diminished if 
multiple wounds are present. Construction of double oblique 
CT images along the trajectory of the knife or bullet (trajec-
tography) can improve specificity of diagnosis. Demonstration 
of a tract extending on both sides of the diaphragm is specific 
for penetrating diaphragm injury and in many cases is ade-
quate impetus for operative exploration [32].
12.13  Thoracic Skeletal or Chest Wall 
Trauma
Rib fractures have prognostic significance and can by them-
selves cause physiologic impairment. In general rib fractures 
are more common in elderly individuals, due to lesser elas-
ticity of the skeleton. In children, on the other hand, rib frac-
tures indicate a significant mechanism of injury and are 
associated with a higher mortality rate [1].Rib fractures are 
uncommon in restrained passengers in collisions at speeds of 
less than 30 miles (<50 km) per hour [1] but overall occur in 
60% of patients with blunt thoracic trauma. The most com-
monly fractured ribs are the fourth through the ninth ribs. 
Mortality increases slightly in patients with two or more rib 
fractures visible on CT but increases more sharply when nine 
or more are visible.
Several patterns of rib fractures are associated with spe-
cific injuries. Fractures of the 10th, 11th, and 12th ribs are 
associated with renal, splenic, and hepatic injuries. First, 
second, and third ribs are associated with a significant mech-
anism of injury and are accompanied by aorta or great vessel 
injury in 14% and tracheobronchial injuries in 2% of cases 
[34]. Rib fractures accompanied by disruption of chest wall 
soft tissues can result in lung herniation. In the setting or 
blunt trauma, this occurs most commonly anteriorly or pos-
teriorly which layers of intercostal muscles are fewest. 
Patients with greater than four continuous ribs that are frac-
tured in two placed (segmental fractures) are at increased 
risk for development of a flail chest.... This is a clinical diag-
nosis in which an unstable portion of the chest wall moves 
paradoxically during respiration, impairing ventilation.
Sternal fractures are seen predominately in restrained pas-
sengers and occur in 8% of individuals with a significant 
mechanism of injury. The presence of sternal fractures is 
associated with severity of chest injury, the degree of dis-
placement being the major determinant. Less than 10% of 
patient with minimally displaced sternal fractures have spine 
fractures or traumatic pericardial effusions. Patients with 
completely displaced sternal fractures, however, have >40% 
chance of having a traumatic pericardial effusion and >30% 
chance of having a spine fracture. Although associated with 
cardiac injury, sternal fractures are not associated with ATAI.
Location of fracture within the sternum is also significant, 
with fractures involving the manubrium having the highest 
association with spine fractures, usually involving the upper 
thoracic spine (T5–T6) and the thoracolumbar junction (T12–
L1) [35]. Sternomanubrial dislocations share this association 
with thoracic spine trauma, specifically type 2 dislocations in 
which the manubrium is displaced posteriorly with respect to 
the sternal body. This type of dislocation is caused by hyper-
flexion, the same mechanism often fracturing the thoracic 
spine. Type-one sternomanubrial dislocations in which the 
sternal body is displaced posteriorly with respect to the manu-
brium are usually the result of a direct blow, rather than 
hyperflexion. Internal mammary arteries can be directly dam-
aged by this posterior displacement of the sternal body.
The sternoclavicular joints and sternum (see above) are 
important sites to evaluate for fracture or dislocation because 
injury in these locations can cause adjacent mediastinal 
hematoma that may raise concern for ATAI if the associated 
fracture is not identified. Sternoclavicular dislocations are 
also clinically relevant due to potential direct damage to 
adjacent structures. These injuries are rare due to extensive 
ligamentous support, such that forces transmitted along the 
clavicle are far more likely to fracture the clavicle than dislo-
cate the joint. Anterior sternoclavicular dislocation is the 
most common type of dislocation, while posterior disloca-
tion is associated with more severe sequelae, such as tra-
cheal, esophageal, and great vessel impingement or injury.
Scapular fractures indicate a significant mechanism of 
injury and can be seen on 57% of initial chest radiographs 
[34]. Approximately 50% of patients with a scapular fracture 
have a pneumothorax. Ipsilateral subclavian, axillary, or bra-
chial artery injury may be present in 11% of patients with 
Key Points
CT Findings in Diaphragmatic Tear
• Blunt 
Injury Findings (Sensitivity of CT – 70–90%)
 – Sharp discontinuity of hemidiaphragm
 – Herniation of omental fat or abdominal viscera
 – Waist-like narrowing of herniated viscera (collar 
sign)
 – Lack of visualization of hemidiaphragm
 – Dependent viscera sign
• Penetrating 
Injury Findings (Sensitivity of CT – 80–100%)
 – Contiguous injury – single wound
 – Contiguous injury – multiple wounds (decreased 
specificity)
 – Transdiaphragmatic trajectory
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scapular fracture [1]. Vascular and neurologic injury are also 
associated with scapulothoracic disassociations, a more 
severe injury that separates the scapula and muscular attach-
ments of upper extremity from the thorax without disrupting 
the overlying skin.
Thoracic spine fractures occur in 3% of blunt trauma 
patients and are most common in the thoracolumbar region 
[34]. Wedge compression and burst fractures secondary to 
hyperflexion and axial load mechanisms are the predominant 
fracture types [36] and frequently result in significant 
 neurologic impairment. Neurologic impairment is common 
because the spinal cord occupies a larger percentage of the 
available space in the canal than in the more spacious cervi-
cal and lumbar spine regions. Additionally, thoracic cord 
blood supply has little collateral reserve, predisposing to 
ischemic insult.
12.13.1  Radiography and Computed 
Tomography
CT is more sensitive than chest radiography in the diagnosis 
of rib and may be used to three-dimensional reformatted 
images to better visualizing rib trauma. In the setting of a 
flail chest, this may aid the surgeon in surgical planning. 
Fixation of rib fractures in the setting of flail segment may 
decrease the patient duration of mechanical ventilation, but 
the evidence is not strong, and operative fixation is not com-
monly performed [37]. Peripheral opacities that parallel the 
chest wall represent extrapleural hematomas adjacent to rib 
fractures. Extrapleural hematoma forms superficial to the 
parietal pleura, arising from bleeding from damaged inter-
costal vessels, and muscles. These extrapleural hematomas 
can be identified on CT by the presence of inward displace-
ment of extrapleural fat and are not treated by tube thoracos-
tomy. Collections that are biconvex may represent an arterial 
bleeding source and are more likely to require surgical inter-
vention [38]. The possibility of a flail chest should also be 
considered whenever a large extrapleural hematoma is seen.
Sternal fractures are rarely seen on frontal radiographs 
but, similar to rib fractures, are readily seen on CT images, 
particularly sagittal reconstructions. Diagnosis of sternocla-
vicular dislocation without CT is also very difficult, even 
with special radiographic views (e.g., serendipity view).
Radiographic diagnosis of scapulothoracic disassociation 
relies on detecting scapular displacement via the scapula 
index, a measurement easily distorted by difference in arm 
positioning and by rotation. In suspected cases CTA is essen-
tial to diagnose occlusion of subclavian and axillary vessels 
from thrombosis or external compression. MRI is best suited 
for evaluating associated brachial plexus injuries; the pres-
ence of >3 pseudomeningoceles suggests irreversible nerve 
root damage.
12.14  Concluding Remarks
Over the last two decades, cross-sectional imaging of both 
blunt and penetrating thoracic traumas has helped clinicians 
select from among widened options for injury management. 
Advances in CT imaging and evolution of treatment for 
ATAI now allow for nonoperative treatment of some injuries 
and delayed endovascular stent placement for others. 
Conversely, the presence of signs of penetrating diaphrag-
matic injury may prompt laparotomy in patients initially tri-
aged to nonoperative management. Despite these 
improvements in CT imaging, diagnostic uncertainty may 
still prompt invasive procedures for some injuries (e.g., cath-
eter angiography for supra-aortic vessel injury, bronchos-
copy for suspected large airway rupture).
Key Points
• Sternal fracture.
 – Completely displaced—traumatic pericardial 
effusion (40%) and spine fracture (30%)
 – Minimally displaced—traumatic pericardial 
effusion/spine fracture (10%)
• Manubrium fracture
 – Thoracic spine (T5–T6) and the thoracolumbar 
junction (T12–L1)
• Sternomanubrial dislocation
 – Type 2—hyperflexion spinal injury
 – Type 1—internal mammary artery injury
• Posterior sternoclavicular joint dislocation
 – Brachiocephalic vein and aortic arch vessels
• Scapulothoracic disassociation
 – Subclavian/axillary artery, brachial plexus, and 
pseudomeningoceles
Take-Home Messages
• Patients with minimal ATAI are managed nonopera-
tively. In the remaining ATAI victims, accurate 
description of pseudoaneurysm extent may facili-
tate management with either imaging follow-up or 
non-emergent endovascular stenting rather than 
emergent intervention.
• CT demonstration of hemopericardium is a nonspe-
cific finding that can be due to pericardial injury, 
cardiac contusion, and rarely rupture of right-sided 
cardiac chambers. Focal constriction of cardiac 
chambers suggests underlying pericardial rupture, 
while accompanying IVC distention and periportal 
edema are indicators of associated tamponade.
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Diagnosis and Staging of Breast Cancer: 
When and How to Use Mammography, 





Breast cancer is the most common cause of female cancer 
deaths in the western world, with early detection of cancer 
being pivotal for an improved prognosis and survival. 
Mammography is the mainstay of breast cancer screening and 
diagnosis [1–3]. Mammography is a two-dimensional image 
and relies on the identification of morphologic findings that 
are suspicious for breast cancer (Fig. 13.1). These findings 
include masses, grouped calcifications, asymmetries, and 
areas of architectural distortion. A standard screening mam-
mogram consists of mediolateral oblique (MLO) and cranio-
caudal (CC) views of each breast. The screening exam is 
intended solely to detect suspicious findings after which the 
woman would return for additional diagnostic views. 
Diagnostic mammographic views may include spot compres-
sion, magnification, rolled, extended views, and true lateral 
views among others in order to characterize and localize 
abnormalities. The Breast Imaging Reporting and Data 
System (BIRADS) was developed by the American College 
of Radiology in order to standardize terminology describing 
mammographic findings [4]. The BIRADS atlas also outlines 
acceptable performance metrics for screening mammography 
programs such as a cancer detection rate of ≥2.5 cancers/1000 
screens and a recall rate between 5 and 12%. Performance 
benchmarks are also available for diagnostic mammography, 
such as a positive predictive value of biopsy of between 20 
and 45%. Randomized controlled trials have found that 
screening mammography has decreased the mortality for 
breast cancer by 30% [1]. However, with a sensitivity of 
approximately 70%, mammography has its limitations. 
Particularly in women with dense breasts, cancers might be 
occult on mammography [5]. Current recommendations for 
breast cancer screening in the United States and Europe are 
somewhat variable. The Society of Breast Imaging, the 
American College of Radiology, and the National 
Comprehensive Cancer Network recommend annual screen-
ing mammography beginning at the age of 40  years for 
women at average risk for breast cancer. Due to varying judg-
ments of the benefits and harms of screening, the American 
College of Obstetricians and Gynecologists guidelines differ 
from the recommendations issued by the US Preventive 
Services Task Force, the American Cancer Society, the 
National Comprehensive Cancer Network, and the American 
College of Radiology/Society of Breast Imaging (Table 13.1). 
Women at increased risk for breast cancer (i.e., ≥ 20% life-
time risk) are recommended to undergo supplemental screen-
ing in addition to mammography with breast MRI [6, 7]. 
Women who are BRCA1/2 gene mutation carriers or who are 
not tested but have an equivalent risk (with TP53 Li Fraumeni 
syndrome, AT homozygote or supradiaphragmatic radiother-
Learning Objectives
• To understand when and how to use mammography, 
digital breast tomosynthesis, ultrasound, contrast- 
enhanced mammography, and magnetic resonance 
imaging for the diagnosis and staging of breast 
cancer.
• To realize the limitations of each imaging 
modality.
• To understand the information that can be obtained 
with each imaging modality and their complemen-
tary value in this context.
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apy before the age 30 years) are offered annual mammogra-
phy ± MRI.  In addition, recent breast density legislation in 
the United States requires that women be informed if they 
have mammographically heterogeneously dense or extremely 
dense breasts and that supplemental breast cancer screening 




Fig. 13.1 Screen-detected multifocal invasive ductal carcinoma III 
between the 9 and 10:00 axis of the left breast in a 72-year-old patient 
with a personal history of right breast cancer, breast conserving therapy 
and radiation treatment in 1983. (a, b) CC and MLO views: Post- 
surgical changes are present in the right breast. There are two new 
irregular shaped and partially spiculated masses in the 9 and 10:00 axis 
of the left breast posterior depth which are best appreciated on addi-
tional tomosynthesis views CC (c) and ML (d, spot). On targeted ultra-
sound (e) these correspond to two irregular shaped and marginated 
hypoechoic masses (9:00 6 cm from the nipple 0.6 × 0.5 cm, 10:00 6 cm 
from the nipple 0.4 × 0.4 cm)
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raphy supplemented with whole-breast screening ultrasound 
in women with dense breast tissue [8].
13.1.1  Staging with Mammography
Mammography, together with ultrasound and MRI as 
detailed below, is used to detect and characterize lesions 
found at screening and to evaluate symptomatic women. In 
patients with breast cancer, diagnostic mammography, often 
in conjunction with specialized views – latero-medial (LM) 
and mediolateral (ML), extended CC, magnification, spot 
compression, and other views – is used to determine lesion 
size and location as well as to image the surrounding tissue 
and lymph nodes [9]. Diagnostic mammography is often tai-
lored to the specific problem. For example, in a woman with 
suspicious mammographic calcifications, magnification 
views are necessary to evaluate the extent of calcifications 
(Fig. 13.2). If calcifications are associated with an asymme-
try or mass, further evaluation with ultrasound is warranted 
to search for a solid mass that may indicate an invasive 
component.
13.2  Digital Breast Tomosynthesis
Digital breast tomosynthesis (DBT) images are created from 
repeated exposure of the breast tissue from different angles 
and data processing interpolated into multiple slices typi-
cally 0.5  mm thick through the breast tissue. Many retro-
spective and prospective studies have demonstrated that this 
technique is acceptable to women, increases the radiation 
dose by an average of 20%, and increases cancer detection 
by approximately 15–30% while reducing recall rates by 
15–20% by decreasing overlapping shadows mimicking 
breast cancer [10]. While the technique is excellent for 
Key Point
• Mammography is a two-dimensional image and 
relies on the identification of morphologic findings 
that are suspicious for breast cancer. Mammography 
is the mainstay of breast cancer screening and 
diagnosis.
Table 13.1 Recommendations for breast cancer screening in average-risk women
















Not recommended Insufficient evidence to 
recommend for or against
Not recommended Recommend every 1–3 
years for women 25–39 
years and annually for 





Offer starting at age 
50 years
Recommend at age 50 years
Age 40–49 years: decision to 
start screening 
mammography before age 50 
years should be an individual 
one
Offer at ages 40–45 
years
Recommend at age 45 
years





Three yearly Biennial Annual for women 
aged 40–54 years
Biennial with the 
option to continue 
annual screening for 





Continue until age 
70 years
Beyond age 70 
years, women may 
continue to attend 
every 3 years
The current evidence is 
insufficient to assess the 
balance of benefits and harms 
of screening mammography 
women 75 years and older
When life expectancy 
is less than 10 years
When severe 
comorbidities limit life 
expectancy to 10 years 
or less
When life 
expectancy is less 
than 5–7 years




Fig 13.2 Multicentric invasive ductal carcinoma III and ductal carci-
noma in situ high grade in a 54-year-old patient presenting with a pal-
pable area of concern in the left breast for diagnostic mammography. 
CC and MLO views (a, b) and left magnification views CC (c) and ML 
(d). In the right breast there are no suspicious mass or tumor calcifica-
tions present. In the left breast there are pleomorphic microcalcifica-
tions spanning both the lower inner and outer quadrant. In addition, 
there is an enlarged axillary lymph node, which was confirmed to be 
metastatic
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assessing soft tissue masses, architectural distortion, and 
asymmetries, the conspicuity and analysis of microcalcifica-
tion were not improved [11]. However, recently, due to faster 
processing techniques manufacturers have been able to ana-
lyze all pixels instead of “binning” (combining pixels with 
the effect of reducing resolution) the data to reduce process-
ing time. This means that fine calcification can now be more 
clearly identified with improved sensitivity and specificity.
DBT has been shown to be particularly useful in women 
with mixed to dense breast tissue (BIRADS B & C) but is not 
advantageous in women with very dense breast tissue. DBT 
is now increasingly used in the clinic either on its own with 
a 2D composite image or in conjunction with a standard 2D 
full-field digital mammography (FFDM) image. The advan-
tage of using DBT is that the need for additional views such 
as the coned view or other supplemental techniques is no 
longer required [12]. In a recent meta-analysis, 17 studies 
were found where DBT was compared with 2D 
 mammography in a screening setting. The pooled incremen-
tal cancer detection rate was 1.6 cancers/1000 screens com-
pared with 2D FFDM with an overall absolute reduction in 
recall rates of 2.2%. However, there were differences 
between European and US-based studies with European 
studies showing a higher cancer detection rate of 2.4 can-
cers/1000 screens and a 0.5% increase in recall rates and US 
studies showing a reduction in the recall rates due the higher 
recall rates initially [13].
In the symptomatic setting, DBT has been found to have 
improved diagnostic accuracy compared with 2D mammog-
raphy and improved reader confidence in distinguishing 
benign from malignant lesions and is more accurate in 
assessing tumor size and at identifying multifocal disease 
[14]. Techniques are also now available for image-guided 
biopsy using DBT to guide targeting.
Key Point
• DBT has the potential to overcome the primary 
limitation of standard two-dimensional mammogra-
phy, a masking effect due to overlapping fibroglan-
dular breast tissue, improving diagnostic accuracy 
by differentiating benign and malignant features, 
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13.3  Contrast-Enhanced Mammography
Contrast-enhanced mammography (CEM) is an emerging 
technology in breast imaging. CEM allows both a morphologic 
evaluation comparable to routine digital mammography and a 
simultaneous assessment of tumor neovascularity as an indica-
tor of malignancy. Contrast-enhanced spectral mammography 
(CESM) acquires a low kV image and a high kV image simul-
taneously before and after the injection of iodinated contrast. 
Retrospective studies comparing CESM with standard 2D 
mammography show significant improvement in the sensitivity 
and specificity for detecting breast carcinomas with CESM; the 
sensitivity of CESM is 93–100% compared with 71.5–93% for 
mammography and increases the specificity from 42 to 87.7%. 
The patient populations in all these studies were either symp-
tomatic patients or patients recalled to assessment after an 
abnormal screening mammogram [15, 16].
In women with heterogeneously or dense breasts (BIRADS 
C & D), small occult cancers can be seen with CESM due to 
increased vascularity from tumor angiogenesis. In women 
with dense breasts, CESM is one of several supplementary 
techniques that can be used to avoid overlooking cancer 
(Fig. 13.3). The low-dose image is virtually as good as a 2D 
FFDM image and has the same resolution as a conventional 
image. However, microcalcification due to low- grade DCIS is 
often not visualized on the subtracted image of CESM.
The disadvantage of this contrast examination is that 
approximately the same dose of iodinated contrast is injected 
intravenously, and sensitivity reactions can occur at the same 
rate as with computed tomography (CT) examinations. This 
means that CESM must be performed in a center with 
 resuscitation facilities in place, and caution must be exer-
cised in patients with impaired renal function, patients with 




Fig. 13.3 Invasive ductal carcinoma II in a 49-year-old patient who 
underwent contrast-enhanced mammography with a personal history of 
right breast cancer and mastectomy and reduction mammoplasty on the 
left. CC and MLO views (a, c), contrast-enhanced CC and MLO views 
(b, d), left CC spot compression view and diagnostic targeted ultra-
sound (f, g with color doppler). On mammography, left lower inner 
focal asymmetry that does not efface on spot compression correlates to 
a 0.4 cm enhancing mass on CEM. Targeted ultrasound shows an irreg-
ular shaped and marginated hypoechoic mass with vascularization
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The diagnostic accuracy in younger women and in those 
with dense breasts in the symptomatic setting is improved 
compared with 2D mammography [17].
13.3.1  Staging with CESM
A major advantage of CESM is that the ability to see addi-
tional foci of disease is enhanced hugely and, in many stud-
ies, it is comparable to MRI.  Jochelson et  al. found equal 
sensitivity between MRI and CESM for detecting the index 
cancer, although MRI was less sensitive for detecting addi-
tional tumor foci [18]. Lee-Felker et al. found that MRI had 
slightly higher sensitivity for the index lesion but equal sen-
sitivity for detecting additional tumor foci [19]. Overall both 
studies showed that CESM had a significantly improved 
positive predictive value and specificity compared with MRI, 
as well as fewer false-positive interpretations. This means 
that once a cancer is suspected on imaging at the clinic visit, 
a CESM examination can be performed which has almost 
comparable sensitivity and specificity to staging breast MRI.
13.4  Ultrasound
Handheld ultrasound (US) has improved enormously over 
the last 20  years with markedly improved resolution and 
rapid image processing. While it is rarely used as a primary 
diagnostic tool, US is used in the majority of patients pre-
senting with a clinical symptom as an adjunctive tool to fur-
ther analyze a mammographic abnormality to determine 
whether a soft tissue mass is solid or cystic and to differenti-
ate benign from malignant masses. It is also used when there 
is a negative mammographic examination, but the patient has 
a clinical symptom or palpable abnormality. The procedure 
is acceptable to patients, is safe with no ionizing radiation, 
but is operator dependent. The drawback for conventional 
US is that in breast tissue with extensive fibrocystic disease 
and shadowing, small tumors can be overlooked especially if 
they are invasive lobular disease. Ductal carcinoma in situ 
(DCIS) can be picked up now due to the improved resolution 
as microcalcification can produce a speckled pattern but 
DCIS with no calcification is difficult to detect.
Whole-breast US or Automated Breast US (ABUS) is a 
technique that is rapidly gaining acceptance. This technique 
requires the operator to undertake three positions with a flat 
panel US plate of each breast. The images are reconstructed 
to produce a 3D examination of the breast. This technique is 
showing promise in many clinical trials and may become 
the examination of choice for women with dense breasts in 
whom a supplemental examination is justified. A third of the 
United States, France, and Belgium have introduced supple-
mental imaging techniques such as US for women with 
BIRADS C & D breast density although in all cases this 
additional examination is insurance or self-funded. The lit-
erature supports the use of the supplemental imaging with 
studies reporting an additional 4 cancers/1000 screens when 
used with annual or 2-yearly screening. While the drawback 
for screening US has traditionally been that it had high 
recall rates ranging from 10 to 30%, a recent publication 
from Sweden has shown more promising results with ABUS 
with recall below 2.5% while good sensitivity is retained 
[20].
A most valuable aspect of US is the ability to rapidly 
undertake an image-guided biopsy. This can be done safely, 
in a timely manner at the first visit to the clinic and has a 
degree of accuracy without any precautions save checking 
for a bleeding diathesis.
13.4.1  Staging with US
US is widely used to confirm a diagnosis of cancer and to 
look for additional disease in the breast which is found in up 
to 20% cases. Additional disease is more often found toward 
the nipple and in the same quadrant as the index tumor.
Assessment of the axilla to look for abnormal lymph nodes 
is a very popular approach. The short axis diameter of axillary 
nodes is less than 5 mm in size, but in reality there is a large 
variation in normal lymph node size. Hence, the more reliable 
indicators of disease are abnormal shape (rounded), loss of 
echogenicity of the hilum, thickened cortex by more than 
3 mm, or irregular lobulated cortex. When proving malignancy 
prior to surgery, US-guided core biopsies are undertaken.
US is also used extensively as a second-look tool in 
patients with abnormalities found on MRI particularly when 
the features are not diagnostic.
Lastly, US is used in localization techniques prior to sur-
gery including the placing of a guide wire into the cancer to 
aid surgical procedure. This can be done accurately and effi-
ciently under US guidance.
Key Point
• CEM allows both a morphologic evaluation compa-
rable to routine digital mammography and a simul-
taneous assessment of tumor neovascularity as an 
indicator of malignancy similar to MRI. CEM has 
an improved sensitivity and increases the specificity 
compared with mammography.
Key Point
• US is widely used to confirm a diagnosis of cancer, 
to look for additional disease in the breast, for 
image-guided breast biopsy and localization, 
assessment of the axilla, and as a second-look tool 
in patients with abnormalities found on MRI.
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13.5  Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is established valuable 
technique in breast imaging with multiple clinical indica-
tions, such as preoperative staging, response assessment to 
neoadjuvant therapy, scar vs. recurrence, assessment of 
breast implant integrity, evaluation of patients with cancer 
of unknown primary, and screening of high-risk patients 
[21, 22]. Dynamic contrast-enhanced magnetic resonance 
imaging (DCE-MRI) provides high-resolution breast mor-
phology and enhancement kinetics to depict angiogenesis 
as a tumor- specific feature. Undisputedly DCE-MRI is the 
most sensitive modality for breast cancer detection with a 
pooled sensitivity of 93%; in terms of specificity, it has 
good pooled specificity of 71% [23]. In women who are at 
high risk for breast cancer, several studies have demon-
strated that DCE- MRI is the superior screening modality 
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Fig. 13.4 0.4 cm invasive ductal carcinoma III medially in the right 
breast of a high-risk 51-year-old patient undergoing screening 
MRI. DCE-MRI (a, b, c) and MIP (d) shows round circumscribed mass 
with initial fast (b)/delayed plateau (c) enhancement signal intensity 
graph (e) sagittal view (f). Screening mammography and ultrasound 
were negative
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Fig. 13.5 MRI for staging of extent of disease in a 50-year-old patient 
with an invasive ductal carcinoma III with extensive intraductal compo-
nent (EIC). On DCE-MRI (a, b), subtractions (d) and MIP (e). In the 
9:00 axis mid depth there is a round irregular marginated mass with 
initial fast (b, f)/delayed plateau (c, f) enhancement measuring 1.4 × 1.4 
× 1.1 cm with susceptibility artifact from clip marker. Extending from 
the index cancer into the anterior third of the breast there is a heteroge-
neous segmental non-mass enhancement representing the EIC.  The 
index cancer and the contiguous non-mass enhancement span an area of 
approximately 3.8 × 1.6 × 1.5 cm. The non-mass enhancement engulfs 
a biopsy marker from a prior benign breast biopsy
(Fig. 13.4). Therefore, adjunct screening with DCE-MRI is 
recommended for women with a high (>20%) lifetime risk 
of breast cancer [21, 22, 24], facilitating earlier cancer 
detection and reducing interval cancers [25–27] in this pop-
ulation. This has also prompted a most recent similar rec-
ommendation for its use in women with an intermediate 
(>15%) lifetime risk of breast cancer [28]. To overcome 
limitations in DCE-MRI specificity and assess more func-
tional data, additional MRI parameters can be combined 
with DCE-MRI; this approach is known as multiparametric 
MRI (MP MRI). In this context, diffusion-weighted imag-
ing (DWI) with apparent diffusion coefficient (ADC) map-
ping has emerged as the most robust and valuable parameter 
with a reported sensitivity of up to 96% for breast cancer 
detection and a specificity of up to 100% for breast tumor 
characterization [29, 30] and is therefore increasingly 
implemented in clinical routine.
13.5.1  Staging with MRI
In patients with a biopsy-proven breast cancer, MRI may be 
used for the assessment of disease extent and detection of 
additional lesions in the same (multifocal) or different quad-
rants (multicentric) or in the contralateral breast potentially 
impacting patient management (Figs. 13.5 and 13.6). In this 
context DCE-MRI is more useful than mammography and 
US when staging multifocal and multicentric disease or 
when DCIS is present (Fig. 13.5) [31]. In addition, numerous 
studies have shown that DCE-MRI is superior to mammog-
raphy and US for assessment of tumor size, yet there is still 
over- and underestimation in up to 15% of patients [31, 32]. 
Although an improved preoperative disease assessment can 
be expected to improve surgical outcomes, currently the evi-
dence is controversial [33, 34] with respect to breast cancer 
histopathology and other studies. There is a good body of 
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evidence that staging MRI has a value in invasive lobular 
cancer (ILC), a histopathological breast cancer subtype that 
is typically underestimated by mammography and US, and 
reduces re-excision rates in ILC, ranging from 11 to 18% 
[35, 36]. It has to be noted that presurgical MRI often detects 
additional suspicious lesions that are occult on mammogra-
phy and US, thus potentially leading to more extensive sur-
gery. Histopathological verification is therefore mandatory 
before changes of treatment strategies are recommended 
based on these additional findings. The primary goal of sur-
gery is to reduce tumor burden and is usually part of a sophis-
ticated treatment strategy that includes radiation therapy, 
chemotherapy, and hormonal therapy. Although additional 
cancerous lesions detected by DCE-MRI might be effec-
tively treated with these therapies, to date, there is a lack of 
evidence that preoperative DCE-MRI improves overall or 
disease-free survival [37].
DCE-MRI may also detect cancers that were occult on 
mammography and/or sonography in the contralateral breast 
in approximately 3% of women with unilateral cancer 
detected by mammography or US [38]. The detection of these 
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Fig. 13.6 Ductal carcinoma in situ (DCIS) intermediate grade, atypi-
cal ductal hyperplasia (ADH) and lobular carcinoma in situ classic type 
in 46-year-old patient with a history of right breast ADH and status post 
excisional biopsy undergoing screening MRI. Screening mammogra-
phy and targeted second look sonography were negative. MRI-guided 
biopsy of the non-mass enhancement in the right breast retroareolar 
area shows right DCIS, ADH and LCIS.  High resolution DCE-MRI 
(a–c), subtractions (e) and MIP (d) show in the early phase unique areas 
of non-mass enhancement with initial fast/delayed persistent enhance-
ment (f)
F. J. Gilbert and K. Pinker-Domenig
165
patient outcomes than the detection of additional ipsilateral 
tumor foci as these would not be treated with concomitant 
radiation therapy. Although patient prognosis is determined 
by the size and grade of the index cancer, early detection of 
second cancers may be associated with a slight increase in 
survival, especially in patients younger than 50  years old 
[22]. Another indication of pretreatment breast MRI is as a 
problem-solving tool when tumor size differs significantly 
among imaging modalities or clinical examination and to 
evaluate eligibility for partial breast radiation therapy [21].
13.6  Concluding Remarks
In conclusion, imaging plays a pivotal role in breast cancer 
detection and staging and helps in guiding treatment deci-
sions. Imaging modalities for diagnosis and staging of breast 
cancer comprise mammography, DBT, ultrasound, CEM, 
and MRI. Whereas mammography is the mainstay of breast 
cancer screening and diagnosis, other imaging modalities 
such as DBT and CEM have emerged with the potential to 
overcome limitations in sensitivity and specificity adding 
valuable information in breast cancer staging. US is widely 
used to confirm a breast cancer diagnosis, to look for addi-
tional disease and for image-guided breast biopsy and local-
ization, staging of the axilla, and as a second-look tool in 
patients with suspicious findings on MRI. DCE-MRI remains 
the most sensitive modality for breast cancer detection with 
excellent sensitivity and good specificity and is more useful 
than mammography and US for the assessment of disease 
extent and detection of additional disease. Each imaging 
modality has its limitations and advantages and therefore 
may be used in conjunction to facilitate an optimal breast 
cancer staging and treatment.
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Breast cancer is the leading cause of cancer-related death 
among women worldwide, with variable incidence and mor-
tality rates. Fortunately, mortality has decreased because of 
advances in screening and treatment [1, 2]. The 10-year sur-
vival rate of breast cancer ranges from 70 to 80%, with up to 
90% for local and 60% for regional disease [3]. The annual 
hazard of recurrent disease (local and or metastases) ranges 
between 2 and 5% in years 5–20 after diagnosis. The yield 
for recurrent disease is likely to be higher in patients with 
advanced stages of disease [4]. Recent studies have demon-
strated that the onset of local recurrence is an independent 
predictor for survival [5]. Thus management of patients with 
breast cancer during surveillance plays an important role. 
The aims of any follow-up are to detect early local recur-
rence or contralateral breast cancer and to diagnose and 
treat cancer and/or therapy-related diseases such as metasta-
ses and osteoporosis [3]. Considering these facts a well-
defined, evidence-based surveillance protocol is needed to 
manage patients with breast cancer after the initial diagno-
sis, including staging and follow-up. Currently mammogra-
phy every 1–2 years is the only recommended evidence-based 
imaging modality. In asymptomatic patients, there are no 
data to indicate that any imaging or laboratory test leads to 
a survival benefit. In symptomatic patients or in case of clin-
ical findings appropriate tests should be performed immedi-
ately [3–8].
The purpose of this chapter is to address the role and 
effectiveness of imaging modalities in the staging and sur-
veillance of patients with breast cancer after primary 
therapy.
14.2  Surveillance Recommendations 
for Local Recurrence
Local recurrence in breast cancer can be defined as recurrent 
disease to the ipsilateral breast, chest wall, or regional lymph 
nodes. Most local recurrences in breast cancer can be treated 
with curative intent and early detection of local recurrence 
will improve the overall prognosis of the patients [9]. Overall, 
the incidence of an ipsilateral breast recurrence (including 
ipsilateral new primary cancers) in women with spontaneous 
early-stage breast cancer treated with breast-conserving ther-
apy will be around 0.5–1% per year and may especially in 
estrogen-receptor-positive tumors remain elevated well 
beyond 10 years after diagnosis [9, 10]. However, a variety 
Learning Objectives
• To learn about the strengths and weaknesses of the 
different imaging modalities for local surveillance 
of patients with a personal history of breast cancer.
• To understand that mammography is the only rou-
tinely recommended imaging modality with which 
to detect local recurrence or contralateral breast 
cancer.
• To discuss the role and effectiveness of imaging 
modalities in the staging and surveillance of patients 
with breast cancer after primary therapy.
• To show that there is little justification for imaging 
to detect metastasis in asymptomatic breast cancer 
patients.
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of factors will influence the likelihood and timing of local 
recurrence. In particular, involved surgical margins, nonad-
herence to adjuvant therapy guidelines, large size, and 
aggressive biology of the primary tumor, young patient age 
at diagnosis, and presence of familial or genetic risk factors 
may substantially increase recurrence rates.
14.2.1  Surveillance After Breast-Conserving 
Surgery
The backbone of surveillance of the ipsilateral breast in 
asymptomatic women with a personal history of breast can-
cer and who were treated with breast-conserving surgery is 
mammography [11–13]. However, specific recommenda-
tions vary substantially between countries and institutions 
regarding the optimal time to begin of mammographic sur-
veillance after local treatment (e.g., 6–24 months after sur-
gery) and the frequency (from semiannual mammography of 
the ipsilateral breast during the first 2 or 3 years after surgery 
to mammography only every 2–3 years) [9]. As sensitivity of 
mammography in the treated breast may be lower due to 
posttreatment changes [9], mammography is usually accom-
panied by a clinical exam and in many European countries 
by breast ultrasound [3]. This has the advantage that the 
axilla and regional lymph nodes can be evaluated at the same 
time. Digital breast tomosynthesis (DBT) has the potential to 
improve screening accuracy compared to 2D mammogra-
phy; however data regarding DBT in the follow-up of patients 
with breast cancer is limited [14]. Contrast-enhanced mag-
netic resonance imaging (MRI) has the highest sensitivity 
regarding ipsilateral breast cancer recurrence. MRI is there-
fore an excellent tool for surveillance of asymptomatic high- 
risk women with a personal history of breast cancer as well 
as for problem-solving in otherwise indeterminate cases. 
However, the available evidence is currently insufficient to 
recommend for or against MRI as routine surveillance 
method in all normal-risk women with a personal history of 
breast cancer [15].
14.2.2  Follow-Up After Mastectomy
Most women treated with mastectomy with or without recon-
struction can safely be followed by clinical exam alone or in 
conjunction with ultrasound. As long as the breast paren-
chyma has been completely removed during mastectomy, 
routine mammography on the affected side will not be neces-
sary [16]. However it should be noted that some centers will 
ignore this advice and perform regular mammography in 
asymptomatic women after mastectomy with or without 
reconstruction [17]. If there is suspicion of significant resid-
ual breast parenchyma after mastectomy, breast MRI can 
reliably confirm or exclude residual parenchyma. Ipsilateral 
remaining breast tissue after mastectomy in women who 
have not received radiation therapy substantially increases 
the risk for local recurrence and may require re-excision or 
careful imaging surveillance [18]. In patients with mastec-
tomy and implant reconstruction, MRI is superior to mam-
mography and palpation regarding detection of recurrent 
disease [19]. MRI will be especially valuable in cases with 
prepectoral positioning of the implant to exclude pectoral 
recurrence behind the implant, as this area will not be acces-
sible to clinical exam and ultrasound.
14.2.3  Imaging Patients with Local Symptoms
Any locoregional symptom such as a palpable lump, new 
pain, changes in breast configuration, or skin changes in a 
patient with a personal history of breast cancer should be 
carefully evaluated by a thorough clinical exam and tailored 
imaging. Many palpable abnormalities are readily accessible 
to targeted ultrasound. Additional imaging such as mammog-
raphy and/or MRI can be added as needed. Positron emission 
tomography-computed tomography (PET/CT) can be very 
helpful in cases with suspected axillary recurrence, especially 
if the findings are not accessible to percutaneous biopsy.
14.2.4  Strengths and Weaknesses of Different 
Surveillance Methods
14.2.4.1  Clinical Exam
The value of a thorough clinical exam that consists of history- 
taking, inspection, and palpation of the breast and regional 
lymph nodes for the detection of local breast cancer recur-
rences should not be underestimated. Skin changes detected 
during clinical inspection may be the only sign of a local 
recurrence around the surgical scar or even for the existence 
of skin metastases. Palpation of the regional lymph nodes is 
also an important part of the clinical exam, especially if 
mammography only (no accompanying ultrasound) surveil-
lance regimes are employed. About half of all ipsilateral 
breast recurrences will have a positive finding on clinical 
exam, and about a one-third of ipsilateral breast recurrences 
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will be detected by the clinical exam with negative mam-
mography [9]. This proportion is substantially higher than 
for healthy women undergoing routine mammography 
screening. Most guidelines therefore recommend clinical 
follow-up visits for breast cancer patients in the first 5 years 
after diagnosis at shorter intervals than the imaging surveil-
lance (e.g., every 3–6 months) [3]. These visits also provide 
psychological support, motivate to follow adjuvant treat-
ments recommendations, and help to detect treatment related 
problems early.
14.2.4.2  Mammography
Regular, usually annual mammography is the foundation of 
every surveillance regime in women after breast-conserv-
ing therapy. Ultrasound (US) and/or MRI can be used to 
supplement, but not to replace mammography in this situa-
tion. Between 50 and 80% of ipsilateral breast recurrences 
will be detectable by mammography. Key to this is the 
detection of suspicious microcalcifications by mammogra-
phy, often an early sign of residual or recurrent disease 
(Fig.  14.1). High breast density as well as postoperative 
changes such as hematoma, seroma, fat necrosis, or scar-
ring may reduce the sensitivity of mammography. There is 
hope that DBT will be able to overcome these limitations at 
least in part, by reducing problems due to superposition.
14.2.4.3  Ultrasound
Breast US is an ideal complementary technique to the clini-
cal exam and mammography. It enables direct correlation 
with and work-up of clinical as well as mammographic find-
ings. In addition, US is able to evaluate the chest wall or the 
reconstructed breast after mastectomy. Breast ultrasound is 
also an excellent tool to evaluate the regional lymph nodes. 
In contrast to mammography, the detection performance of 
US is not affected by dense breast tissue. The main limitation 
of US is the high number of non-specific or false-positive 
findings, although this is less of a problem if US is performed 
on a regular basis during follow-up.
14.2.4.4  MRI of the Breast
MRI of the breast has by far the highest sensitivity for inva-
sive breast cancer of all available imaging modalities. This 
translates into a very high negative predictive value approach-
ing 100% and makes MRI the ideal problem-solving tool. If 
no relevant contrast enhancement is found on MRI in the 
area of an equivocal clinical, mammographic, or sonographic 
finding, clinically relevant changes can be excluded with suf-
ficient certainty, and the patient can safely be placed on 
short-term follow-up. With the exception of the immediate 
postoperative phase, MRI can also reliably differentiate 
between postoperative changes/scarring and recurrence. 
However, it is important to realize that local recurrence may 
lack typical malignant features at imaging such as irregular 
borders or rapid contrast uptake on MRI.  Therefore histo-
logical confirmation, if necessary by open excisional biopsy, 
is advisable for all new solid lesions with enhancement on 
MRI (Fig. 14.2). The disadvantage of MRI is that many oth-
erwise occult benign breast changes (including high-risk 
lesions) will also show enhancement on MRI. For MRI to 
have the highest benefit in routine surveillance/screening, 
the underlying incidence of malignant changes has to be high 
enough, or the positive predictive value of an abnormal MRI 
finding will be too low. This is the reason why routine sur-
veillance with MRI is currently recommended only in the 
high-risk setting [15].
14.2.4.5  Other Imaging
Contrast-enhanced mammography is an emerging technol-
ogy, which may serve as an alternative if MRI cannot be per-
formed (e.g., due to claustrophobia). Positron emission 
technologies such as PET/PEM are not recommended for 
routine surveillance of the breast due to the relatively high 
associated radiation dose associated with these modalities. 
However, PET/CT may be helpful in the evaluation of a pos-
sible regional lymph node recurrence or if there is the possi-
bility of additional distant metastasis.
Key Point
• The detection of suspicious microcalcifications by 
mammography plays a crucial role in the early 
detection of not only in situ but also invasive ipsilat-
eral breast cancer recurrence.
Key Point
• Any new solid enhancing lesion in the ipsilateral 
breast or chest wall should be considered suspicious 
for recurrence regardless of size, morphology, or 
enhancement characteristics.
14 Follow-Up of Patients with Breast Cancer: Imaging of Local Recurrence and Distant Metastases
170
Fig. 14.1 A 48-year-old asymptomatic female, 11 years after breast-
conserving treatment for right breast cancer (invasive NST with associ-
ated DCIS high-grade, pN2, pN1a, G2, ER/PR positive, Her2 negative) 
treated with adjuvant chemotherapy and endocrine therapy under rou-
tine surveillance. CC (a) and MLO (b) views of the right breast. 
Enlarged views of the retroareolar region of the prior CC 1 year ago (c) 
and the current CC (d) demonstrate a slight increase in the number of 
subtle calcifications in this area. Clinical exam and tailored ultrasound 
were normal. Stereotactic vacuum-assisted biopsy with specimen radi-
ography of the obtained cores (e) and post-biopsy views (f) to confirm 
correct clip placement was performed and revealed a poorly differenti-
ated invasive breast cancer (NST). Mastectomy confirmed a 13-mm 
invasive breast cancer (rpT1c, rpN0, G3, ER 100%, PR 100%, Her2 
negative, MIB-1 proliferation index 10%). The patient was placed on 











Fig. 14.2 A 37-year-old asymptomatic female, 6  years after right 
nipple- sparing mastectomy and implant reconstruction for extensive 
DCIS. Routine surveillance ultrasound (a) shows a new, small, oval, 
circumscribed, hypoechoic mass with parallel orientation in the remain-
ing subcutaneous tissue surrounding the implant on the right. Contrast- 
enhanced MRI for further evaluation was performed. MIP images in the 
second minute after contrast enhancement (b) and delayed images with 
fat saturation (c) confirm a small, oval, circumscribed enhancing mass 
with persistent enhancement in the delayed phase. On surgical excision 
an invasive breast cancer (NST) with a maximum size of 6 mm was 
found (pT1b, pN0, G2, ER 100%, PR 0%, Her2 positive, MIB-1 prolif-
eration index 30%). The patient was treated with chemotherapy in com-
bination with trastuzumab as well as tamoxifen and is currently healthy 
at age 40
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14.3  Imaging of Distant Metastases
14.3.1  Initial Staging
Once breast cancer is diagnosed, staging of the axilla must be 
performed. Currently, sentinel lymph node biopsy is recom-
mended because imaging is not accurate enough [7]. Several 
guidelines recommend against the routine use of imaging 
modalities to stage asymptomatic metastases in newly diag-
nosed breast cancer [4]. Modern imaging technologies have 
improved the detection capability; thus the current NCCN 
guidelines [8] recommend against routine staging of patients 
with stage I and II disease but recommend CT (lung plus 
abdomen) or MRI (abdomen/liver) in addition to bone scin-
tigraphy for stage III and IV disease. The use of FDG-PET/
CT is viewed with caution though several studies demonstrate 
more accurate breast cancer staging with  PET/CT. The use of 
FDG-PET/CT changed the clinical stage in 30% and found 
unsuspected metastases in 21% of patients with stage IIA and 
IIIC disease. Particular in younger patients (<40  years of 
age), an upstaging of 17% was seen in stage IIB disease [20]. 
Even more in bone metastases FDG-PET/CT outperforms CT 
or bone scintigraphy, with accuracies of up to 90%. The role 
of PET/CT may be less clinically relevant in extensive meta-
static disease; however there are cases where a single metas-
tasis is detected which affects the prognosis and the therapy 
(Fig. 14.3). The results of FDG-PET/CT are excellent; how-
ever it should be noted that its utility depends on cancer type 
being less sensitive in lobular breast cancer disease. 
Nevertheless it can be expected that PET/CT with more spe-
cific tracers than FDG will enhance the ability to stage breast 
cancer more accurately and will allow better prediction and 
assessment of treatment response during targeted therapy [7].
14.3.2  Distant Metastases
Distant recurrence (metastasis) is the main cause of breast 
cancer death. Mastectomy or lumpectomy followed by radia-
tion therapy does not influence this risk [21]. The most com-
mon sites for breast cancer metastases are the skeleton, lung, 
liver, and brain [22]. In a Cochrane review by Rojas et al., 
which included 3055 women, there was no difference in over-
all or disease-free survival rates for patients who underwent 
intensive laboratory and imaging testing compared to those 
managed with clinical visits and mammography were seen 
[22]. Similar results were observed in two multicentric ran-
domized surveillance studies performed in Italy in asymp-
tomatic breast cancer patients. In both studies patients were 
randomized in two groups. One group had intensive follow-
 up, including bone scintigraphy, chest x-ray, and ultrasound 
of the liver, whereas the control group was examined only 
with imaging and laboratory test when clinical symptoms 
were present. In both studies intensive testing found more 
metastases; however, there was no significant difference seen 
in the overall survival between the two groups [23, 24]. As a 
consequence [3, 5, 6], several guidelines (Table 14.1) do not 
recommend intensive surveillance that would include routine 
blood tests, blood tests for tumor markers, chest x-ray, ultra-
sound of the liver, CT, MRI, or even PET/CT [5]. Nevertheless, 
surveillance programs vary among countries, organizations, 
and physicians. Physicians and patients favor intensive sur-
veillance. In addition patients overestimate the role of labora-
tory and imaging tests and often incorrectly perceive the 
significance of a normal test [25, 26]. Keating et al. showed 
that patients who received care from oncologists had higher 
rates of testing than patients who were followed by their pri-
mary care physicians [25]. Grunfeld et al. [27] saw similar 
results were seen be in a retrospective study of 11,219 asymp-
tomatic breast cancer survivors. Twenty-five percent of all 
patients had fewer than the recommended surveillance mam-
mograms, and 50% had more than the recommended surveil-
lance for metastatic disease (including bone scans, chest 
x-ray, CT, or MRI). Higher morbidity (more mastectomies) 
and seeing both an oncologist and primary care physicians 
increased the odds of having more intense imaging testing. 
Other studies found similar results, with the overuse of blood 
tests although rising tumor markers (i.e., CA 15-3 and CEA) 
suggest recurrence in asymptomatic patients [28]. Recently 
several studies demonstrated that in breast cancer patients 
with rising CA 15-3 and CEA levels the use of FDG-PET/CT 
would be of high diagnostic value, reporting an accuracy of 
up to 92% [29, 30]. Although FDG- PET/CT is not recom-
mended for follow-up, suspected cases of recurrence that 
have equivocal conventional studies would be the best candi-
date for PET/CT [29]. In a recent study, Parmar et  al. [5] 
assessed the role of imaging modalities in follow-up pro-
grams. Surprisingly, only 55% of patients showed strict 
adherence to the surveillance program. During the study 
period (2011–2007), the use of bone scans and mammograms 
decreased (21% to 13% and 81% to 75%, respectively), 
whereas use of MRI and FDG-PET/CT increased signifi-
cantly (0.5% to 7% and 2% to 9%, respectively).
Overall, when imaging and laboratory tests are ordered in 
asymptomatic patients during follow-up surveillance, the 
cost-effectiveness and accuracy of applying supplemental 
testing must be considered. In addition efforts should be 
made to a more intensively educate of physicians to reduce 
to use of non-guideline conforming surveillance testing. 
Nevertheless, it has been evidentially seen that physicians 
Key Point
• NCCN guidelines recommend against routine stag-
ing of patients with stage I and II disease but recom-
mend CT or MRI in addition to bone scintigraphy 
for stage III and IV disease [8].
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and patients are not confident in the current surveillance pro-
grams with mammography as the only imaging modality 
considering the development of new and promising imaging 
technologies [29, 30]. Currently there is no evidence that 
early detection of metastases during follow-up improves 
 survival. However, early detection may allow more accurate 
and curative intervention, and this may be the cause for the 
current trends, in which advanced imaging modalities other 
than mammography are used [5, 29].
a b
c
Fig. 14.3 A 41-year-old female with multicentric biopsy proven left 
breast cancer measuring 8 cm in dimensions and suspicious ipsilateral 
axillary nodes (stage T3 N1). Patient underwent 18F-FDG PET/CT for 
staging (histology: invasive ductal carcinoma NOS, G3, ER weakly 
positive, PR negative, HER2 positive, p53 weakly positive (10%), 
MIB-1 positive). (a) Coronal fused PET/CT image shows bulky FDG 
avid left axillary nodes (arrow). (b) Axial fused PET/CT image shows a 
FDG avid lesion in the left ilium (arrow) and biopsy proven osseous 
metastases. This was occult on the CT component (c). PET/CT cor-
rectly upstaged the disease to stage IV thus illustrating the value of 
PET/CT in distant staging
Key Point
• Breast cancer patients who receive intensive screen-
ing and surveillance with imaging and laboratory 
studies have no survival benefit compared to those 
who undergo testing after clinical symptoms are 
evident.
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14.3.3  Imaging for Bone, Lung, and Liver 
Metastases
Current guidelines (Table 14.1) recommend against the rou-
tine use of laboratory or imaging tests to detect asymptom-
atic metastases during staging or follow-up after breast 
cancer diagnosis. This paragraph describes briefly which 
imaging modalities should be used to detect distant metasta-
ses if clinical symptoms are present [6]. To detect skeletal 
metastases, bone scintigraphy is more effective than conven-
tional radiography. Several recent studies suggest that 
 FDG- PET/CT, PET/MRI, or whole-body MRI is signifi-
cantly more accurate than bone scintigraphy, but both can 
still miss some metastases, particularly sclerotic ones. It is 
expected that these new imaging techniques will replace cur-
rent technologies (Fig. 14.4). To detect lung metastases chest 
x-ray and CT are recommended. Chest x-ray is considered 
the most reasonable approach because of the low costs. In 
case of any questionable findings, CT is recommended as a 
baseline for monitoring and for follow-up. Liver metastases 
are not as common as lung or bone metastases; however, 
their appearance is associated with the worst prognosis. In 
symptomatic patients CT or MRI is recommended as more 
lesions can be diagnosed with a higher accuracy compared to 
US. Particularly for follow-up during therapy MRI should be 
advantageously used. Breast cancer is second only to lung 
carcinoma as a cause of brain metastases. Contrast-enhanced 
MRI has largely replaced CT for the detection and evaluation 
of brain lesions because of its high sensitivity (Fig. 14.5) [6].
14.3.4  Assessing Treatment Response 
of Distant Metastases
Once a breast cancer patient has been diagnosed with metas-
tases, accurate assessment of treatment response is of the 
uppermost importance. Currently follow-up assessment is 
based on anatomic imaging (CT or MRI) (Fig.  14.6). 
Treatment response, particularly in clinical trials, is evalu-
ated by the RECIST (Response Evaluation Criteria in Solid 
Tumors) 1.1 criteria. A change in the size of a given metasta-
sis during treatment is a measure of response. In soft tissue 
metastases (e.g., liver, lung, and brain), this approach is cur-
rently acceptable. However, in bone metastases – the most 
common site of metastatic disease – this approach is prob-
lematic unless there is an extra-osseous soft tissue mass 
associated with the bone lesion. If FDG-PET/CT is used 
metabolic activity can be assessed and thus determine the 
response to treatment [7, 29, 30]. By comparing FDG-PET/
CT with conventional anatomic CT, Vranjesevic et  al. 
showed that the PPV (93% vs. 85%) and NPV (84% vs. 
59%) of FDG-PET/CT were higher than with conventional 
imaging [7]. Other PET tracers (e.g., 18F-fluorothymidine) 
predict response at an early time point, and thus treatment 
change can be determined earlier which may lead to a better 
outcome with respect to disease burden and morbidity. Such 
approaches have been seen in lymphoma patients and should 
be implemented for breast cancer as well [7]. In addition 
PET/CT shows great promise in the assessment of patients 
who have various responses in different sites of metastases 
Table 14.1 Surveillance recommendations for women treated for primary breast cancer
Year
History and physical 




2012 Every 3–6 month for 
first 3 years




Posttreatment MG 1 year 
after initial mammogram
At least 6 months after 
completion of radiation 
therapy
Annual MG
Chest radiography, bone scans, liver US, CT, PET, MRI, 
or other laboratory tests: NOT recommended in 









MG every 12 months MRI considered in women with lifetime risk of second 
primary breast cancer greater than 20%
Imaging and laboratory tests not recommended in 
asymptomatic patients
European Society of 
Medical Oncology
2013 Every 3–4 months for 
first 2 years




Ipsilateral (after BCS) and 
contralateral MG every 
1–2 years
MRI may be indicated for young women with dense 
breasts, genetic of familial predispositions
Laboratory or imaging tests not recommended in 
asymptomatic patients
National Institute for 
Clinical Excellence
2011 Regular check-up, 
determined by 
physician or patient
Annual MG Laboratory or imaging tests not recommended routinely
Note: Modified from [5]
BCS breast-conserving surgery, CT computed tomography, MRI magnetic resonance imaging, PET positron emission tomography, US 
ultrasonography
U. Bick and T. H. Helbich
175
a b c
Fig. 14.4 A 66-year-old female with bilateral biopsy proven multicen-
tric breast cancers underwent whole-body 18F-FDG PET/MRI which 
enables “one stop” staging of both locoregional and distant disease 
(histology: right invasive ductal carcinoma NOS, G2, ER/PR positive, 
HER2 negative, p53 weakly positive (10%), MIB-1 20% positive; left 
invasive ductal carcinoma NOS G2, ER/PR positive, HER2 weakly 
positive (20%), p53 weakly positive (10%), MIB-1 10% positive). (a) 
Contrast-enhanced axial T1 subtracted breast MRI image shows multi-
centric disease on the right (arrows) involving the skin, nipple, and 
chest wall and a dominant left breast mass (arrow) involving the nipple; 
bilateral T4 tumors (b, c) Coronal fused whole-body PET/MRI images 
show bilateral FDG avid breast tumors (arrows) (b) and multiple FDG 
avid osseous metastases (arrows) (c). PET/MRI also revealed bilateral 
FDG avid axillary and supraclavicular nodes (not shown). Overall stage 
T4, N3, M1
due to tumor heterogeneity. Several studies have reported 
discordant responses between bone and non-bone metastases 
in 30–43% [7]. Further FDG-PET/CT demonstrated response 
in patients who had no change at anatomic CT and predicted 
progression-free survival and disease-specific survival sig-
nificantly better than CT [7].
14.4  Concluding Remarks
A well-defined evidence-based surveillance protocol is 
needed to manage patients with breast cancer after the initial 
diagnosis, as well as during staging and follow-up. The aims 
of any follow-up are to detect early local recurrence and to 
diagnose and treat cancer and/or therapy-related diseases 
such as metastases. Currently, mammography every 
1–2 years is the only recommended evidence-based imaging 
modality. In asymptomatic patients, there are no data to indi-
cate that any imaging or laboratory test leads to a survival 
benefit; thus these tests are not recommended during surveil-
lance. Recent guidelines recommend CT or MRI in addition 
to bone scintigraphy for stage III and IV disease at the time 
of diagnosis. In the near future, it can be expected that sensi-
tive imaging tests (whole-body MRI or PET/CT/MRI) will 
enhance the ability to stage breast cancer more accurately 
and will allow better prediction and assessment of treatment 
response during targeted therapy.





Fig. 14.5 A 40-year-old female with biopsy proven left breast cancer 
underwent contrast-enhanced brain MRI for further evaluation of head-
ache (histology: invasive ductal carcinoma NOS, G2, ER positive, PR 
negative, HER2 positive, p53 negative, MIB-1 positive). Axial FLAIR 
(a), T1(b) and post-contrast T1 (c) images show enhancing left tempo-
ral lesions in keeping with brain metastases which are heterogeneous 
predominantly hypointense on FLAIR and hypointense on T1 (arrows)
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Fig. 14.6 A 76-year-old 
female with biopsy proven 
right breast cancer and 
ipsilateral nodal disease 
(histology: invasive lobular 
carcinoma, G3, ER/PR 
negative, HER-2 positive, p53 
positive, MIB-1 positive) with 
multiple mixed lytic and 
sclerotic osseous metastases 
in the spine and sternum on 
the sagittal CT bone window 
image (arrows) (a). Post 
chemotherapy the breast and 
nodal lesions regressed (not 
shown). On the post- 
chemotherapy sagittal CT 
image (b), the osseous 
metastases (arrows) show 
interval increased sclerosis in 
keeping with posttreatment 
changes
Take-Home Messages
• Regular, usually annual mammography is the 
cornerstone of surveillance of the ipsilateral 
breast in patients with a personal history of breast 
cancer who were treated with breast-conserving 
therapy.
• Local breast cancer recurrence may lack the typical 
imaging features of primary breast cancer, and reli-
able diagnosis is often based on the combination of 
a thorough clinical exam and tailored multimodal-
ity imaging.
• Current guidelines do not recommend intensive sur-
veillance in asymptomatic breast cancer patients, 
which includes routine blood tests, chest x-ray, 
ultrasound of the liver, CT, MRI, or even PET/
CT. At time of diagnosis, CT or MRI in addition to 
bone scintigraphy is recommended in stage III and 
IV disease.
• More sensitive imaging tests (e.g., whole-body 
MRI or PET/CT/MRI) will enhance the ability to 
stage breast cancer more accurately and may change 
current guidelines.
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CT and MRI have made enormous strides over the past 
decades becoming established imaging techniques in patients 
with suspected ischemic heart disease. The impact of these 
imaging techniques cannot be overestimated in the diagnosis 
and prognostication of patients with ischemic heart disease. 
As ischemic heart disease is highly prevalent, any contribu-
tion to improving the diagnosis and work-up of these patients 
by noninvasive imaging techniques has direct implications to 
more cost-effective diagnosis and therapy. For a long time, 
the mainstay in the diagnosis and treatment of ischemic heart 
disease was conventional x-ray angiography and echocar-
diography. The recognition of limitations inherent to these 
well-established diagnostic methods has led to a surge of 
interest in cardiovascular imaging by CT and MRI. In addi-
tion, nuclear medicine imaging is a well-established imaging 
technology for myocardial perfusion assessment in patients 
with suspected ischemic heart disease. The strength of this 
imaging technology is the wealth of outcome data for patient 
management, but CT and MRI have also made big strides to 
pose as an alternative for myocardial perfusion imaging as 
well as other approaches to assess the functional significance 
of coronary artery disease.
CT and MRI have their own strengths and weaknesses to 
provide diagnostic information in the work-up of patients 
with suspected ischemic heart disease. The main break-
through was coronary CT angiography providing unparal-
leled high-quality noninvasive visualization of coronary 
artery disease, now firmly established as the preferred tool to 
exclude coronary artery disease in patients with intermediate 
likelihood for coronary disease based on their clinical risk 
profile. The main limitation of CT was the lack of functional 
information to estimate the significance of a stenosis as a 
flow-limiting lesion that may cause myocardial ischemia. 
Nowadays CT may provide this crucial information for 
patient management by rest/stress CT perfusion and nonin-
vasive estimation of the fractional flow reserve (CT-FFR). 
The integration of diagnosing coronary artery anatomy (ste-
nosis) in conjunction with functional assessment (ischemia) 
provides a complete tool for clinical decision-making (indi-
cation for percutaneous coronary intervention or bypass sur-
gery). In contrast, MRI has lacked behind to CT as a robust 
imaging tool for noninvasive coronary artery imaging. The 
main strengths of cardiac MRI are the unsurpassed high- 
quality images of cardiac anatomy and global left ventricular 
function and a wide armamentarium for myocardial tissue 
characterization. For example, MRI late gadolinium enhance-
ment (LGE) started over 30  years ago and took a relative 
long time before becoming established as a unique noninva-
sive tool to assess the transmural extent of a myocardial scar 
with great clinical implications. The combined use of cine 
MRI and LGE is clinically highly relevant to characterize 
ischemic heart disease and to differentiate ischemic from 
nonischemic heart disease. Cine MRI is unsurpassed in accu-
racy for precisely measuring structure (wall thickness) and 
function (ejection fraction). Next to LGE, a number of other 
Learning Objectives
• To understand basic approaches of CT and MRI in 
ischemic heart disease.
• To learn systematic approach to diagnose ischemic 
heart disease.
• To learn about differential diagnoses shown by CT 
and MRI.
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MRI techniques have been established for myocardial tissue 
characterization that provide additional information on acute 
versus chronic scar (T2 mapping, STIR) and diffuse myocar-
dial fibrosis (T1 mapping, extracellular volume or ECV). 
Combining these MRI techniques for tissue characterization 
has some similarity with how a pathologist may combine dif-
ferent staining techniques for tissue characterization to come 
to a final diagnosis. MRI myocardial tissue “staining” has 
been established as an invaluable tool for characterizing 
myocardial disease in patients with suspected ischemic heart 
disease as well as in patients with unexplained heart failure 
to differentiate ischemic heart disease from the large number 
of nonischemic cardiomyopathies (nonischemic dilated car-
diomyopathy, hypertrophic cardiomyopathy, amyloid, other 
storage diseases, and alike).
Patients are referred to cardiac or chest CT and MRI by 
various medical disciplines (e.g., cardiology, internal medi-
cine, emergency department) with different clinical ques-
tions and scenarios. For example, many referrals for 
evaluating acute chest pain come from the emergency depart-
ment (“rule out pulmonary embolism”). The current high 
volume of pulmonary embolism referrals may lead to a num-
ber of unexpected findings on chest CT, as the yield of this 
referral for a positive diagnosis of pulmonary embolism is 
quite low and the clinical work-up of these patients may be 
suboptimal. The high-quality CT images of today, even if 
ungated, provide good diagnostic information on cardiac 
anatomy and coronary disease. So, coronary artery disease is 
becoming an “incidental finding” on routine chest CT 
requested for other indications. Radiologists are now in a 
central and responsible position to diagnose or rule out not 
only pulmonary embolism in acute chest pain evaluation but 
also be prepared to diagnose the extensive differential diag-
nosis (over 30 differential diagnoses) of a patient presenting 
with acute chest pain (main causes are life-threatening acute 
coronary occlusion, aortic dissection, and pulmonary 
embolism).
In this course we will discuss the role of CT and MRI 
in patients with suspected ischemic heart disease. First, 
the basic aspects of the pathophysiology (ischemic cas-
cade) and technology will be shortly summarized. 
Secondly, the specific utility of CT and MRI in suspected 
ischemic heart disease will be illustrated using patient 
examples. The patient presentations will also consider a 
stepwise approach on how to differentiate ischemic from 
nonischemic cardiomyopathies and the differential diag-
nosis of acute chest pain.
15.2  Cardiac MRI
15.2.1  MRI Techniques
Myocardial function is typically evaluated using cine bal-
anced steady-state free precession (bSSFP) imaging, provid-
ing optimal contrast between the blood pool (bright signal) 
and myocardium (intermediate-low signal). Cine MRI is 
used to assess ventricular function and valvular function in 
various orientations (transverse, angulated). As a starting 
point, the transverse cine images provide a global impression 
on left ventricular function, regional function (scar, aneu-
rysm), and valvular function (stenosis jet, regurgitation jet, 
valve morphology). Short-axis cine images are routinely 
applied for calculation of ventricular volumes (ejection frac-
tion is very important for clinical decision-making and prog-
nostication). LGE-MRI is the reference standard for imaging 
myocardial scar. Based on inversion recovery methods, con-
trast is created between normal (dark, gadolinium excluded 
from intact cells) myocardium and scar (white due to gado-
linium accumulation). Both acute and chronic infarct may 
display LGE.  Acute infarcts show LGE due to cell mem-
brane breakdown, whereas chronic collagen scar has little 
cellular volume and larger volume of distribution and there-
fore accumulates gadolinium. A particular strength of LGE 
is visualization of very small scars as well as the transmural 
extent of necrosis (starts at the subendocardium and may 
progress through the ventricular wall as a wave front with 
longer durations of coronary occlusion). Myocardial signal 
intensity depends on the T1, T2, T2*, and proton density of 
the tissue. All these parameters are actively explored for bet-
ter characterizing the severity of myocardial injury. 
Quantitative maps of myocardial T1, T2, T2*, and extracel-
lular volume (ECV) are attractive alternative methods for 
better tissue characterization. Quantitative methods for char-
acterizing myocardial tissue based on parametric mapping of 
T1 and T2 have been explored as an objective tool of detect-
ing and quantifying focal as well as global myocardial tissue 
alterations. In combination with extracellular contrast agent 
(gadolinium) injection, T1 mapping can also estimate the 
extracellular volume (ECV) fraction. Non-contrast enhanced, 
native T1 mapping and ECV mapping are explored as a diag-
nostic tool in both acute and chronic myocardial infarction 
and may be used to assess the area at risk (edema). Many 
other disease processes in the myocardium may result in 
elevated (e.g., myocarditis, amyloidosis) or decreased (e.g., 
Fabry disease, high iron content) native T1 values. Native T2 
mapping can detect edema in myocarditis, area at risk, and 
acute myocardial infarction. Technical details of pulse 
sequences, acquisition protocols, scanner adjustments, arti-
facts, image processing (windowing) and other confounders 
are affecting and complicating reliable determination of 
parametric maps. Well-controlled and optimized techniques 
Key Point
• LGE is helpful MRI technique to differentiate isch-
emic from nonischemic cardiomyopathy.
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are crucial to improve accuracy (saturation methods), preci-
sion (inversion methods), and reproducibility of the use of 
parametric imaging. The acquisition technique combines an 
inversion or saturation pulse to pertubate T1, sampling of the 
relaxation curve, and a model to fit the sampled curve and 
extract the myocardial T1 value. Initial methods for pixel-
wise parametric T1 mapping are MOLLI and shMOLLI 
(modified Look-Locker inversion and shortened breath-hold 
modified Look-Locker inversion, respectively) sequences. 
Inversion methods (e.g., MOLLI, shMOLLI), saturation 
methods (e.g., SASHA, saturation recovery single-shot 
acquisition), and combined inversion and saturation methods 
(e.g., SAPPHIRE, saturation pulse prepared heart-rate- 
independent inversion recovery) are explored to optimize the 
reliability of acquisition schemes. Motion artifacts have been 
reduced by schemes that allow high-resolution imaging at 
the same cardiac and respiratory phase. The ECV in the 
myocardium is estimated from the concentration of extracel-
lular contrast agent in the myocardium relative to the blood 
in a dynamic state. The formula for calculation of ECV 
incorporates hematocrit (determined for each individual 
from blood sample or synthetic Ht, reflecting blood volume 
of distribution) and change in relaxation rate between pre-
contrast and postcontrast (proportional to gadolinium con-
centration, 15  min after bolus injection). Quantitative T2 
mapping is commonly performed using single-shot 
T2-prepared SSFP approach, although other approaches are 
available. For example, images may be acquired at three 
echo times, and after monoexponential curve fitting, a pixel-
wise T2 map is produced.
The initial area at risk after coronary occlusion (before 
necrosis develops) may be visualized as a bright region by 
using T2-weighted MRI techniques. Multiple MRI tech-
niques are available to provide optimal T2 contrast. 
T2-weighted imaging is also helpful to differentiate acute 
(white) from chronic scar (dark), as both may show similar 
LGE. Shortly after coronary occlusion edema may develop 
in the area at risk (the myocardium dependent on that coro-
nary artery) and may be shown as a bright region on 
T2-weighted imaging. Initially dark-blood T2-weighted 
sequences were used for defining the presumed edema in the 
area at risk. However, when limitations and artifacts of these 
techniques raised some controversy on their utility, T2 map-
ping, T1 mapping, early gadolinium enhancement, and 
contrast- enhanced bSSFP cine MRI were proposed as alter-
native methods to visualize the area at risk. The area at risk 
appears bright on T2-weighted imaging (long T2) or dark on 
T1-weighted imaging (long T1) and in the bright range of the 
color scale on quantitative T1 and T2 maps due to long T1 
and long T2. The endocardial surface area (approximation of 
the wave front) method of acute infarction has also been used 
to estimate the area at risk. The ischemic cascade may fur-
ther progress with necrosis starting at the subendocardial 
level and depending on duration of occlusion may progress 
throughout the entire wall (transmural, full thickness infarct). 
LGE MRI may show the transmural extent of the infarct to 
best advantage. In large infarcts with extensive necrosis, a 
central area of no enhancement may be seen (microvascular 
obstruction). T2* imaging is useful to detect intramyocardial 
hemorrhage due to susceptibility for breakdown products of 
hemoglobin. Intramyocardial hemorrhage is considered as 
an additional marker of more severe myocardial injury, like 
microvascular obstruction. A number of other complications 
may be observed on cardiac MRI in ischemic heart disease 
(aneurysm, thrombus, contained rupture).
15.3  Myocardial Infarction
Acute coronary occlusion leads to myocardial necrosis in 
the distribution area of the culprit coronary artery. Occlusion 
of the left anterior descending area will cause necrosis in the 
anterolateral wall, occlusion of the right coronary artery 
most commonly involves the inferoseptal wall, and occlu-
sion of the circumflex coronary artery will involve the lat-
eral wall. Inversely, recognizing scar in these locations may 
help to suspect the culprit artery. Ischemic heart disease can 
be suspected by regional abnormalities in the distribution 
area of individual coronary arteries. LGE is currently the 
highest- resolution method for detecting acute myocardial 
infarction with very high sensitivity, even to demonstrate 
microinfarcts (e.g., embolic infarction in patients undergo-
ing percutaneous coronary intervention). The size of the 
region of hyperenhancement is a clinically validated mea-
surement of infarct size, correlating with the degree of ele-
vations of cardiac enzymes and other markers of necrosis. 
Acute myocardial infarcts will show LGE with variable 
transmurality and sometimes central microvascular obstruc-
tion (larger infarcts, worse prognosis). Microvascular 
obstruction and related no- reflow phenomenon can prevent 
reperfusion of the core of the infarct after reperfusion ther-
apy and indicates more severe ischemia. Note the transmu-
ral extent of the infarct (grading more or less than 50% of 
wall thickness, indicating residual viability if less than 
50%). Viability assessment based on grading transmurality 
of the infarct may help to guide revascularization options 
(percutaneous intervention or bypass surgery). When ana-
lyzing patients with heart failure, the first step is to suspect 
regional abnormalities in the myocardium (e.g., a scar or 
Key Point
• Acute as well as chronic myocardial infarction 
show LGE. T2-weighted MRI is helpful to differen-
tiate acute from chronic myocardial injury.
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wall thinning in the anterior wall is likely due to occlusion 
of the left anterior descending (LAD) artery). Wall thinning 
indicates the presence of long- standing scar (i.e., chronic 
infarct). For example, coronary CT angiography may show 
occlusion of the LAD and MRI may show LGE of chronic 
scar in the anterior wall. However, recanalization of a coro-
nary artery may occur after myocardial infarction; therefore 
not all patients with a previous infarct will reveal occlusive 
coronary artery disease. Complications of previous infarcts 
include a left ventricular aneurysm (wide connection, 
involving all wall layers, true aneurysm), pseudoaneurysm 
(narrow neck, pericardial enhancement due to contained 
rupture in pericardial sack, predilection for inferior wall, 
large size), and thrombus adjacent to scar (best shown on 
LGE imaging). Thrombus is a common complication after 
myocardial infarction and may be missed by echocardiogra-
phy, especially in apical location. LGE imaging is helpful to 
detect both acute and chronic infarction. T2-weighted imag-
ing is used to differentiate acute versus chronic infarction. 
CT may also show the infarct as a perfusion defect and 
sometimes late iodine enhancement may reveal the infarct, 
although LGE MRI is better suited to demonstrate late 
enhancement with greater conspicuity. It is important to be 
aware of “incidental perfusion defects” in the myocardium 
when evaluating chest CT in patients with unexplained chest 
pain. In the scenario of acute chest pain, look for the pres-
ence and extent of coronary calcifications as a marker of 
coronary atherosclerosis (visual grading minor, moderate or 
severe works well as compared to the Agatston score). 
Coronary anomalies may be noted in young patients (coro-
nary aneurysm in Kawasaki disease) or “malignant” course 
between the pulmonary artery and aorta (cause for ischemia 
and sudden death in young people). There are a number of 
anatomic variants of coronary anatomy that may have lim-
ited clinical significance (e.g., anomalous course of circum-
flex posterior to aorta, bridging of LAD).
15.4  Heart Failure
In patients presenting with heart failure the first question is 
whether coronary artery disease (previous infarcts) is the 
underlying problem. Coronary CT angiography and cardiac 
MRI are well suited to assess comprehensively the presence 
and extent of ischemic cardiomyopathy (see above). 
However, many patients with unexplained heart failure may 
suffer from a large number of other disease entities that may 
lead to heart failure. A common cause for heart failure is 
idiopathic, nonischemic dilated cardiomyopathy. The sys-
tematic analysis of CT and MRI images may help to clarify 
the diagnosis of nonischemic dilating cardiomyopathy. 
Coronary CT angiography will most commonly show nor-
mal coronary anatomy, although sometimes coexisting coro-
nary disease may be noted. The overall appearance of the left 
ventricle indicates global dilation and diffuse wall thinning 
in patients with nonischemic dilating cardiomyopathy (in 
contrast to ischemic cardiomyopathy where we expect 
regional scar or wall thinning), although sometimes three- 
vessel coronary artery disease may also result in this pheno-
type (hibernating left ventricle where bypass surgery can be 
advantageous to reverse global ischemia). Cardiac MRI 
using cine imaging will show the same appearance in a 
dynamic format. Cine MRI is very accurate to estimate the 
volumes and ejection fraction. The ejection fraction is a cru-
cial parameter to decide for ICD placement. LGE will most 
commonly show no scar or LGE in patients with nonisch-
emic dilating cardiomyopathy. In a minority of these patients, 
a scar in the middle of the ventricular wall can be shown 
(midwall scar is a trigger point for arrhythmias and may be 
an indication for preventive ICD placement).
Another common cause for heart failure is characterized 
by the hypertrophic phenotype. The hypertrophic phenotype 
has a number of underlying causes for myocardial thicken-
ing. The wall thickening can be local (“humps and bumps”) 
in any location, most common in the septum in patients with 
genetically determined hypertrophic cardiomyopathy (the 
most common cause for sudden death in young people), but 
can also present as diffuse wall thickening. Simple explana-
tions for left ventricular hypertrophy may be the presence of 
long-standing high blood pressure and outflow obstruction 
(e.g., aortic valve stenosis, bicuspid aortic valve). Sometimes 
physiological hypertrophy may occur in endurance athletes 
that may be reversible after stopping heavy exercise. After 
excluding these obvious causes for left ventricular hypertro-
phy, it is important to analyze cine MRI images and LGE 
images to narrow the differential diagnosis of the hypertro-
phic phenotype. Cardiac MRI is now playing a crucial role in 
systematically analyzing the potential underlying cause in 
unexplained heart failure presenting with the hypertrophic 
phenotype. The genetic hypertrophic phenotype is an impor-
tant first consideration. Most commonly local hypertrophy 
will be recognized in the septum, but it may occur in any 
location and may even present with diffuse, global hypertro-
phy. There are a number of secondary helpful clues for this 
diagnosis on imaging. On cine imaging there may be a jet 
phenomenon in the outflow tract to the aorta (hypertrophic 
obstructive cardiomyopathy, exaggerated by the elongated 
anterior leaflet of the mitral valve, systolic anterior motion 
(SAM)), secondary mitral regurgitation with enlargement of 
the left atrium is frequent, supernormal ejection fraction 
(hypercontractile left ventricle), and clefts in the myocar-
dium. LGE is helpful to assess scar distributed in the myo-
cardium in genetic hypertrophy (nonischemic pattern) and is 
a marker for arrhythmia risk. Cardiac amyloidosis is another 
disease that may present with the hypertrophic phenotype 
and is characterized by diffuse subendocardial LGE (not 
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confined to a coronary artery distribution area). A number of 
other storage diseases may present with the hypertrophic 
phenotype (e.g., Fabry disease, typical LGE in posterolateral 
wall, sometimes focal hypertrophy, dilated aorta). Fabry dis-
ease is characterized by sphingolipid accumulation intracel-
lularly (shown by native T1 mapping, ECV unchanged), 
sometimes complicated by diffuse or focal scar. Therapy is 
available for Fabry disease, so important to recognize and 
diagnose early. Inflammatory diseases (SLE, myocarditis, 
sarcoid) may present also with heart failure and the hypertro-
phic phenotype. Myocarditis may be recognized by subepi-
cardial LGE in typical locations. A number of drugs may 
accumulate in the heart and present with heart failure and 
hypertrophy (e.g., amiodarone, hydroxychloroquine used in 
rheumatology, simulating Fabry disease).
15.5  Cardiac CT
15.5.1  CT Technique and Low-Dose CT 
Coronary Angiography
Technical developments such as wide detectors, dual source 
configuration, low kV scanning and high-pitch acquisitions 
have allowed to establish coronary CT angiography (CCTA) 
as an imaging modality that provides high temporal and 
spatial resolution, for motion-free cardiac imaging and 
detailed visualization of coronary or myocardial pathology. 
With increasing utilization of coronary CT angiography, 
especially low-dose CCTA acquisitions are constantly 
improving, in order to combine CT’s high anatomical reso-
lution with short examination times while still maintaining 
very low radiation exposure. Specifically, high-pitch CT 
(pitch >3), low kV (as low as 70 kV), and iterative recon-
struction algorithms have resulted in cardiovascular exams 
with radiation exposure of <1 mSv [1]. For a detailed visu-
alization of the cardiac and coronary anatomy, ECG-
triggered protocols are recommended, although it has also 
been demonstrated, that the detection of the coronary arter-
ies is possible even in a non-ECG-triggered spiral mode 
with high temporal resolution [2]. Most CCTA cases today 
will be scanned in a prospective ECG-triggered sequential 
scan (“step-and-shoot mode”) or, if a dual-source CT scan-
ner is available, in high- pitch scan mode, whereas retro-
spective ECG-gating should be avoided or reserved to 
special cases (high heart rates, arrhythmia) due to poten-
tially high radiation exposure.
15.5.2  Stable Angina
Consequently, CCTA has emerged as a noninvasive, robust, 
and well-established diagnostic tool for the assessment and 
evaluation of patients with known or suspected CAD and in 
stable angina pectoris. There is a large body of evidence for 
these indications, demonstrating a high diagnostic accuracy 
with a sensitivity ranging from 94 to 99% and a specificity 
of 64–83% for the detection of significant coronary stenoses 
(i.e., diameter stenoses >50% in a morphological assess-
ment) [3]. Clinically, with its high negative predictive value 
ranging from 97 to 99%, CCTA represents a reliable diag-
nostic imaging tool to rule out obstructive CAD, especially 
in low- to intermediate-risk settings [3–6]. As such, large- 
scale registries and prospective trials have shown that CCTA 
serves as a valuable alternative to invasive diagnostic testing 
in patients with stable angina [7–9] and low to intermediate 
pretest likelihood of CAD (e.g., asymptomatic, younger 
patients) and in those with less extensive coronary artery 
calcification, especially in patients who are unable to 
undergo stress testing for functional testing [6, 9]. An exam-
ple of a negative coronary CT angiography in a relatively 
young female patient with suspected CAD is provided in 
Fig. 15.1. Furthermore, due to the ability of CCTA for visu-
alization and assessment of coronary atherosclerotic plaque, 
three- dimensional vessel trajectories and anatomical fea-
tures of the coronary vessel segments as well as detection of 
pathological coronary artery alterations such as calcifica-
tions or occlusions, CCTA is gaining recognition as a useful 
imaging tool in pre-procedural planning of cardiovascular 
interventions, providing improved success rates for revascu-
larization and post-procedural outcome after percutaneous 
techniques [10]. Besides its diagnostic value, there is also an 
increasing role of CCTA to predict cardiovascular risk over 
time, as several follow-up studies report an excellent prog-
nosis for patients negative at CCTA for any CAD or coro-
nary atherosclerosis, whereas outcome in patients with 
obstructive and also nonobstructive CAD is substantially 
worse [11, 12].
15.5.3  Acute Chest Pain
The work-up of patients in the emergency room is complex 
and sometimes suboptimal, leading to a high number of 
unnecessary hospital admissions. Both CT and MRI have 
been successfully used as a gatekeeper to diagnose life- 
threatening causes of acute chest pain (i.e., acute myocardial 
infarction, aortic dissection, and pulmonary embolism). In 
the setting of acute chest pain potentially caused by an acute 
coronary syndrome (ACS) or non-ST-elevation myocardial 
infarction (NSTEMI), there is strong evidence that CCTA 
improves the efficiency of clinical decision-making in the 
Key Point
• MRI is a first-line modality to diagnose the underly-
ing cause in patients with heart failure.
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emergency department, resulting in a shorter length of hospi-
talization and reduced costs [13]. Several large randomized 
trials (CT-STAT, ACRIN-PA, ROMICAT II, and 
CT-COMPARE) compared coronary CT angiography to the 
current standard of care in patients with acute chest pain 
[13–16]. Their clinical implementations illustrated the reli-
ability of a negative coronary CT angiography in identifying 
patients for discharge from the emergency department [17]. 
Here, coronary CT angiography allows for fast and safe tri-
age of patients. In clinical practice, individuals demonstrat-
ing severe coronary stenosis are often directly referred to 
invasive catheter angiography, and patients with intermedi-
ate stenosis, high overall plaque burden, or equivocal find-
ings typically undergo functional testing [18, 19].
15.6  Functional Assessment of Coronary 
Artery Disease
15.6.1  CT-Based Fractional Flow Reserve 
(CT-FFR) and Imaging of Myocardial 
Perfusion
Given its established value in morphologic imaging of CAD, 
research efforts over the last years have focused on providing 
information beyond the assessment of coronary stenosis and 
atherosclerotic vessel wall changes. To date, CT offers two 
different approaches to assess the functional relevance of a 
given stenosis: (A) myocardial perfusion imaging (which 
can be performed in a dynamic or static fashion) and (B) the 
calculation of a CT-based fractional flow reserve (CT-FFR). 
CT myocardial perfusion is based on the first-pass effect of 
iodinated contrast media through the myocardium during 
vasodilator stress (pharmacologically induced using regade-
noson, adenosine, or dipyridamole). The study can either be 
performed by obtaining one single scan during maximum 
enhancement (also referred to as “static” or “snapshot/
Key Point
• Coronary CT angiography is a first-line modality 
for excluding coronary artery disease in patients 
with intermediate likelihood of disease.
a
b d e f
cFig. 15.1 Coronary CT of a 
48-year-old female with 
exertional atypical chest pain. 
The CT reveals the absence of 
coronary atherosclerotic 
plaque or stenosis. (a) Axial 
slice demonstrating the left 
main coronary artery 
(asterisk) and the left anterior 
descending coronary artery 
(arrow head). (b) Origin of 
the right coronary artery 
(white arrow) and proximal 
segment of the left anterior 
descending coronary artery 
(arrow head) and left 
circumflex coronary artery 
(open arrow). (c) Volume 
rendered three-dimensional 
reconstruction showing the 
left anterior descending 
coronary artery as well as the 
branch of the right coronary 
artery and the circumflex 
coronary artery. (d–f) 
Multiplanar curved 
reconstructions of the right 
coronary artery (d), the left 
anterior descending coronary 
artery (e), and the circumflex 
coronary artery (f) 
demonstrating the absence of 
coronary atherosclerotic 
plaque or coronary artery 
stenosis. AA ascending aorta, 
LA left atrium, RV right 
ventricle
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single- shot” perfusion imaging) or by acquiring multiple 
scans during contrast passage (i.e., a “dynamic,” time- 
resolved imaging of myocardial perfusion). The benefit of 
the “snapshot” protocol is the reduction of radiation expo-
sure, whereas the “dynamic” protocol enables the absolute 
quantification of myocardial blood flow and volume. 
Perfusion defects as obtained by these techniques are identi-
fied as areas of hypo-attenuated myocardium compared to 
perfusion at baseline. While reversible malperfusion indi-
cates ischemic myocardium, persistent perfusion defects are 
considered to represent myocardial scar tissue [20, 21]. The 
calculation of the CT-FFR using flow dynamics from coro-
nary computed tomography angiography images is another 
noninvasive method for the assessment of flow dynamics 
[22]. This novel approach allows lesion-specific flow analy-
sis throughout the coronary tree without additional imaging 
or vasodilator stress, i.e., this calculation is based on the 
original CCTA examination. The currently most widely used 
technique (known as FFRCT) uses a complex reconstruction 
algorithm to create a three-dimensional (3D) model of the 
coronary arteries and assess the left ventricular mass which 
is directly proportional to the total blood flow at rest. By 
combining the information of branch diameter from the 3D 
model and resting blood flow, it is possible to specifically 
calculate the blood flow for each coronary segment (see an 
example in Figs. 15.2 and 15.3). Recently, freely available 
and simplified approaches using a one-dimensional (1D) 
analysis (cFFR) are under investigation [23].
Key Point
• The presence or absence of flow limitation caused 
by a coronary artery stenosis can be estimated by 
computational fluid dynamics using the coronary 













Fig. 15.2 Example of a CT-based derivation of fractional flow reserve 
model (CT-FFR, upper bar) and source coronary CT datasets demonstrat-
ing diffuse calcified and non-calcified plaques with hemodynamically 
relevant coronary stenosis present in the distal left anterior descending 
coronary artery (also A) and a large diagonal branch (red color-coding in 
the FFR model), whereas the right coronary artery and the left circumflex 
coronary artery (C and B, respectively) have diffuse coronary artery dis-
ease without hemodynamically relevant coronary lesions
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15.7  Assessment of Atherosclerotic Plaque
Given its high spatial resolution, CCTA offers the unique 
potential to noninvasively visualize, characterize, and quan-
tify atherosclerotic plaque [24]. The notion of vulnerable 
plaques is a rather complex concept; however, specific high- 
risk plaque features can be identified on standard CCTA 
datasets. Several adverse features associated with vulnerable 
plaques have already been identified with CCTA; these 
include the presence of positive remodeling, low-attenuation 
plaque, spotty calcifications, and the napkin ring sign (see a 
typical low-attenuation plaque in Fig. 15.3) [25–28]. In con-
trast, larger calcification is more likely to be found in stable 
coronary lesions. Although the evidence is still very limited, 
detailed assessment of plaque morphology for detection of 
high-risk plaque features in patients presenting to the ED 
with acute chest pain but negative initial electrocardiogram 
and troponin may provide incremental diagnostic value, as 
the presence of high-risk plaque increases the likelihood of 
ACS, independent of significant CAD and clinical risk 
assessment, including age, sex, and number of cardiovascu-
lar risk factors [29]. Thus, identification of such high-risk 
plaques may thus improve risk estimates for the individual 
patient and may be of use in the selection of patients who 
benefit from revascularization.
15.8  Summary
Cardiac MR and CT imaging have seen an incredible 
speed of development over the past years. Today, both 
technique are readily and widely available and have 
reached a point of robustness while providing complex 
and complementary information at the same time, making 
both ever more important in clinical routine management 
of CAD patients.
a b
Fig. 15.3 Coronary CT of an atherosclerotic plaque in the LAD, dem-
onstrating high-risk plaque features, including low-attenuation and 
positive remodeling in the proximal segment of the left anterior 
descending coronary artery. (a) curved multiplanar reformat and corre-
sponding cross section of the vessel (b)
Take-Home Messages
• Parametric T1 mapping of the myocardium may 
provide an objective method to diagnose acute 
infarction, area at risk, and diffuse fibrosis unseen 
by LGE.
• Late gadolinium enhancement by MRI has the 
unique feature to demonstrate the transmural extent 
of scar. Transmural extent of scar is very important 
for diagnosis of remaining myocardial viability and 
therefore for clinical decision-making in patients 
with ischemic heart disease.
• Coronary CT angiography is highly reliable for 
excluding coronary artery disease in patients with 
intermediate likelihood of disease.
• Functional assessment of an intermediate coronary 
stenosis requires ischemia testing by using myocar-
dial perfusion or estimating fractional flow reserve 
by state-of-the-art CT techniques to guide treatment 
options.
A. de Roos and K. Nikolaou
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Symptomatic myocardial disease not the result of flow- 
limiting coronary artery disease or prior myocardial infarc-
tion is commonly known as nonischemic cardiomyopathy. 
Clinical manifestations include arrhythmia, palpitations, 
heart failure, shortness of breath, lower extremity edema, 
syncope, and chest pain. Nonischemic cardiomyopathy is 
more common in women and younger patients. In general, 
the prognosis for nonischemic cardiomyopathy is better than 
for ischemic disease. There may be either systolic, diastolic, 
or combined heart failure. Infiltrative cardiomyopathies in 
particular tend to result in diastolic dysfunction.
In most patients, ischemic cardiomyopathy should be 
considered and excluded prior to further work-up of nonisch-
emic cardiomyopathy. Echocardiography is the primary 
modality for evaluating left ventricular function as well as 
valvular and diastolic function. Advanced techniques includ-
ing pulsed tissue Doppler and 3-D imaging have added diag-
nostic and prognostic information when evaluating 
nonischemic cardiomyopathy. Stress tests either exercise or 
chemical with or without imaging are commonly used to 
exclude underlying ischemia. If these studies are inconclu-
sive, the patient may require cardiac catheterization with 
ventriculography. However, if the patient is low to intermedi-
ate likelihood for coronary artery disease, coronary com-
puted tomography angiography can be performed to 
differentiate between ischemic and nonischemic cardiomy-
opathy. Positron emission tomography may be utilized for 
the evaluation of cardiac sarcoidosis.
Cardiac MRI (CMR) is considered the reference standard 
to assess myocardial anatomy, function, and viability and 
often reveals the underlying etiology of heart failure [1]. 
Delayed enhancement in nonischemic cardiomyopathy usu-
ally occurs in a mid-myocardial or subepicardial location 
rather than subendocardial or transmural as seen in ischemic 
disease. The location of delayed enhancement can also help to 
guide myocardial biopsy thus increasing yield of a diagnosis. 
It can also be utilized to screen in genetically positive but phe-
notypically negative patients to better help with risk stratifica-
tion. Finally, there has been significant prognostic value shown 
related to the location and extent of delayed enhancement.
16.2  Hypertrophic
Hypertrophic cardiomyopathy is the most common genetic 
cardiac disorder with heterogeneous phenotypic expression. 
Patients present clinically most commonly with sudden 
death from ventricular fibrillation, atrial fibrillation, or heart 
failure but may be asymptomatic. MRI is utilized not only to 
make the diagnosis of hypertrophic cardiomyopathy but also 
to characterize the morphologic types related to the distribu-
tion of the hypertrophied muscle. Different types include 
apical, mid-ventricular, concentric, and mass-like although 
the most common is asymmetric septal hypertrophy. 
Ventricular wall thickness of >30 mm (normal <15 mm) has 
Learning Objectives
• Identify nonischemic pattern of delayed 
enhancement.
• Develop a differential diagnosis for dilated 
cardiomyopathy.
• Evaluate the functional impact of nonischemic 
cardiomyopathy.
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been shown to be an independent risk factor for sudden car-
diac death [2]. MRI is the procedure of choice for monitoring 
left ventricular mass over time and in response to treatment.
The area of hypertrophy in asymmetric septal type is 
commonly located at the basal aspect of the interventricular 
septum which can result in left ventricular outflow tract 
obstruction as shown in Fig.  16.1. Using phase-contrast 
imaging on MRI, the degree of obstruction can be evaluated 
based on the velocity in the left ventricular outflow tract 
using the modified Bernoulli equation (gradient = 4 V2) to 
calculate the gradient (severe >50 mm Hg). If conservative 
treatments are not effective, septal ablation or surgical proce-
dures may be required for LVOT obstruction. The acceler-
ated flow in the left ventricular outflow tract can result in 
systolic anterior motion of the mitral valve which can result 
in mitral regurgitation. Not only can these two findings be 
identified during MRI examinations, but the severity of 
mitral regurgitation can also be quantified. MRI can also be 
utilized to assess cardiac function and regional wall motion.
Delayed enhancement imaging is performed in all hyper-
trophic cardiomyopathy patients in order to evaluate for inter-
stitial fibrosis, microfibrillar disarray, or microvascular 
obstruction. The delayed enhancement images are positive in 
60% of these patients [3]. While the delayed enhancement is 
most commonly seen in a patchy distribution in the mid- 
myocardium at the right ventricular insertion point, it can be 
seen throughout the hypertrophied myocardium and some-
times even in the non-hypertrophied muscle. Delayed 
enhancement has demonstrated prognostic information in 
several studies of cardiac outcomes including worsening 
heart failure symptoms, ventricular arrhythmias, ICD dis-
charge, and sudden cardiac death [4]. The absence of delayed 
enhancement has prognostic information as well with overall 
lower risk for adverse cardiac outcomes although the risk is 
still not absent [5]. Not only is the presence or absence of 
delayed enhancement important, but the extent of late delayed 
enhancement is a significant predictor of adverse cardiac out-
comes [5]. The largest study to date in this patient cohort 
demonstrated that only the extent of delayed enhancement 
was a strong predictor of adverse cardiac events and mortality 
[6]. Limited studies are available regarding the utilization of 
MRI to monitor treatment for hypertrophic cardiomyopathy.
16.3  Dilated Cardiomyopathy
16.3.1  Idiopathic
Idiopathic dilated cardiomyopathy represents an end-stage 
pump failure of the heart; the disease is considered to be 
idiopathic when no immediate cause is discerned. However, 
Key Point
• In hypertrophic cardiomyopathy, MRI is used not 
only to make the diagnosis but also to characterize the 
morphology and evaluate for outflow obstruction.
Fig. 16.1 Septal hypertrophic cardiomyopathy. Short axis steady-state 
free precession image demonstrates thickening of the myocardium 
involving the anteroseptal segment of the basal left ventricle. Three- 
chamber image from a cine steady-state free precession series demon-
strates septal hypertrophy with anterior motion of the anterior leaflet of 
the mitral valve and associated flow jet in the left ventricular outflow 
tract below the level of the aortic valve
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it is believed that this end-stage condition of the heart may be 
produced by a variety of toxic, metabolic, or infectious 
agents. Idiopathic dilated cardiomyopathy may be the late 
sequela of infection such as viral myocarditis. In some cases, 
genetic abnormalities are also associated with this condition. 
In this condition, there is gradual increased left ventricular 
end-systolic and end-diastolic volumes with continuously 
declining ejection fraction. The walls of the ventricle are 
thinned.
On CMR, decreased function, ventricular dilatation, and 
wall thinning are readily demonstrated. However, the primary 
advantage of CMR compared to other imaging modalities is 
the use of late gadolinium enhancement. Late gadolinium is 
not seen in all patients. However, in some patients, there is 
characteristic enhancement if the mid- myocardium in a non-
coronary artery distribution. This pattern of late gadolinium 
enhancement has also been recognized in postmortem hearts 
as a hallmark of this condition. Right ventricular dilatation is 
also characteristic of idiopathic dilated cardiomyopathy. 
Furthermore, the presence and extent of myocardial late 
enhancement have been shown to predict the clinical outcome 
[7]. After adjustment for LVEF and other conventional prog-
nostic factors, both the presence of fibrosis and the extent of 
midwall enhancement on CMR were independently and 
incrementally associated with all- cause mortality.
16.3.2  Viral Myocarditis
The use of CMR for the evaluation of viral myocarditis is 
increasingly accepted. The diagnosis of viral myocarditis is 
challenging, as no single test may be used alone for diagno-
sis. Patient presentation is with chest pain in the setting of a 
recent or ongoing viral syndrome. The primary differential 
diagnoses include acute coronary artery syndrome and peri-
carditis. Other inflammatory myocarditis may also be con-
sidered. Troponin values are typically only mildly elevated.
CMR is used for assessment of inflammatory changes 
such as edema, hyperemia, and myocyte necrosis. No single 
pathognomonic finding is present. Rather, the Lake Louise 
criteria are applied. This requires abnormalities in two of the 
three tissue characterization techniques: T2-weighted images 
for edema, T1 early gadolinium enhancement imaging for 
hyperemia, and late gadolinium enhancement for myocyte 
necrosis and fibrosis. T1 and T2 mapping techniques can 
help reduce uncertainty that is otherwise associated with 
qualitative assessment of signal intensity change. A recent 
multicenter study showed that LV function may be normal or 
mildly depressed [8]. Overall sensitivity of CMR was 82%. 
Late gadolinium enhancement may be present in a nonisch-
emic pattern in 80% of cases. The distribution of LGE is 
typically either subepicardial or midwall. Pericardial effu-
sions are not common.
16.3.3  Takotsubo Myocarditis
Takotsubo is a transient condition involving a distinctive pat-
tern of left ventricular dysfunction. The unusual aspect of the 
LV dysfunction is its temporal relationship with stressful 
events, either emotional (e.g., death of a loved one) or physi-
cal (e.g., major neurological or abdominal surgery). Patients 
with this condition recover normal function either days to 
weeks of the clinical presentation. The underlying etiology is 
an excess of catecholamines precipitated by a stressful event. 
The primary differential diagnosis is an acute coronary artery 
syndrome or possibly viral myocarditis.
The term takotsubo derives from the original Japanese 
description of the syndrome; there is distinct apical balloon-
ing of the left ventricle that resembles an octopus pot. The 
ventricular dilation involves multiple coronary territories, 
beginning in the mid-ventricle but extending into the apex. 
Ventricular hypokinesis is present, particularly in these 
dilated myocardial regions. One of the primary CMR fea-
tures is myocardial edema seen on T2-weighted images. 
Perfusion images are normal. Typically, LGE images do not 
show focal lesions that my otherwise be associated with 
acute myocardial infarction. However, LGE is infrequently 
reported in less than 10% of cases [9].
16.3.4  Alcoholic Cardiomyopathy
Alcoholic cardiomyopathy is an acquired cardiomyopathy. 
For diagnosis, documentation of long-term consumption of 
alcohol at high quantities (>80  g per day over 5  years or 
more) is required. For many patients, successful clinical his-
tory over this period is not available. Like other dilated car-
diomyopathies, alcoholic cardiomyopathy is characterized 
by global ventricular dilatation, decreased myocardial func-
tion, and myocardial thinning in its end-stage presentation. 
Women may be more susceptible than men given equivalent 
quantities of ingested alcohol. Pathologic changes are simi-
lar to idiopathic dilated cardiomyopathy.
No specific CMR findings are present, other than that of 
abnormal ventricular size and shape. Scar patterns may be 
assumed to be nonischemic in nature, so that CMR can 
exclude myocardial scar associated with prior infarction 
[10]. As opposed to echocardiography, CMR may be useful 
to exclude other etiologies of cardiomyopathy such ischemic 
heart disease, iron overload, or amyloidosis.
16.3.5  Left Ventricular Noncompaction
Left ventricular noncompaction cardiomyopathy (LVNC) is 
a rare primary genetic cardiomyopathy characterized by 
excess myocardial trabeculation more than twice as thick as 
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the underlying myocardial wall (Fig. 16.2) [11]. The trabec-
ulae carneae consist of slim columns of myocardial cells at 
the luminal ventricular surfaces. The function of the trabec-
ula is to increase cardiac output and enable oxygen supply 
prior to coronary vascularization. During myocardial 
 development, trabeculae compact leading to an increase in 
thickness of the compact myocardium.
LVNC is associated with heart failure, regional wall 
motion abnormalities, and myocardial fibrosis. The ratio of 
the thickness of noncompacted (NC) versus compacted (C) 
myocardium (NC/C) is a simple and fast method to quantify 
trabeculation [12]; a ratio greater than 2.3 to 1 is commonly 
used as an MRI index of noncompacted myocardium. 
Although the NC/C ratio is easy to measure, the specificity is 
low; 33% of the subjects in the MESA cohort had a NC/C 
ratio greater than 2.3 [13]. Improved specificity of the NC/C 
ratio is obtained when several segments show high NC/C 
ratios and LV dysfunction is present. In a study by Wan et al., 
the mean number of compacted segments was 7.4; noncom-
paction was present in the apical segments in all patients. 
Forty percent of patients demonstrated a nonischemic pat-
tern of late gadolinium enhancement, most commonly mid- 
myocardial in location [14].
16.3.6  Collagen Vascular Disease/Connective 
Tissue Disorders
Connective tissue disease consists of a heterogeneous group 
of disorders including systemic lupus erythematosus, sys-
temic sclerosis, and Sjogren’s syndrome, as well as overlap 
between these conditions. Cardiac involvement includes 
abnormalities of valves, myocardium, and pericardium. The 
underlying common pathologic features are abnormal activa-
tion of the immune system, often targeted toward small 
blood vessels and internal organs.
Myocardial involvement is often subclinical, with diffuse 
myocardial fibrosis. Ejection fraction is preserved in early 
stages of disease in the majority of cases. Reports of focal 
late gadolinium enhancement are highly variable, from 0 (in 
our own experience) to 60% of patients [15]; likely this vari-
ability depends on the particular subset of patients evaluated. 
As a result, T1 mapping techniques, including evaluation of 
extracellular volume fraction, have been evaluated. The pri-
mary T1 mapping findings are (a) increased native T1, (b) 
increased extracellular volume fraction, and (c) decreased T1 
times after gadolinium administration [16]. However, these 
findings are not specific, and changes in myocardial T1 map-




Cardiac involvement in amyloidosis is common with deposi-
tion of insoluble glycoproteins in the extracellular spaces of 
myocardial tissue, valve leaflets, and vessels. It can result in 
restrictive cardiomyopathy which is the leading cause of 
death in approximately half of amyloid patients.
On cine imaging, there is biventricular myocardial thick-
ening with normal ventricular chamber size, atrial enlarge-
ment, and preserved systolic function. Diastolic dysfunction 
can be demonstrated on mitral inflowing imaging with cine 
phase-contrast pulse sequence imaging. In the late fibrotic 
stage, cine images can demonstrate mitral and tricuspid 
insufficiency.
There is rapid redistribution of gadolinium from the 
blood pool resulting in altered T1 kinetics in which the 
myocardium nulls before the blood pool on inversion time 
(TI) scout images. The altered kinetics can make selection 
of an appropriate TI time difficult. Phase-sensitive inversion 
recovery (PSIR) sequence images can be helpful given that 
they are independent of the TI value. The prognostic value 
of delayed enhancement imaging has not shown consistent 
Key Point
• Clinical history, ventricular structure and function, 
and pattern of late gadolinium enhancement are 
used to identify subtypes of dilated cardiomyopathy 
by CMR.
Fig. 16.2 Noncompaction cardiomyopathy. Vertical long axis view of 
the left ventricle shows a stellate pattern of prominent trabeculation. 
The left ventricle is dilated, and the myocardium at the apical anterior 
wall is thinned
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value. The emerging T1 mapping and ECV estimation tech-
niques have shown promise in correlating with cardiac func-
tion and risk stratification [17]. The delayed enhancement 
pattern is quite variable but most often diffuse and irregular 
in a noncoronary distribution as shown in Fig. 16.3.
CMR has shown promise in differentiating subtypes of 
cardiac amyloidosis primarily between light chain amyloid 
and transthyretin-related amyloidosis based on LV mass as 
well as location and extent of delayed enhancement. The 
determination of subtype is important given differences in 
treatment as well as determining prognosis with survival 
worse for light chain amyloid.
16.4.2  Sarcoid
The hallmark of cardiac sarcoidosis is the presence of necro-
tizing granulomas in the myocardium. In the acute phase, 
there can be myocardial thickening and edema with delayed 
enhancement of the mid-myocardium and/or subepicardium. 
Perfusion or early post contrast T1-weighted images may 
demonstrate increased contrast enhancement suggesting 
inflammation with hyperemia. In the chronic phase, edema is 
absent, but wall thickening and delayed enhancement may be 
seen. In the burnt-out phase, transmural delayed enhance-
ment may be seen [18] with wall thinning. The imaging 
appearance alone can be difficult to distinguish from 
myocarditis.
Delayed enhancement has prognostic value as a predictor 
of death as well as other adverse events such as aborted sud-
den death, appropriate ICD discharge, and ventricular 
arrhythmias [19]. It is a stronger predictor than other mea-
sures such as LVEF and symptoms. The lack of delayed 
enhancement also appears to have high negative predicative 
value with respect to adverse outcomes.
CMR also appears to have value in monitoring disease 
status during treatment with steroids [20]. Steroid treat-
ment has been associated with decrease in delayed enhance-
ment as well as overall improvement in functional 
parameters.
The AHA consensus guidelines reserve the recommended 
use of CMR for diagnosis and differentiation from other car-
diomyopathies as well as for functional assessment rather 
than specifically for risk stratification and prognosis [21].
16.5  Storage Disease
16.5.1  Hemochromatosis
Systemic iron overload due to hemosiderosis or transfusion- 
dependent anemias can result in dilated or restrictive cardio-
myopathy with progressive diastolic and systolic dysfunction. 
Dysrhythmias are also commonly present.
Myocardial iron deposition, in the form of ferritin and 
hemosiderin, is demonstrated on gradient-echo images. 
Utilizing multiple different TE values, the absolute T2* 
value can be determined which is the best indicator of myo-
cardial iron content [22]. A T2* <20 ms is considered diag-
nostic of significant iron overload. T2* values have been 
shown to detect iron overload earlier than changes of LVEF 
and have also been shown to be a strong independent predic-
tor of adverse clinical outcomes such as heart failure, 
arrhythmias, and sudden cardiac death [22].
CMR is invaluable in monitoring treatment response to 
chelation therapies demonstrated by improvements in T2* 
and LVEF [23]. Pennell et  al. [24] demonstrated a signifi-
cantly reduced risk of developing heart failure with improve-
ment in T2* with only minimal improvement in LVEF 
suggesting LVEF may underestimate the clinical impact of 
chelation therapies.
Key Point
• Midwall myocardial delayed enhancement is sug-
gestive of an infiltrative process rather than ischemia 
and raises concern for a restrictive cardiomyopathy.
Fig. 16.3 Cardiac amyloid. Short axis delayed enhancement image 
demonstrates diffuse subendocardial delayed enhancement with more 
extensive diffuse delayed enhancement in the septum. Note the blood 
pool is also dark on these images when there is appropriate nulling of 
the myocardium in the lateral wall which is very characteristic for myo-
cardial amyloidosis
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CMR is recognized in the AHA Consensus Statement 
[25] as a critical tool in the diagnosis and clinical manage-
ment of iron overload cardiomyopathy.
16.5.2  Fabry Disease
Fabry disease is an X-linked recessive disorder of glyco-
sphingolipid metabolism with resultant intracellular accu-
mulation of glycosphingolipids especially in the skin, 
kidneys, and heart.
There is concentric LV thickening on CMR which can be 
confused with hypertrophic cardiomyopathy. Mid- myocardial 
or subepicardial pattern of delayed enhancement may be seen 
typically involving the basal inferolateral segment. Delayed 
enhancement has been shown to be associated with develop-
ment of ventricular arrhythmias as well as sudden cardiac 
death [26]. Rather than the presence or absence of delayed 
enhancement, it was the annual increase in fibrosis demon-
strated on delayed enhancement images that was an indepen-
dent predictor of ventricular arrhythmias.
T1 mapping technique has been utilized to characterize 
Fabry’s cardiomyopathy. Reduction in T1 values are associ-
ated with reduced longitudinal strain and early diastolic dys-
function prior to the development of LV hypertrophy. This 
suggests T1 mapping may be valuable in detecting early dys-
function before structural abnormalities [27]. CMR has also 
been utilized to monitor response to enzyme replacement 
therapies. One study demonstrated that despite enzyme 
replacement therapy, there can be progression of delayed 
enhancement suggesting progressive fibrosis [26].
16.6  Arrhythmogenic Right Ventricular 
Cardiomyopathy/Dysplasia (ARVC/D)
Arrhythmogenic right ventricular cardiomyopathy (ARVC) 
is a heritable heart muscle disease characterized by fibrofatty 
replacement of predominantly the right ventricular (RV) 
myocardium. This predisposes patients to potentially life- 
threatening arrhythmias and ventricular dysfunction. 
Affected patients typically present between the second and 
fourth decade of life with arrhythmias coming from the RV2. 
ARVC is an unusual condition, with an estimated prevalence 
of 1 in 1000 to 1 in 5000 Caucasian individuals. Approximately 
60% of index cases harbor mutations in genes encoding the 
cardiac desmosome, a structure that provides mechanical 
connection between cardiomyocytes. The defective mechan-
ical connections in ARVC may structurally be represented by 
global or regional contraction abnormalities, ventricular 
enlargement, and/or fibrofatty replacement. As such, accu-
rate evaluation of cardiac morphology and function is essen-
tial for ARVC diagnosis and management.
ARVC is generally transmitted as an autosomal dominant 
trait with incomplete penetrance and variable expressivity. 
However, it is important to realize that 50–70% of mutation 
carriers will never develop disease expression and that sever-
ity of disease may vary greatly, even among members of the 
same family or those carrying the same mutation. In contrast, 
a negative genetic test result in a proband does not exclude 
the possibility of disease, nor does it exclude the possibility 
of a genetic process in the individual or family.
The CMR protocol for ARVC is somewhat unique com-
pared to other cardiomyopathies. The primary difference is 
the addition of axial black blood T1-weighted fast spin echo 
images. These cover the left and right ventricles from the 
base to the diaphragm. Cine SSFP axial images are then 
obtained in the same plane, with the same slice thickness and 
gap (8 mm × 2 mm is typically used). After this, standard 
SSFP cine imaging of the ventricles is obtained in the short 
and long axes. Many sites also obtain a vertical long axis 
cine view of the right ventricle. After gadolinium administra-
tion, short and long axis late gadolinium enhancement 
images are obtained. In patients with significant ventricular 
ectopy, a low dose of a beta-blocker (metoprolol 25–50 mg) 
is recommended for arrhythmia suppression during the CMR 
scan.
The diagnostic TFC for CMR require the presence of both 
qualitative findings (RV regional akinesia, dyskinesia, dys-
synchronous contraction) and quantitative metrics (decreased 
ejection fraction or increased indexed RV end-diastolic vol-
ume) (Table 16.1).
Besides global reduction in RV function, more subtle 
regional disease of the RV has been described in the litera-
ture using a variety of terms including focal bulges, microan-
eurysms, segmental dilatation, regional hypokinesis, etc. In 
Table 16.1 MRI task force criteria for ARVC
Global or regional dysfunction and structural alterations
Major
Regional RV akinesia or dyskinesia or dyssynchronous RV 
contraction AND one of the following:
– RV EDV/BSA ≥110 mL/m2 (male) or ≥100 mL/m2 (female)
– RV ejection fraction ≤40%
Minor
Regional RV akinesia or dyskinesia or dyssynchronous RV 
contraction AND one of the following:
– RV EDV/BSA ≥100 to 110 mL/m2 (male) or ≥90 to 100 mL/m2 
(female)
– RV ejection fraction >40 to ≤45%
EDV end-diastolic volume, BSA body surface area, RV right ventricle
Key Point
• CMR is a critical tool in the diagnosis and in moni-
toring treatment of iron overload cardiomyopathy.
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the current TFC, the terms “akinesia” (lack of motion) and 
“dyskinesia” (abnormal movement, instead of contracting in 
systole, the myocardium bulges outward in systole) and 
“dyssynchronous” (regional peak contraction occurring at 
different times in adjacent myocardium) are used for all 
imaging modalities (CMR, echocardiography and angiogra-
phy) to describe regional wall motion abnormalities in 
ARVC. The RV apex is spared in early ARVC. The so-called 
accordion sign represents a focal “crinkling” of the myocar-
dium in the subtricuspid region [28] (Fig. 16.4). In terms of 
TFC, the accordion sign is due to a small region of highly 
localized myocardium with dyssynchronous contraction.
RV LGE has been observed in up to 88% of ARVC 
patients, while LV LGE was reported in up to 61% of cases. 
In ARVC, RV wall thinning is pronounced, which makes the 
LGE technique less reliable than for the LV. Second, distin-
guishing fat from fibrosis by LGE sequences is challenging, 
which makes its interpretation highly subject to the CMR 
physician’s experience.
Some ARVC subjects have early and predominant LV 
involvement [29]. LV involvement has even been reported in 
76% of ARVC subjects, of whom the majority had advanced 
disease. The disease is, therefore, increasingly being referred 
to as “arrhythmogenic cardiomyopathy.” LV involvement in 
ARVC typically manifests as LGE, often involving the infe-
rior and lateral walls without concomitant wall motion 
abnormalities. Figure 16.5 shows an example. Septal LGE is 
present in more than 50% of cases with left dominant ARVC, 
in contrast to the right dominant pattern in which septal 
involvement is unusual. In addition, LV fatty infiltration was 
shown to be a prevalent finding in ARVC, often involving the 
subepicardial lateral LV and resulting in myocardial wall 
thinning [30].
16.7  Concluding Remarks
Nonischemic cardiomyopathy encompasses a heterogeneous 
group of diseases. Genetic components of these disease are 
increasingly being recognized. The myocardium responds to 
injury by accumulation of either fibrotic tissue or fatty 
replacement or both. MRI is very good at detecting fatty tis-
sue; the detection of myocardial fibrosis is performed using 
late gadolinium enhancement techniques and/or T1 map-
ping. While all patients undergo echocardiography screening 
to assess for myocardial function, tissue characterization 
remains in the realm of cardiac MRI evaluation.
Key Point
• ARVC typically manifests as right heart dysfunc-
tion and dilation out of proportion to similar find-
ings in the left heat.
Fig. 16.4 Arrhythmogenic right ventricular cardiomyopathy. End- 
diastolic (left) and end-systolic (right) images are shown. In systole at 
the arrows, there is infolding of the right ventricle wall, termed the 
accordion sign. This is due to dyskinesia of the right ventricle free wall 
in the subtricuspid region
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The conventional chest radiograph, computed tomography 
(CT), and, with restrictions, magnetic resonance imaging 
(MRI) are the three most commonly used imaging modali-
ties for evaluating patients with suspected pulmonary vascu-
lar disease. Additionally, in the very recent past, 
fluorodeoxyglucose positron emission tomography (FDG- 
PET) and FDG-PET/CT have been attributed clinical useful-
ness in the evaluation of large vessel vasculitis. In general 
clinical routine, however, CT remains the imaging modality 
of choice for evaluation of patients with suspected pulmo-
nary vascular disease. This is currently emphasized by new 
technical developments, such as dual-source and dual-energy 
scanners, that enable to simultaneously generate morpho-
logical and functional information from a sole data set. 
Therefore, CT has become crucial for evaluating the pulmo-
nary vasculature. This is based on the following: Among the 
various imaging modalities available in recent decades, com-
puted tomography (CT) has remained the core technique for 
evaluating respiratory disorders. Over the last few years, this 
central position has been reinforced by the possibility of 
deriving morphological and functional information from the 
same data set. This approach is of major interest for evaluat-
ing pulmonary vascular diseases for three main reasons: (1) 
Pulmonary vascular disorders require good morphological 
evaluation, not only for the vascular tree per se but also the 
surrounding lung parenchyma; (2) given that we have 
reached an upper limit in terms of morphologic image reso-
lution, but simultaneously can provide functional informa-
tion, CT is the ideal combination of high-end morphologic 
imaging with perfusion and ventilation imaging; and (3) it is 
becoming increasingly important to evaluate the cardiac con-
sequences or causes of pulmonary vascular diseases, which 
requires all advantages tha t CT can provide. Because of 
these reasons, and given the general importance of CT, this 
course will focus on CT. Other imaging modalities will not 
be disregarded but rather discussed in the case-based presen-
tations and framed in their distinct clinical context.
17.2  Optimized Evaluation of Pulmonary 
Vessels on Chest CT Examinations
17.2.1  Temporal Resolution of Pulmonary CT 
Angiograms
Given the anatomical complexity of the lungs, the most cru-
cial prerequisite for optimal chest imaging is a high spatial 
resolution, required not only to detect subtle morphologic 
abnormalities but also to adequately image thoracic vessels 
on CT angiography (CTA) and to differentiate between nor-
mal and abnormal vascular structures and dimensions. 
However, high spatial resolution is optimally employed 
when short overall examination times and high temporal 
resolution (i.e., short acquisition times of the individual axial 
image planes) are available simultaneously. This allows for 
Learning Objectives
• To provide clinical background information about 
the most relevant vascular disorders of the thorax
• To elucidate the role of imaging in the work-up of 
these disorders
• To discuss the role of diagnostic imaging in patient 
management and clinical decision-making
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the analysis of high-resolution images with a minimum of 
motion artifacts. The technical progress in development of 
multidetector-row CT (MDCT) has enabled radiologists to 
image the entire thorax with increasing spatial resolution in 
decreasing time durations. As a consequence, more patients 
are able to hold their breath throughout the entire period of 
data acquisition. This results in a substantial decrease in 
number and frequency of respiratory motion artifacts. 
Shorter CT rotation times have furthermore enabled shorter 
acquisition times and significantly artifacts caused by  cardiac 
motion. These have, in the past, not only decreased image 
quality in the proximity of cardiac structures but could also 
cause pulsation artifacts at the anatomical level of systemic 
and pulmonary vessels, thus mimicking endovascular abnor-
malities, such as thrombi or neoplastic tissue. In order to 
image patients with the highest temporal resolution and 
shortest examination time, it is preferable to choose the 
shortest rotation time possible and the highest pitch, defined 
as the table feed per rotation, divided by the nominal beam 
width at the isocenter of the scanner. For example, on a 
64-slice MDCT using a single X-ray source, rotation times 
range from 0.30 to 0.40 s, resulting in a temporal resolution 
per image not better than half the rotation time, and the pitch 
values usually do not exceed 1.5 [1]. The introduction of 
dual-source 64-slice MDCT technology offers the possibility 
of improving the technical requirements for CT. When both 
available tubes are operated at the same kilovoltage, the tem-
poral resolution of each image is 1/4 of the rotation time, 
each of the two detectors contributing 90° of data in parallel- 
ray geometry to each image plane [2]. Moreover, the second 
measurement system of dual-source CT allows for a higher 
pitch mode than those available with a single-source CT, but 
without image distortion inside the field of view of the sec-
ond detector. In a recent study, Tacelli et al. showed that this 
scanning mode provides CT angiographic examinations of 
excellent quality for thoracic applications in routine clinical 
practice, including those referred for pulmonary vascular 
diseases such as acute pulmonary embolism (PE) [3].
17.3  Improved Morphological Evaluation 
of the Peripheral Pulmonary 
Vasculature
With the introduction of MDCT, CTA is now recognized as 
the reference standard for diagnosing acute PE [4]. The 
advantages of MDCT over single-slice CT result from the 
opportunity of scanning the entire volume of the thorax with 
submillimetric collimation in a very short periods of time, 
most often under the duration of a single breath-hold, which 
is particularly useful when evaluating dyspneic patients. 
These technological advances have improved the evaluation 
of peripheral pulmonary arteries and the accuracy of CT in 
the work-up of acute PE.  Simultaneously, MDCT allows 
radiologists to scan patients at a low kilovoltage with two 
subsequent advantages, in particular, the possibility of reduc-
ing the doses of contrast material and reducing the overall 
radiation dose. This is of particular importance in young 
female patients who may be exposed to substantial levels of 
radiation to breast tissue. In the context of acute PE, the latter 
concern is clinically relevant when keeping in mind the 
lower prevalence of acute PE, which has dropped from 33% 
on angiographic studies to <20% on CT/MDCT scans. To 
date, several studies have investigated the clinical benefits of 
low-kilovoltage techniques [i.e., 80–100  kV(p) vs 120–
140 kV(p)], the parameters at which most CT angiograms 
are performed. However, for obvious ethical reasons, these 
studies were based on the comparative analysis of different 
populations scanned with single-source CT [5–8]. The limi-
tations of these comparisons include the lack of systematic 
adjustment for individual patient morphology, cardiac hemo-
dynamics, and potential underlying respiratory disease. With 
the introduction of dual-source CT, it is now possible to two 
tubes being set at different kilovoltages. In addition to the 
opportunity to evaluate lung perfusion, standard CT angio-
grams can also benefit from this scanning mode, which has 
been shown to improve the ability to analyze small pulmo-
nary arteries with 80 kV(p) [9].
17.4  Perfusion Imaging with Dual-
Energy CT
Lung perfusion with dual-energy CT does not reflect blood 
flow analysis per se, as it represents a measurement at only 
one time point, but it rather reflects an iodine map of the 
lung microcirculation at this particular time point. There are 
numerous parameters known to influence the iodine distri-
bution within pulmonary capillaries. Some are technique- 
related, whereas others are due to the anatomical and/or 
physiological circumstances under which data acquisition 
was performed. Dual-energy CT angiographic examinations 
can be obtained using a scanning protocol similar to that 
utilized in clinical practice. The acquisitions are acquired 
from top to bottom of the chest, with an injection protocol 
similar to that of a standard CT angiogram obtained with 
single energy on a 64-slice scanner. Two categories of 
images can be reconstructed. Diagnostic scans correspond 
to contiguous 1-mm-thick transverse CT scans generated 
from the raw spiral projection data of tube A and tube B 
(60% from the acquisition with tube A, 40% from the acqui-
sition with tube B). Lung perfusion scans (i.e., images of the 
perfused blood volume of the lung parenchyma) are gener-
ated after determination of the iodine content of every voxel 
of the lung parenchyma on the separate 80- and 140-kV(p) 
images. They can be rendered as gray-scale or color-coded 
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images. All images can be displayed as transverse scans, 
complemented as needed by coronal and sagittal reformats. 
Even though a dual-energy acquisition does not correspond 
to true perfusion imaging, several applications of this pul-
monary micro- CTA have been investigated [10].
17.5  Acute Pulmonary Embolism
Dual-energy CT can detect endoluminal clots on averaged 
images of tubes A and B as reliably as can single-source 
CTA [11]. In a preliminary study, the authors validated the 
detectability of perfusion defects beyond obstructive clots. 
Perfusion defects in the adjacent lung parenchyma have the 
typical perfusion-territorial triangular shape well known 
from pulmonary angiographic, scintigraphic, and magnetic 
resonance imaging (MRI) perfusion studies. Dual-energy 
CTA can help predict perfusion defects without directly 
identifying peripheral endoluminal clots that may be located 
in subsegmental or more distal pulmonary arterial branches. 
Dual-energy CT can help differentiate lung infarction from 
less specific peripheral lung consolidation.
17.6  Chronic Thromboembolic Pulmonary 
Hypertension (CTEPH)
Dual-energy CTA may depict perfusion defects distal to 
chronic clots (Fig. 17.1). In a study of 40 patients referred 
with PH of whom 14 were diagnosed with CTEPH, the sen-
sitivity of DECT was 100% with a specificity of 92% com-
pared to planar VQ [12]. DECT still has limitations with 
regard to imaging artifacts, but these are expected to improve 
with technical advancements.
Three vascular characteristics of chronic PE may manifest 
on dual-energy CT imaging. First, chronic PE causes a mosaic 
pattern of lung attenuation, characterized by areas of ground-
glass attenuation, with enlarged vascular segments intermin-
gled with areas of normal lung attenuation and smaller 
vascular segments (Fig. 17.2). When present, these findings 
are suggestive of blood flow redistribution, but are not consis-
tently seen on conventional CT in patients with chronic PE. In 
such patients, dual-energy CT has the potential to detect 
ground-glass attenuation of vascular origin via high iodine 
content within the areas of ground-glass attenuation, thus 
a b c
Fig. 17.1 (a–c) Chronic thromboembolic disease. Oblique coronal 
MIP CTPA image (a) shows a mural filling defect in the right interlobar 
artery (arrow). Oblique coronal MIP CTPA image (b) in the same 
patient depicts focal stenosis (arrow) and post-stenotic dilatation 
involving a segmental artery in the left lower lobe. DECT coronal refor-
matted image (c) in a different patient reveals almost completely absent 
perfusion in the lower lobes
Fig. 17.2 Mosaic attenuation pattern. Coronal reformat (lung window) 
shows areas of high attenuation (arrows) which contain larger vessels 
than those within areas of lower attenuation (arrowheads)
17 Modern Diagnosis in the Evaluation of Pulmonary Vascular Disease
202
enabling their distinction from ground-glass attenuation sec-
ondary to bronchial or alveolar diseases [13]. Second, chronic 
PE can cause calcifications within partially or completely 
occlusive chronic clots as well as within pulmonary artery 
walls, when chronic PE is complicated by long-standing or 
severe pulmonary hypertension. Such calcifications can be 
detected via virtual non-contrast imaging, accessible by dual-
energy CT imaging. Third, the images generated at 80 kV can 
improve visualization of the systemic collateral supply pres-
ent in chronic PE that originates from bronchial and non-
bronchial systemic arteries (Fig. 17.3).
17.7  Obstructive Airway Diseases
Abnormalities of pulmonary perfusion are present in numer-
ous smoking-related respiratory diseases. Investigating 
endothelial dysfunction in pulmonary arteries of patients 
with mild chronic obstructive pulmonary disease (COPD), 
Peinado et al. showed that endothelial dysfunction of pulmo-
nary arteries is present even in patients with mild COPD 
[14]. In these patients, as well as in smokers with normal 
lung function, some arteries show a thickened intima, 
 suggesting that tobacco consumption may play an important 
role in the pathogenesis of pulmonary vascular pathologies 
in COPD. Several structural changes in early stages of COPD 
have been described in experimental and animal models, 
including proliferation of smooth muscle fibers within peri-
bronchiolar arterioles and collagen and elastin deposition in 
the thickened intima of vessels [15, 16]. In preliminary stud-
ies, Hoffman et al. [17] showed an increased heterogeneity 
of local mean transit times of the contrast material within 
pulmonary microvasculature of smokers with normal pulmo-
nary function tests. More recently, Pansini et al. studied pul-
monary lobar perfusion with dual-source, dual-energy CTA 
in COPD patients [18]. These authors found that nonsmokers 
had no alterations in lung structure and that there is a uni-
form distribution of iodine content within upper and lower 
lobes and between right and left lungs. Perfusion scans of 
emphysematous patients showed significantly lower iodine 
content within lung microcirculation of the upper lobes, as 
compared to smokers without emphysema, and a signifi-
cantly lower perfusion in the upper lung zones as compared 
with lower lung zones, thus matching lung parenchymal 
destruction. These structural abnormalities are substantial 
observations, given the epidemiologic and socioeconomic 
burden of COPD.
17.8  Restrictive Airway Diseases
The substantial importance of pulmonary hypertension on 
the clinical course and prognosis of patients with fibrotic 
lung disease has been extensively recognized. Similar to 
obstructive lung disorders, MDCT and DSCT have a role to 
play in the evaluation of these disorders. Recent research 
suggests that the mere measurement of pulmonary artery 
diameters might not be a reliable parameter for disease sever-
ity assessment, given the potentially confounding role of 
parenchymal traction on central and peripheral pulmonary 
vessels. Moreover, given the age of the population in which 
these diseases usually occur, age-related changes have to be 
taken into account of any morphometric-based clinical 
decision- making and classification. Overall, and despite 
promising initial scientific evidence, the role of MDCT and 
DSCT in assessing patients with fibrotic lung diseases still 
needs to be determined. The many ongoing pharmacological 
trials, notably in patients with usual interstitial pneumonitis, 
may provide an ample study ground in this field.
17.9  Pulmonary Hypertension
Once left heart causes and intracardiac shunts have been 
ruled out with echocardiography, CT can play a key role in 
the classification of patients with pulmonary hypertension 
Fig. 17.3 Systemic collateral supply. Coronal reformat CTPA image 
reveals bronchial artery collaterals (arrows)
Key Point
• With technical advancements, DECT may replace 
VQ in the future in the detection of chronic pulmo-
nary embolism.
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(PH) (Table 17.1) [19]. There are vascular, cardiac, and pul-
monary parenchymal features of pulmonary hypertension on 
CT.  A main pulmonary artery (MPA) diameter of greater 
than 29.5 mm has a sensitivity of 70.8% and specificity of 
79.4% for the detection of pulmonary hypertension [20]. 
However, there is no correlation between the degree of PH 
and MPA diameter. The specificity is lower in patients who 
have interstitial fibrosis which is postulated to cause MPA 
dilatation due to traction without PH [21]. A ratio of diame-
ter of MPA to that of ascending aorta in the same axial plane 
of ≥1.0 is also indicative of PH, especially in younger 
patients (<50), and may be a more useful predictor of PH in 
those with advanced interstitial fibrosis [22]. In one study, 
the segmental artery-to-bronchus diameter ratio of >1:1  in 
three or four lobes along with a dilated MPA had almost 
100% specificity in the diagnosis of PH [23].
Other CT features of PH include right ventricular dilata-
tion and hypertrophy (>4 mm), straightening or bowing of 
the interventricular septum, and reflux of contrast into a 
dilated inferior vena cava ± hepatic veins. Pulmonary paren-
chymal features include the mosaic attenuation pattern most 
commonly seen in patients with chronic thromboembolic 
pulmonary hypertension (CTEPH). Other less common find-
ings include centrilobular ground-glass nodules due to the 
presence of cholesterol granulomas, plexogenic arteriopathy 
or capillary proliferation, and serpiginous centrilobular arte-
rioles as a sign of neovascularity [24].
Electrocardiograph (ECG)-gated MDCT acquisitions of 
the entire thorax enable the evaluation of novel functional 
parameters in addition to the standard morphology. In 
patients with PH, right pulmonary artery distensibility has 
been reported as an accurate predictor for PH on ECG-gated 
64-slice MDCT scans of the chest [25]. In this study, its diag-
nostic value was superior to that of the single measurement 
of PA diameter.
17.10  Right Ventricular Function
Fast rotation speed and dedicated cardiac reconstruction 
algorithms designed to extend the conventional multislice 
acquisition data scheme have opened new opportunities for 
cardiac and thoracic imaging applications. However, cardiac 
MRI (CMR) has become the gold standard for the assess-
ment of right function due to superior reproducibility in 
comparison to echo and its superior temporal resolution 
compared to CT. CMR also provides prognostic information 
and can be performed at baseline and in follow-up without 
the use of ionizing radiation.
Multiple MR parameters have been assessed in patients 
with PH.  Increased right ventricular volumes and reduced 
stoke volumes at baseline have been shown to be predictors 
of treatment failure and increased mortality [26]. On 
velocity- encoded phase contrast imaging, an average veloc-
ity in the MPA of <11.7 cm/s has a 92.9% sensitivity and 
82.4% specificity for the detection of PH, and interventricu-
lar septal bowing has been correlated with a systolic pulmo-
nary artery pressure (PAP) of >67  mm Hg [76]. Swift 
retrospectively analyzed CMR and right heart catheteriza-
tion in 233 patients with suspected PH.  Ventricular mass 
index (VMI) was the CMR measurement with the strongest 
correlation with mean PAP (r = 0.78) and the highest diag-
nostic accuracy (area under ROC = 0.91) for the detection of 
PH. Late gadolinium enhancement (Fig. 17.4), VMI ≥ 0.4, 
and pulmonary artery relative area change ≤15% predicted 
the presence of PH with ≥ 94% positive predictive value 
[27]. Recently, 4D flow MRI has revealed turbulent vortices 
Table 17.1 Abbreviated Nice classification of pulmonary 
hypertension
1. Pulmonary arterial hypertension (PAH)
  a. Idiopathic
  b. Heritable
  c. Drugs and toxins induced
  d.  Associated with connective tissue disease, HIV infection, 
portal hypertension, congenital heart disease, 
schistosomiasis
  •  Pulmonary veno-occlusive disease and/or pulmonary 
capillary hemangiomatosis
  •  Persistent pulmonary hypertension of the newborn
 2. Pulmonary hypertension due to left heart disease
 3. Pulmonary hypertension due to lung disease and/or hypoxia
 4.  Chronic thromboembolic pulmonary hypertension and other 
pulmonary artery
obstructions
 5.  Pulmonary hypertension with unclear and/or multifactorial 
mechanisms
Fig. 17.4 Late gadolinium enhancement short axis image shows the 
typical enhancement pattern seen in PH with enhancement at the supe-
rior and inferior insertion points of the right ventricle into the interven-
tricular septum (arrows)
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in the central pulmonary arteries and has enabled measure-
ment of wall shear stress [28, 29]. Other novel CMR tech-
niques include right ventricular T1 mapping and strain 
imaging [30].
17.11  Imaging of Pulmonary Vasculitis
Systemic primary vasculitides are idiopathic diseases caus-
ing an inflammatory injury to the vessel walls. Pulmonary 
involvement is frequent, and chest CT often in combination 
with PET/CT is the reference imaging technique in its assess-
ment. Pulmonary vasculitis occurs in a wide variety of sys-
temic and pulmonary vascular disorders. Most vasculitic 
entities affecting the lung induce overlapping disease pat-
terns such as pneumonitis with or without capillaritis, diffuse 
alveolar damage and acute pulmonary hemorrhage, or 
inflammatory obstruction of central pulmonary arteries down 
to small vessels with chronic secondary pulmonary hyper-
tension with or without interstitial lung disease, and there-
fore the clinical symptoms per se or the CT morphology 
alone is often nonspecific.
Owing to their complementary value in imaging of central 
and peripheral vascular territories and their secondary paren-
chymal or interstitial abnormalities, CT angiography (CTA), 
high-resolution CT (HRCT), and fusion imaging play key 
roles in the noninvasive work-up of patients with suspected 
pulmonary vasculitis. They enable indicative for further clini-
cal tests, imaging, or invasive diagnostics and direct medical 
treatment during follow-up. This course will familiarize radi-
ologists with CT diagnostic key features that reflect pulmo-
nary vasculitic pathology inherent to the underlying disease.
17.12  The Role of CT in the Differential 
Diagnosis of Pulmonary Vasculitis
A wide variety of CT pathology of the lung parenchyma, 
vessels, and airways has been described, and diagnosis is a 
challenging interdisciplinary field. Clinical and laboratory 
data have to be included in close cooperation with the refer-
ring physician. This course will describe the most common 
typical and atypical CT features of pulmonary vasculitis and 
their possible changes over time and therapy, focusing on the 
differential diagnosis with other inflammatory/infectious 
hereditary and neoplastic disorders.
In large vessel vasculitis, CT is the method of choice 
often in combination with PET to discriminate macroscopic 
vascular abnormality presenting key pathological features 
such as pulmonary arterial wall thickening with late enhance-
ment, steno-occlusive or thrombo-obliterating disease with 
resulting oligemia, infarction in the dependent lung, or arte-
rial aneurysms as a facultative cause of massive pulmonary 
hemorrhage. CT is the modality of choice to demonstrate 
effects of peripheral small vessel pulmonary vasculitis on the 
central pulmonary arteries such as secondary chronic pulmo-
nary hypertension due to reduction of the total cross- sectional 
area with arteriolar remodeling or narrowing of the capillary 
bed in capillaritis. The variety of peripheral vascular bron-
chial and parenchymal CT patterns of small vessel vasculitis 
is great, often complex requiring interpretation in combina-
tion with clinical symptoms and laboratory test results. 
However, many vasculitic disorders present CT features, 
which are suggestive of a vasculitic disorder. CT-pathologic 
correlates of the peribronchovascular axial interstitium, pul-
monary hemorrhage, types of inflammatory parenchymal 
infiltration, and secondary pathologies such as organizing 
pneumonia are discussed with reference to the revised 2012 
International Chapel Hill Consensus Conference on pulmo-
nary vasculitis and the American College of Rheumatology 
(ACR) [31].
17.13  Concluding Remarks
Pulmonary vascular diseases are a complex group of condi-
tions with various potential causes. Radiological techniques 
play a key role in diagnosing and managing these diseases. A 
thorough knowledge is required from the radiologist about 
the manifestations of these diseases, and about the reason-
able use of the various imaging techniques available, to facil-
itate the diagnostic process and to streamline patient 
management.
Key Point
• Although CT can be very useful in determining the 
cause of PH, CMR is the gold standard for the 
assessment of right ventricular function and can 
provide information on pulmonary artery dynam-
ics. Importantly, it can also impart prognostic 
information.
Take-Home Messages
• Thorough knowledge of pulmonary vascular dis-
eases is required from radiologists to contribute to 
diagnosis and work-up.
• The imaging armamentarium plays a key role in the 
diagnosis and management of these disorders.
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Imaging of Acute Aortic Syndromes
Thomas M. Grist and Geoffrey D. Rubin
The accurate detection and evaluation of acute aortic syn-
drome is one of the radiologist’s most important and imme-
diately impactful opportunities to avoid unnecessary death 
and disability. Acute aortic syndrome is often a clinical 
emergency and a situation that demands accurate radiologic 
diagnosis and intervention to provide lifesaving care. The 
diagnosis of acute aortic syndrome has evolved significantly 
over the last two decades, evolving from an arteriographic 
diagnosis to a diagnosis based upon multi-detector CT angi-
ography [1] and, to a limited extent, MRI. With the advent of 
these new techniques for diagnosis, investigators have revis-
ited the questions and pathologies surrounding acute aortic 
syndromes.
18.1  Anatomic and Pathological 
Considerations
Acute aortic syndromes are principally diseases of the aortic 
wall. As a result, it is useful to review the fundamental fea-
tures of the aortic wall in order to categorize the acute aortic 
syndromes.
The aorta is composed of three layers. From inner to 
outer, they are the intima, media, and adventitia. The intima 
is made up of a single layer of flattened epithelial cells with 
a supporting layer of elastin-rich collagen, fibroblasts, and 
myointimal cells. The latter myointimal cells tend to accu-
mulate lipid with aging resulting in intimal thickening which 
is the earliest sign of atherosclerosis. The majority of the aor-
tic wall thickness is composed of the media which itself is 
broad and elastic with concentric fenestrated sheets of elas-
tin, collagen, and sparsely distributed smooth muscle fibers. 
The predominance of elastin arrayed as elastic lamina reflects 
the fact that the aorta and the pulmonary arteries are consid-
ered to be the only elastic arteries of the body. Because the 
aorta and the pulmonary arteries receive the entirety of the 
cardiac output, they undergo substantial deformation in order 
to accommodate large volume changes with each cardiac 
contraction. The remaining arteries of the body are consid-
ered muscular arteries with minimal elastin and a predomi-
nance of smooth muscle allowing for the body to regulate 
regional blood flow. The boundary between the intima and 
media is not readily defined. The division between the intima 
and media is defined histologically at the internal elastic 
lamina, which represents the innermost of the many elastic 
lamellae within the aortic media. The adventitia lacks elastic 
lamellae and is predominantly composed of loose connective 
tissue and blood vessels or vasa vasorum.
Anatomically, the aorta can be divided longitudinally into 
five zones—the aortic root, ascending thoracic aorta, aortic 
arch, descending thoracic aorta, and abdominal aorta. Acute 
aortic syndromes can involve any of these five anatomic 
zones; however they only rarely originate within the abdomi-
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• Understand the pathological classification of acute 
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nal aorta. An important principle in the management of acute 
aortic syndromes is the classification of lesions into Stanford 
type A or type B. Type A lesions, defined as those involving 
the ascending aorta or aortic root, are considered lesions that 
demand urgent surgical intervention with replacement of the 
diseased ascending aortic segment. The rationale for this 
urgent intervention is a high risk of aortic rupture, which can 
lead to pericardial tamponade or frank exsanguination. Type 
B lesions do not involve the ascending aorta and as a result 
can occur within the aortic arch or the descending thoracic 
aorta. If there is evidence for active aortic rupture, then these 
patients too should be referred for urgent surgical interven-
tion with endografting becoming an increasingly important 
option, for treating descending thoracic aortic leaks and 
pseudoaneurysms [2, 3]. In the absence of active bleeding, 
they are typically managed with blood pressure reduction 
and regular monitoring to assess the evolution of aortic 
dimension and disease extension.
18.2  Definitions and Classifications
Collectively, acute aortic syndromes represent life- 
threatening conditions that are associated with a high risk of 
aortic rupture and sudden death. The typical presentation is 
the sudden onset of chest pain, which may be accompanied 
by signs or symptoms of hypoperfusion or ischemia to distal 
organs, extremities, or the brain.
Traditionally, acute aortic syndromes are categorized as 
aortic dissection, intramural hematoma, and penetrating ath-
erosclerotic ulcer.
Aortic dissection (AD) is characterized by a separation of 
the aortic media creating an intimal medial complex, which 
separates from the remaining aortic wall. Blood flowing 
between the intimal medial complex or flap and the remain-
ing wall is considered to be within a false lumen, whereas 
blood flow bounded by the intima is considered to be within 
a true lumen. Multiple communication points can be observed 
between the true and false lumen. The proximal most com-
munication is considered to be the “entry tear” with the 
remaining points of communication are considered to be 
“exit tears” implying flow directionality from true to false 
lumen and from false to true lumen, respectively. The actual 
incidence of AD is difficult to define, since AD involving the 
ascending aorta is often a fatal disease and patients fre-
quently die prior to hospitalization. Likewise, AD is some-
times misdiagnosed on initial presentation, and these patients 
are also at risk for death outside of the hospital. Nevertheless, 
various population-based studies suggest that the incidence 
of AD ranges from 2 to 4 case per 100,000 patients [4].
The temporal definition of acute AD is a dissection that is 
identified less than 2  weeks after the onset of symptoms, 
while subacute ranges from 2 to 6 weeks following initial 
painful episode, and a chronic AD more than 6 weeks after 
the onset of pain.
Intramural hematoma (IMH) is an entity that was first 
described approximately 30 years ago as a stagnant collec-
tion of blood within the aortic wall. The common association 
of IMH with pathologically detected intimal defects led to 
the hypothesis that most are sequelae of penetrating athero-
sclerotic ulcer. An alternative cause of IMH, typically 
invoked in the absence of an intimal defect, is rupture of the 
vasa vasorum. This hypothetical cause of IMH has never 
been definitively proven. IMH is treated similar to dissec-
tions in terms of initial diagnosis as well as clinical manage-
ment. Most IMH occur in the descending thoracic aorta and 
can be associated with severe pain. The imaging features 
vary depending on the amount of blood accumulated in the 
wall of the aorta, but typically the normal wall measures less 
than 7 mm in thickness. The natural history of IMH can be 
quite variable. Roughly one third of them will progress to 
aortic dissection, whereas one third will be stable and one 
third will resolve [5]. The mortality for patients with IMH 
involving the ascending aorta is similar to that of classic dis-
section, and therefore these patients are treated as though 
they have a classic AD with emergent surgery [6]. On the 
other hand, IMH involving the descending thoracic aorta can 
be followed, given appropriate therapy for hypertension.
Penetrating atherosclerotic ulcer (PAU) is a condition that 
originates with atherosclerotic plaque involvement of the 
aorta, primarily the descending thoracic aorta (Fig. 18.1). As 
the plaque evolves, the ulceration “penetrates” through the 
internal elastic lamina into the media of the aortic wall. 
Overtime the PAU may extend through all three layers of the 
aortic wall to form a false or pseudoaneurysm. A finding of 
PAU does not necessarily imply the existence of an acute aor-
tic syndrome. Signs of IMH or extravasation indicate acuity.
There are two limitations to this traditional classification. 
One concerns the omission of a rupturing true aortic aneu-
rysm, as the nature of the presentation and the severity of the 
event are similar to that of the other acute aortic syndromes. 
The other limitation is that IMH, defined as a stagnant intra-
mural collection of blood, can be observed in the setting of 
AD, PAU, and rupturing aortic aneurysm. As such, it is a 
feature or characteristic associated with any of the acute aor-
tic syndromes reflecting degradation of the aortic wall as a 
harbinger of impending aortic rupture.
In consideration of these two points, a new classification 
scheme has been proposed based upon the primary location 
of the lesion within the aortic wall. In this new classification 
scheme, there are three pathological entities: AD, PAU, and 
rupturing aortic aneurism [7]. These three entities are differ-
entiated by the fact that AD principally involves the aortic 
media, PAU originates within the aortic intima, and aortic 
aneurysm is a disease of all three layers. The presence of 
IMH is an observation or epiphenomenon to be applied to 
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any of these three fundamental pathologies. In the setting of 
an isolated IMH without PAU, “non-communicating dissec-
tion” has been proposed as a descriptor, although most peo-
ple will associate the term “IMH” with this lesion. Recently, 
a subtype of aortic dissection has been described as “limited 
intimal tears” [8], which has similar natural history as AD 
and IMH, but can be particularly subtle to detect given their 
limited extent along the length of the thoracic aorta.
18.3  Essential Elements of Aortic Imaging 
Reports
In 2010, a group of medical organizations representing the dis-
ciplines of cardiology, radiology, thoracic surgery, and anes-
thesia published guidelines for the diagnosis and management 
of patients with thoracic aortic diseases. In this report, the 
authors identified eight essential elements that should be 
addressed in aortic imaging reports [4]. While these guidelines 
are not comprehensive, nor do they imply the necessity of 
reporting every element in every case, they are a useful con-
struct from which to build any formalized description of the 
imaging findings of an acute aortic syndrome. They are:
 1. The location at which the aorta is abnormal
 2. The maximum diameter of any dilation, measured from 
the external wall of the aorta, perpendicular to the axis of 
flow and the length of the aorta that is abnormal
 3. For patients with genetic syndromes at risk for aortic root 
disease, measurements of aortic valve, sinuses of Valsalva, 
sinotubular junction, and ascending aorta
 4. The presence of internal filling defects consistent with 
thrombus or atheroma
 5. The presence of IMH, PAU, or calcification
 6. Extension of aortic abnormality inter-branch vessels, 
including dissection and aneurism, and secondary evi-
dence of end-organ injury (e.g., renal or bowel 
hypoperfusion)
 7. Evidence of aortic rupture, including periaortic and medi-
astinal hematoma, pericardial, and pleural fluid, and con-
trast extravasation from the aortic lumen (Fig. 18.2)
 8. When a prior examination is available, direct image-to- 
image comparison to determine if there has been any 
increase in diameter
Recently, predication models have been developed to 
identify predictors of late adverse events following Type B 
AD. In particular, false luminal circumferential coverage and 
maximum aortic diameter at the time of index presentation 
and a diameter increase of 5 mm or more in the first 6 months 
following presentation have been associated with a signifi-
cant increase in adverse events [9, 10].
18.4  Imaging Approaches to Acute Aortic 
Syndromes Using CT
High-quality and comprehensive aortic and end-organ 
assessment should be performed using multi-detector row 
CT with at least 16 detector rows. This scanner configura-
tion allows for imaging from the neck through the pelvis, 
acquiring ≤1.5  mm thick transverse sections during the 
arterial phase of enhancement from an intravenous contrast 
administration. It also allows for the use of electrocardio-
graphic gating of the scan when appropriate, as described 
below.
a b c
Fig. 18.1 Rupturing thoracic aortic aneurysm: (a) Unenhanced CT 
demonstrates high-attenuation hematoma in the right pleural space and 
the middle mediastinum. There is an aneurysm of the descending aorta. 
(b) Unenhanced CT section 5 cm inferior to (a) reveals an IMH at the 
inferior margin of the aneurysm with extravasation of blood into the 
middle mediastinum. Note displacement of intimal calcium along the 
inner wall of the IMH. (c) Following administration of IV contrast 
material, the IMH is harder to visualize owing to the wider window 
used to display the CT angiogram
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18.5  Unenhanced CT
An unenhanced scan can be valuable prior to the adminis-
tration of intravenous contrast for the detection of what 
can be subtle intramural and periaortic blood. It can also 
be useful for mapping the specific regions of the aorta that 
are abnormal and thus guide the mode of subsequent CT 
angiographic acquisition. While an associated increase in 
radiation exposure results from this approach, the potential 
value of the information almost always outweighs the risk. 
It has been hypothesized that using dual energy scanning, 
a virtual unenhanced scan might obviate the need for a 
separate unenhanced acquisition. However, this approach 
has not been comprehensively validated in acute aortic 
syndromes.
18.6  CT Angiography
While unenhanced imaging can reveal aortic dilation, intra-
mural and extra-aortic hemorrhage, and in uncommon cir-
cumstances directly visualize an intimal flap, the use of 
intravenously administered contrast medium is required for a 
complete assessment in suspected acute aortic syndrome 
(Fig. 18.3). The volume and flow rate of the contrast material 
should be adjusted based on patient size. A concentrated 
iodine solution of ≥350 mg of iodine/ml should be used in 
order to assure adequate intravenous delivery of iodine with 
a safe and reliable flow rate of the contrast material into the 
peripheral vein. Typical volumes and injector flow rates for 
iodinated contrast range between 60 and 115  mL at flow 
rates between 3.5 and 6 mL/sec.
To assure diagnostic aortic enhancement throughout the 
CT acquisition, the duration of the contrast injection should 
exceed the scan duration by 5–10 s, and the initiation of the 
CT angiographic acquisition should be based upon the active 
monitoring on the arrival of iodine within the descending 
thoracic aorta.
18.7  Imaging the Abdominal Aorta 
and Iliac Arteries
Because of the likelihood of direct extension of thoracic aor-
tic disease into the abdominal aorta and iliac arteries, unre-
lated but important abdominal aortoiliac pathology, the value 
a b
Fig. 18.2 Type B aortic dissection. (a) The true lumen is completely 
collapsed posteriorly, and only the true lumen fills with contrast mate-
rial. The entry tear was (not shown) in the proximal descending aorta. 
(b) Because of their supply from the aortic true lumen, the renal arteries 
do not opacity, and the kidneys are not perfused
Fig. 18.3 PAU with pseudoaneurysm formation in the proximal 
descending aorta
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of assessing the caliber of a transfemoral delivery route to 
intra-aortic repair devices, and the possibility for abdominal 
visceral ischemia, scan ranges that extend through the abdo-
men and pelvis are highly recommended as a routine 
approach to imaging acute aortic syndromes. By beginning 
the scan in the neck and extending inferiorly below the lesser 
trochanters of the femurs, the scan range will comfortably 
include several centimeters of the cervical carotid arteries 
through the bifurcation of the femoral artery. Scan ranges 
that include less anatomy risk the possibility that important 
observations will be missed, and additional CT scans with 
further injections of iodinated contrast material may be 
required.
18.8  ECG Gating
When the ascending aorta is involved with an acute aortic 
syndrome, electrocardiographic (ECG) gating can be valu-
able. ECG gating allows for clear delineation of the position 
of the intimal flap across the cardiac period, distinction of 
the involvement of the structures of the aortic root including 
the coronary artery ostia and the aortic annulus, elimination 
of pulsation-related artifacts that can blur the aortic wall, 
and subtle regions of extravasation. Unlike the use of ECG 
gating in the setting of coronary artery disease assessment, 
the strategy for using ECG gating in acute aortic syndromes 
does not rely upon the manipulation of heart rate or coro-
nary artery dimension using beta-blockers or nitrates. 
Regardless of the basal heart rate, the placement of ECG 
leads and acquisition of a retrospectively gated CT scan 
(with judicious use of ECG directed X-ray tube current 
pulsing to minimize radiation exposure) allows for a four-
dimensional assessment of the aortic root, aortic valve, cor-
onary arteries, and ascending aorta. It is sufficient to 
reconstruct ten phases every 10% of the R-R interval. Gating 
is only beneficial through the thoracic aorta. For patients 
with heart rates less than 80 beats per minute, prospective 
triggering of multiple axial slabs, a single wide area acquisi-
tion, or a single high-pitch dual source may suffice to delin-
eate the structures of the aortic root, depending upon the 
type of CT scanner available. The abdomen and pelvis are 
acquired after the chest using a non- gated acquisition with 
minimization of delay between the two scans so that only 
one contrast injection is required.
ECG gating is not required for all patients; however, it can 
be critical in patients with aortic root involvement. Review of 
preliminary unenhanced CT sections by a radiologist can 
help to identify patients for whom gating may be of value. 
Otherwise a second CT scan may be required and could 
delay treatment.
18.9  Clinical Indications for MRI in Acute 
Aortic Syndrome
While CT remains the mainstay for the initial diagnosis of 
patients with acute aortic syndrome, MRI may play a limited 
role in patients who cannot have a contrast-enhanced CTA, 
as well as in the follow-up of patients for complications fol-
lowing prior aortic dissection. However, due to the immedi-
ate availability of non-contrast CT in most emergency rooms, 
a non-contrast CT in patients who have a severe allergy to 
iodinated contrast may still be the method of choice for eval-
uating the potential complications of acute aortic syndrome, 
including IMH, ruptured aorta, pericardial or pleural effu-
sions, and a displaced, calcified intimomedial flap.
Nevertheless, in patients who cannot have iodinated con-
trast associated with CT, MR may plan a useful role in the 
diagnosis of patients with acute aortic dissection. 
Investigators have demonstrated the value of rapid MRI 
using steady-state free precession (SSFP) for detecting the 
intimal media flap associated with dissection [11, 12]. Using 
SSFP, it is possible to perform the diagnostic exam with min-
imal MRI table time in the acutely ill patient. In addition, 
contrast-enhanced MRA may be performed quickly and will 
provide information regarding branch vessel involvement, 
the presence of intraluminal abnormalities, PAU, and for 
demonstrating the intimomedial flap location and the entry 
and exit tears in dissection. We have successfully performed 
a rapid MR evaluation of the thoracic aorta and great vessels 
in the acutely ill patient presenting with chest pain in less 
than 15-minute room time using a rapid MR evaluation pro-
tocol in patients presenting to the emergency room [13]. 
Nevertheless, it should be emphasized the CTA remains the 
mainstay for evaluating patients with suspected acute aortic 
syndrome also in part related to the ease of evaluation of the 
entire thoracic and abdominal aorta.
18.10  MRI Technique and Imaging Findings
Evaluation of thoracic pathology with MRI begins with rapid 
SSFP imaging of the aorta and its major branches 
(Table 18.1). This technique, when high-performance gradi-
ents are used to acquire images using a short repetition time 
(TR) and short echo time (TE), is especially helpful for 
imaging aortic vascular pathology in the absence of gado-
linium contrast media. These images are typically acquired 
initially in axial and oblique sagittal projections and gated to 
the diastolic phase of the cardiac waveform. In addition, for 
more complete characterization of intimal flap motion in the 
setting of aortic dissection, cine SSFP MRI can be used to 
further delineate the entry and exit zones of the intimal media 
18 Imaging of Acute Aortic Syndromes
212
flap, as well as potential dynamic compression of branch 
vessels. Likewise, cine MRI can be used to further character-
ize the relationship of a type A dissection flap to the aortic 
valve and any resultant aortic valve insufficiency.
Gadolinium contrast-enhanced MRA is used to character-
ize the luminal pathology associated with acute aortic syn-
drome [14]. Contrast-enhanced MRA is usually acquired 
during the arterial phase of contrast as well as during the 
delayed “steady-state” phase of contrast enhancement. Some 
authors describe the use of time-resolved 3D MRA during a 
small bolus of GBCA first, thus allowing the radiologist to 
delineate filling pathways of the true and false lumen and 
branch vessels dynamically [15]. However, time-resolved 
images are typically followed by high-resolution 3D images 
for more precise characterization of the anatomy.
Extracellular Gd contrast agents are the primary diagnos-
tic enhancement agents, and higher relaxivity contrast agents 
are preferred due to their greater signal at a lower dose as 
well as their protein binding, which facilitates delayed imag-
ing in the steady state. For delayed imaging, we typically use 
a fat-suppressed post-contrast T1-weighted gradient echo 
image with spoiling of the transverse magnetization. The 
delayed images are particularly helpful for evaluation of 
extra luminal pathology affecting the aorta, including aortic 
leaks, arteritis, and infection, and characterizing the size and 
extent of hematoma outside of the wall.
The arterial phase contrast-enhanced MRA findings in 
classic aortic dissection are similar to those identified on CT, 
including displaced intimal flap, thrombosed lumen, and 
demonstration of entry and exit tears [12]. One key finding 
on CT that is not reliable on MR is the displaced intimal 
calcifications associated with a displaced intimal flap. 
Contrast-enhanced MRA demonstrates filling patterns in 
aortic dissection and is helpful in delineating branch vessel 
involvement and assessing end-organ perfusion.
The exquisite soft tissue contrast in delayed contrast- 
enhanced MR images may be helpful for delineating pene-
trating aortic ulceration. The immediate arterial phase images 
on contrast-enhanced MR may show the size and extent of 
ulceration; however the delayed images add enhanced visu-
alization of the aortic adventitia and surrounding soft tissues, 
thus allowing more definitive characterization of the aortic 
enlargement and associated structures in penetrating aortic 
ulceration (Fig. 18.4).
In the setting of suspected intramural hematoma, SSFP 
MRI or contrast-enhanced MRA alone is inadequate for 
detecting hemorrhage in the wall of the aorta. In this clinical 
scenario, T1- and T2-weighted spin-echo technique is typi-
cally necessary for diagnosis. MRI using fast spin-echo tech-
nique is useful for detecting IMH and characterizing its age 
or confirming and dating suspected IMH identified on an 
unenhanced CT scan. IMH exhibits the expected signal char-
acteristics associated with the transition of hemorrhage from 
deoxyhemoglobin (low T1 and T2) in the hyperacute stage to 
intracellular methemoglobin (high T1, intermediate T2) in 
the subacute stage and extracellular methemoglobin (high T1 
and T2) in the late stage of IMH (Fig. 18.5).
Finally, phase contrast MR may be helpful for delineating 
entry and exit zone sites in classic aortic dissection, as well 
as for documenting flow patterns in the true and false lumen. 
In addition, in the setting of suspected branch vessel isch-
emia, phase contrast MR may demonstrate and quantify the 
abnormal aortic and branch vessel flow associated with dis-
section. Future work may allow the use of computational 
fluid dynamics to predict the likelihood of vascular rupture 
in patients with aortic aneurysm or dissection; however addi-
tional validation of the predictive power of these techniques 
is necessary.
18.11  Summary
High-resolution CT and MR imaging have fundamentally 
changed the diagnosis and treatment of acute aortic syn-
drome in the modern era. Multi-detector CTA has stream-
lined the early diagnosis and management of these patients 
and has allowed us to rethink the classification of the syn-
drome as a manifestation of specific pathologies involving 
the aortic wall. Recent improvements in understanding of 
this entity contribute to the improved survival with broader 
Table 18.1 MRI techniques for diagnosis and monitoring AAS
Sequence Plane TR/TE (MS) Matrix Accel factor Gating +Gd
MRI in the acute setting
SSFP 2D axial/SAG 3/1.5 256 × 192 1–2 Yes No
High-res CE MRA 3D SAG 3/1 320 × 256 × 128 4 No 0.1 mmol/ kg
Spin echo for characterization of IMH
T1 fast spin echo 2D axial ~600/10 256 × 192 n/a No No
T2 fast spin echo 2D axial ~2500/60 256 × 192 n/a No No
For characterization of flow abnormalities in complicated subacute or chronic dissection
4D flow phase contrast 3D SAG 10/4 256 × 128 × 64 6–10 Yes Yes
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a bFig. 18.4 Penetrating aortic ulcer. (a) Early arterial-phase 
and (b) delayed “steady-state” 
phase MRA demonstrating 
penetrating aortic ulceration 
involving the superior surface 
of the aortic arch. Note the 
excellent delineation of the 
aortic adventitia on the 
delayed images due to the 
contrast enhancement that 
occurs in the steady-state 
imaging phase
a b
Fig. 18.5 (a) T1-weighted MRI demonstrating IMH with mixed signal 
intensity components including low signal intensity corresponding to 
deoxyhemoglobin and high signal intensity extracellular methemoglo-
bin suggesting an IMH of subacute or chronic duration. (b) T2-weighted 
image demonstrating high signal intensity associated with extracellular 
methemoglobin due to chronic IMH
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treatment options for patients who are correctly diagnosed, 
including significant advances in endovascular therapy for 
complicated type B dissections over the last decade. The role 
of MRI in patients with aortic disease is more limited to the 
diagnosis and management of complications, follow-up 
studies, and in the initial diagnosis in patients who cannot 
undergo CTA. The accurate detection and evaluation of acute 
aortic syndrome is one of the radiologist’s most immediately 
impactful opportunities to reduce morbidity and mortality 
associated with this spectrum of diseases.
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Take-Home Messages
• Radiologists can save lives by accurate and imme-
diate diagnosis of acute aortic syndromes.
• Unenhanced and contrast-enhanced CTA is the 
quickest, most available, and accurate method to 
determine the pathological cause of acute aortic 
syndrome.
• An understanding of the pathological origin of aor-
tic disease is important to accurate description of 
the key imaging findings identified in the setting of 
acute aortic syndrome.
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Key Points
• A new classification scheme has been proposed 
based upon the primary location of the lesion within 
the aortic wall: aortic dissection principally involves 
the aortic media, penetrating aortic ulcer originates 
within the aortic intima, and aortic aneurysm is a 
disease of all three layers.
• The presence of intramural hematoma is an obser-
vation or epiphenomenon to be applied to any of 
these three fundamental pathologies.
• An unenhanced CT scan is important to perform 
prior to the administration of intravenous contrast 
for the detection of what can be subtle intramural 
and periaortic blood and for characterizing the post-
operative aorta.
• MRI is useful for specific problem-solving, post-
dissection surveillance, and hemodynamic assess-
ment in patients with mal-perfusion syndromes.
T. M. Grist and G. D. Rubin
215© The Author(s) 2019
J. Hodler et al. (eds.), Diseases of the Chest, Breast, Heart and Vessels 2019–2022, IDKD Springer Series, 
https://doi.org/10.1007/978-3-030-11149-6_19
Pre- and Post-aortic Endovascular 




Aortic aneurysmal disease of the thoracic and abdominal 
aorta is a potentially life-threatening disease and requires 
besides preventive measures early detection of the disease 
and if present for the patient-tailored interventional treatment. 
Per definition, an abdominal aortic aneurysm is present if the 
abdominal aorta exceeds 1.5  times the normal diameter of 
2.5–3  cm [1]. Many AAA remain asymptomatic and are 
found incidentally on routine imaging. Among a variable 
number of risk factors, such as arterial hypertension, inher-
ited diseases, connective tissue diseases, and age, smoking 
appears to be the most important risk factor. Since rupture of 
an AAA is related with a very high mortality, repair is recom-
mended with a size exceeding more than 5.0–5.5  cm, if a 
patient turns symptomatic or an interval annual growth rate of 
>1  cm is detected [2]. Endovascular aneurysmal repair 
(EVAR) surpassed the method of open surgical repair since 
approximately a decade and became the method of choice to 
treat AAA [3]. Newest generations of EVAR devices allow to 
exclude the vast majority of AAA, despite their sometimes 
challenging anatomical morphology. Pre- procedural imaging 
is pivotal and important for EVAR to adequately assess the 
aneurysm size and anatomical configuration and with this to 
choose an adequate device and access site [4]. Post-procedural 
complications are relatively frequent (e.g., endoleaks) and 
demand regular post-EVAR surveillance [5]. Different imag-
ing modalities, such as conventional radiography (CR), ultra-
sound (US), magnetic resonance angiography (MRA), and 
computed tomography angiography (CTA), play a role in pre- 
and post-procedural EVAR assessment with their relative 
strengths and weaknesses. In this article we focus on CTA as 
being the workhorse imaging modality used in the vast major-
ity of institutions due to its high accuracy for pre- and post- 
procedural imaging [6].
EVAR devices are basically bifurcated metallic stents 
with a mounted layer of nonporous graft material. Their 
modular design normally includes one aortoiliac limb with 
an ipsilateral long component and a contralateral short limb 
that is secondly joined with a uniiliac component [4]. 
Different design variants are available to help to circumvent 
anatomical challenges. In general, EVAR endografts are 
placed with attention to the proximal and distal landing 
zones, where proper sealing of the device to the native aorta 
is crucial to exclude blood flow into the aneurysmal sac, 
thereby resulting in lowered sac pressures and decreased 
risk of further expansion. In case of incomplete exclusion of 
Learning Objectives
• To discuss elements of vascular anatomy pertinent 
to endovascular aneurysm repair of the thoracic and 
abdominal aorta
• To understand common complications of post-
endovascular stent-graft placement
Key Point
• An abdominal aortic aneurysm is present if the 
abdominal aorta exceeds 1.5 times the normal 
diameter of 2.5–3 cm. CT angiography is consid-
ered the workhorse imaging modality used in the 
vast majority of institutions due to its high accuracy 
for pre- and post-procedural imaging.
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the blood flow influx into the aneurysmal sac, the AAA 
remains pressurized. Different sources, so-called endoleaks, 
are causative for a persistent blood flow into the aneurysmal 
sac [7, 8].
Similar to the EVAR procedure, several pathologies of the 
thoracic aorta and the aortic arch such as thoracic aortic 
aneurysm (TAA), penetrating aortic ulcer (PAU), intramural 
hemorrhage (IMH), traumatic aortic rupture, and aortic dis-
section (AD) can be treated with the so-called thoracic 
 endovascular aortic repair (TEVAR) [9]. Technical success 
of TEVAR reaches <90% in studies with substantially lower 
rates of neurologic complications and mortality as compared 
to open surgery [10–13]. No sternotomy or thoracotomy is 
necessary for the TEVAR procedure. TEVAR devices may 
consist of a short section of bare metal stent for better con-
formity and alignment in the aortic arch in order to reduce 
the risk of endoleak [14].
19.2  Pre-procedural Imaging
Figure 19.1 summarizes a number of anatomic and morpho-
logic parameters every pre-procedural CTA report needs to 
address, in order to reliably select the right EVAR device, to 
anticipate procedural challenges, and to plan for ancillary 
Key Point
• Indications for endovascular aneurysmal repair of 
the abdominal aorta (EVAR) or the thoracic aorta 
(TEVAR) include besides aneurysmal disease, pen-
etrating aortic ulcer (PAU), intramural hemorrhage 
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Fig. 19.1 Anatomical considerations to be addressed at pre-procedural 
imaging: Description of the proximal fixation site with infrarenal neck 
length, diameter, and configuration (mural thrombus, mural calcifica-
tions, shape). Description of the aneurysm morphology (saccular, fusi-
form), aneurysm size (largest diameter), aneurysm length, aneurysm flow 
lumen, aorta diameter at the level of the lowest renal artery and aortic 
bifurcation, and angle between supra-renal aorta and AAA. Description 
of the distal fixation site with the length of the iliac landing zone, iliac 
artery minimal diameter, iliac tortuosity and mural calcifications, exten-
sion of AAA into common iliac artery (CIA) aneurysms, and patency of 
internal iliac arteries. Description of the vascular access site with mini-
mal luminal diameter, tortuosity, mural calcifications, location, and status 
of common femoral artery CFA (e.g., anterior luminal calcifications). 
Note: Optimal anatomical configurations for EVAR are indicated with 
letters, whereas suboptimal or unfavorable anatomical parameters are 
indicated within parentheses
T. Bley and J. Roos
217
procedures during or after EVAR [15, 16]. In general, four 
anatomical areas thereby have to be addressed: (a) proximal 
fixation site, (b) aneurysm morphology, (c) distal fixation 
site, and (d) access vessel evaluation.
In general, optimal anatomical AAA configuration for 
EVAR includes an infrarenal aortic neck length of >25 mm; 
no mural neck thrombus/calcifications; no reverse taper 
infrarenal neck; lack of AAA tortuosity or angulation; patent 
non-tortuous, non-stenotic iliac arteries with a distal landing 
zone of >30 mm; patient internal iliac arteries; and normal 
common femoral artery non-calcified anatomy.
As with EVAR a suitable landing zone is of utmost impor-
tance for the success of the TEVAR procedure. A proximal 
landing zone of 15–25 mm is desirable [17]. Depending on the 
anatomic conditions, a sufficient proximal landing zone may 
need to be generated by supra-aortic debranching surgery, in 
which, for example, the left subclavian artery is transposed to 
the brachiocephalic trunk (Fig. 19.2). By doing so the left sub-
clavian ostium can be overstented, and the proximal landing 
zone will be enlarged. Overstenting the left subclavian artery 
without prior debranching increases the risk of a type II 
endoleak, a subclavian steal phenomenon or ischemia of the 
vertebral artery territory, of the left upper extremity or spinal 
ischemia. Variants of the supra-aortic arteries must be taken 
into account when evaluating the proximal landing zone [9].
Thrombotic plaques in the aortic arch increase the risk of 
embolic stroke since catheter and stent-graft maneuvers in 
the arch may loosen the plaque [18]. Assessing the plaque 
burden of the thoracic aorta with focus on mobile atheromas 
is important to estimate the risk of embolic stroke which is as 
high in TEVAR as in open surgery with 4–10% [6, 19].
The risk of spinal ischemia with paraplegia due to over-
stenting the artery of Adamkiewicz feeding intercostal artery, 
which is of variable location, is lower in TEVAR procedures 
than open surgery [20]. Extensive coverage of the thoracic 
aorta by the stent-graft and coverage of the left subclavian 
artery are recognized risks of spinal ischemia following 
TEVAR. Occurrence of stroke following TEVAR with left 
subclavian coverage is almost twice as high as following 
TEVAR without left subclavian coverage (6.3% vs 3.2%) 
[21, 22].
Proper alignment of the stent graft to the aortic wall 
depends on the curvature of the aortic arch and on the con-
formability of the stent-graft material. In a sharp angulating 
aortic arch, the forces on the stent graft will hamper proper 
alignment, and the risk of a type I endoleak increases. Proper 
and in some cases adaptive radial forces of the stent-graft 
enable seamless adaption of the stent-graft to the inner and 
outer curvature of the aortic arch without leaving space for 
an endoleak and without damaging the aortic wall.
For better adaption to the aortic wall, tapered stent grafts 
are also available that have a conic architecture and adapt to 
the aortic wall despite different luminal diameters of the 
proximal and distal landing zones. Low-profile stent-graft 
systems enable better handling of the graft and access 
through smaller or via kinging iliac vessels.
Fig. 19.2 Volume-rendered CT images of a 72-year-old lady with 
aneurysmal aortic disease readily reveal penetrating aortic ulcer of the 
aortic arch at the level of the ostium of the left subclavian artery and two 
sequential aneurysms of the descending thoracic aorta (a). Debranching 
surgery with transposition of the left subclavian and left common 
carotid artery to the brachiocephalic trunk created a suitable proximal 
landing zone (b) for TEVAR placement (c). In the second step, the 
descending aortic aneurysms were treated with TEVAR extension (d)
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19.3  Post-procedural Imaging
Post-procedural surveillance imaging primarily focuses on 
early detection of EVAR stent-graft complications and fail-
ures. The complications may manifest immediately flowing 
EVAR, may resolve or persist over time, or appear at a time 
remote from the procedure itself.
The most common complication is the development of an 
endoleak following EVAR.  With an endoleak, part of the 
blood flow remains outside the endograft and goes into the 
native aneurysmal sac. Endoleaks are classified by their 
source of blood flow and subclassified based on their loca-
tion (Fig.  19.3). Approximately 25% of patients within 
30 days post EVAR develop an endoleak; however,  endoleaks 
can first occur years after EVAR continued surveillance 
imaging is required. Five types of endoleaks have been clas-
sified [7, 8].
Type I endoleak (Fig. 19.4) occurs due to an incomplete 
endograft seal at the proximal (type Ia) or distal (type Ib) 
fixation site or due to a leak around an iliac occludes plug in 
a patient with a aorto-uniiliac device and fem-fem crossover 
device [23]. With an endoleak type I, CTA detects contrast 
flow passing outside the fixation seal directly into the aneu-
rysmal sac. Predisposing factors for type I endoleak are sub-
optimal infrarenal neck configurations (e.g., mural thrombus, 
reverse taper neck), neck dilatation from EVAR remodeling, 
complex chimney graft installations, or endograft migration 
to due insufficient endograft fixation (e.g., endograft frac-
ture). Type I endoleaks are normally treated with reinforce-
ment of the proximal/distal seal with placement of extender 
cuffs/stents.
Type II endoleak (Fig. 19.4) is the most common type of 
endoleaks occurring in patients post EVAR [24–26]. The 
incidence to develop an endoleak type II is approx. 25% per 
year [27]. They are fed by one (type IIa) or multiple (type 
IIb) collateral arterial pathways, such as lumbar arteries or 
inferior mesenteric artery (IMA). With an endoleak type II, 
CTA detects contrast flow within the aneurysmal sac, which 
can be traced back to an offending feeding/draining native 
vessel. Since approx. 40% of type II endoleaks spontane-
ously occlude and are often not associated with aneurysm 
sac enlargement in the first year, they do not require prompt 
treatment and are rather observed. In contrast, type II endole-
aks occurring later than 1 year require often treatment since 
they are associated with aneurysm enlargement. 
Interventional vascular radiology offers various methods to 
halt blood flow of the type II feeder vessels.
Type III endoleak (Fig. 19.5) is rare and related to struc-
tural failure of the device. Endograft factures have been 
described in earlier generations of devices. Disconnection 
between the aortic body component and the uniiliac contra-
lateral limb is the most common cause of a type III endoleak 
[28]. CTA may detect the endograft fracture site resulting 
into a direct contrast influx in the aneurysm sac [5, 29]. 




Typ II Typ III Typ IV Typ V
Fig. 19.3 Schematic drawing of the five types of endoleaks after aortic stent-graft placement
Key Point
• Every radiology pre-procedural imaging report has 
to address specific anatomical and morphological 
parameters allowing to accurately select the right 
EVAR device, to anticipate procedural challenges, 
and to plan for ancillary procedures during or after 
EVAR.





Fig. 19.4 Demonstration of type Ia and IIa endoleak in a patient 
30 days post EVAR. (a) Volume-rendered image demonstrates contrast 
leaking along the proximal endograft fixation site (arrows) tracking into 
the aneurysm sac (aneurysm wall calcifications indicated by arrow-
heads). (b) Axial image at the uppermost proximal end of the endograft 
depicts contrast flowing outside the endograft lumen due to incomplete 
seal of the endograft device within the infrarenal neck. (c) Volume- 
rendered image visualizes deformed stent-struts forming a channel for 
contrast and blood causing a type Ia endoleak (arrows). (d) Coronal 
reformatted image reveals the contrast column flowing outside and (e) 
around the endograft device within the aneurysm sac. (f) Axial thin slab 
MIP image demonstrates the communication of the type I endoleak 
with a type II endoleak fed by lumbar arteries
a b c d
Fig. 19.5 Demonstration of type III endoleak in the first post-EVAR 
control. (a) Volume-rendered image demonstrates contrast leaking into 
the aneurysm sac (aneurysm wall calcifications indicated by arrow-
heads) at approx. Mid level of the endograft device. (b) Corresponding 
volume-rendered image reveals a stent-graft fracture at the proximal 
limb of the left uniiliac endograft limb (arrows). (c) Curved planar 
reformatted image shows active contrast extravasation at the level of the 
structural failure (arrows) flowing into the aneurysmal sac. (d) Volume- 
rendered image demonstrates result of immediate repair with placement 
of aorto-uniiliac endograft to seal the leak. Contralateral endograft limb 
is occluded; femoro-femoral bypass (arrows) provides blood 
flow to the pelvis and leg
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cuffs/stents. Since type III endoleaks may easily occur sev-
eral years post EVAR, continuous surveillance is of para-
mount importance.
Type IV endoleak has never been seen with newer- 
generation devices. It is related to a transient graft fabric 
porosity, where contrast penetrating the fabric component 
can be seen as a blush with intra-arterial contrast injection. 
Type IV endoleak is typically of no clinical significance and 
rarely to never seen with CTA [30].
Type V endoleak, also called endotension, represents the 
group of growing aneurysms without any identifiable 
endoleak [31]. Endotension theories include systemic pres-
sure transmittance across the graft to the aneurysm sac, pres-
ent but not detectable type I–IV endoleaks, slow-grade 
infection, and difference in osmotic pressures among com-
partments [32]. Type V endoleaks normally occur later after 
EVAR, and surgical repair becomes necessary if aneurysm 
size becomes critical.
Other complications post EVAR include early complica-
tions at the vascular access site (thrombosis, dissection, 
pseudoaneurysm or AV fistula formation, infection), embolic 
mesenteric or renal disease related to migrated thrombotic 
material from the aneurysm sac, renal insufficiency, and 
endograft infection [33]. Endograft migration may occur 
several years after stent-graft placement (Fig. 19.6) [34].
Lifelong surveillance and meticulous attention to any pos-
sible endograft dysfunction are the goals to prevent the cata-
strophic event of a delayed rupture of EVAR.  Mehta et  al. 
a b c
d
Fig. 19.6 Demonstration of slow endograft migration over a period of 
6 years. (a) Abdominal ap plain film immediately post EVAR demon-
strates endograft device in appropriate location with the proximal 
device end at the level of L1 lumbar inferior endplate. (b) Abdominal ap 
plain film demonstrates gradually inferior migration (arrows) of the 
endograft device. (c) Corresponding lateral views demonstrate signifi-
cant inferior migration (arrow) of the endograft device. (d) Coronal 
multiplanar reformatted images confirm inferior migration of the proxi-
mal endograft device initially located at the orifice of the renal 
arteries (arrows)
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reported an incidence of delayed rupture after EVAR at 1.5% 
occurring at mean 29 months. The majority of patients had a 
type I endoleak (74%), and endograft migration was present in 
90% of patients [35]. Important to note is that patients with 
delayed ruptures may not show increasing aneurysm size on 
surveillance imaging. In case of rupture, unlike in native AAA 
rupture, the patients mostly remained hemodynamically stable 
and were able to undergo imaging. Emergent CTA imaging 
has to determine the underlying cause of rupture and to guide 
subsequent open surgical or endovascular repair.
19.4  Concluding Remarks
CT angiography is the most valuable modality for pre- and 
post-imaging of aortic endovascular interventions. 
Assessment of the proximal and distal landing zones with 
meticulous attention to details of the branching vessels, aortic 
geometry, atheromatous plaques, and suitable access vessels 
are of utmost importance in the planning scan. Detection of 
potential endoleaks, aneurysm sack volume increase, stent-
graft migration, infection, and false aneurysm in the access 
vessel are the main focus of post-intervention surveillance.
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Take-Home Messages
• Aortic aneurysmal disease of the thoracic and 
abdominal aorta is a potentially life-threatening dis-
ease and requires besides preventive measures early 
detection of the disease and patient-tailored inter-
ventional treatment.
• Endovascular aneurysmal repair (EVAR) surpassed 
the method of open surgical repair since approxi-
mately a decade and became the method of choice 
to treat thoracic and abdominal aortic aneurysmal 
disease.
• Pre-procedural imaging reports have to address spe-
cific anatomical and morphological parameters in 
order to accurately select the right EVAR device, to 
anticipate procedural challenges, and to plan for 
ancillary procedures during or after intervention.
Key Point
• Reliable detection of potential endoleaks, aneurysm 
sack volume increase, stent-graft migration, infec-
tion, and false aneurysm in the access vessel has to 
be assured for post-interventional surveillance of 
EVAR.
• In general, four anatomical areas have to be 
assessed: (a) proximal fixation site, (b) aneurysm 
morphology, (c) distal fixation site, and (d) access 
vessel evaluation.
• Post-interventional surveillance is of paramount 
importance in order to detect potential life-threaten-
ing early and late complications, such as stent-graft 
migration, endoleaks, aneurysm sack volume 
increase, delayed aortic rupture, or endograft 
infection.
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Noninvasive Angiography of Peripheral 
Arteries
Tim Leiner and James C. Carr
Technical advances over the past decade have facilitated fast 
and robust noninvasive imaging of the peripheral vascular 
tree in routine clinical practice for the entire spectrum of 
peripheral arterial disease (PAD). Both magnetic resonance 
angiography (MRA) and computed tomography angiogra-
phy (CTA) are highly accurate methods that enable high- 
fidelity depiction of arterial anatomy, atherosclerotic plaque, 
and narrowing of the peripheral vasculature from the aorta 
down to the feet. In addition, due to their ability to depict 
extra-arterial anatomy of the entire lower extremity, both 
methods are well suited for the detection of non- 
atherosclerotic peripheral arterial disease.
Below, we first detail the clinical context and technical 
background of both MRA and CTA since high-quality 
peripheral vascular imaging demands careful attention to 
proper patient positioning and acquisition. We include sug-
gestions for imaging protocols for both modalities. 
Subsequently, we discuss the most common clinical applica-
tions of both MRA and CTA. We conclude with a short dis-
cussion of the clinical efficacy of both methods.
20.1  Epidemiology and Different 
Manifestations of Peripheral Arterial 
Disease
Peripheral arterial disease refers to conditions affecting 
blood flow to the lower extremities due to obstruction of 
some part of the arterial system from the infrarenal aorta or 
further distally. Total disease prevalence based on objective 
testing has been evaluated in several epidemiologic studies 
and is in the range of 3–10%, increasing to 15–20% in per-
sons over 70 years [1].
Although atherosclerosis is the underlying cause in the 
vast majority of cases, there are many diseases that can cause 
PAD (see below). It is important to keep in mind that causes 
of arterial obstruction vary primarily as a function of age. 
Identification of the underlying cause necessitates careful 
review of the patients’ history, symptoms, risk factors, and 
other medical conditions. In patients below 45 years of age, 
one should always consider non-atherosclerotic causes of 
PAD such as vasculitis, fibromuscular dysplasia, popliteal 
entrapment, cystic adventitial disease, and other uncommon 
entities, especially if there are little or no risk factors for 
atherosclerosis.
Learning Objectives
• To describe the most commonly used clinical clas-
sification systems for peripheral arterial disease
• To describe the technical principles of both MRA 
and CTA of peripheral arteries
• To learn about the diagnostic accuracy of both 
MRA and CTA for detection of peripheral arterial 
disease
• To name several causes of non-atherosclerotic 
peripheral arterial disease
Key Point
• Peripheral arterial disease is highly prevalent in 
older patients. In patients <45 years old, alternative 
causes should be considered.
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20.2  Clinical Background and Classification 
Systems
There are various classification systems for PAD. Clinically 
the primary distinction is between patients with intermittent 
claudication (IC) and patients with the more severe form of 
PAD, chronic critical ischemia (CCI). The former is usually 
limited to “single-level” disease, i.e., a stenosis or short 
occlusion in the iliac or femoral arteries. IC is a lifestyle lim-
iting disease, and first-line treatment consists of treatment of 
risk factors and supervised exercise therapy [1]. There is a 
relative indication for invasive therapy, and the risk for major 
complications such as amputations is very low. This is 
opposed to patients with CCI, who have high-grade stenoses 
and/or occlusions at multiple levels of the vascular tree. In 
CCI resting perfusion is inadequate to meet basic metabolic 
demand, and patients suffer from rest pain and sometimes 
even tissue loss. Patients with CCI have an absolute indica-
tion for invasive treatment to restore adequate perfusion to 
the tissues subtended by the stenosed or occluded arteries. If 
perfusion is not restored, major complications such as per-
manent loss of function and amputation can result.
The simplest and most commonly used system to classify 
chronic hypoperfusion of the lower extremity is that 
described by Fontaine in 1954, who distinguishes four cate-
gories of PAD (Table 20.1). A more elaborate system with 
six categories is the one described by Rutherford (Table 20.2). 
The distinction between the two systems is primarily based 
on the addition of objective findings such as Doppler signals, 
arterial brachial index (ABI), and pulse volume recordings, 
in addition to anamnestic pain-free walking distance. 
Rutherford also described a system for classification of acute 
limb ischemia (Table 20.3). There are various other clinical 
classification systems, all refinements of the systems by 
Fontaine and Rutherford. Hardman et al. review these addi-
tional PAD classification systems in [2].
20.3  Technical Background of Peripheral 
MRA and Imaging Protocol
Magnetic resonance angiography of the peripheral vascular 
tree (pMRA) is a highly reliable method to identify arterial 
stenoses and obstructions, and several meta-analyses 
reported high sensitivities and specificities for the detection 
of angiographically proven arterial narrowing [3, 4]. 
Currently, two methods are used: contrast-enhanced pMRA 
and non-contrast-enhanced pMRA. Contrast-enhanced tech-
niques are most commonly used although the latter method 
is potentially more attractive because no injection of contrast 
agent is needed.
20.3.1  Contrast-Enhanced Techniques
The typical pMRA imaging protocol consists of imaging of 
three consecutive fields of view (FOV) in rapid succession 
during infusion of a gadolinium-based contrast agent. Imaging 
parameters and spatial resolution are optimized for each FOV 
to balance the required time to complete the acquisition versus 
Table 20.1 The Fontaine classification system for peripheral arterial 
disease as first described in [28]
Grade Symptoms
Stage I Asymptomatic, incomplete blood vessel obstruction
Stage II Mild claudication pain in the limb
Stage IIA Claudication at a distance >200 m
Stage IIB Claudication at a distance <200 m
Stage III Rest pain, mostly in the feet
Stage IV Necrosis and/or gangrene of the limb
Table 20.2 Rutherford classification for chronic limb ischemia [29, 30]
Grade Category Clinical description Objective criteria
0 0 Asymptomatic—no hemodynamically 
significant occlusive disease
Normal treadmill or reactive hyperemia test
1 Mild claudication Completes treadmill exercise; AP after exercise >50 mmHg but at least 
20 mmHg lower than resting value
I 2 Moderate claudication Between categories 1 and 3
3 Severe claudication Cannot complete standard treadmill exercise and AP after exercise <50 mm 
Hg
II 4 Ischemic rest pain Resting AP <40 mm Hg, flat or barely pulsatile ankle or metatarsal PVR; 
TP < 30 mm Hg
III 5 Minor tissue loss—nonhealing ulcer, focal 
gangrene with diffuse pedal ischemia
Resting AP < 60 mm Hg, ankle or metatarsal PVR flat or barely pulsatile; 
TP < 40 mm Hg
6 Major tissue loss—extending above TM 
level, functional foot no longer salvageable
Same as category 5
Key Point
• The Fontaine and Rutherford classifications are 
important clinical tools to communicate the severity 
of peripheral arterial disease.
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the level of detail required to optimize detection of arterial nar-
rowing with high sensitivity and specificity.
The arterial system is imaged with a heavily T1-weighted 
sequence during the first arterial passage of the contrast 
agent. Because the length of the peripheral vascular tree 
exceeds the FOV of the MRI scanner, it takes three to four 
acquisitions to depict the abdominal aorta and the lower 
extremities. In patients with IC a “top-to-bottom” approach 
whereby the acquisition commences in the abdomen fol-
lowed by acquisitions of the upper and lower leg stations 
usually suffices to obtain the necessary information for clin-
ical decision-making. Occasionally, venous enhancement is 
encountered in the lower leg station that may hamper detec-
tion of stenosis in the lower leg arteries. Although this may 
degrade image quality, it almost never leads to a study that 
yields insufficient information for clinical management 
since treatment is primarily focused on the aortoiliac and 
superficial femoral arteries. In patients with CCI, this is usu-
ally supplemented with a dedicated dynamic acquisition 
with a separate contrast agent injection to depict lower leg 
arterial anatomy. High-fidelity depiction of the outflow vas-
culature is essential in patients with CCI because treatment 
options may involve percutaneous transluminal angioplasty 
(PTA) or bypass surgery involving lower leg or pedal 
arteries.
Injection of contrast agent renders the vascular system 
bright, while signal from the background is suppressed due 
to the short repetition time (TR). The vascular tree is typi-
cally displayed using maximum intensity projections (MIP) 
to provide a complete overview of the vascular system at a 
glance. In order to obtain sufficient background suppres-
sion to identify small peripheral arteries, it is essential to 
suppress signal from fat, since this has the lowest T1 of any 
tissue in the body. The most commonly used strategy to 
suppress fat is to use subtraction. This approach requires 
acquisition imaging the peripheral vascular tree without the 
injection of contrast agent with identical imaging parame-
ters [5]. The acquired images are subtracted from the 
images with contrast agent with the aim to suppress signal 
from fat and background tissue (Fig. 20.1a). Advantages of 
this approach are the high vessel-to-background contrast 
and the simplicity (i.e., it can be applied on virtually any 
MRI scanner). Disadvantages are the √2 drop in signal to 
noise and the additional time it takes to acquire the images 
without contrast agent. Also, the resulting subtracted 
images may suffer from misregistration artifacts in case of 
patient motion between the acquisition with and without 
contrast agent of the same anatomical location. To avoid 
false-positive diagnosis of stenosis, contrast-enhanced 
source images always need to be evaluated. A second 
approach to suppress signal from fat is to combine the 
acquisition with Dixon-based water-fat decomposition 
techniques [6]. In contrast to subtraction, there is no need 
to acquire to same anatomy twice. Instead, images are 
acquired with two instead of one echoes for every TR, 
which allows to decompose the signal of protons in water 
and fat in each voxel. Subsequently, images can be recon-
structed in which only the water component is shown and 
the signal from fat is disregarded (Fig. 20.1b).
20.3.2  Non-contrast-Enhanced Techniques
There has been considerable interest in non-contrast or native 
MR angiography in recent years. The excellent review by 
Lim and Koktzoglou [7] will provide the interested reader 
with a technical overview. An in-depth discussion of the dif-
ferent techniques is beyond the scope of this chapter because 
of the wide variety of methods offered by different vendors. 
To date most experience in the peripheral vasculature has 
been obtained with quiescent interval single-shot magnetic 
resonance angiography (QISS). QISS angiography is partic-
ularly useful for imaging the lower extremities because the 
technique allows for large anatomical coverage in short 
imaging times (Fig.  20.2). Also, good results have been 
obtained versus standard of reference techniques [8].
Table 20.3 Rutherford classification for acute limb ischemia




I. Viable Not immediately threatened None None Audible Audible
II. Threatened
  (a) Marginally Salvageable if promptly treated None or minimal (toes) None Inaudible Audible
  (b) Immediately Salvageable with immediate revascularization More than toes, associated 
rest pain
Mild or moderate Inaudible Audible
III. Irreversible Major tissue loss or permanent nerve damage 
inevitable




• In MRA the signal of fat is suppressed using either 
subtraction or Dixon techniques.
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20.4  Technical Background of Peripheral 
CTA and Imaging Protocol
Multi-detector CTA (MDCTA) has revolutionized vascular 
imaging due to its larger volumetric extent of coverage, rapid 
acquisition speeds, and high spatial resolution. Modern 
multi-detector CT scanners have tube rotation speeds as low 
as 0.28 s and slice thickness of 0.33 mm allowing submilli-
meter isotropic imaging, which is comparable to the gold 
standard digital subtraction angiography (DSA). Multi- 
detector CTA produces a larger volume of coverage per 
 gantry rotation permitting rapid acquisitions from the abdo-
men to the toe in a matter of seconds. One advantage of this, 
in addition to patient comfort, is the potential for lowering 
contrast doses; however, contrast timing also becomes more 
critical with these devices due to higher acquisition speeds.
20.4.1  Technical Aspects
Image quality in CT angiography is dependent on both spa-
tial resolution and temporal resolution. Axial in-plane spatial 
resolution within the scan plane is increased by smaller field 
a b
Fig. 20.1 Maximum 
intensity projection (MIP) of 
three-station MRA of the 
peripheral arteries in a 
67-year-old female. Image on 
the left (a) is obtained using 
subtraction. Image on the 




• Non-contrast MRA refers to a variety of different 
MRA techniques.
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of view, larger matrix size, and smaller focal spot. Through 
plane z-axis resolution is improved by having a greater num-
ber of smaller detectors. High isotropic spatial resolution 
with modern MDCTA has regular square-shaped voxels of 
0.3–0.4 mm or less, allowing full reconstruction of the entire 
3D dataset in any arbitrary orientation, making this tech-
nique arguably more powerful than DSA [9]. Noise, caused 
by random fluctuations in radiation exposure, is another 
important factor affecting image quality in MDCTA, reduc-
ing overall image contrast, and can be remedied by increas-
ing tube current/voltage or increasing voxel size. Finally, 
image contrast which is the difference in intensity between 
a b
Fig. 20.2 Maximum 
intensity projection (MIP) 
images of non-contrast MRA 
(a) and corresponding 
contrast-enhanced MRA (b) 
in a 66-year-old male with 
intermittent claudication. The 
number and severity of 
arterial stenoses correspond 
well between the two 
methods. Image courtesy of 
Robert R. Edelman, MD, 
Department of Radiology, 
North Shore Hospital, 
Evanston, IL
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one tissue and another can be improved by lower kVp but is 
also amplified in MDCTA by use of an iodinated contrast 
agent.
20.4.2  Scanner Design
Modern CT scanners have a wide array of detectors, with as 
many as 500–600  in a single row, which absorb the X-ray 
exposure from the X-ray tube during a single rotation. This 
allows greater anatomic coverage at high spatial resolution. 
This is combined with spiral CT mode, where the table and 
patient are moved steadily through the scanner gantry, as the 
tube is rotated around the patient. The relationship between 
patient and gantry motion is referred to as pitch, which is 
defined as table movement (mm) per tube rotation divided by 
collimator width (mm). A higher pitch, which is frequently 
used with CTA of the peripheral arteries, results in lower 
z-axis resolution but faster coverage and lower radiation 
exposure. Dual source CT technology consists of two X-ray 
tubes orientated at right angles to each other and two corre-
sponding sets of detectors. This design improves temporal 
resolution and overall image quality. Dual-energy CT is when 
each of the two X-ray tubes on the dual source CT scanner 
emits X-rays at different energy levels and is detected by the 
corresponding detector array. The unique absorptive spectra 
allow discrimination of different tissues. In peripheral CTA, 
this may have a role in improved characterization of pathol-
ogy in the vessel wall. Other manufacturers offer alternative 
scanner designs with rapid kV switching or dual- layer detec-
tor technology. Apart from the increased temporal resolution, 
the improved capability to discriminate tissues is similar.
20.4.3  Radiation Dose
CT is responsible for a significant share of overall radiation 
dosage to the patient population in medical imaging and 
MDCTA of the peripheral vasculature, with its extensive 
anatomic coverage, may result in higher than normal radia-
tion exposure [10]. Radiation dose is dependent on tube cur-
rent (mAs) and tube voltage (kV). Increasing mAs may 
improve image quality by increasing contrast to noise and 
lowering overall noise; however, radiation dose doubles with 
a doubling of mAs. Lower kV results in lower radiation 
exposure, but higher kV may be required to attain adequate 
penetration of the X-ray beam in larger patients. Adaptive 
scanning, whereby tube current is either reduced or switched 
off during rotations over sensitive body parts, such as the 
breast, can result in significant decreases in radiation dose. It 
has also been shown that peripheral CTA at tube currents as 
low as low as 50  mAs results in decreased radiation dose 
without a compromise in diagnostic efficacy [11].
20.4.4  Contrast Administration
With the more rapid acquisition speeds of MDCTA, contrast 
administration becomes challenging, and timing takes on 
added importance [12, 13]. High-quality CTA typically 
necessitates contrast densities of greater than 200 HU in 
vessels of interest. There are several factors affecting con-
trast enhancement and time to peak following contrast 
administration including iodine content [14], injection rate, 
and patient’s cardiac status. In general, higher injection 
rates will produce a higher peak of enhancement with a 
tighter bolus; injection rates of 4–5 mL/s are typical with 
CTA. Similarly, higher iodine content contrast medium will 
produce a greater enhancement peak, although when 
adjusted for iodine delivery rate differences are minimized. 
One disadvantage of modern scanners is that the scanner 
may “overshoot” the contrast bolus so that for peripheral 
CTA it may be necessary to slow down the acquisition by 
slowing the table speed [15].
Accurate contrast timing is typically achieved with either 
bolus tracking or test bolus techniques. With bolus tracking, 
scan acquisition is triggered when contrast density reaches a 
predefined threshold (e.g., 150 HU in abdominal aorta for 
peripheral CTA), as defined by operator (Fig. 20.3). The test 
bolus technique involves injecting a small dose of contrast 
(e.g., 20–30  mL) first to accurately measure the contrast 
transit time beforehand.
20.4.5  Lower Extremity CTA Technique
A scout view is typically carried out initially. A pre-contrast 
scan from the upper abdomen to the feet is optional and may 
be desirable in patients who may have extensive calcifica-
tions (e.g., diabetics, dialysis-dependent chronic renal fail-
ure) or those with metal in soft tissues (e.g., prior surgery, 
trauma with metallic foreign body) [16]. Bolus tracking is 
usually used for contrast timing in CTA of lower extremities. 
A region of interest (ROI) is placed in the abdominal aorta at 
the level of the celiac origin, and the scan acquisition is trig-
gered when the density within the vascular lumen reaches 
more than 150 HU. Contrast agent is injected at 5 mL/s via a 
large bore (i.e., 18G) intravenous cannula. Images are 
acquired in a cranial to caudal direction with slice thickness 
of 1 mm or less and collimator thickness of 0.4–0.6 mm.
Typically, a slower scan time is preferable for lower 
extremity CTA so as not to overshoot the contrast bolus. 
Table pitch of 1.1, gantry rotation of 0.37 s, table increment 
of 21.1 mm/360° rotation, and table speed of 63 mm/s will 
have a scan time of 23 s; a fast contrast injection is preferred. 
If there is suspected severe disease with slow flow, then a 
slower contrast injection bolus and longer scan time may be 
preferred. This can be achieved by reducing the table speed 
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through the scanner, i.e., the pitch, and by slowing the gantry 
rotation time.
Dual-energy MDCTA may have advantages at separating 
calcium from contrast in the vessel lumen. Subtraction of 
both datasets will produce a contrast only luminal image. 
Additionally, the calculation of a “virtual” non-contrast data-
set will avoid the need for a separate acquisition and may 
reduce overall radiation exposure. Dual-energy MDCTA has 
shown high sensitivity for detecting stenosis compared to the 
gold standard DSA [17].
Dynamic CT, whereby multiphase CT acquisitions are 
acquired to follow contrast filling and drainage in a time- 
resolved manner, may have benefits for evaluating the infra- 
popliteal vessels, particularly in patients with slow or 
asymmetric flow. Dynamic CTA has been shown to have 
higher contrast and diagnostic confidence compared to con-
ventional CTA [18]. Limitations of this technique include 
higher radiation dose and increased volumes of contrast.
20.4.6  Image Processing
With fully isotropic submillimeter spatial resolution, it is 
possible to reconstruct the acquired CTA 3D dataset in any 
anatomic orientation. The 3D data is reconstructed with mul-
tiplanar reformatted (MPR), maximum intensity projection 
(MIP) and volume rendered (VR) algorithms (Fig.  20.4). 
Basic axial, coronal, and sagittal MPR images are recon-
Key Point
• In CTA of the peripheral arteries, images are 
acquired during continuous infusion of contrast 
agent. Acquisition is initiated by bolus tracking 
software. The exact CTA protocol for imaging the 
peripheral arteries depends on the hardware used.
a b c
Fig. 20.3 Scout image of the abdomen and lower extremities is used 
for planning the CT scan (a). Source CT images from CTA study of the 
abdomen, pelvis, and lower extremities following intravenous injection 
of iodinated contrast (b). Bolus tracking technique where region of 
interest placed in abdominal aorta detects contrast arrival; scan is auto-
matically triggered when density rises above a predefined threshold (c)
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structed automatically at the scanner immediately following 
the CT acquisition. Image data is then transferred to dedi-
cated post-processing software where specific MIP and VR 
images are created. Curved MPR images of the vessel may 
be useful to accurately quantify the degree of stenosis and 
interrogate the vessel wall (Fig. 20.5).
a bFig. 20.4 Coronal MIP images with positive (a) and 
negative (b) contrast from a 
patient with significant 
infra-popliteal peripheral 
vascular disease. Note 
incomplete bone removal in 
the pelvis, which is a 
limitation of automatic image 
post processing. In this case 
bone needed to be manually 
edited away
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20.4.7  Diagnostic Accuracy
The diagnostic accuracy of CTA for detection and grading of 
peripheral arterial disease is high and similar to that of 
MRA. Several meta-analyses have been performed, and all 
of these report uniformly high values for sensitivity, specific-
ity, and accuracy in patients with intermittent claudication 
[19–21]. There is a relative lack of data on the diagnostic 
accuracy of CTA in patients with CCI.
20.5  Clinical Applications
20.5.1  Atherosclerotic Peripheral Arterial 
Disease
In patients with suspected or known PAD, it is essential to 
determine and describe the exact location of arterial and 
extent of arterial lesions. Almost invariably, PAD affects the 
aorta and iliac and lower extremity arteries. In patients with 
Fig. 20.5 Curved MPR 
displays the vessel along its 
entire length and allows 
accurate measure of stenosis 
and depiction of vessel wall, 
if needed
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diabetes mellitus, PAD typically presents with lower leg 
arterial involvement, while the proximal arteries are rela-
tively spared. Apart from the aortic arch branch vessel ori-
gins, the upper extremity is almost never affected. The degree 
of stenosis is usually described as more or less than 50% 
luminal narrowing, and occlusions need to be mentioned 
separately. There is no consensus on how stenosis should be 
measured (i.e., percentage reduction of luminal diameter or 
percentage reduction in cross-sectional area); therefore, most 
observers use visual analysis to estimate the former. Both 
methods are highly accurate if images of good quality are 
available. Regardless of which method is used, sensitivity, 
specificity, and accuracy for detection of angiographically 
proven stenosis are generally in the range of 90–100% [3, 4, 
19–21] with MRA and CTA.
In patients with known stents or metal implants, image 
quality may be degraded with both MRA and CTA.  For 
pMRA examinations are especially important that the 
requesting physicians note this on the study request in order 
to avoid false impression of stenosis. An example of stent 
artifacts is shown in Fig. 20.6.
20.5.2  Aneurysmal Disease
Aneurysm is defined as a focal enlargement of an artery to 
more than 1.5  times its normal diameter. For the aorta the 
general cutoff value that warrants follow-up is 3.0 cm and for 
the iliac arteries 1.8 cm. Measurements of aneurysms should 
always be performed perpendicular to the center lumen line 
and should include any mural thrombus as well as the arterial 
wall (Fig. 20.7). True aneurysms involve the intima, media, 
and adventitial layers of the vessel. Aneurysm is categorized 
as false when fewer than three layers are involved.
20.5.3  Non-atherosclerotic Peripheral Arterial 
Occlusive Disease
Although atherosclerosis is by far the most common cause of 
PAD, there are other causes as well. Any disease process that 
leads to narrowing or occlusion of peripheral arteries may lead 
to the typical history and complaints of IC or CCI.  Non- 
atherosclerotic causes of PAD should be considered in young 
patients or patients without typical risk factors. Depending on 
the underlying disease process, involvement of specific ana-
tomic sites or characteristic angiographic findings may be seen.
20.5.3.1  Vasculitis
Vasculitis refers to the process of acute or chronic inflamma-
tory changes of small, medium, or large arteries as well as 
veins. In addition to signs of vascular narrowing or occlusion, 
patients typically present with systemic signs such as fever, 
Key Point
• Both MRA and CTA have high diagnostic accuracy 
for detection of location and extent of atheroscle-
rotic narrowing.
Fig. 20.6 There is signal loss in the right common iliac artery due to 
the presence of a stainless steel stent (arrow). Artifacts can be recog-
nized by abrupt caliber change of arterial lumen. In this patient it is not 
possible to assess the degree of stenosis with certainty due to the signal 
loss
Key Point
• Both MRA and CTA can help identify non- 
atherosclerotic causes of peripheral arterial disease. 
These modalities are the technique of choice in 
patients with incongruencies between symptoms 
and risk factors for atherosclerotic peripheral arte-
rial disease.
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malaise, weight loss, and abnormal laboratory tests such high 
erythrocyte sedimentation rate (ESR), C-reactive protein 
(CRP), as well as leukocytosis with granulocytosis, thrombo-
cytosis, and normochromic/normocytic anemia. The latter 
reflect the acute phase response. It is important to understand 
that there are no universally accepted diagnostic criteria for 
large-vessel vasculitides, including giant cell arteritis and 
Takayasu arteritis. More information about the diagnostic 
aspects can be found in the excellent review by Keser and 
Aksu [22]. Both CTA and MRA can suggest the diagnosis of 
vasculitis, but nowadays whole-body PET imaging is often 
used in the diagnostic workup. There is a large list of inflam-
matory arteriopathies that may lead to symptoms of 
PAD. Below, we discuss the commonly encountered diseases.
20.5.3.2  Takayasu Arteritis
Takayasu arteritis (TA) is a large vessel vasculitis that 




Fig. 20.7 Partial volume maximum intensity projection of bilateral 
common iliac artery aneurysms in a 68-year-old male (a). Diameter 
measurements of aneurysms should always be performed perpendicular 
to the center lumen line to avoid over- or underestimation of aneurysm 
diameters (b)
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upper extremities. Occasionally, the iliac arteries are 
involved. The disease mainly affects younger women and 
can go unrecognized for a prolonged period due to its rel-
atively low prevalence. Besides the typical history of 
vague, non-specific complaints, TA is characterized by a 
specific morphological pattern of arterial narrowing; ste-
noses typically have an elongated “hourglass” aspect 
(Fig.  20.8). This is in contrast to the more serrated and 
Fig. 20.8 Coronal (a) and 
sagittal (b) maximum intensity 
projections of thoracic MR 
angiogram show typical smooth 
elongated “hour-glass” 
narrowing of the descending 
thoracic aorta in a 22-year-old 
female patient with Takayasu 
disease. PET scanning confirmed 
active disease in the narrowed 
segment (c and d)
a b
c d
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a b c
Fig. 20.9 MR angiogram of a 29-year-old male patient with symptoms 
of critical ischemia in the left lower leg. The patient was a heavy 
smoker. Left panel (a) shows maximum intensity projection with 
impression of distal lower leg arterial occlusion and moderate to severe 
venous enhancement. Source images (b) show multiple thrombi in pos-
terior tibial artery (arrows). Transverse multiplanar reconstructions at 
two different levels (c) show arterial thombi in posterior tibial and fibu-
lar arteries (arrows). Image courtesy of Roland Bezooijen, MD PhD, 
Medisch Spectrum Twente, Enschede, The Netherlands
abrupt appearance of atherosclerotic stenoses. Both MRA 
and CTA are excellent diagnostic tools for diagnosis of 
TA [23].
20.5.3.3  Thromboangiitis Obliterans
Thromboangiitis obliterans (TAO) is an uncommon segmen-
tal inflammatory arteriopathy that affects medium- and 
small-sized arteries, veins, and nerves of the arms and legs. 
The typical clinical scenario is that of a young male heavy 
smoker [24]. The main differential diagnosis in case of distal 
lower extremity involvement is atherosclerotic PAD in dia-
betes mellitus. However, the presence of diabetes rules out 
the diagnosis of TAO. Angiographically, TAO is character-
ized by short segmental occlusions of arteries or veins by 
inflammatory thrombi. Often, these occlusions are bridged 
by corkscrew collaterals. This is known as Martorell’s sign 
(Fig. 20.9).
20.5.3.4  Fibromuscular Dysplasia
Fibromuscular dysplasia (FMD) is a noninflammatory 
arteriopathy that usually affects the medium-sized arteries 
such as the renal, carotid, and iliac arteries in young 
Caucasian women. Several subtypes are distinguished 
[25]. The characteristic angiographic appearance is the so-
called string of beads which refers to the presence of mul-
tiple stenoses interspersed with aneurysmal dilatations 
(Fig. 20.10). Fig. 20.10 A 37-year-old female patient with bilateral intermittent 
claudication. In both external iliac arteries, typical “string-of-beads” 
arterial narrowing can be seen (arrows). This finding is highly sugges-
tive of fibromuscular dysplasia
20 Noninvasive Angiography of Peripheral Arteries
236
20.5.3.5  Popliteal Entrapment
Popliteal artery entrapment refers to abnormalities of the 
popliteal fossa anatomy, whereby the popliteal artery is dis-
placed medially by the medial head of the gastrocnemius 
muscle or when it courses anterior to the popliteus muscle 
[26]. The popliteal artery can be dynamically compressed 
when the gastrocnemius muscle is actively used. There are 
four types of popliteal entrapment that may be encountered. 
Types I–III refer to various degrees of medial displacement 
by the medial head of the gastrocnemius muscle, and in 
type IV, both the popliteal artery and vein course anterior to 
the popliteus muscle. Because the diagnosis of popliteal 
entrapment relies on precise anatomical knowledge of the 
popliteal fossa, it is necessary to supplement the MR angi-
ography acquisition with high spatial resolution T2-TSE 
anatomical images of the popliteal fossa to visualize the 
relationship between the muscles and the vascular struc-
tures (Fig. 20.11).
20.5.3.6  Cystic Adventitial Disease
Another non-atherosclerotic cause of PAD is cystic adventi-
tial disease (CAD). In CAD, a mucoid cyst develops in the 
arterial wall which can lead to compression of the lumen and 
symptoms of PAD. The disease leads to smooth arterial nar-
rowing of the affected artery. The cyst can easily be diag-
nosed by ultrasonography, CT, or MRI (Fig. 20.12), although 
MRI is the technique of choice in case of suspected CAD due 
to its ability to definitively identify the mucoid cystic source 
of the arterial narrowing. Although infrequently encoun-
tered, treatment consists of simple percutaneous aspiration 
of the mucoid material which results in immediate relief of 
symptoms [27].
a b
Fig. 20.11 A 39-year-old male patient with complaints of intermittent 
claudication of the right leg. MR angiogram in neutral position shows 
normal caliber of popliteal artery on both sides. Supplemental T2-TSE 
images in neutral position (left) and during plantar flexion (right) show 
dynamic compression of right popliteal artery (arrows) due to crowding 
of the right popliteal fossa. Note patent left popliteal artery at rest and 
during plantar flexion
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Take-Home Messages
• MRA and CTA are highly reliable modalities to 
noninvasively depict the entire peripheral vascular 
tree.
• Knowledge about the technical background of both 
MRA and CTA is helpful to obtain the best possible 
results with each modality.
• MRA and CTA accurately depict the location and 
severity of atherosclerotic arterial obstruction.
• Noninvasive imaging of the peripheral arteries can 
help elucidate the cause of symptoms in symptom-
atic patients with low likelihood of atherosclerotic 
peripheral arterial disease.
Fig. 20.12 A 41-year-old male patient with intermittent claudication 
of the right leg. MR angiogram shows smooth luminal narrowing of the 
right popliteal artery. The age of the patient in combination with the 
aspect of the stenosis is highly suggestive for non-atherosclerotic 
peripheral arterial disease. Presence of arterial wall cyst is confirmed on 
fat-suppressed T2-weighted images (arrows)
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